{
  "meta": {
    "title": "72_Mission_Neet_Pg-Inicet_Grand_Test-28_-_07-08-2025",
    "url": "https://brainandscalpel.vercel.app/72-mission-neet-pg-inicet-grand-test-28-07-08-2025-46ed0e5b.html",
    "scrapedAt": "2025-11-29T17:24:13.068Z"
  },
  "questions": [
    {
      "id": 89366,
      "choices": [
        {
          "id": 355864,
          "text": "<p><span style=\"font-size:14.0pt;\">Outer mitochondrial membrane</span></p>"
        },
        {
          "id": 355865,
          "text": "<p><span style=\"font-size:14.0pt;\">Myelin sheath</span></p>"
        },
        {
          "id": 355866,
          "text": "<p><span style=\"font-size:14.0pt;\">Inner mitochondrial membrane</span></p>"
        },
        {
          "id": 355867,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasma membrane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which one of the following membranes has the highest content of protein per gram of tissue?&nbsp;</span></p>",
      "unique_key": "Q6683449",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inner mitochondrial membrane</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The inner mitochondrial membrane has the highest content of proteins per gram of tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This membrane is packed with proteins because it contains the electron transport chain and ATP synthase complexes, which are essential for cellular respiration and energy production.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These proteins are critical for oxidative phosphorylation, the process that generates ATP, the cell's energy currency. The high demand for energy in cells explains the abundance of protein in this membrane.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Outer mitochondrial membrane:</strong> The outer mitochondrial membrane has a balanced lipid-to-protein ratio of 1:1, meaning it does not have as high a concentration of proteins as the inner mitochondrial membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Myelin sheath:</strong> The myelin sheath is rich in lipids rather than proteins. It primarily serves as insulation for nerve fibers, facilitating rapid transmission of electrical impulses. Therefore, the lipid content is much higher than the protein content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Plasma membrane:</strong> The plasma membrane, like the outer mitochondrial membrane, has a lipid-to-protein ratio of about 1:1. It functions as a selective barrier around the cell, with proteins embedded within it, but it does not have as high a protein concentration as the inner mitochondrial membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>inner mitochondrial membrane</strong> has the highest protein content among the listed membranes, reflecting its crucial role in energy production and cellular respiration.</span></p>",
      "correct_choice_id": 355866,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89366/PHYSIOLOGY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89366/PHYSIOLOGY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89373,
      "choices": [
        {
          "id": 355892,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased hydrogen secretion via α-intercalated cells</span></p>"
        },
        {
          "id": 355893,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased bicarbonate reabsorption in the proximal tubule</span></p>"
        },
        {
          "id": 355894,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired renal ammoniagenesis leading to inadequate acid excretion</span></p>"
        },
        {
          "id": 355895,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive loss of H⁺ via β-intercalated cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with a history of chronic obstructive pulmonary disease (COPD) presents with confusion, lethargy, and asterixis. Arterial blood gas shows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">pH: 7.32</span></li><li><span style=\"font-size:14.0pt;\">pCO₂: 60 mmHg</span></li><li><span style=\"font-size:14.0pt;\">HCO₃⁻: 31 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lab values show:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Na⁺: 138 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">K⁺: 5.6 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">Cl⁻: 96 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Urine pH is 6.8, and ammonium excretion is low. Which of the following best explains the renal action responsible in this patient?</span></p>",
      "unique_key": "Q9821478",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Impaired renal ammoniagenesis leading to inadequate acid excretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a case of <strong>chronic respiratory acidosis with partial metabolic compensation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>renal compensation</strong> involves increased <strong>ammoniagenesis</strong>, <strong>H⁺ secretion</strong>, and <strong>bicarbonate reabsorption</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, in <strong>advanced COPD</strong>, <strong>chronic hypoxia</strong> and <strong>renal dysfunction</strong> impair <strong>ammonia production</strong>, which is essential for excreting H⁺ as NH₄⁺.</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>incomplete compensation</strong>, persistent acidemia, and features like <strong>hyperkalemia</strong> and <strong>high urine pH</strong> (suggesting poor acid excretion).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased hydrogen secretion</strong> <strong>via α-intercalated cells:</strong> Should occur in compensation, but <strong>urine pH is high</strong>, indicating it’s not effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased bicarbonate reabsorption</strong> <strong>in the proximal tubule:</strong> Already elevated (HCO₃⁻ = 31), but <strong>not sufficient alone</strong> without ammoniagenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Excessive loss of H⁺ via β-intercalated cells:</strong> <strong>β-intercalated cells secrete bicarbonate</strong>, not H⁺—this would worsen acidosis, not help.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In chronic respiratory acidosis, <strong>renal ammoniagenesis</strong> is key to acid excretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Failure of this mechanism</strong> (e.g., in hypoxic states or CKD) leads to <strong>inadequate compensation</strong> despite elevated bicarbonate.</span></li></ul>",
      "correct_choice_id": 355894,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89373/PHYSIOLOGY_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89373/PHYSIOLOGY_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89416,
      "choices": [
        {
          "id": 356060,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastroduodenostomy</span></p>"
        },
        {
          "id": 356061,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodeno-duodenostomy</span></p>"
        },
        {
          "id": 356062,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastrojejunostomy</span></p>"
        },
        {
          "id": 356063,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenojejunostomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the treatment in the neonate having bilious vomiting, showing the below abdominal x-ray.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6XLF1gH.png\" width=\"337\" height=\"276\"></strong></span></p>",
      "unique_key": "Q4621374",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Duodeno-duodenostomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Duodeno-duodenostomy is the surgical treatment of choice for <strong>duodenal atresia</strong>, a congenital condition in which the duodenum fails to recanalize during development.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The procedure involves creating an anastomosis between the two segments of the duodenum to bypass the atresia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach restores intestinal continuity while preserving normal gastric emptying and physiology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gastroduodenostomy:</strong> Gastroduodenostomy is not suitable for duodenal atresia as it does not address the atresia site in the duodenum. This procedure is typically used in other conditions like gastric outlet obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gastrojejunostomy:</strong> Gastrojejunostomy bypasses the duodenum entirely and is used for distal gastric or duodenal obstructions that cannot be repaired directly. It is not indicated for congenital duodenal atresia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Duodenojejunostomy:</strong> While duodenojejunostomy can also bypass the obstruction, it is not the preferred approach for duodenal atresia. Duodeno-duodenostomy is simpler, more physiological, and maintains continuity of the proximal small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The \"double bubble\" sign on abdominal X-ray is pathognomonic for <strong>duodenal atresia</strong>, a congenital condition requiring surgical correction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Duodeno-duodenostomy</strong> is the treatment of choice, creating a direct anastomosis to bypass the atretic segment and restore intestinal continuity.</span></li><li><span style=\"font-size:14.0pt;\">Early surgical intervention is critical for preventing complications such as malnutrition and aspiration.</span></li></ul>",
      "correct_choice_id": 356061,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89416/SURGERY_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89416/SURGERY_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89073,
      "choices": [
        {
          "id": 354708,
          "text": "<p><span style=\"font-size:14.0pt;\">Square root of crown-rump length in cms</span></p>"
        },
        {
          "id": 354709,
          "text": "<p><span style=\"font-size:14.0pt;\">Square root of crown-heel length in cms</span></p>"
        },
        {
          "id": 354710,
          "text": "<p><span style=\"font-size:14.0pt;\">Crown-rump length in cms divided by 5</span></p>"
        },
        {
          "id": 354711,
          "text": "<p><span style=\"font-size:14.0pt;\">Crown-heel length in cms divided by 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to Hasse’s rule, which of the following formulas is used to estimate the age of the fetus in months during the first 5 months of pregnancy?</span></p>",
      "unique_key": "Q6903617",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Square root of crown-heel length in cms&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Square root of crown-heel length in cms is used to calculate age during the first 5 months of pregnancy as per Hasse`s rule.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rule of Hasse-</strong> a rough method of calculating approximate age of the fetus by measuring the crown to heel length of the fetus.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>During the first 5 months of pregnancy,&nbsp;</strong></span></li></ul></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Age (months)=&nbsp;</strong>square root of crown-heel length in&nbsp;centimeters</span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">&nbsp;<strong>During the last 5 months,&nbsp;</strong></span></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Age (months)=&nbsp;</strong>crown-heel length in centimeters divided by 5</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hasse’s rule estimates fetal age during the first 5 months of pregnancy by calculating the square root of the crown-heel length in centimeters.</span></p>",
      "correct_choice_id": 354709,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89073/FMT_NEETPG-INICET_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89073/FMT_NEETPG-INICET_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89246,
      "choices": [
        {
          "id": 355388,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 355389,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 355390,
          "text": "<p><span style=\"font-size:14.0pt;\">Pindolol</span></p>"
        },
        {
          "id": 355391,
          "text": "<p><span style=\"font-size:14.0pt;\">Atenolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman with episodic migraine (4 attacks/month) is started on a β-blocker for prophylaxis. Which agent should not be used because of its intrinsic sympathomimetic activity?&nbsp;</span></p>",
      "unique_key": "Q1542713",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\">&nbsp;<strong>Ans. C) Pindolol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pindolol</strong> is a nonselective β-blocker with <strong>intrinsic sympathomimetic activity (ISA)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Its partial agonism at β-receptors blunts the full β-blocking effect needed for migraine prophylaxis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because ISA maintains basal sympathetic tone, pindolol is <strong>less effective</strong> at reducing the vascular and neuronal hyperexcitability thought to trigger migraines, and is therefore <strong>not recommended</strong> for migraine prevention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Propranolol</strong>: Non-selective β-blocker with <strong>no intrinsic sympathomimetic activity (ISA)</strong>; commonly used for migraine prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metoprolol</strong>: β1-selective blocker with <strong>no ISA</strong>; also used for migraine prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Atenolol</strong>: β1-selective blocker without ISA; used in migraine prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For migraine prevention, choose a β-blocker <strong>without</strong> ISA—such as propranolol, metoprolol, or atenolol—and <strong>avoid</strong> agents like pindolol that exhibit intrinsic sympathomimetic activity.</span></p>",
      "correct_choice_id": 355390,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89246/PHARMA_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89246/PHARMA_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89380,
      "choices": [
        {
          "id": 355920,
          "text": "<p><span style=\"font-size:14.0pt;\">Caudate nucleus</span></p>"
        },
        {
          "id": 355921,
          "text": "<p><span style=\"font-size:14.0pt;\">Occipital cortex</span></p>"
        },
        {
          "id": 355922,
          "text": "<p><span style=\"font-size:14.0pt;\">Hippocampus</span></p>"
        },
        {
          "id": 355923,
          "text": "<p><span style=\"font-size:14.0pt;\">Parietal lobe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old woman with OCD undergoes neuroimaging as part of a study. Structural abnormalities are likely to be found in which of the following areas?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5120188",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Caudate nucleus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Obsessive-Compulsive Disorder (OCD) is associated with dysfunction in <strong>cortico-striato-thalamo-cortical (CSTC)</strong> circuits, particularly involving the <strong>orbitofrontal cortex, anterior cingulate cortex, and basal ganglia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Within the basal ganglia, the <strong>caudate nucleus</strong> plays a central role in filtering intrusive thoughts and regulating repetitive behaviors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Abnormalities in this region — including hyperactivity and structural changes — are commonly reported in OCD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Occipital cortex:&nbsp;</strong>This region is mainly involved in <strong>visual processing</strong> and is <strong>not typically implicated</strong> in OCD pathophysiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hippocampus:&nbsp;</strong>While important for <strong>memory and emotional regulation</strong>, the hippocampus is <strong>more commonly affected in mood disorders</strong> (like depression and PTSD) rather than OCD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Parietal lobe:&nbsp;</strong>Responsible for <strong>sensory integration and spatial orientation</strong>, the parietal lobe has <strong>no primary role in OCD’s core symptoms</strong> of obsessions and compulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Structural and functional imaging studies in OCD frequently implicate the <strong>caudate nucleus</strong>, a component of the CSTC loop involved in the pathogenesis of obsessions and compulsions.</span></p>",
      "correct_choice_id": 355920,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89380/Psychiatry_NEET_PG_GT_Question_4_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89380/Psychiatry_NEET_PG_GT_Question_4_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89063,
      "choices": [
        {
          "id": 354672,
          "text": "<p><span style=\"font-size:14.0pt;\">Catheter‐associated urinary tract infection on day 4 of hospitalization</span></p>"
        },
        {
          "id": 354673,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumonia developing on day 3 after admission</span></p>"
        },
        {
          "id": 354674,
          "text": "<p><span style=\"font-size:14.0pt;\">MRSA colonization in a patient new to the hospital with no prior hospitalization</span></p>"
        },
        {
          "id": 354675,
          "text": "<p><span style=\"font-size:14.0pt;\">Central line–associated bloodstream infection on day 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following does not meet the standard criteria for a healthcare‐associated infection (HAI)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8587069",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) MRSA colonization in a patient new to the hospital with no prior hospitalization</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">An HAI is an infection that</span><ul><li><span style=\"font-size:14.0pt;\">Infection contracted at the time of admission&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Was <strong>not</strong> present or incubating on admission,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Manifests ≥48 hours</strong> after admission,</span></li><li><span style=\"font-size:14.0pt;\">Includes infections appearing after discharge but attributable to hospitalization, and</span></li><li><span style=\"font-size:14.0pt;\">Covers occupational infections among healthcare staff (but only for surveillance, not patient HAIs).</span></li><li><span style=\"font-size:14.0pt;\">Symptoms appearing within 3 days after discharge or &lt;30 days for general surgeries or &lt;90 days after prosthetic surgeries (heart valve implants, breast implants, orthopedic implants)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>MRSA colonization</strong> without signs or symptoms is not an infection; it lacks tissue invasion or host response and therefore falls outside HAI definitions.</span></li><li><span style=\"font-size:14.0pt;\">Colonization in a newly admitted patient does not meet the “acquired during care” or “clinically infected” criteria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Catheter‐associated urinary tract infection on day 4 of hospitalization:</strong> Occurrence ≥48 hours after admission in a patient without UTI on arrival meets HAI criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pneumonia developing on day 3 after admission:</strong> Onset ≥48 hours post-admission qualifies as a hospital-acquired pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Central line–associated bloodstream infection on day 5</strong>: Infection occurring ≥48 hours after central line placement is classified as an HAI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Asymptomatic MRSA carriage</strong> in a new admission is <strong>colonization</strong>, not a healthcare-associated infection—HAIs require clinical infection acquired during care.</span></p>",
      "correct_choice_id": 354674,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89063/MICROBIOLOGY_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89063/MICROBIOLOGY_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89808,
      "choices": [
        {
          "id": 357624,
          "text": "<p><span style=\"font-size:14.0pt;\">Malignancy</span></p>"
        },
        {
          "id": 357625,
          "text": "<p><span style=\"font-size:14.0pt;\">Joint destruction</span></p>"
        },
        {
          "id": 357626,
          "text": "<p><span style=\"font-size:14.0pt;\">Life-threatening infection</span></p>"
        },
        {
          "id": 357627,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old woman with a history of ectopic pregnancy presents with vaginal dryness, dry eyes requiring cessation of contact lenses, and increased dental caries despite no prior history. Examination shows reduced saliva pooling and bilateral parotid fullness, with regular menses and no arthralgias or rash. What is she at highest risk of long-term?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9964554",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Malignancy</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s dry eyes, dry mouth, parotid fullness, and dental caries suggest Sjögren’s syndrome, an autoimmune disorder.</span></li><li><span style=\"font-size:14.0pt;\">Sjögren’s increases the risk of non-Hodgkin lymphoma due to chronic inflammation and immune dysregulation.</span></li><li><span style=\"font-size:14.0pt;\">Regular monitoring for lymphoproliferative disorders is essential in these patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Joint destruction:</strong> Is more common in rheumatoid arthritis, not Sjögren’s.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Life-threatening infection:&nbsp;</strong>Infections are a risk but not the primary long-term concern compared to lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulmonary hypertension:</strong> Is associated with systemic sclerosis, not Sjögren’s.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sjögren’s syndrome increases the risk of non-Hodgkin lymphoma due to chronic inflammation.</span></li><li><span style=\"font-size:14.0pt;\">Regular screening is critical for early detection of malignancy.</span></li></ul>",
      "correct_choice_id": 357624,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89808/Medicine_Neet_Pg_Gt_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89808/Medicine_Neet_Pg_Gt_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89343,
      "choices": [
        {
          "id": 355772,
          "text": "<p><span style=\"font-size:14.0pt;\">Suboccipito-bregmatic diameter</span></p>"
        },
        {
          "id": 355773,
          "text": "<p><span style=\"font-size:14.0pt;\">Suboccipito-frontal diameter</span></p>"
        },
        {
          "id": 355774,
          "text": "<p><span style=\"font-size:14.0pt;\">Occipito-frontal diameter</span></p>"
        },
        {
          "id": 355775,
          "text": "<p><span style=\"font-size:14.0pt;\">Occipito-posterior position</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a fetus presenting in vertex presentation with the head in complete flexion attitude, which of the following is the engaging diameter of the fetal skull?</span></p>",
      "unique_key": "Q7162658",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Suboccipito-bregmatic diameter</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>vertex presentation with complete flexion of the fetal head</strong>, the <strong>suboccipito-bregmatic diameter</strong> is the presenting and engaging diameter.</span></li><li><span style=\"font-size:14.0pt;\">This is the <strong>smallest anteroposterior diameter</strong> of the fetal skull, measuring approximately <strong>9.5 cm</strong>, extending from the <strong>suboccipital region</strong> to the <strong>center of the anterior fontanelle (bregma)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Complete flexion</strong> ensures that this smallest diameter passes through the birth canal, facilitating normal vaginal delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Suboccipito-frontal diameter:&nbsp;</strong>Incorrect. This diameter (<strong>10 cm</strong>) engages when the fetal head is in <strong>incomplete flexion</strong> (partial flexion), not in complete flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Occipito-frontal diameter:&nbsp;</strong>Incorrect. The <strong>occipito-frontal diameter</strong> (<strong>11.5 cm</strong>) engages when the head is in <strong>deflexion</strong>, seen in vertex presentations with <strong>no flexion</strong> or <strong>deflexion</strong>, which is less favorable for vaginal delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Occipito-posterior position:&nbsp;</strong>Incorrect. This is a <strong>fetal position</strong>, not a diameter. It describes the orientation of the occiput relative to the maternal pelvis, typically associated with labor difficulties, but it does not refer to the presenting diameter.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a vertex presentation with complete flexion of the fetal head, the suboccipito-bregmatic diameter (9.5 cm) is the presenting and engaging diameter, allowing optimal passage through the birth canal.</span></p>",
      "correct_choice_id": 355772,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89343/OBG_NEET_PG_GT_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89343/OBG_NEET_PG_GT_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89804,
      "choices": [
        {
          "id": 357608,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat thyroid tests after recovery</span></p>"
        },
        {
          "id": 357609,
          "text": "<p><span style=\"font-size:14.0pt;\">Start levothyroxine 25 μg IV daily</span></p>"
        },
        {
          "id": 357610,
          "text": "<p><span style=\"font-size:14.0pt;\">Start levothyroxine 25 μg IV daily and T3 10 μg IV daily</span></p>"
        },
        {
          "id": 357611,
          "text": "<p><span style=\"font-size:14.0pt;\">Start levothyroxine 50 μg oral daily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman with multiple sclerosis, admitted for Staphylococcus aureus pneumonia and bacteremia, develops thyroid function abnormalities 1 week into hospitalization. A chest CT is done and shows multifocal infiltrates. Labs show TSH 1.2 mU/L (normal 0.5-5) and fT4 1.2 (normal 0.8 to 1.9 ng/mL), fT3 0.5 (normal 0.8-2 ng/mL). What is the appropriate management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6533255",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Repeat thyroid tests after recovery</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The chest CT shows multifocal infiltrates consistent with S. aureus pneumonia.</span></li><li><span style=\"font-size:14.0pt;\">Low TSH (0.3 mU/L) and fT4 (0.7 ng/dL) suggest non-thyroidal illness syndrome (NTIS), common in critical illness like sepsis, reflecting an adaptive response.</span></li><li><span style=\"font-size:14.0pt;\">Thyroid hormone replacement is not indicated; repeat testing after recovery is appropriate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start levothyroxine 25 μg IV daily:&nbsp;</strong>Levothyroxine IV is for primary hypothyroidism, not NTIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start levothyroxine 25 μg IV daily and T3 10 μg IV daily:&nbsp;</strong>Combined T4/T3 is unnecessary in NTIS, which is transient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Start levothyroxine 50 μg oral daily:&nbsp;</strong>Oral levothyroxine is inappropriate in critical illness and NTIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NTIS in critical illness presents with low thyroid hormone levels and does not require treatment.</span></li><li><span style=\"font-size:14.0pt;\">Thyroid function should be reassessed after recovery.</span></li></ul>",
      "correct_choice_id": 357608,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89804/MEDICINE_NEET_PG_GT_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89804/MEDICINE_NEET_PG_GT_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89410,
      "choices": [
        {
          "id": 356036,
          "text": "<p><span style=\"font-size:14.0pt;\">It leads to hypokalemic alkalosis</span></p>"
        },
        {
          "id": 356037,
          "text": "<p><span style=\"font-size:14.0pt;\">Olive-shaped palpable mass is best felt when the baby is crying</span></p>"
        },
        {
          "id": 356038,
          "text": "<p><span style=\"font-size:14.0pt;\">Peristalsis from the left to right side of abdomen may be seen on feeding</span></p>"
        },
        {
          "id": 356039,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment involves Ramstead’s pyloromyotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A male child presented with non-bilious vomiting at 4 weeks of age. An X-ray was taken that shows the following. What is false regarding the above condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mV2KSIU.png\" width=\"307\" height=\"350\"></span></p>",
      "unique_key": "Q5743637",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Olive-shaped palpable mass is best felt when the baby is crying</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The scenario and the X ray (showing single bubble sign) suggests <strong>infantile hypertrophic pyloric stenosis (IHPS)</strong>, a common cause of non-bilious projectile vomiting in infants around 3–6 weeks of age.</span></li><li><span style=\"font-size:14.0pt;\">The mass is <strong>best felt during a calm moment or during feeding</strong>, not while the baby is crying.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Crying tenses the abdominal muscles, making palpation difficult.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>test feed</strong> is often used to relax the baby and enhance palpation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It leads to hypokalemic alkalosis: </strong>True<strong>.</strong> Persistent vomiting causes loss of gastric hydrochloric acid, leading to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypochloremic metabolic alkalosis.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Secondary hypokalemia</strong> due to renal compensation and aldosterone-mediated potassium loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Peristalsis from the left to right side of abdomen may be seen on feeding: </strong>True<strong>.</strong> Visible gastric peristalsis is a hallmark sign.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen as waves moving <strong>left to right</strong> across the upper abdomen.</span></li><li><span style=\"font-size:14.0pt;\">Reflects the stomach's effort to push contents past the obstructed pylorus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Treatment involves Ramstedt’s pyloromyotomy: </strong>True<strong>.</strong> This is the <strong>definitive surgical treatment</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves splitting the hypertrophied pyloric muscle to relieve obstruction.</span></li><li><span style=\"font-size:14.0pt;\">Can be done via open or laparoscopic approach.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_j2XbPop.png\" width=\"686\" height=\"356\"></strong></span></p>",
      "correct_choice_id": 356037,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89410/SURGERY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89410/SURGERY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89101,
      "choices": [
        {
          "id": 354820,
          "text": "<p><span style=\"font-size:14.0pt;\">Isocitrate dehydrogenase</span></p>"
        },
        {
          "id": 354821,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactate dehydrogenase</span></p>"
        },
        {
          "id": 354822,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutamate dehydrogenase</span></p>"
        },
        {
          "id": 354823,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyruvate dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man presents with fatigue, nausea, and confusion after a high-protein meal. Labs show elevated serum glutamate and mild hyperammonemia, but liver function is normal. Further testing indicates a mitochondrial enzyme involved in oxidative deamination is overactive. Notably, this enzyme can use both NAD⁺ and NADP⁺ as cofactors. Which of the following enzymes fits this description?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6424989",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Glutamate dehydrogenase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Glutamate dehydrogenase (GDH)</strong> catalyzes the conversion of <strong>glutamate to α-ketoglutarate and ammonia</strong>, crucial for amino acid and nitrogen metabolism.</span></li><li><span style=\"font-size:14.0pt;\">It is unique in using <strong>both NAD⁺ and NADP⁺</strong> as cofactors depending on cellular conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Isocitrate dehydrogenase</strong>: Has separate NAD⁺ and NADP⁺ isoforms, not dual use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lactate dehydrogenase</strong>: Uses only NAD⁺.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pyruvate dehydrogenase</strong>: Uses NAD⁺, not NADP⁺.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glutamate dehydrogenase is a mitochondrial enzyme critical in amino acid catabolism and nitrogen metabolism.</span></li><li><span style=\"font-size:14.0pt;\">It uniquely uses both NAD⁺ and NADP⁺ as cofactors and catalyzes the oxidative deamination of glutamate, contributing to ammonia production.</span></li></ul>",
      "correct_choice_id": 354822,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89101/BIOCHEM_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89101/BIOCHEM_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89016,
      "choices": [
        {
          "id": 354484,
          "text": "<p><span style=\"font-size:14.0pt;\">2 J/kg</span></p>"
        },
        {
          "id": 354485,
          "text": "<p><span style=\"font-size:14.0pt;\">4 J/kg</span></p>"
        },
        {
          "id": 354486,
          "text": "<p><span style=\"font-size:14.0pt;\">10 J/kg</span></p>"
        },
        {
          "id": 354487,
          "text": "<p><span style=\"font-size:14.0pt;\">12 J/kg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the maximum defibrillator shock energy that can be given to a pediatric patient during CPR?</span></p>",
      "unique_key": "Q9207811",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 10 J/kg</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>pediatric cardiac arrest</strong>, the energy levels for <strong>defibrillation</strong> are carefully prescribed to be <strong>both effective</strong> and <strong>safe</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The guidelines typically recommend:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Initial shock</strong>: The <strong>first defibrillation attempt</strong> should be at <strong>2 J/kg</strong>. This initial energy level is chosen to provide <strong>sufficient electrical current</strong> to <strong>depolarize</strong> the <strong>cardiac cells</strong> and <strong>attempt</strong> to <strong>terminate</strong> the <strong>abnormal rhythm</strong> <strong>without</strong> causing <strong>unnecessary cardiac injury</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Second shock</strong>: If the first shock does not result in the return of a normal rhythm, a second shock may be delivered <strong>at 4 J/kg</strong>. The <strong>increase</strong> in <strong>energy</strong> aims to <strong>enhance</strong> the likelihood of <strong>achieving defibrillation</strong> if the lower energy was not successful.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Maximum shock energy</strong>: The maximum recommended energy level for subsequent shocks is usually up to <strong>10 J/kg</strong>. This cap is set to <strong>prevent potential damage</strong> to the <strong>pediatric heart</strong>, which may be <strong>more susceptible</strong> to <strong>injury</strong> from <strong>high-energy shocks</strong>. In some cases, the adult maximum defibrillation dose may be used if it does not exceed the pediatric maximum of 10 J/kg.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>maximum defibrillation shock energy</strong> for <strong>pediatric CPR</strong> is <strong>10 J/kg</strong>, intended to <strong>effectively terminate arrhythmic activity</strong> while <strong>minimizing</strong> the risk of <strong>cardiac injury</strong> in <strong>children</strong>.</span></p>",
      "correct_choice_id": 354486,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89016/ANESTHESIA_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89016/ANESTHESIA_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89068,
      "choices": [
        {
          "id": 354692,
          "text": "<p><span style=\"font-size:14.0pt;\">Glossopharyngeal neuralgia</span></p>"
        },
        {
          "id": 354693,
          "text": "<p><span style=\"font-size:14.0pt;\">Peritonsillar abscess</span></p>"
        },
        {
          "id": 354694,
          "text": "<p><span style=\"font-size:14.0pt;\">Eagle syndrome</span></p>"
        },
        {
          "id": 354695,
          "text": "<p><span style=\"font-size:14.0pt;\">Temporomandibular joint (TMJ) dysfunction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman presents with dull, persistent throat pain radiating to the ear for the past 3 months. The pain worsens when she turns her head to the left or swallows. She also complains of a foreign body sensation in the throat and mild difficulty swallowing. On examination, a bony projection is palpable in the tonsillar fossa. She has a history of tonsillectomy done 5 years ago. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q4313302",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Eagle syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Eagle syndrome</strong> is caused by an <strong>elongated styloid process</strong> or <strong>calcified stylohyoid ligament</strong>, and is often seen <strong>post-tonsillectomy</strong> or after <strong>pharyngeal trauma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It presents in two forms:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Classic Eagle syndrome</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Dull pharyngeal pain referred to the ear</span></li><li><span style=\"font-size:14.0pt;\">Pain worsens with head rotation</span></li><li><span style=\"font-size:14.0pt;\">Palpable mass/bulge in tonsillar fossa</span></li><li><span style=\"font-size:14.0pt;\">Dysphagia, foreign body sensation, tinnitus</span></li><li><span style=\"font-size:14.0pt;\">Commonly bilateral</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Stylocarotid syndrome</strong>: Vascular compression symptoms (carotid artery)</span></li></ol></li><li><span style=\"font-size:14.0pt;\">In this case, the <strong>classic form</strong> is described.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key features—<strong>post-tonsillectomy</strong>, <strong>pharyngeal pain referred to the ear</strong>, <strong>pain with head movement</strong>, and <strong>tonsillar bulge</strong>—are hallmark clues.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cAN1Zbe.png\" width=\"873\" height=\"477\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glossopharyngeal neuralgia</strong>: Sudden, sharp, shock-like pain—not dull and persistent—and no tonsillar mass or post-tonsillectomy association.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Peritonsillar abscess</strong>: Presents acutely with fever, trismus, and unilateral swelling; not chronic and bilateral.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Temporomandibular joint (TMJ) dysfunction</strong>: Presents with jaw pain aggravated by chewing, clicking sounds—not throat pain or tonsillar mass.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Eagle syndrome</strong> is a post-tonsillectomy complication characterized by <strong>elongated styloid process</strong> causing <strong>pharyngeal and ear pain</strong>, <strong>tonsillar bulge</strong>, and <strong>dysphagia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is diagnosed clinically and treated with <strong>styloidectomy</strong> if analgesics fail.</span></li></ul>",
      "correct_choice_id": 354694,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89068/ENT_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89068/ENT_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89251,
      "choices": [
        {
          "id": 355404,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer protamine sulfate</span></p>"
        },
        {
          "id": 355405,
          "text": "<p><span style=\"font-size:14.0pt;\">Give intravenous vitamin K</span></p>"
        },
        {
          "id": 355406,
          "text": "<p><span style=\"font-size:14.0pt;\">Infuse recombinant factor VIIa</span></p>"
        },
        {
          "id": 355407,
          "text": "<p><span style=\"font-size:14.0pt;\">Provide supportive care and blood product replacement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old woman with acute pulmonary embolism is receiving fondaparinux. She develops a life-threatening gastrointestinal bleed. Which is the most appropriate next step in managing her anticoagulation?</span></p>",
      "unique_key": "Q7740582",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Provide supportive care and blood product replacement</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fondaparinux is a synthetic pentasaccharide that selectively inhibits factor Xa via antithrombin III and <strong>lacks a specific antidote</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Protamine only neutralizes heparin and partially LMWH, not fondaparinux. Vitamin K reverses vitamin K–dependent factors (II, VII, IX, X) but does not affect direct or indirect factor Xa inhibitors.</span></li><li><span style=\"font-size:14.0pt;\">Recombinant factor VIIa may enhance thrombin generation but carries high thrombotic risk and is not routinely recommended.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, management focuses on <strong>supportive measures</strong>—stop the drug, hemodynamic stabilization, transfusion of packed red blood cells and fresh frozen plasma or prothrombin complex concentrates as needed, and local hemostatic control.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Administer protamine sulfate:</strong> Ineffective against fondaparinux; no binding affinity. It is antidote for heparin&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Give intravenous vitamin K:</strong> Does not restore antithrombin–Xa inhibition; irrelevant to fondaparinux’s mechanism. It is antidote for warfarin</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infuse recombinant factor VIIa:</strong> Off-label and high-risk for thrombosis; not first-line for fondaparinux bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fondaparinux has no reversal agent</strong>—treat severe bleeding with <strong>supportive measures</strong>, including drug discontinuation, volume resuscitation, and judicious use of blood products or procoagulant concentrates.</span></p>",
      "correct_choice_id": 355407,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89251/PHARMA_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89251/PHARMA_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89379,
      "choices": [
        {
          "id": 355916,
          "text": "<p><span style=\"font-size:14.0pt;\">Trazodone</span></p>"
        },
        {
          "id": 355917,
          "text": "<p><span style=\"font-size:14.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 355918,
          "text": "<p><span style=\"font-size:14.0pt;\">Mirtazapine</span></p>"
        },
        {
          "id": 355919,
          "text": "<p><span style=\"font-size:14.0pt;\">Escitalopram</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with symptoms of depression. He is started on a medication ‘A’ that improves depressive symptoms but causes sedation and weight gain. The drug is known to antagonize central α2-adrenergic receptors and 5-HT2 and 5-HT3 receptors. Which of the following drugs is most likely to be medicine ‘A’?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7591563",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mirtazapine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mirtazapine</strong> is an atypical antidepressant that improves depressive symptoms through <strong>antagonism of central α2-adrenergic receptors</strong> (which increases norepinephrine and serotonin release) and <strong>blockade of 5-HT2 and 5-HT3 receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;This mechanism enhances serotonergic neurotransmission while minimizing certain serotonergic side effects.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mirtazapine is also a <strong>potent H1 histamine receptor blocker</strong>, leading to <strong>sedation and weight gain</strong>, which are well-known side effects.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Trazodone:&nbsp;</strong>Primarily a <strong>serotonin antagonist and reuptake inhibitor (SARI)</strong>. It also blocks <strong>5-HT2A receptors</strong> and has antihistaminic properties, causing sedation, but <strong>does not antagonize α2 receptors</strong>.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amitriptyline:&nbsp;</strong>A <strong>tricyclic antidepressant (TCA)</strong> that inhibits <strong>norepinephrine and serotonin reuptake</strong> and has <strong>anticholinergic, antihistaminic, and α1-blocking effects</strong>, but not significant <strong>α2-adrenergic or 5-HT2/5-HT3 antagonism</strong>.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Escitalopram:&nbsp;</strong>A <strong>selective serotonin reuptake inhibitor (SSRI)</strong> that increases serotonin levels by inhibiting reuptake. It does <strong>not block α2 or 5-HT2/5-HT3 receptors</strong>, and is <strong>not typically associated with sedation and weight gain</strong> to the extent seen with mirtazapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mirtazapine</strong> is a noradrenergic and specific serotonergic antidepressant (<strong>NaSSA</strong>) that enhances mood by <strong>α2-adrenergic antagonism</strong> and <strong>5-HT2/5-HT3 blockade</strong>, while its <strong>H1 antagonism</strong> leads to common side effects like <strong>sedation and weight gain</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is particularly useful in patients with <strong>depression and insomnia or weight loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RTUN3CU.png\" width=\"765\" height=\"371\"></span></p>",
      "correct_choice_id": 355918,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89379/Psychiatry_NEET_PG_GT_Question_3_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89379/Psychiatry_NEET_PG_GT_Question_3_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89259,
      "choices": [
        {
          "id": 355436,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 355437,
          "text": "<p><span style=\"font-size:14.0pt;\">Lasmiditan</span></p>"
        },
        {
          "id": 355438,
          "text": "<p><span style=\"font-size:14.0pt;\">Topiramate</span></p>"
        },
        {
          "id": 355439,
          "text": "<p><span style=\"font-size:14.0pt;\">Erenumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?</span></p>",
      "unique_key": "Q8254047",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lasmiditan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The symptoms described, including severe throbbing headache, nausea, vomiting, photophobia (sensitivity to light), and phonophobia (sensitivity to sound), are characteristic of a migraine headache.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lasmiditan is a new drug that belongs to a class called 5HT1F agonist.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is specifically approved for the acute treatment of migraine attacks in adults.</span></li><li><span style=\"font-size:14.0pt;\">It provides immediate relief by inhibiting the release of CGRP from the neurons.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Propranolol:</strong> A nonselective β-blocker used for <strong>migraine prophylaxis (DOC)</strong>, not for aborting an active attack.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Topiramate:</strong> An antiepileptic agent effective in <strong>preventing</strong> migraine episodes by modulating ion channels and neurotransmission; it is <strong>not</strong> used for acute relief.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Erenumab:</strong> A monoclonal antibody targeting the CGRP receptor for <strong>preventive</strong> therapy; it does <strong>not</strong> treat acute migraine attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For <strong>acute</strong> migraine relief, use agents like <strong>lasmiditan</strong>; reserve propranolol, topiramate, and erenumab for <strong>prophylaxis</strong>, not abortive therapy.</span></li><li><span style=\"font-size:14.0pt;\">Propranolol is DOC for prophylaxis of migraine.&nbsp;</span></li></ul>",
      "correct_choice_id": 355437,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89259/PHARMA_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89259/PHARMA_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89102,
      "choices": [
        {
          "id": 354824,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased conversion of pyruvate to oxaloacetate</span></p>"
        },
        {
          "id": 354825,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased gluconeogenesis</span></p>"
        },
        {
          "id": 354826,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased lactate/pyruvate ratio</span></p>"
        },
        {
          "id": 354827,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased NADH/NAD+ ratio</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a history of chronic alcohol use is brought to the emergency room by his family due to agitation, confusion, and aggressive behavior. His family members report that he has not eaten much in the past few days. On examination, he is disoriented, and his blood glucose level is measured at 41 mg/dL. Which of the following biochemical processes is most likely responsible for his hypoglycemia?</span></p>",
      "unique_key": "Q8776290",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increased lactate/pyruvate ratio</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic alcohol consumption results in an increase in the NADH/NAD+ ratio due to alcohol metabolism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This shift favors the conversion of pyruvate to lactate, leading to an <strong>increased lactate/pyruvate ratio</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As a result, gluconeogenesis is impaired because pyruvate, a key gluconeogenic substrate, is diverted to lactate instead of entering the gluconeogenic pathway.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This disruption in gluconeogenesis leads to hypoglycemia, particularly in patients who have poor nutritional intake (such as alcoholics) and are dependent on gluconeogenesis for maintaining blood glucose levels during fasting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased conversion of pyruvate to oxaloacetate:</strong> In alcohol metabolism, the increased NADH/NAD+ ratio inhibits the conversion of pyruvate to oxaloacetate. Instead, pyruvate is converted to lactate, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased gluconeogenesis:</strong> Alcohol impairs gluconeogenesis, not increases it. The increased NADH/NAD+ ratio shifts metabolism away from producing glucose from pyruvate, leading to hypoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decreased NADH/NAD+ ratio:</strong> Alcohol metabolism leads to an <strong>increased</strong> NADH/NAD+ ratio, not decreased. The elevated NADH levels are what interfere with gluconeogenesis and promote the formation of lactate from pyruvate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Alcohol metabolism increases the <strong>NADH/NAD+ ratio</strong>, leading to an <strong>increased lactate/pyruvate ratio</strong>, which impairs gluconeogenesis and can result in hypoglycemia, especially in patients with poor nutritional intake or fasting.</span></p>",
      "correct_choice_id": 354826,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89102/BIOCHEM_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89102/BIOCHEM_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89794,
      "choices": [
        {
          "id": 357568,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassurance</span></p>"
        },
        {
          "id": 357569,
          "text": "<p><span style=\"font-size:14.0pt;\">CT arteriography</span></p>"
        },
        {
          "id": 357570,
          "text": "<p><span style=\"font-size:14.0pt;\">Tagged white blood cell (WBC) scan</span></p>"
        },
        {
          "id": 357571,
          "text": "<p><span style=\"font-size:14.0pt;\">Video capsule endoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 75-year-old woman with diabetes and coronary artery disease presents with a 4-week history of progressive dyspnea on exertion, fatigue, and occasional dizziness. Recent cardiology evaluation ruled out cardiac ischemia, but labs show new anemia (hemoglobin 8.5 g/dL, MCV 75 fL, RDW 19%) and positive occult blood in stool. Colonoscopy and EGD are unrevealing, and she denies melena or hematochezia. What is the next best step in her management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1471038",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Video capsule endoscopy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Iron deficiency anemia (low hemoglobin, low MCV, high RDW) with positive occult blood suggests gastrointestinal bleeding, likely from the small bowel since colonoscopy and EGD are negative.</span></li><li><span style=\"font-size:14.0pt;\">Video capsule endoscopy is the best test to identify small bowel sources like angiodysplasia or tumors.</span></li><li><span style=\"font-size:14.0pt;\">This non-invasive approach is critical for pinpointing the bleeding site in occult GI bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Reassurance:&nbsp;</strong>Is inappropriate with anemia and occult bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CT arteriography</strong>: Is for large vascular bleeds, not occult small bowel sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tagged white blood cell (WBC) scan</strong>: Is for inflammatory conditions, not bleeding sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Iron deficiency anemia with occult GI bleeding requires small bowel evaluation via video capsule endoscopy when standard endoscopies are negative.</span></li><li><span style=\"font-size:14.0pt;\">Identifying the bleeding source prevents ongoing anemia and complications.</span></li></ul>",
      "correct_choice_id": 357571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89794/Medicine_Neet_Pg_Gt_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89794/Medicine_Neet_Pg_Gt_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89194,
      "choices": [
        {
          "id": 355180,
          "text": "<p><span style=\"font-size:14.0pt;\">Human plague risk is highest, given abundant fleas and burrows</span></p>"
        },
        {
          "id": 355181,
          "text": "<p><span style=\"font-size:14.0pt;\">The low cheopsis index suggests Xenopsylla cheopis is a minor vector here</span></p>"
        },
        {
          "id": 355182,
          "text": "<p><span style=\"font-size:14.0pt;\">A burrow index of 4 indicates fewer than four fleas per rodent burrow</span></p>"
        },
        {
          "id": 355183,
          "text": "<p><span style=\"font-size:14.0pt;\">Total flea index &gt;10 always correlates with pneumonic rather than bubonic plague</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In evaluating plague transmission risk in a village, field entomologists report:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Total flea index = 15</span></li><li><span style=\"font-size:14.0pt;\">Burrow index = 4</span></li><li><span style=\"font-size:14.0pt;\">Cheopsis index = 0.2</span></li></ul><p><span style=\"font-size:14.0pt;\">Which statement is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4147245",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) The low cheopsis index suggests Xenopsylla cheopis is a minor vector here</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cheopsis index</strong> (average number of X. cheopis fleas per rat) of <strong>0.2</strong> means there are only 0.2 of the primary rat flea vector per rat on average—far below the threshold (usually ≥1) that indicates X.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cheopis is driving transmission.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Total flea index</strong> of 15 shows many fleas overall, but if they are non–X. cheopis species, plague risk may remain lower than expected.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Burrow index</strong> of 4 means an average of 4 fleas (all species) per rodent burrow, not fewer than four.</span></li><li><span style=\"font-size:14.0pt;\">A high total flea index does <strong>not</strong> dictate the form of plague (bubonic vs. pneumonic), which depends on disease progression and human‐to‐human spread, not vector density alone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Human plague risk is highest, given abundant fleas and burrows:</strong> Abundant fleas and burrows can increase risk, but if most fleas are non–X. cheopis, the principal vector’s low density limits efficient transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>A burrow index of 4 indicates fewer than four fleas per rodent burrow:&nbsp;</strong>The burrow index counts all flea species per burrow; <strong>4</strong> means four fleas per burrow on average, not “fewer than four.”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Total flea index &gt;10 always correlates with pneumonic rather than bubonic</strong> <strong>plague:&nbsp;</strong>The type of plague (bubonic vs. pneumonic) depends on disease manifestation. High flea density fosters bubonic cases; pneumonic plague requires human respiratory spread, unrelated to vector indices.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Flea Indices in Plague:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Total flea index: Is average no. of fleas of all species per rat</span></li><li><span style=\"font-size:14.0pt;\">Cheopsis index: Is average no. of X. cheopsis per rat; Is an ‘indicator of potential explosiveness, if outbreak occurs</span></li><li><span style=\"font-size:14.0pt;\">Specific percentage of fleas: Percentage of different fleas</span></li><li><span style=\"font-size:14.0pt;\">Burrow index: Average no. of fleas per species per rodent burrow</span></li></ul></li></ul>",
      "correct_choice_id": 355181,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89194/PSM_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89194/PSM_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89283,
      "choices": [
        {
          "id": 355532,
          "text": "<p><span style=\"font-size:14.0pt;\">Timolol</span></p>"
        },
        {
          "id": 355533,
          "text": "<p><span style=\"font-size:14.0pt;\">Latanoprost</span></p>"
        },
        {
          "id": 355534,
          "text": "<p><span style=\"font-size:14.0pt;\">Brimonidine</span></p>"
        },
        {
          "id": 355535,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorzolamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Upon further evaluation, it is discovered that the patient has experienced darkening of the iris and eyelid skin as well as increased length, thickness, and pigmentation of the eyelashes. Which of the following anti-glaucoma drugs is likely to produce these adverse effects?</span></p>",
      "unique_key": "Q7866776",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Latanoprost.&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The patient's symptoms are consistent with the known side effects of latanoprost, which is a prostaglandin analog used in the treatment of glaucoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Latanoprost can cause:&nbsp;</strong></span><ul><li><span style=\"font-size:14.0pt;\">Pigmentation of Iris: It is also known as heterochromia iridis</span></li><li><span style=\"font-size:14.0pt;\">Growth of Eyelashes: It is also called hypertrichosis</span></li><li><span style=\"font-size:14.0pt;\">Macular Edema</span></li><li><span style=\"font-size:14.0pt;\">Worsening of inflammation: So contraindicated in patients with uveitis.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Timolol:</strong> A nonselective β-blocker that <strong>reduces aqueous humor production</strong>. Side effects include ocular irritation and systemic β-blockade (bradycardia, bronchospasm), but <strong>no changes</strong> in iris or eyelash pigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Brimonidine:</strong> An α₂-adrenergic agonist that <strong>decreases aqueous humor production</strong> and increases uveoscleral outflow. Adverse effects include allergic conjunctivitis and dry mouth; it does <strong>not</strong> affect iris color or lash growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dorzolamide:</strong> A carbonic anhydrase inhibitor that <strong>reduces aqueous secretion</strong> by the ciliary epithelium. Commonly causes local stinging or bitter taste, but <strong>no</strong> pigmentary or eyelash changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a glaucoma patient develops <strong>iris hyperpigmentation</strong> and <strong>eyelash hypertrichosis</strong>, suspect a <strong>prostaglandin analogue</strong>—most commonly <strong>latanoprost</strong>—and consider alternative therapies if these cosmetic changes are problematic.</span></p>",
      "correct_choice_id": 355533,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89283/PHARMA_NEET_PG_GT_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89283/PHARMA_NEET_PG_GT_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89202,
      "choices": [
        {
          "id": 355212,
          "text": "<p><span style=\"font-size:14.0pt;\">Recall bias</span></p>"
        },
        {
          "id": 355213,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead‐time bias</span></p>"
        },
        {
          "id": 355214,
          "text": "<p><span style=\"font-size:14.0pt;\">Differential misclassification</span></p>"
        },
        {
          "id": 355215,
          "text": "<p><span style=\"font-size:14.0pt;\">Berkson’s bias</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Researchers enroll participants in a nutrition cohort and collect baseline dietary data via standardized questionnaires. Years later, when a subset develops a chronic disease, investigators re-interview only the cases about their current diet at diagnosis, while using only the original baseline data for controls. This approach is most likely to introduce which of the following biases?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2344379",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Differential misclassification</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In this nested design, <strong>cases</strong> have their exposure (diet) assessed twice—at baseline and again at diagnosis—whereas <strong>controls</strong> are assessed only once at baseline.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This creates <strong>differential misclassification</strong>, because the <strong>accuracy or consistency</strong> of exposure measurement differs between cases and controls.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cases’ second interviews may reflect recall influenced by disease status or changes over time, whereas controls’ exposure data remain “frozen” at baseline, distorting the comparison.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Recall bias:</strong> Occurs when cases and controls differ in recollection of past exposures <strong>at the same time point</strong>, typically in retrospective studies. Here, the error arises from <strong>different measurement schedules</strong>, not purely memory recall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lead‐time bias:</strong> Pertains to earlier detection of disease (e.g., via screening) that artificially inflates apparent survival time without affecting the disease course. It does not apply to exposure measurement error.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Berkson’s bias:</strong> A selection bias from hospital‐based sampling when two conditions influence admission probability. It is unrelated to differing exposure measurement methods in a nested design.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ensure that <strong>exposure measurements</strong> are <strong>comparable</strong> between cases and controls—using identical methods and timing—to avoid <strong>differential misclassification</strong> and preserve study validity.</span></p>",
      "correct_choice_id": 355214,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89202/PSM_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89202/PSM_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89806,
      "choices": [
        {
          "id": 357616,
          "text": "<p><span style=\"font-size:14.0pt;\">Observation</span></p>"
        },
        {
          "id": 357617,
          "text": "<p><span style=\"font-size:14.0pt;\">Magnetic resonance cholangiopancreatography</span></p>"
        },
        {
          "id": 357618,
          "text": "<p><span style=\"font-size:14.0pt;\">Endoscopic ultrasound with biopsy</span></p>"
        },
        {
          "id": 357619,
          "text": "<p><span style=\"font-size:14.0pt;\">Referral for Whipple procedure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with hypertension, hyperlipidemia and COPD presents with a 1-week history of painless jaundice. On examination he has axillary lymphadenopathy, but has no fever or weight loss. A CT scan of the chest, abdomen, and pelvis reveals a 3-cm pancreatic head mass with mediastinal/hilar lymphadenopathy. ERCP shows bile duct dilation without gallstones. S.IgG4 is elevated. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9783106",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Endoscopic ultrasound with biopsy</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The CT scan shows a pancreatic head mass and lymphadenopathy, with elevated IgG4 suggesting IgG4-related sclerosing pancreatitis, mimicking pancreatic cancer.</span></li><li><span style=\"font-size:14.0pt;\">Endoscopic ultrasound with biopsy is critical to confirm the diagnosis via histopathology, distinguishing it from malignancy.</span></li><li><span style=\"font-size:14.0pt;\">The absence of weight loss and presence of IgG4 elevation support a benign etiology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Observation:&nbsp;</strong>Is inappropriate with a pancreatic mass requiring diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Magnetic resonance cholangiopancreatography:&nbsp;</strong>MRCP provides imaging but not tissue diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Referral for Whipple procedure:&nbsp;</strong>Whipple procedure is premature without confirming a malignant etiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IgG4-related pancreatitis mimics pancreatic cancer and requires endoscopic ultrasound with biopsy for diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Elevated IgG4 and lymphadenopathy are key diagnostic clues.</span></li></ul>",
      "correct_choice_id": 357618,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89806/Medicine_Neet_Pg_Gt_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89806/Medicine_Neet_Pg_Gt_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89421,
      "choices": [
        {
          "id": 356080,
          "text": "<p><span style=\"font-size:14.0pt;\">Hurthle cell adenoma</span></p>"
        },
        {
          "id": 356081,
          "text": "<p><span style=\"font-size:14.0pt;\">Poorly differentiated thyroid carcinoma</span></p>"
        },
        {
          "id": 356082,
          "text": "<p><span style=\"font-size:14.0pt;\">Papillary carcinoma</span></p>"
        },
        {
          "id": 356083,
          "text": "<p><span style=\"font-size:14.0pt;\">Follicular carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with a gradually enlarging, painless thyroid swelling for the past 3 months. There are no compressive symptoms like dysphagia or dyspnea. Physical examination reveals a firm, non-tender 4 × 4 cm nodule in the right thyroid lobe. Histological examination of the thyroid mass shows the features depicted in the image below. Which of the following is the most likely diagnosis?&nbsp; &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_emH2euy.png\" width=\"305\" height=\"230\"></span></p>",
      "unique_key": "Q3037404",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Papillary carcinoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The findings of <strong>nuclear grooves</strong>, <strong>intranuclear cytoplasmic inclusions</strong>, and <strong>papillary fronds with fibrovascular cores</strong> on FNA are <strong>pathognomonic</strong> for <strong>papillary thyroid carcinoma (PTC)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PTC is the <strong>most common thyroid cancer</strong>, particularly in young to middle-aged women, and is the <strong>only thyroid malignancy reliably diagnosed by FNA cytology</strong> due to its distinctive nuclear morphology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hurthle cell adenoma</strong>: A variant of follicular neoplasm showing <strong>oncocytic cells</strong> with abundant granular eosinophilic cytoplasm. It lacks the papillary architecture, nuclear grooves, or INCI seen in PTC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Poorly differentiated thyroid carcinoma</strong>: Typically presents with <strong>high-grade features</strong>, such as mitotic figures, necrosis, and cellular pleomorphism. It lacks the classic nuclear features seen in PTC and is usually diagnosed by histopathology, not cytology alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Follicular carcinoma</strong>: Characterized by <strong>follicular architecture</strong>, but <strong>requires capsular and vascular invasion for diagnosis</strong>, which cannot be determined on FNA. The presence of papillary structures and nuclear features rules out follicular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Papillary thyroid carcinoma is the only thyroid malignancy with diagnostic nuclear features identifiable on FNAC, including nuclear grooves and intranuclear cytoplasmic inclusions.</span></p>",
      "correct_choice_id": 356082,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89421/PATHOLOGY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89421/PATHOLOGY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89098,
      "choices": [
        {
          "id": 354808,
          "text": "<p><span style=\"font-size:14.0pt;\">5′CTAGATG3′</span></p>"
        },
        {
          "id": 354809,
          "text": "<p><span style=\"font-size:14.0pt;\">5′GAUCUAC3′</span></p>"
        },
        {
          "id": 354810,
          "text": "<p><span style=\"font-size:14.0pt;\">5′GTAGATC3′</span></p>"
        },
        {
          "id": 354811,
          "text": "<p><span style=\"font-size:14.0pt;\">5′GUAGAUC3′</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A template strand of DNA has the sequence 5′GATCTAC3′. What is the sequence of the RNA transcript produced from this template?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9502378",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 5′GUAGAUC3′</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">RNA polymerase reads the DNA template strand in the 3′→5′ direction and synthesizes the RNA transcript in the 5′→3′ direction, pairing A (in DNA) with U (in RNA) and T (in DNA) with A (in RNA), while C pairs with G.</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Write the template strand in the 3′→5′ orientation</strong>:</span><br><span style=\"font-size:14.0pt;\">Template given as 5′–G A T C T A C–3′ becomes 3′–C A T C T A G–5′.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Determine the complementary RNA bases</strong> (A→U, T→A, C→G, G→C) in the 5′→3′ direction:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Template 3′–C → RNA 5′–G</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–A → RNA 5′–U</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–T → RNA 5′–A</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–C → RNA 5′–G</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–T → RNA 5′–A</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–A → RNA 5′–U</span></li><li><span style=\"font-size:14.0pt;\">Template 3′–G → RNA 5′–C</span></li></ul></li></ol></li><li><span style=\"font-size:14.0pt;\">This yields <strong>5′–G U A G A U C–3′</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When transcribing DNA to RNA, read the template strand 3′→5′, synthesize RNA 5′→3′, replace T with U, and use complementary base pairing (A→U, T→A, C→G, G→C).</span></p>",
      "correct_choice_id": 354811,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89098/BIOCHEM_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89098/BIOCHEM_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89081,
      "choices": [
        {
          "id": 354740,
          "text": "<p><span style=\"font-size:14.0pt;\">She died before entering the water</span></p>"
        },
        {
          "id": 354741,
          "text": "<p><span style=\"font-size:14.0pt;\">She inhaled water and drowned</span></p>"
        },
        {
          "id": 354742,
          "text": "<p><span style=\"font-size:14.0pt;\">She was submerged after death</span></p>"
        },
        {
          "id": 354743,
          "text": "<p><span style=\"font-size:14.0pt;\">The lung findings are due to putrefactive gas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman is found unconscious in a lake. At autopsy 3 days later, her trachea and bronchi contain mud and algae, and her stomach has similar debris. Her lungs are bulky, and the Griess (diatom) test is positive. Which conclusion is most accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7422043",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) She inhaled water and drowned</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When a person <strong>dies by drowning</strong>, active breathing efforts pull water—and any suspended particulate matter—into the airways and stomach.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This produces:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Mud and algae</strong> in the trachea, bronchi, and gastrointestinal tract</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bulky, edematous lungs</strong> from water and air trapping</span></li><li><span style=\"font-size:14.0pt;\">Positive <strong>diatom test</strong>, since diatoms are inhaled into the circulation and deposited in organs like bone marrow</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These findings confirm <strong>antemortem</strong> aspiration of water, establishing that she was alive and breathing when she entered the lake.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. She died before entering the water:</strong> If death occurred prior to immersion, there would be <strong>no</strong> mud/algae in the airways or stomach, lungs would be <strong>collapsed</strong>, and diatoms would be <strong>absent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. She was submerged after death:</strong> Postmortem submersion allows only passive water entry. Airways remain largely free of debris, lungs collapse or decompose, and diatom tests are <strong>negative</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The lung findings are due to putrefactive gas:</strong> Putrefaction can cause lung “bulking,” but it does <strong>not</strong> deposit mud/algae or yield a positive diatom test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Active inhalation of water</strong> during life produces <strong>airway debris</strong>, <strong>bulky lungs</strong>, and <strong>positive diatoms</strong>—the hallmarks that distinguish true drowning from postmortem immersion.</span></p>",
      "correct_choice_id": 354741,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89081/FMT_NEETPG-INICET_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89081/FMT_NEETPG-INICET_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89408,
      "choices": [
        {
          "id": 356028,
          "text": "<p><span style=\"font-size:14.0pt;\">Splenic infarct</span></p>"
        },
        {
          "id": 356029,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pancreatitis</span></p>"
        },
        {
          "id": 356030,
          "text": "<p><span style=\"font-size:14.0pt;\">Gall stone disease</span></p>"
        },
        {
          "id": 356031,
          "text": "<p><span style=\"font-size:14.0pt;\">Amoebic liver abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old female presented to the hospital with a history of recurrent pain in the right Hypochondrium for 1 week. She is a known case of hereditary spherocytosis. What is the likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1028885",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Gall stone disease&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with hemolytic disorders, black pigment stones are seen in the gall bladder, which are likely to block cystic duct and cause biliary colic or cholecystitis.</span><br><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6DOCqnv.png\" width=\"798\" height=\"798\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Splenic infarct:</strong> May occur in sickle cell disease and will present with LUQ pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute Pancreatitis:</strong> Patient with Acute Pancreatitis presents with severe epigastric pain radiating to the back. Lab investigations reveal increase serum amylase and lipase levels. Its management is mainly supportive care with adequate analgesia, IV Fluid therapy and oxygen administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amoebic liver abscess:</strong> Patients with amoebic liver abscess are mostly asymptomatic. There is usually a history of dysentery with mucus in stools. It is caused by E. histolytica and on aspiration, pus with Anchovy-sauce appearance is obtained.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Haemolytic disorders with RUQ pain is likely to be due to gall stones and will be confirmed by USG abdomen.</span></p>",
      "correct_choice_id": 356030,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89408/SURGERY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89408/SURGERY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89802,
      "choices": [
        {
          "id": 357600,
          "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone suppression test</span></p>"
        },
        {
          "id": 357601,
          "text": "<p><span style=\"font-size:14.0pt;\">Morning plasma renin and aldosterone</span></p>"
        },
        {
          "id": 357602,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal ultrasound</span></p>"
        },
        {
          "id": 357603,
          "text": "<p><span style=\"font-size:14.0pt;\">24h urinary fractionated metanephrines</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man with newly diagnosed hypertension presents with persistent elevated BP (165/95 mmHg) despite maximum-dose triple therapy with amlodipine, Enalapril and hydrochlorothiazide. Labs show creatinine 0.8 mg/dL, potassium 3.6 mEq/L, and sodium 141 mEq/L. What is the next step to evaluate the most likely cause?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4066754",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Morning plasma renin and aldosterone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Resistant hypertension in a young patient without Cushing’s or pheochromocytoma symptoms suggests primary hyperaldosteronism.</span></li><li><span style=\"font-size:14.0pt;\">An elevated aldosterone/renin ratio indicates hyperaldosteronism, common in resistant hypertension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dexamethasone suppression test:&nbsp;</strong>DST is for Cushing’s syndrome, not suggested by the patient’s symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Renal ultrasound:&nbsp;</strong>Is for renovascular disease, less likely without suggestive findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 24h urinary fractionated metanephrines:&nbsp;</strong>Urinary metanephrines are for pheochromocytoma, not indicated here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Primary hyperaldosteronism is a common cause of resistant hypertension, screened with plasma renin and aldosterone.</span></li><li><span style=\"font-size:14.0pt;\">Early diagnosis prevents cardiovascular complications.</span></li></ul>",
      "correct_choice_id": 357601,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89802/MEDICINE_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89802/MEDICINE_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89400,
      "choices": [
        {
          "id": 355996,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 355997,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 355998,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 355999,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding muscles with dual nerve supply is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Subscapularis is innervated by the upper and lower subscapular nerves.</span></li><li><span style=\"font-size:14.0pt;\">Pectoralis major is innervated by both the medial and lateral pectoral nerves.</span></li><li><span style=\"font-size:14.0pt;\">Pronator teres is a hybrid muscle and is innervated by the median and ulnar nerves.</span></li><li><span style=\"font-size:14.0pt;\">Flexor digitorum profundus is partially innervated by the anterior interosseous nerve (median nerve branch) and partially by the ulnar nerve.</span></li></ol>",
      "unique_key": "Q3520704",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Subscapularis is innervated by the upper and lower subscapular nerves:</strong> Correct. Subscapularis is innervated by the upper and lower subscapular nerves, making it a muscle with dual nerve supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Pectoralis major is innervated by both the medial and lateral pectoral nerves:</strong> Correct. Pectoralis major receives its nerve supply from both the medial and lateral pectoral nerves, qualifying as a hybrid muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Flexor digitorum profundus is partially innervated by the anterior interosseous nerve (median nerve branch) and partially by the ulnar nerve:</strong> Correct. Flexor digitorum profundus has a dual nerve supply:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lateral half: Anterior interosseous nerve (branch of the median nerve).</span></li><li><span style=\"font-size:14.0pt;\">Medial half: Ulnar nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Pronator teres is a hybrid muscle and is innervated by the median and ulnar nerves:</strong> Incorrect. Pronator teres is not a hybrid muscle; it is solely innervated by the median nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Hybrid muscles of the upper limb receive dual nerve supply, but pronator teres is solely innervated by the median nerve and is not classified as a hybrid muscle.</span></p>",
      "correct_choice_id": 355997,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89400/ANATOMY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89400/ANATOMY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89365,
      "choices": [
        {
          "id": 355860,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 355861,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 355862,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 355863,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-month-old infant presents with an abdominal mass and features such as macroglossia and umbilical hernia. Genetic testing confirms Wilms' tumor. Which of the following statements are true regarding the underlying syndrome?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The syndrome is associated with hemihypertrophy.</span></li><li><span style=\"font-size:14.0pt;\">It involves an overgrowth disorder caused by IGF-2 dysregulation.</span></li><li><span style=\"font-size:14.0pt;\">The risk of Wilms’ tumor decreases after 8 years of age.</span></li><li><span style=\"font-size:14.0pt;\">The most likely diagnosis is Beckwith-Wiedemann Syndrome.</span></li></ol>",
      "unique_key": "Q8693116",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The syndrome is associated with hemihypertrophy: </strong>True<strong>.</strong> Beckwith-Wiedemann syndrome is associated with hemihypertrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It involves an overgrowth disorder caused by IGF-2 dysregulation. </strong>True<strong>.</strong> It is caused by IGF-2 dysregulation, leading to overgrowth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The risk of Wilms’ tumor decreases after 8 years of age: </strong>True. The risk of Wilms’ tumor significantly decreases after 8 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. The most likely diagnosis is Beckwith-Wiedemann Syndrome: </strong>True<strong>.</strong> The clinical presentation strongly suggests Beckwith-Wiedemann syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Beckwith-Wiedemann syndrome is an overgrowth disorder associated with hemihypertrophy and Wilms’ tumor.</span></p>",
      "correct_choice_id": 355863,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89365/PEDIATRICS_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89365/PEDIATRICS_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89023,
      "choices": [
        {
          "id": 354512,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypothermia</span></p>"
        },
        {
          "id": 354513,
          "text": "<p><span style=\"font-size:14.0pt;\">Old age</span></p>"
        },
        {
          "id": 354514,
          "text": "<p><span style=\"font-size:14.0pt;\">Preoperative medication</span></p>"
        },
        {
          "id": 354515,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of these factors cause a decrease in MAC requirement of the patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4599053",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) All of the above</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Considering the <strong>individual effects</strong> of <strong>hypothermia, old age</strong>, and <strong>preoperative medication</strong>, all these factors can contribute to a <strong>decreased MAC requirement</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Minimum Alveolar Concentration (MAC)</strong> is the <strong>concentration</strong> of an <strong>inhaled anesthetic</strong> required to <strong>prevent movement</strong> in <strong>50% of subjects</strong> in response to a <strong>painful stimulus</strong>.&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypothermia</strong>: <strong>Lower body temperature</strong> can <strong>reduce metabolic rate</strong> and <strong>anesthetic requirements</strong>, thereby <strong>lowering MAC</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Old Age</strong>: As patients age, the <strong>MAC</strong> requirement <strong>typically decreases</strong>. The <strong>anesthetic requirement</strong> is <strong>greatest in infants</strong> and <strong>young children</strong> and <strong>decreases with advancing age</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preoperative Medication</strong>: Certain preoperative medications, especially those with <strong>sedative or analgesic properties</strong> like <strong>opioids</strong> and <strong>benzodiazepines</strong>, can <strong>lower the MAC</strong> of <strong>inhaled anesthetics</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Factors causing <strong>decrease in MAC</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Age (MAC is greatest at 6-12 months of age)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Decreased temperature.</span></li><li><span style=\"font-size:14.0pt;\">Hyponatremia&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Opioids&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Barbiturates&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Alpha 2-blockers (clonidine, dexmedetomidine)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Calcium channel blockers&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Acute alcohol intoxication&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pregnancy&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">MAC is NOT affected by gender.</span></li></ul>",
      "correct_choice_id": 354515,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89023/ANESTHESIA_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89023/ANESTHESIA_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89058,
      "choices": [
        {
          "id": 354652,
          "text": "<p><span style=\"font-size:14.0pt;\">Finger-like pseudopods</span></p>"
        },
        {
          "id": 354653,
          "text": "<p><span style=\"font-size:14.0pt;\">Ingested leukocytes and RBCs</span></p>"
        },
        {
          "id": 354654,
          "text": "<p><span style=\"font-size:14.0pt;\">Sluggish, non-purposeful motility</span></p>"
        },
        {
          "id": 354655,
          "text": "<p><span style=\"font-size:14.0pt;\">Differentiated ecto- and endoplasm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following trophozoite characteristics is absent in Entamoeba histolytica but commonly observed in Entamoeba coli?</span></p>",
      "unique_key": "Q5086499",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Sluggish, non-purposeful motility</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sluggish, non-purposeful motility</strong> is a hallmark of E. coli trophozoites. They move slowly with blunt, wide pseudopods in an erratic fashion.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, E. histolytica exhibits <strong>very active, unidirectional motility</strong> with finger-like pseudopodia, moving rapidly toward food or host tissues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Finger-like pseudopods</strong>: Entamoeba histolytica extends slender, pointed pseudopods for rapid, directional movement. E. coli has blunt, broad pseudopods.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ingested leukocytes and RBCs</strong>: E. histolytica trophozoites are invasive and often contain ingested RBCs and leukocytes in their cytoplasm. E. coli may ingest bacteria but <strong>never</strong> red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Differentiated ectoplasm and endoplasm:</strong> E. histolytica shows a distinct clear outer ectoplasm and granular inner endoplasm. E. coli trophozoites have more homogeneous cytoplasm without sharp differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Differentiate E. histolytica from E. coli trophozoites by their motility patterns, ingestion of host cells, and cytoplasmic features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">E. histolytica: rapid, purposeful motility with finger-like pseudopods, ingestion of RBCs, clear ectoplasm vs. endoplasm.</span></li><li><span style=\"font-size:14.0pt;\">E. coli: sluggish, aimless movement, lack of erythrophagy, and uniform cytoplasm.</span></li></ul></li></ul>",
      "correct_choice_id": 354654,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89058/MICROBIOLOGY_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89058/MICROBIOLOGY_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89433,
      "choices": [
        {
          "id": 356128,
          "text": "<p><span style=\"font-size:14.0pt;\">Capable of directly lysing macrophages harboring intracellular pathogens</span></p>"
        },
        {
          "id": 356129,
          "text": "<p><span style=\"font-size:14.0pt;\">Recognizes peptide antigens presented via classical MHC molecules</span></p>"
        },
        {
          "id": 356130,
          "text": "<p><span style=\"font-size:14.0pt;\">Plays a role in antimicrobial defense against Mycobacterium tuberculosis</span></p>"
        },
        {
          "id": 356131,
          "text": "<p><span style=\"font-size:14.0pt;\">Releases cytotoxic mediators such as perforin and granulysin to eliminate pathogens</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following characteristics is incorrect regarding the immune functions of gamma-delta (γδ) T lymphocytes?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5511512",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Recognizes peptide antigens presented via classical MHC molecules</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>γδ T-cells</strong> are a distinct subset of T lymphocytes that differ from conventional αβ T-cells in several key ways.</span></li><li><span style=\"font-size:14.0pt;\">Unlike αβ T-cells, γδ T-cells:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Do <strong>not require antigen processing and classical MHC presentation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Recognize <strong>non-peptide antigens</strong>, such as phosphoantigens and lipid antigens, <strong>in an MHC-independent manner</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Act more like <strong>innate immune cells</strong>, bridging innate and adaptive immunity.</span></li><li><span style=\"font-size:14.0pt;\">Possess <strong>cytotoxic activity</strong>, utilizing molecules such as <strong>perforin and granulysin</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Can <strong>directly kill infected macrophages</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Contribute to host defense, particularly against <strong>mycobacterial infections</strong>, such as M. tuberculosis.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the statement that γδ T-cells \"recognize peptide antigens presented via classical MHC molecules\" is <strong>not accurate.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Capable of directly lysing macrophages harboring intracellular pathogens</strong>: Correct. γδ T-cells contribute to immune surveillance by <strong>directly lysing infected macrophages</strong> through cytolytic mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Plays a role in antimicrobial defense against Mycobacterium tuberculosis</strong>: Correct. γδ T-cells are known to play a role in <strong>protective immunity against mycobacteria</strong>, especially via recognition of lipid antigens and cytokine release.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Releases cytotoxic mediators such as perforin and granulysin to eliminate pathogens</strong>: Correct. γδ T-cells kill infected or stressed cells via release of <strong>granulysin and perforin</strong>, mechanisms shared with cytotoxic T lymphocytes and NK cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>γδ T-cells</strong> are unique lymphocytes that participate in early host defense and <strong>do not require classical MHC-dependent antigen presentation</strong>, instead responding to non-peptide antigens and contributing to innate immune responses, particularly against intracellular pathogens like <strong>mycobacteria</strong>.</span></p>",
      "correct_choice_id": 356129,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89433/PATHOLOGY_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89433/PATHOLOGY_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89336,
      "choices": [
        {
          "id": 355744,
          "text": "<p><span style=\"font-size:14.0pt;\">OHVIRA syndrome</span></p>"
        },
        {
          "id": 355745,
          "text": "<p><span style=\"font-size:14.0pt;\">MRKH syndrome</span></p>"
        },
        {
          "id": 355746,
          "text": "<p><span style=\"font-size:14.0pt;\">Robert’s uterus</span></p>"
        },
        {
          "id": 355747,
          "text": "<p><span style=\"font-size:14.0pt;\">Noncommunicating functional uterine horn</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 17-year-old adolescent presents with painful menstruation (dysmenorrhea). On physical examination, she has normal secondary sexual characteristics, and the vagina is patent, but a bulge is noted on the right side near the cervix. On per rectal examination, a bulge is felt about 4 cm from the anal verge, more towards the left side. Pelvic ultrasound reveals hematocolpos, and the left kidney is absent. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8460068",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) OHVIRA syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>OHVIRA syndrome</strong> (Obstructed Hemivagina and Ipsilateral Renal Agenesis), also known as <strong>Herlyn-Werner-Wunderlich syndrome</strong>, is a rare congenital Müllerian anomaly.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically presents in <strong>adolescent girls</strong> after menarche with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Cyclic pelvic pain/dysmenorrhea</strong> due to obstruction</span></li><li><span style=\"font-size:14.0pt;\"><strong>Patent external genitalia with normal secondary sexual characteristics</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>A bulging obstructed hemivagina</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hematocolpos/hematometra</strong> due to trapped menstrual blood</span></li><li><span style=\"font-size:14.0pt;\"><strong>Renal agenesis on the same side as the obstructed hemivagina</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vaginal bulge near cervix</strong> suggests obstructed hemivagina</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hematocolpos on ultrasound</strong> confirms trapped menstrual blood</span></li><li><span style=\"font-size:14.0pt;\"><strong>Left-sided renal agenesis</strong> supports diagnosis</span><br><span style=\"font-size:14.0pt;\">Thus, the findings are diagnostic of <strong>OHVIRA syndrome</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. MRKH syndrome</strong>: Incorrect. MRKH <strong>(Mayer-Rokitansky-Küster-Hauser syndrome)&nbsp;</strong>presents with <strong>primary amenorrhea</strong>, <strong>absent vagina and uterus</strong>, and <strong>normal secondary sexual characteristics</strong>. This patient has a <strong>patent vagina</strong> and <strong>hematocolpos</strong>, ruling out MRKH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Robert’s uterus</strong>: Incorrect. Robert’s uterus is a rare <strong>asymmetric septate uterus</strong> where one side is obstructed. It can cause similar symptoms but is not typically associated with <strong>ipsilateral renal agenesis</strong>. The presence of <strong>renal agenesis</strong> supports OHVIRA over Robert’s uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Noncommunicating functional uterine horn:</strong> Incorrect. This can cause <strong>hematometra</strong> and <strong>cyclic pain</strong>, but it usually doesn't involve a bulge at the vaginal level or <strong>renal agenesis</strong>, and the anomaly lies within the uterus rather than hemivaginal obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">OHVIRA syndrome (Obstructed Hemivagina and Ipsilateral Renal Agenesis) should be suspected in adolescents presenting with dysmenorrhea, hematocolpos, and renal agenesis.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Key features include a vaginal bulge, normal secondary sexual characteristics, and unilateral renal absence.</span></li></ul>",
      "correct_choice_id": 355744,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89336/OBG_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89336/OBG_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89198,
      "choices": [
        {
          "id": 355196,
          "text": "<p><span style=\"font-size:14.0pt;\">A positive test increases the odds of disease 10-fold.</span></p>"
        },
        {
          "id": 355197,
          "text": "<p><span style=\"font-size:14.0pt;\">A negative test reduces the odds of disease to one-tenth.</span></p>"
        },
        {
          "id": 355198,
          "text": "<p><span style=\"font-size:14.0pt;\">LR⁻ = (1 − Sensitivity) / Specificity = 0.1 implies very poor rule-out capability.</span></p>"
        },
        {
          "id": 355199,
          "text": "<p><span style=\"font-size:14.0pt;\">Both LR⁺ ≥ 10 and LR⁻ ≤ 0.1 indicate the test is excellent for both ruling in and ruling out disease.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In evaluating Test Y for Condition Z, you find a positive likelihood ratio (LR⁺) of 10 and a negative likelihood ratio (LR⁻) of 0.1. Which of the following statements is false?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7897372",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) LR⁻ = (1 − Sensitivity) / Specificity = 0.1 implies very poor rule-out capability.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An LR⁻ of 0.1 actually represents <strong>excellent</strong> rule-out capability—post-test odds fall to 10% of pre-test odds.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A “poor” rule-out test would have an LR⁻ closer to 1 (e.g., 0.5–1.0).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>A positive test increases the odds of disease 10-fold: </strong>True. By definition, LR⁺ tells you how much to multiply pre-test odds when the test is positive. An LR⁺ of 10 means a positive result raises the odds by tenfold.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A negative test reduces the odds of disease to one-tenth: </strong>True. LR⁻ indicates how much to multiply pre-test odds when the test is negative. An LR⁻ of 0.1 reduces the odds to one-tenth, dramatically lowering the likelihood of disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Both LR⁺ ≥ 10 and LR⁻ ≤ 0.1 indicate the test is excellent for both ruling in and ruling out disease:</strong> True. General benchmarks hold that LR⁺ ≥ 10 strongly “rules in” disease, and LR⁻ ≤ 0.1 strongly “rules out” disease, making this test robust for both confirming and excluding Condition Z.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A test with <strong>LR⁺ ≥ 10</strong> and <strong>LR⁻ ≤ 0.1</strong> is considered excellent for both confirming and excluding disease—an LR⁻ of 0.1 <strong>does not</strong> imply poor rule-out ability but rather a tenfold reduction in post-test odds.</span></p>",
      "correct_choice_id": 355198,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89198/PSM_NEET_PG_GT_Question_10_EDmWzHo.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89198/PSM_NEET_PG_GT_Question_10_EDmWzHo.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89258,
      "choices": [
        {
          "id": 355432,
          "text": "<p><span style=\"font-size:14.0pt;\">It is longest acting anti arrhythmic drug.</span></p>"
        },
        {
          "id": 355433,
          "text": "<p><span style=\"font-size:14.0pt;\">It has positive ionotropic action.</span></p>"
        },
        {
          "id": 355434,
          "text": "<p><span style=\"font-size:14.0pt;\">It contains iodine.</span></p>"
        },
        {
          "id": 355435,
          "text": "<p><span style=\"font-size:14.0pt;\">It causes pulmonary fibrosis.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is wrong about amiodarone?</span></p>",
      "unique_key": "Q1005956",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans B) It has positive ionotropic action.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Side effects of amiodarone</span><ul><li><span style=\"font-size:14.0pt;\">Thyroid&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Peripheral neuropathy&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Myocardial depression&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lung fibrosis</span></li><li><span style=\"font-size:14.0pt;\">Liver damage&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Corneal deposits&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Photosensitivity – Blue man syndrome&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Amiodarone is a potent antiarrhythmic medication with multiple actions on cardiac ion channels.</span></li><li><span style=\"font-size:14.0pt;\">However, it does not have a positive ionotropic action.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In fact, amiodarone has predominantly negative inotropic effects, meaning it reduces the force of cardiac contractions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is the longest-acting antiarrhythmic drug:</strong> Amiodarone has a half-life of around 3 weeks, meaning it remains in the body for an extended period. This allows for a once-daily dosing regimen in many cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It contains iodine:</strong> Amiodarone contains around 40 percent iodine, which contribute to its structure. This iodine content is responsible for some of the medication's potential adverse effects, such as thyroid abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It can cause pulmonary fibrosis:</strong> Amiodarone has been associated with pulmonary toxicity, which can manifest as lung inflammation and fibrosis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Amiodarone</strong> is a long-acting, iodine-containing antiarrhythmic with <strong>negative inotropic</strong> properties and a risk of <strong>pulmonary fibrosis</strong>, distinguishing it from agents that enhance contractility.</span></p>",
      "correct_choice_id": 355433,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89258/PHARMA_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89258/PHARMA_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89396,
      "choices": [
        {
          "id": 355980,
          "text": "<p><span style=\"font-size:14.0pt;\">External branch of superior laryngeal nerve</span></p>"
        },
        {
          "id": 355981,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrent laryngeal nerve</span></p>"
        },
        {
          "id": 355982,
          "text": "<p><span style=\"font-size:14.0pt;\">Glossopharyngeal nerve</span></p>"
        },
        {
          "id": 355983,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal branch of superior laryngeal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman undergoes a total thyroidectomy for papillary carcinoma. Postoperatively, she develops hoarseness and a weak, breathy voice. Laryngoscopy reveals immobility of the left vocal cord in a paramedian position<strong>.&nbsp;</strong>Which of the following nerves was most likely injured during surgery?&nbsp;</span></p>",
      "unique_key": "Q9512027",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Recurrent laryngeal nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>recurrent laryngeal nerve</strong> supplies <strong>motor innervation</strong> to all intrinsic muscles of the larynx (except cricothyroid).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Injury leads to <strong>vocal cord paralysis</strong> in a paramedian position, resulting in hoarseness and weak phonation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This nerve is highly susceptible during <strong>thyroid surgery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. External branch of superior laryngeal nerve</strong>: Supplies only <strong>cricothyroid</strong>, injury causes pitch alteration, not hoarseness or cord immobility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glossopharyngeal nerve</strong>: Affects pharyngeal sensation and taste, not vocal cord movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Internal branch of superior laryngeal nerve</strong>: Purely sensory to larynx above vocal cords; injury leads to aspiration, not hoarseness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>recurrent laryngeal nerve</strong> is the most commonly injured nerve during thyroid surgery and causes <strong>vocal cord paralysis with hoarseness</strong>.</span></p>",
      "correct_choice_id": 355981,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89396/ANATOMY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89396/ANATOMY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89787,
      "choices": [
        {
          "id": 357540,
          "text": "<p><span style=\"font-size:14.0pt;\">Order a low-dose dexamethasone suppression test (DST)</span></p>"
        },
        {
          "id": 357541,
          "text": "<p><span style=\"font-size:14.0pt;\">Order fasting insulin-like growth factor-1 (IGF-1) level</span></p>"
        },
        {
          "id": 357542,
          "text": "<p><span style=\"font-size:14.0pt;\">Order morning cortisol with adrenocorticotopic hormone (ACTH)</span></p>"
        },
        {
          "id": 357543,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for pituitary MRI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents to the endocrinology clinic with a 15kg weight gain over 6 months, easy bruising, mild leg swelling, and increased fatigue. Examination reveals BP 145/90 mmHg, facial plethora, and 1+ pitting edema. HbA1c is 7.4% (up from 5.3% last year). What is the next best step in her management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1709050",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Order a low-dose dexamethasone suppression test (DST)</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s symptoms (central obesity, moon facies, easy bruising, hyperglycemia) are highly suggestive of Cushing’s syndrome due to glucocorticoid excess.</span></li><li><span style=\"font-size:14.0pt;\">The low-dose DST is the initial screening test to confirm cortisol excess by assessing suppression of cortisol secretion.</span></li><li><span style=\"font-size:14.0pt;\">Failure to suppress cortisol indicates Cushing’s syndrome, prompting further tests to identify the cause (pituitary, adrenal, or ectopic).</span></li><li><span style=\"font-size:14.0pt;\">The test is non-invasive and highly sensitive for detecting cortisol overproduction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Order fasting</strong> <strong>insulin-like growth factor-1 (IGF-1) level</strong>: IGF-1 screens for acromegaly, which presents with enlarged extremities and facial changes, not matching this patient’s symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Order morning cortisol with&nbsp;adrenocorticotopic hormone</strong> <strong>(ACTH)</strong>: These tests help determine the etiology of Cushing’s syndrome but are not the initial screening step; DST is preferred first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Refer for pituitary MRI</strong>: Imaging is premature without confirming cortisol excess via DST, as it may not be the cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cushing’s syndrome should be suspected in patients with central obesity, moon facies, easy bruising, and hyperglycemia.</span></li><li><span style=\"font-size:14.0pt;\">The low-dose dexamethasone suppression test is the first-line screening tool for cortisol excess.</span></li><li><span style=\"font-size:14.0pt;\">Subsequent tests like ACTH levels and imaging are used to pinpoint the cause after confirmation.</span></li></ul>",
      "correct_choice_id": 357540,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89787/Medicine_Neet_Pg_Gt_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89787/Medicine_Neet_Pg_Gt_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89067,
      "choices": [
        {
          "id": 354688,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue antibiotics for 7 more days and observe</span></p>"
        },
        {
          "id": 354689,
          "text": "<p><span style=\"font-size:14.0pt;\">Add intranasal decongestants and antihistamines</span></p>"
        },
        {
          "id": 354690,
          "text": "<p><span style=\"font-size:14.0pt;\">Myringotomy with or without grommet insertion</span></p>"
        },
        {
          "id": 354691,
          "text": "<p><span style=\"font-size:14.0pt;\">Tympanoplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child is brought to the emergency department with complaints of high-grade fever and severe right ear pain for 2 days. On examination, the child is irritable, and otoscopy reveals a bulging, opaque tympanic membrane with loss of light reflex. There is no response to a 48-hour course of oral<strong>&nbsp;</strong>amoxicillin-clavulanate, and hearing loss is noted in the affected ear. The pediatrician suspects impending tympanic membrane rupture. What is the next best step in management?</span></p>",
      "unique_key": "Q5445365",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Myringotomy with or without grommet insertion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child has <strong>acute suppurative otitis media (ASOM)</strong> with <strong>severe earache, bulging tympanic membrane</strong>, and <strong>incomplete resolution despite antibiotics</strong>, along with <strong>persistent conductive hearing loss</strong>—all of which are <strong>indications for myringotomy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Myringotomy relieves pressure, prevents rupture, and facilitates pus drainage.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xCAmDB8.png\" width=\"453\" height=\"467\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Continue antibiotics</strong> <strong>for 7 more days and observe</strong>: Already tried without resolution; continued observation risks complications like perforation or facial nerve palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Add</strong> <strong>intranasal decongestants and antihistamines</strong>: These may relieve Eustachian tube congestion but are not definitive management in this case with clear signs of <strong>bulging and non-resolution</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tympanoplasty</strong>: This is a reconstructive surgery for <strong>chronic perforation</strong> or ossicular discontinuity, <strong>not indicated</strong> in acute ASOM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Myringotomy</strong> is indicated in ASOM when there is <strong>severe earache with a bulging tympanic membrane</strong>, <strong>failure to respond to antibiotics</strong>, or <strong>complications like facial palsy or meningitis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early intervention prevents spontaneous rupture and long-term hearing loss.</span></li></ul>",
      "correct_choice_id": 354690,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89067/ENT_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89067/ENT_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89041,
      "choices": [
        {
          "id": 354584,
          "text": "<p><span style=\"font-size:14.0pt;\">Gb₃</span></p>"
        },
        {
          "id": 354585,
          "text": "<p><span style=\"font-size:14.0pt;\">GM₁</span></p>"
        },
        {
          "id": 354586,
          "text": "<p><span style=\"font-size:14.0pt;\">LacCer</span></p>"
        },
        {
          "id": 354587,
          "text": "<p><span style=\"font-size:14.0pt;\">Cer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old girl presents with oliguria, hypertension, and microangiopathic hemolysis two days after an episode of bloody diarrhea. Laboratory studies reveal fragmented red cells and rising creatinine, and Shiga toxin is detected in her circulation. Which endothelial surface glycolipid is the primary receptor for this toxin, explaining the renal‐predominant damage?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7165613",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Gb₃&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Shiga toxin consists of a B-subunit pentamer and an A-subunit enzymatic moiety.</span></li><li><span style=\"font-size:14.0pt;\">The B-subunit specifically binds to <strong>globotriaosylceramide (Gb₃)</strong> on the cell surface. Gb₃ is highly expressed on renal glomerular endothelial cells, which facilitates receptor-mediated endocytosis of the toxin. The toxin goes and attach on the 60s ribosomes leads to kidney damage.</span></li><li><span style=\"font-size:14.0pt;\">Once inside the cell, the A-subunit de-purinates the 28S rRNA of the 60S ribosomal subunit, halting protein synthesis and causing cell death.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The abundance of Gb₃ in kidney endothelium explains why Shiga toxin–mediated hemolytic uremic syndrome (HUS) predominantly injures the renal microvasculature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. GM₁ (monosialotetrahexosylganglioside)</strong>: This glycolipid is the receptor for cholera toxin, not Shiga toxin. Binding to GM₁ does not facilitate Shiga toxin entry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. LacCer (lactosylceramide)</strong>: While a glycosphingolipid, LacCer lacks the specific trisaccharide structure required for high-affinity Shiga toxin binding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cer (ceramide):&nbsp;</strong>Ceramide is the simple lipid backbone of complex glycosphingolipids; it does not itself serve as a toxin receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In Shiga toxin–mediated HUS, the toxin’s renal tropism is due to high expression of <strong>globotriaosylceramide (Gb₃)</strong> on glomerular endothelium, making Gb₃ the critical docking receptor.</span></p>",
      "correct_choice_id": 354584,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89041/MICROBIOLOGY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89041/MICROBIOLOGY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89792,
      "choices": [
        {
          "id": 357560,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute cytomegalovirus infection</span></p>"
        },
        {
          "id": 357561,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute graft-versus-host disease</span></p>"
        },
        {
          "id": 357562,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug toxicity from pre-HSCT conditioning chemotherapy</span></p>"
        },
        {
          "id": 357563,
          "text": "<p><span style=\"font-size:14.0pt;\">Sinusoidal obstruction syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old man, 12 days post-hematopoietic stem cell transplantation for acute myelogenous leukemia, presents with a 3-day history of right upper quadrant pain, hepatomegaly, ascites, and a 8-kg weight gain. He reports lower extremity edema and fatigue, with no recent infections or trauma. USG of the abdomen demonstrates reversal of flow in the portal vein, with bilirubin at 6.5 mg/dL and normal transaminases. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9305681",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Sinusoidal obstruction syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ultrasonography showing reversal of portal vein flow, with hepatomegaly, ascites, and rapid weight gain, indicates sinusoidal obstruction syndrome (SOS), a common complication within 3 weeks post-HSCT due to endothelial damage from chemotherapy.</span></li><li><span style=\"font-size:14.0pt;\">Elevated bilirubin and edema further support SOS, which can lead to liver failure if untreated.</span></li><li><span style=\"font-size:14.0pt;\">The absence of infectious or chronic symptoms narrows the diagnosis to SOS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute cytomegalovirus infection:&nbsp;</strong>CMV infection causes fever, rash, and diarrhea, not portal vein reversal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute graft-versus-host disease:&nbsp;</strong>GVHD affects skin, GI, and liver but lacks rapid ascites or portal vein changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Drug toxicity from pre-HSCT conditioning chemotherapy:&nbsp;</strong>Chemotherapy toxicity causes hepatocellular injury, not portal vein flow reversal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SOS post-HSCT presents with hepatomegaly, ascites, and reversed portal vein flow.</span></li><li><span style=\"font-size:14.0pt;\">Early recognition is critical to manage this life-threatening condition.</span></li></ul>",
      "correct_choice_id": 357563,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89792/Medicine_Neet_Pg_Gt_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89792/Medicine_Neet_Pg_Gt_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89585,
      "choices": [
        {
          "id": 356732,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Perthes disease</span></p>"
        },
        {
          "id": 356733,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Slipped capital femoral epiphysis (SCFE)</span></p>"
        },
        {
          "id": 356734,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Osteomyelitis</span></p>"
        },
        {
          "id": 356735,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteosarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy presents with knee pain and limping. He has limited internal rotation of the hip, and X-rays reveal a \"frog-leg\" view of the hip. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9IHu0SU.png\" width=\"434\" height=\"280\"></span></p>",
      "unique_key": "Q2346141",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Perthes disease</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Perthes disease, or Legg-Calvé-Perthes disease, is a condition characterized by avascular necrosis of the femoral head in children, typically affecting those aged 4 to 10 years.</span></li><li><span style=\"font-size:14.0pt;\">The exact cause of Perthes disease is unknown, but it is thought to result from a temporary loss of blood supply to the femoral head, leading to bone necrosis.</span></li><li><span style=\"font-size:14.0pt;\">Children with Perthes disease often present with hip or knee pain, limping, and limited range of motion, particularly internal rotation and abduction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Symptoms can be insidious and may not always correlate with the severity of radiographic findings.</span></li><li><span style=\"font-size:14.0pt;\">On X-ray, the \"frog-leg\" view can show various stages of the disease, including initial lateralization of the femoral head and eventual fragmentation and deformity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">MRI can also be used to assess the extent of necrosis.</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is made through clinical evaluation, imaging studies, and sometimes MRI.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given the child’s age, symptoms, and imaging findings, Perthes disease is a strong consideration.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option B. Slipped Capital Femoral Epiphysis (SCFE):&nbsp;</strong>SCFE is a condition in which the femoral head slips posteriorly and inferiorly due to displacement at the growth plate (physis), typically occurring in adolescents. SCFE is associated with growth plate instability and can be related to obesity or hormonal factors. It is most commonly seen during periods of rapid growth. Symptoms include hip or knee pain, limping, and reduced range of motion, particularly internal rotation. The pain may be referred to the knee, leading to initial misdiagnosis. X-rays in SCFE often show a displaced femoral head relative to the neck, particularly on the frog-leg view.&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_J4JXWhM.png\" width=\"370\" height=\"293\"></span></p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">This condition is more common in older children and adolescents, which makes it less likely in a 10-year-old. Diagnosis is confirmed with clinical and imaging findings. While SCFE could present similarly, the patient's age and symptoms are more consistent with Perthes disease.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Osteomyelitis:&nbsp;</strong>Osteomyelitis is an infection of the bone, typically caused by bacteria, which can occur in children following trauma or hematogenous spread. It can occur after an injury or surgery but can also arise without any clear precipitating event, particularly in immunocompromised children. Symptoms include localized bone pain, swelling, fever, and sometimes a limp. Pain may be severe and localized rather than diffuse. X-rays may show bone changes, but early osteomyelitis may not be visible until there is significant bone loss. MRI is often more sensitive for detecting early changes. Diagnosis typically involves clinical evaluation, blood tests, and imaging. Given the chronic presentation and specific findings, osteomyelitis is less likely in this scenario.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Osteosarcoma:&nbsp;</strong>Osteosarcoma is a malignant bone tumour that typically arises in the metaphysis of long bones, most commonly around the knee in adolescents. The exact cause is unknown, but factors may include genetic predispositions or pre-existing conditions. Patients usually present with localized pain, swelling, and sometimes a palpable mass. The pain may worsen over time and is often associated with activity. X-rays may show a destructive lesion with a sunburst pattern, and an MRI or CT scan would be needed for further evaluation.&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aJbxzVG.png\" width=\"891\" height=\"287\"></p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">However, the acute nature of the symptoms in this case points more towards a developmental condition. Diagnosis involves imaging and often a biopsy for histological confirmation. Given the patient’s age and symptoms, osteosarcoma is less likely.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Perthes Disease fits the age of the patient, the symptom profile, and the characteristic findings on imaging, making it the most appropriate diagnosis in this scenario.</span></li></ul>",
      "correct_choice_id": 356732,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89585/Orthopedics_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89585/Orthopedics_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89413,
      "choices": [
        {
          "id": 356048,
          "text": "<p><span style=\"font-size:14.0pt;\">Richter's hernia</span></p>"
        },
        {
          "id": 356049,
          "text": "<p><span style=\"font-size:14.0pt;\">Pantaloon’s hernia</span></p>"
        },
        {
          "id": 356050,
          "text": "<p><span style=\"font-size:14.0pt;\">Littre's hernia</span></p>"
        },
        {
          "id": 356051,
          "text": "<p><span style=\"font-size:14.0pt;\">Maydl hernia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which type of hernia is depicted in the following diagram?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I8Qpjz6.png\" width=\"1125\" height=\"888\"></span></p>",
      "unique_key": "Q9107228",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Maydl’s hernia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The diagram shows Maydl's hernia/Hernia-en-W/Retrograde hernia, where 2 loops of the bowel remain in the sac with the connecting loop inside the abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Richter's hernia:</strong> In Richter's hernia, a small portion of the antimesenteric wall of the intestine is trapped within the hernia. Strangulation can occur without the presence of intestinal obstruction. Clinically, it mimics gastroenteritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pantaloon hernia:</strong> In pantaloon hernia, both direct and indirect hernia occur on the same side.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Littre's hernia:</strong> In Littre's hernia, Meckel's diverticulum is the content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Maydl’s hernia, a condition where two bowel loops are within a hernial sac with the intervening segment lying within the peritoneal cavity and at risk for strangulation.</span></p>",
      "correct_choice_id": 356051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89413/SURGERY_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89413/SURGERY_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89249,
      "choices": [
        {
          "id": 355396,
          "text": "<p><span style=\"font-size:14.0pt;\">Carmustine</span></p>"
        },
        {
          "id": 355397,
          "text": "<p><span style=\"font-size:14.0pt;\">Lomustine</span></p>"
        },
        {
          "id": 355398,
          "text": "<p><span style=\"font-size:14.0pt;\">Temozolomide</span></p>"
        },
        {
          "id": 355399,
          "text": "<p><span style=\"font-size:14.0pt;\">Procarbazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with newly diagnosed glioblastoma multiforme begins chemoradiation. His oncologist prescribes an oral alkylating agent that crosses the blood–brain barrier. Which drug is this?</span></p>",
      "unique_key": "Q9420923",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Temozolomide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Temozolomide is an oral prodrug that spontaneously converts at physiologic pH to the active methylating species MTIC.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its small, lipophilic nature allows excellent penetration of the blood–brain barrier, achieving therapeutic concentrations in the CNS.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This property, along with its favorable oral dosing and toxicity profile, makes temozolomide the standard alkylating agent used concurrently with radiotherapy for glioblastoma multiforme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carmustine:</strong> Although it also penetrates the CNS and alkylates DNA, carmustine is given intravenously (or via wafer implants) and carries a higher risk of pulmonary fibrosis and delayed myelosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lomustine:</strong> This oral nitrosourea does cross the blood–brain barrier but causes prolonged, delayed bone marrow suppression and is typically reserved for recurrent disease rather than frontline chemoradiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Procarbazine:</strong> An oral methylhydrazine derivative used in Hodgkin lymphoma and brain tumor regimens (e.g., PCV), but its CNS penetration is inferior to temozolomide and it has more complex drug interactions and dietary restrictions (MAO inhibition).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Temozolomide is the preferred oral alkylating agent for glioblastoma because it is a lipophilic prodrug that readily crosses the blood–brain barrier and converts to a DNA‐methylating agent within the CNS.</span></p>",
      "correct_choice_id": 355398,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89249/PHARMA_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89249/PHARMA_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89034,
      "choices": [
        {
          "id": 354556,
          "text": "<p><span style=\"font-size:14.0pt;\">Laser photocoagulation of the neovascularization on Optic Disc</span></p>"
        },
        {
          "id": 354557,
          "text": "<p><span style=\"font-size:14.0pt;\">Laser photocoagulation of the entire Retina</span></p>"
        },
        {
          "id": 354558,
          "text": "<p><span style=\"font-size:14.0pt;\">Laser photocoagulation of the Retina outside the Central Posterior Pole</span></p>"
        },
        {
          "id": 354559,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravitreal Anti-VEGF Injection only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with proliferative diabetic retinopathy and poor clinic follow-up is found to have early neovascularization on his optic disc (NVD). He admits missing his last two appointments. What is the most appropriate intervention?</span></p>",
      "unique_key": "Q6338985",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Laser photocoagulation of the Retina outside the Central Posterior Pole&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Pan-retinal photocoagulation (PRP) is the standard of care for proliferative diabetic retinopathy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It:</span><ul><li><span style=\"font-size:14.0pt;\">Targets the ischemic peripheral retina, which reduces VEGF production.</span></li><li><span style=\"font-size:14.0pt;\">Leads to regression of neovascularization, including NVD.</span></li><li><span style=\"font-size:14.0pt;\">Is preferred especially in patients with poor follow-up, because it provides a durable response.</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_74AXao7.png\" width=\"396\" height=\"322\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Laser photocoagulation of the neovascularization on Optic Disc</strong>: Incorrect. This is not done because, Laser directly to the optic disc can cause damage to nerve fibers. It’s ineffective at treating the underlying ischemic drive for neovascularization. Neovascularization is a response to ischemia, and treating the ischemic peripheral retina is the key.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laser photocoagulation of the entire Retina</strong>: Incorrect. This is not precise or safe. The entire retina should not be treated, this would include healthy macula and posterior pole, leading to permanent central vision loss. Treatment needs to spare the central macula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intravitreal Anti-VEGF Injection only</strong>: Incorrect, but not best as monotherapy. Anti-VEGF is useful especially in NVE/NVD and macular edema. However, in patients with poor follow-up, PRP is more reliable because:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anti-VEGF effects are temporary.</span></li><li><span style=\"font-size:14.0pt;\">Patients may not return for re-injections.</span></li><li><span style=\"font-size:14.0pt;\">Monotherapy with anti-VEGF is not first-line in this setting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pan-retinal photocoagulation (PRP)&nbsp; treats the underlying ischemia that drives neovascularization.</span></li><li><span style=\"font-size:14.0pt;\">It is particularly important in non-compliant patients due to its longer-lasting effect compared to anti-VEGF injections.&nbsp;</span></li></ul>",
      "correct_choice_id": 354558,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89034/OPTHALMOLOGY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89034/OPTHALMOLOGY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89356,
      "choices": [
        {
          "id": 355824,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a maculopapular lesion caused by eosinophils.</span></p>"
        },
        {
          "id": 355825,
          "text": "<p><span style=\"font-size:14.0pt;\">It is due to neutrophil accumulation and resolves in 2-3 days.</span></p>"
        },
        {
          "id": 355826,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a capillary hemangioma and typically fades within the first year.</span></p>"
        },
        {
          "id": 355827,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a melanocyte-derived lesion that persists into adulthood.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about this lesion is true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QGtM5M5.png\" width=\"649\" height=\"465\"></p>",
      "unique_key": "Q1764014",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) It is a capillary hemangioma and typically fades within the first year.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Salmon patches, also known as stork bites or nevus simplex, are capillary hemangiomas that fade spontaneously within the first year of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is a maculopapular lesion caused by eosinophils:</strong> Describes erythema toxicum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It is due to neutrophil accumulation and resolves in 2-3 days:</strong> Seen in neonatal pustular melanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is a melanocyte-derived lesion that persists into adulthood:</strong> Describes Mongolian spots, not salmon patches.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Salmon patches are benign capillary hemangiomas that are self-limiting and usually resolve within the first year.</span></p>",
      "correct_choice_id": 355826,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89356/PEDIATRICS_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89356/PEDIATRICS_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89205,
      "choices": [
        {
          "id": 355224,
          "text": "<p><span style=\"font-size:14.0pt;\">85% of participants in the trials had a positive treatment response.</span></p>"
        },
        {
          "id": 355225,
          "text": "<p><span style=\"font-size:14.0pt;\">85% of the observed variability in effect sizes is due to heterogeneity rather than chance.</span></p>"
        },
        {
          "id": 355226,
          "text": "<p><span style=\"font-size:14.0pt;\">There is an 85% probability that the meta-analytic estimate is invalid.</span></p>"
        },
        {
          "id": 355227,
          "text": "<p><span style=\"font-size:14.0pt;\">85% of the included studies are of low methodological quality.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a meta-analysis of statin trials, the I² statistic is reported as 85%. Which interpretation is most accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5919098",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 85% of the observed variability in effect sizes is due to heterogeneity rather than chance.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>I² statistic</strong> quantifies the proportion of total variation across studies in a meta-analysis that is due to <strong>real differences</strong> (heterogeneity) rather than sampling error (chance).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">An I² of 85% indicates <strong>substantial heterogeneity</strong>, meaning that most of the variability among study results reflects genuine differences in effect sizes (e.g., populations, interventions, study designs) instead of random variation.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20111234.jpeg\" width=\"937\" height=\"305\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 85% of participants in the trials had a positive treatment</strong> <strong>response:</strong> I² is about <strong>between-study</strong> variability, not the proportion of individual participants responding to treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. There is an 85% probability that the meta-analytic estimate is invalid:&nbsp;</strong>I² does <strong>not</strong> measure validity or the likelihood of being wrong. It assesses consistency among included studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 85% of the included studies are of low methodological quality:</strong> I² does not reflect study quality. Poor methodology can contribute to heterogeneity, but I² itself only quantifies variance, not quality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A high I² (e.g., ≥75%) signals substantial heterogeneity among studies’ results in a meta-analysis, prompting further investigation of sources of variability (e.g., subgroup analyses, sensitivity analyses) before drawing definitive conclusions.</span></p>",
      "correct_choice_id": 355225,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89205/PSM_NEET_PG_GT_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89205/PSM_NEET_PG_GT_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89435,
      "choices": [
        {
          "id": 356136,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholangiocarcinoma</span></p>"
        },
        {
          "id": 356137,
          "text": "<p><span style=\"font-size:14.0pt;\">Metastatic colorectal carcinoma</span></p>"
        },
        {
          "id": 356138,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatocellular carcinoma</span></p>"
        },
        {
          "id": 356139,
          "text": "<p><span style=\"font-size:14.0pt;\">Pancreatic adenocarcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with a history of chronic hepatitis B presents with progressive abdominal distension, weight loss, and right upper quadrant discomfort. Laboratory studies reveal elevated alpha-fetoprotein levels. A liver biopsy is performed, and IHC staining is positive for Hep Par 1. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q6033421",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hepatocellular carcinoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hep Par 1 (Hepatocyte Paraffin 1)</strong> is a <strong>sensitive and specific immunohistochemical marker</strong> used to identify cells of <strong>hepatocellular origin</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It stains <strong>cytoplasmic enzymes in hepatocytes</strong>, and is especially useful in confirming <strong>hepatocellular carcinoma (HCC)</strong>, particularly when histologic features overlap with metastatic carcinomas or cholangiocarcinomas.</span></li><li><span style=\"font-size:14.0pt;\">This patient with a history of hepatitis B (a known risk factor for HCC), elevated AFP, and positive Hep Par 1 staining is most consistent with hepatocellular carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cholangiocarcinoma</strong>: Arises from bile ducts and typically does <strong>not express Hep Par 1</strong>; may stain for CK7/CK19 instead.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Metastatic colorectal carcinoma</strong>: Usually expresses <strong>CK20 and CDX2</strong>, not Hep Par 1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pancreatic adenocarcinoma</strong>: Typically expresses <strong>CK7 and CA19-9</strong>, not Hep Par 1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hep Par 1 is a specific immunohistochemical marker for hepatocellular differentiation and is most commonly used to confirm hepatocellular carcinoma.</span></p>",
      "correct_choice_id": 356138,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89435/PATHOLOGY_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89435/PATHOLOGY_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89065,
      "choices": [
        {
          "id": 354680,
          "text": "<p><span style=\"font-size:14.0pt;\">Chocolate agar</span></p>"
        },
        {
          "id": 354681,
          "text": "<p><span style=\"font-size:14.0pt;\">Buffered charcoal yeast extract (BCYE) agar</span></p>"
        },
        {
          "id": 354682,
          "text": "<p><span style=\"font-size:14.0pt;\">Thayer–Martin agar</span></p>"
        },
        {
          "id": 354683,
          "text": "<p><span style=\"font-size:14.0pt;\">MacConkey agar</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man presents with high fever, cough, and confusion after returning from a hotel stay. Sputum Gram stain shows abundant neutrophils but no organisms. Silver stain reveals faint, slender bacilli. Which culture medium is required to isolate the causative organism?</span></p>",
      "unique_key": "Q6416521",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Buffered charcoal yeast extract (BCYE) agar</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Legionella pneumophila is a <strong>fastidious</strong>, <strong>aerobic</strong>, Gram-negative bacillus that often eludes routine Gram and MacConkey cultures.</span></li><li><span style=\"font-size:14.0pt;\">It requires a specialized medium—<strong>BCYE agar</strong>—which provides L-cysteine and iron for growth.</span></li><li><span style=\"font-size:14.0pt;\">Culture on BCYE at 35 °C yields gray–white, glistening colonies within 3–5 days, confirming the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chocolate agar:</strong> Supports growth of many respiratory pathogens (e.g., Haemophilus, Neisseria), but <strong>lacks</strong> the cysteine/iron enrichment needed by Legionella.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Thayer–Martin agar:</strong> A selective medium for Neisseria gonorrhoeae and N. meningitidis, containing antibiotics that <strong>inhibit</strong> Legionella growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. MacConkey agar:</strong> Selective for lactose-fermenting Enterobacteriaceae; <strong>does not</strong> support Legionella due to its nutritional requirements and inhibitory bile salts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Legionella pneumophila is a <strong>fastidious</strong>, aerobic Gram-negative bacillus requiring <strong>L-cysteine</strong> and <strong>iron</strong> supplementation for growth; the only routine medium that provides these factors is <strong>Buffered Charcoal Yeast Extract (BCYE) agar</strong>.</span></p>",
      "correct_choice_id": 354681,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89065/MICROBIOLOGY_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89065/MICROBIOLOGY_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89039,
      "choices": [
        {
          "id": 354576,
          "text": "<p><span style=\"font-size:14.0pt;\">Precipitation zone forming around colonies</span></p>"
        },
        {
          "id": 354577,
          "text": "<p><span style=\"font-size:14.0pt;\">Color change from a pH indicator</span></p>"
        },
        {
          "id": 354578,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemolysis of embedded red blood cells</span></p>"
        },
        {
          "id": 354579,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluorescence under ultraviolet light</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A clinical laboratory inoculates egg yolk agar to identify Clostridium perfringens by its lecithinase activity. Which characteristic of this medium allows direct visualization of lecithinase action?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6542509",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Precipitation zone forming around colonies</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Egg yolk agar contains lecithin (phosphatidylcholine) from the yolk. C. perfringens produces <strong>lecithinase</strong>, an enzyme that hydrolyzes lecithin into phosphorylcholine and <strong>insoluble diglycerides</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These diglycerides precipitate in the agar immediately surrounding colonies, creating an <strong>opaque, white zone</strong>—a direct visual marker of lecithinase activity.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_A9ZbjWJ.png\" width=\"469\" height=\"476\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Color change from a pH indicator:</strong> Egg yolk agar does not include a pH-sensitive dye; opacity, not hue shift, indicates enzyme activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hemolysis of embedded red blood cells:</strong> Hemolysis occurs on blood agar. Egg yolk agar lacks intact erythrocytes, so no hemolytic clearing is observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fluorescence under ultraviolet light:</strong> No fluorogenic substrates are present; lecithinase activity is detected by precipitation, not fluorescence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lecithinase-positive organisms like C. perfringens produce an opaque precipitation halo on egg yolk agar due to hydrolysis of lecithin into insoluble diglycerides.</span></p>",
      "correct_choice_id": 354576,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89039/MICROBIOLOGY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89039/MICROBIOLOGY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89178,
      "choices": [
        {
          "id": 355116,
          "text": "<p><span style=\"font-size:14.0pt;\">Resting in dark bottom corners of water containers</span></p>"
        },
        {
          "id": 355117,
          "text": "<p><span style=\"font-size:14.0pt;\">Inclined adult resting posture at the water’s edge</span></p>"
        },
        {
          "id": 355118,
          "text": "<p><span style=\"font-size:14.0pt;\">Eggs laid singly with lateral floats</span></p>"
        },
        {
          "id": 355119,
          "text": "<p><span style=\"font-size:14.0pt;\">Larvae lacking a siphon tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A fogging team targets a mosquito species that breeds exclusively in clean, sunlit water collections and whose adults fly up to 3–5 km seeking human blood. Which behavior mismatches this vector’s biology?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9600036",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Resting in dark bottom corners of water containers</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described species is <strong>Anopheles</strong>, the primary malaria vector in India.</span></li><li><span style=\"font-size:14.0pt;\">Key Anopheles features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Breeding habitat:</strong> Clean, sunlit, fresh water (e.g., ponds, rice fields)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flight range:</strong> Relatively long (3–5 km), enabling wide dispersal</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eggs:</strong> Laid singly on the water surface; boat-shaped with lateral floats</span></li><li><span style=\"font-size:14.0pt;\"><strong>Larvae:</strong> Lack a siphon tube and rest parallel to the water surface</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adults:</strong> Rest with bodies inclined at an angle (head down) against surfaces near water. It sits at 45 degrees on the surface of skin while taking a bite.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Wings:</strong> Black spots&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Larvae or adults of container-breeding, short-flight mosquitoes (Aedes).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Aedes adults rest in dark container corners, not Anopheles.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20104602.jpeg\" width=\"713\" height=\"645\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inclined adult resting posture at the water’s edge:</strong> Anopheles adults rest at a characteristic 45° angle to the surface, often on vegetation or walls near breeding sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Eggs laid singly with lateral floats:</strong> Anopheles females deposit single boat-shaped eggs, each stabilized by paired floats—distinct from raft-laying Culex or strip-laying Aedes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Larvae lacking a siphon tube:</strong> Anopheles larvae breathe through spiracles on their eighth abdominal segment (no siphon) and lie parallel to the surface, unlike other genera with siphoned larvae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Anopheles</strong> mosquitoes breed in <strong>clean, sunlit waters</strong>, lay <strong>single boat-shaped eggs</strong>, have <strong>siphon-less larvae</strong> resting parallel to the surface, and adults rest <strong>inclined near water</strong>—they <strong>do not</strong> congregate in dark container corners (an Aedes trait).</span></p>",
      "correct_choice_id": 355116,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89178/PSM_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89178/PSM_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89423,
      "choices": [
        {
          "id": 356088,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are incorrect</span></p>"
        },
        {
          "id": 356089,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 are incorrect</span></p>"
        },
        {
          "id": 356090,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 are incorrect</span></p>"
        },
        {
          "id": 356091,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 are incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding pleomorphic adenoma, which of the following statement is/ are incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">These tumors are composed exclusively of ductal epithelial cells forming gland-like structures.</span></li><li><span style=\"font-size:14.0pt;\">Myoepithelial cells contribute to the diverse stromal components such as myxoid and chondroid areas.</span></li><li><span style=\"font-size:14.0pt;\">The tumor demonstrates dual immunoreactivity for both epithelial and myoepithelial markers like cytokeratin and S-100.</span></li><li><span style=\"font-size:14.0pt;\">Perineural invasion is a characteristic feature seen in pleomorphic adenoma.</span></li></ol><p><br><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20182107.jpeg\" width=\"505\" height=\"491\"></p>",
      "unique_key": "Q5344586",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1 and 4 are incorrect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>These tumors are composed exclusively of ductal epithelial cells forming gland-like structures: </strong>Incorrect. Pleomorphic adenomas are <strong>not composed exclusively of ductal epithelial cells</strong>. They are defined by the presence of <strong>both ductal (epithelial) and myoepithelial cells</strong>, contributing to their pleomorphic histology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Perineural invasion is a characteristic feature seen in pleomorphic adenoma: </strong>Incorrect. <strong>Perineural invasion is not characteristic</strong> of pleomorphic adenoma. It is more typically seen in <strong>malignant salivary gland tumors</strong> like adenoid cystic carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Myoepithelial cells contribute to the diverse stromal components such as myxoid and chondroid areas: </strong>Correct. Myoepithelial cells are responsible for producing the diverse stromal features such as <strong>myxoid</strong>, <strong>hyaline</strong>, <strong>chondroid</strong>, and sometimes <strong>osseous</strong> tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The tumor demonstrates dual immunoreactivity for both epithelial and myoepithelial markers like cytokeratin and S-100: </strong>Correct. Immunohistochemical profile includes dual staining: <strong>cytokeratin, EMA, and CEA</strong> for epithelial components, and <strong>S-100, actin, and vimentin</strong> for myoepithelial cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pleomorphic adenomas</strong> are benign salivary gland tumors composed of <strong>both epithelial and myoepithelial elements</strong>, showing <strong>epithelial and mesenchymal differentiation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Perineural invasion is not typical</strong> and suggests a malignant transformation.</span></li></ul>",
      "correct_choice_id": 356090,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89423/PATHOLOGY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89423/PATHOLOGY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89381,
      "choices": [
        {
          "id": 355924,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a&nbsp;</span></p>"
        },
        {
          "id": 355925,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
        },
        {
          "id": 355926,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
        },
        {
          "id": 355927,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-c, 4-d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the correct pair:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZMpg3Vn.png\" width=\"950\" height=\"342\"></strong></span></p>",
      "unique_key": "Q7521317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-b, 2-a, 3-d, 4-c</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagrammatic presentation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ecz0R2C.png\" width=\"656\" height=\"558\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1- b. Pressure Epiphysis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pressure epiphyses are regions of <strong>long bones</strong> where <strong>growth</strong> occurs due to the <strong>pressure</strong> applied to the <strong>epiphyseal plate</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Growth</strong> is a result of&nbsp;<strong>compression forces</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Example: </strong>The&nbsp;<strong>distal end</strong> of the femur is a <strong>pressure epiphysis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>During childhood</strong> and&nbsp;<strong>adolescence</strong>, the <strong>weight-bearing activities</strong> apply <strong>pressure</strong> on this epiphysis, <strong>allowing</strong> for&nbsp;<strong>bone elongation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2-a. Traction Epiphysis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Traction epiphyses are areas in long bones where <strong>growth happens</strong> in <strong>response</strong> to <strong>pulling</strong> or&nbsp;<strong>traction forces</strong> on the <strong>epiphyseal plate</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These forces are <strong>typically exerted</strong> by&nbsp;<strong>tendons</strong> or&nbsp;<strong>muscles</strong> attached to the bone.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Example: </strong>The&nbsp;<strong>proximal end</strong> of the tibia is a <strong>traction epiphysis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>action</strong> of the&nbsp;<strong>patellar tendon</strong>, connected to the&nbsp;<strong>tibial tuberosity</strong>, leads to&nbsp;<strong>traction forces</strong> that <strong>promote bone growth</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-d. Atavistic Epiphysis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Atavistic epiphyses are <strong>secondary centers of ossification</strong> that are&nbsp;<strong>rare</strong> and may&nbsp;<strong>resemble ancestral bone structures</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are considered&nbsp;<strong>vestigial</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Example: </strong>The presence of an additional <strong>epiphysis</strong> in the <strong>elbow joint</strong> that is not typically seen in modern humans would be considered an atavistic epiphysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4-c. Aberrant Epiphysis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aberrant epiphyses are <strong>anomalous growth centers</strong> or <strong>irregularities</strong> in <strong>bone development</strong> that&nbsp;<strong>deviate</strong> from the usual patterns.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Example:</strong> An individual with an&nbsp;<strong>extra epiphyseal center</strong> in the&nbsp;<strong>metacarpal bone</strong>, not commonly observed in the general population, would have an aberrant epiphysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2JShdUs.png\" width=\"866\" height=\"361\"></strong></span></p>",
      "correct_choice_id": 355925,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89381/Anatomy_FMGE_GT__Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89381/Anatomy_FMGE_GT__Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89587,
      "choices": [
        {
          "id": 356740,
          "text": "<p><span style=\"font-size:14.0pt;\">Colle’s fracture&nbsp;</span></p>"
        },
        {
          "id": 356741,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral epicondyle fracture&nbsp;</span></p>"
        },
        {
          "id": 356742,
          "text": "<p><span style=\"font-size:14.0pt;\">Medial epicondyle fracture&nbsp;</span></p>"
        },
        {
          "id": 356743,
          "text": "<p><span style=\"font-size:14.0pt;\">Supracondylar fracture&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old child presents to your clinic with the following deformity of the right arm. Which is the most likely fracture leading to such a defect?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ygbs8U6.png\" width=\"390\" height=\"406\"></span></p>",
      "unique_key": "Q3897850",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"color:windowtext;font-size:14.0pt;\"><strong>Ans. D)&nbsp;Supracondylar fracture</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>supracondylar fracture</strong> is a common type of <strong>elbow fracture</strong> in children, typically occurring in children aged 5 to 10 years old.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It usually results from a <strong>fall on an outstretched hand (FOOSH)</strong> or a direct trauma to the elbow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The fracture occurs just above the <strong>condyles</strong> of the humerus, involving the distal part of the bone.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It can lead to significant deformity and complications, such as nerve injury (like <strong>median nerve</strong> damage) or vascular compromise (like <strong>brachial artery</strong> injury).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Supracondylar fractures</strong> often present with a typical <strong>“gunstock deformity”</strong> in the elbow, which results in <strong>cubitus varus</strong> (a varus angulation of the elbow).</span></li><li><span style=\"font-size:14.0pt;\">This deformity involves the angulation of the elbow, which can resemble the deformity shown in the question, especially if it is a displaced or malaligned fracture. This makes it the most likely diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Colle’s Fracture:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>Colle’s fracture</strong> is a type of <strong>distal radius fracture</strong> that occurs when a person falls onto an outstretched hand, causing the distal radius to break and displace <strong>dorsally</strong> (toward the back of the hand).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This fracture is common in older adults, especially those with osteoporosis, but can also occur in children. It is characterized by <strong>dorsal displacement</strong> of the distal fragment.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>Colle's fracture</strong> involves the <strong>radius</strong> and affects the wrist, not the <strong>elbow</strong>. Therefore, this fracture would not lead to a deformity at the elbow as shown in the question. This fracture does not match the typical presentation of <strong>supracondylar fractures</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lateral Epicondyle Fracture:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>lateral epicondyle fracture</strong> involves the <strong>lateral epicondyle</strong> of the humerus, which is located on the outer part of the elbow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This injury is less common in children compared to other elbow fractures and typically occurs due to direct trauma or a <strong>fall</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lateral epicondyle fractures can lead to elbow instability or disruption of the <strong>extensor tendon attachments</strong>, but they do not typically cause the same deformity seen in <strong>supracondylar fractures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">While a <strong>lateral epicondyle fracture</strong> may cause some elbow pain and dysfunction, it is <strong>less likely</strong> to cause a noticeable deformity such as a <strong>gunstock deformity</strong> or angulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This type of fracture would be less likely to present as the deformity described in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Medial Epicondyle Fracture:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>medial epicondyle fracture</strong> involves the <strong>medial epicondyle</strong> of the humerus, which is located on the inner part of the elbow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This type of fracture can occur due to direct trauma or excessive stress, such as in <strong>throwing injuries</strong> (e.g., in young athletes who participate in baseball or other throwing sports).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Medial epicondyle fractures are also associated with the avulsion of the <strong>flexor tendons</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Although a <strong>medial epicondyle fracture</strong> can cause elbow pain and dysfunction, it does not typically lead to the characteristic deformities seen with <strong>supracondylar fractures</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The deformity shown in the question is more consistent with a <strong>supracondylar fracture</strong> rather than a medial epicondyle fracture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Supracondylar fractures are the most common elbow fractures in children and can result in the characteristic cubitus varus deformity (also called the gunstock deformity).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This deformity is caused by improper alignment during healing and is the most likely outcome based on the deformity shown in the question.</span></li></ul>",
      "correct_choice_id": 356743,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89587/Orthopedics_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89587/Orthopedics_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89337,
      "choices": [
        {
          "id": 355748,
          "text": "<p><span style=\"font-size:14.0pt;\">Follow-up ultrasound after 6 weeks</span></p>"
        },
        {
          "id": 355749,
          "text": "<p><span style=\"font-size:14.0pt;\">Pelvic computed tomography (CT scan)</span></p>"
        },
        {
          "id": 355750,
          "text": "<p><span style=\"font-size:14.0pt;\">Diagnostic laparoscopy</span></p>"
        },
        {
          "id": 355751,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum CA-125 level estimation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old multiparous woman complains of mild dull aching abdominal pain. Her periods are regular and her LMP was 3 weeks back. On pelvic examination, a mass is felt through the posterior fornix. Ultrasound reveals a simple ovarian cyst measuring 5 x 5 cm. What is the next best step in the management of this patient?</span></p>",
      "unique_key": "Q6347825",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Follow-up ultrasound after 6 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>premenopausal women</strong>, <strong>simple ovarian cysts</strong> up to <strong>5 cm in size</strong> are commonly <strong>functional cysts</strong> and often resolve spontaneously without intervention.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>clear ovarian cyst</strong> seen on <strong>ultrasound</strong>, especially if <strong>unilocular, thin-walled, and less than or equal to 5 cm</strong>, is generally benign.</span></li><li><span style=\"font-size:14.0pt;\">The standard recommendation is to perform <strong>repeat ultrasound in 6 weeks</strong> to assess for spontaneous resolution.</span></li><li><span style=\"font-size:14.0pt;\">Surgical intervention or further diagnostic tests are unnecessary unless the cyst persists, grows in size, becomes symptomatic, or exhibits complex features.</span></li><li><span style=\"font-size:14.0pt;\">This conservative approach minimizes unnecessary surgical risk while ensuring appropriate surveillance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pelvic computed tomography (CT scan):</strong> Incorrect. <strong>CT pelvis</strong> is not the first-line modality for ovarian cyst evaluation. <strong>Ultrasound</strong> is more sensitive for pelvic pathology. CT is generally reserved for staging known malignancies or complex masses with atypical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diagnostic laparoscopy:</strong> Incorrect. <strong>Laparoscopy</strong> is indicated if the cyst persists, grows, or exhibits suspicious features such as septations, solid components, or papillary projections. It is not indicated for an initial finding of a <strong>simple cyst measuring 5 cm</strong> in a premenopausal woman.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum CA-125 level estimation:</strong> Incorrect. <strong>CA-125</strong> is not routinely indicated for simple ovarian cysts in <strong>premenopausal women</strong>, as it lacks specificity and can be elevated in benign conditions like endometriosis or pelvic inflammatory disease. CA-125 is more useful in postmenopausal women or if the mass appears suspicious on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In premenopausal women, a simple ovarian cyst measuring up to 5 cm on ultrasound is managed conservatively with repeat imaging after 6 weeks to monitor for spontaneous resolution, avoiding unnecessary interventions.</span></p>",
      "correct_choice_id": 355748,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89337/OBG_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89337/OBG_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89030,
      "choices": [
        {
          "id": 354540,
          "text": "<p><span style=\"font-size:14.0pt;\">Weiss ring</span></p>"
        },
        {
          "id": 354541,
          "text": "<p><span style=\"font-size:14.0pt;\">Fleischer’s ring</span></p>"
        },
        {
          "id": 354542,
          "text": "<p><span style=\"font-size:14.0pt;\">Vossius ring</span></p>"
        },
        {
          "id": 354543,
          "text": "<p><span style=\"font-size:14.0pt;\">Soemmering’ ring</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">On slit-lamp examination of a patient with early keratoconus, you note a pigmented iron ring encircling the base of the cone. What is this finding called?&nbsp;</span></p>",
      "unique_key": "Q9890231",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Fleischer’s ring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fleischer’s ring</strong> is an epithelial iron deposition that appears as a yellow-brown or greenish pigmented ring at the base of the cone in keratoconus.</span></li><li><span style=\"font-size:14.0pt;\">It forms because tears pool in the trough created by the conical protrusion, allowing iron to accumulate in the epithelial cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This ring often correlates with the area of maximal corneal thinning and steepening, and can be highlighted with cobalt blue illumination to improve visibility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20103041.jpg\" width=\"637\" height=\"466\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mQQjWXr.png\" width=\"707\" height=\"305\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Other Signs in Keratoconus include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vogt’s striae:</strong> These are fine vertical stress lines in the stromal collagen of the cone that temporarily disappear when gentle pressure is applied to the cornea; they are <strong>not</strong> pigmented.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rizzuti’s sign:</strong> Observed when a penlight shone from the temporal side produces a bright, triangular reflection on the nasal cornea; this reflects the cone shape but does <strong>not</strong> involve iron deposition.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Munson’s sign:</strong> A V-shaped indentation of the lower eyelid seen on downgaze, caused by the protruding conical cornea; this is a lid configuration sign rather than an epithelial finding.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Weiss ring</strong>: A vitreous opacity seen in posterior vitreous detachment at the optic disc&nbsp; (not corneal).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dtakYMr.png\" width=\"438\" height=\"428\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vossius ring</strong>: Represents pigment on the anterior lens capsule after blunt trauma to the eye (not related to keratoconus). It is iron deposition on anterior lens capsule</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LO2G77q.png\" width=\"406\" height=\"395\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Soemmering’s ring</strong>:&nbsp; A ring of retained lens epithelial cells seen after cataract extraction (not corneal). It is posterior capsular ossification.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YB3ML3F.png\" width=\"533\" height=\"419\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In keratoconus, <strong>Fleischer’s ring</strong> is the pigmented iron ring at the base of the cone, distinguishing it from stress lines (Vogt’s striae), light reflex signs (Rizzuti), and lid changes (Munson).</span></p>",
      "correct_choice_id": 354541,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89030/OPTHALMOLOGY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89030/OPTHALMOLOGY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89183,
      "choices": [
        {
          "id": 355136,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 355137,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 355138,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 355139,
          "text": "<p><span style=\"font-size:14.0pt;\">All except 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman had a non-medicated (inert) copper IUD placed 6 weeks ago. She now reports significantly heavier menses lasting 7 days but is hemodynamically stable and mildly anemic. Which statements are true regarding management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Increased bleeding is the most common&nbsp;side effect and often resolves by 1–2 months.</span></li><li><span style=\"font-size:14.0pt;\">You should remove the IUD immediately to stop the bleeding.</span></li><li><span style=\"font-size:14.0pt;\">First‐line management is reassurance and a course of IFA for 1–2 months.</span></li><li><span style=\"font-size:14.0pt;\">If bleeding remains heavy or persists beyond 2 months, removal is indicated.</span></li></ol>",
      "unique_key": "Q8072832",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>1.</strong> <strong>Increased bleeding is the MC side effect and often resolves by 1–2 months: </strong>True. Copper IUDs frequently cause heavier menstrual bleeding in the first 1–2 months. This side effect is well recognized and typically improves as the endometrium adapts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>First‐line management is reassurance and a course of IFA for 1–2 months: </strong>True. Initial management consists of reassuring the patient that this is common, prescribing <strong>IFA for 1–2 months</strong> to address mild anemia, and monitoring her response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">She should take Tab. FeSO<sub>4&nbsp;</sub>200 mg TDS for 8 weeks&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>If bleeding remains heavy or persists beyond 2 months, removal is indicated: </strong>True. If bleeding is <strong>heavy</strong> (e.g., soaking through pads every 1–2 hours) or <strong>persists beyond 2 months</strong>, then removal of the IUD is appropriate to alleviate symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>You should remove the IUD immediately to stop the bleeding: </strong>False. Immediate removal is <strong>not</strong> recommended for mild to moderate increased bleeding. The protocol is to observe and manage medically unless bleeding becomes severe or the patient is unstable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Don’t remove</strong> a copper IUD for mild-to-moderate early bleeding. <strong>Reassure</strong>, <strong>supplement with iron</strong>, and reserve <strong>removal</strong> for persistent or severe bleeding lasting longer than two months.</span></p>",
      "correct_choice_id": 355137,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89183/PSM_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89183/PSM_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89350,
      "choices": [
        {
          "id": 355800,
          "text": "<p><span style=\"font-size:14.0pt;\">Cri du Chat Syndrome</span></p>"
        },
        {
          "id": 355801,
          "text": "<p><span style=\"font-size:14.0pt;\">Smith-Lemli-Opitz Syndrome</span></p>"
        },
        {
          "id": 355802,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubinstein-Taybi Syndrome</span></p>"
        },
        {
          "id": 355803,
          "text": "<p><span style=\"font-size:14.0pt;\">Edward Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-month-old infant presents with a high-pitched cry, severe developmental delay, and microcephaly. Genetic testing confirms a chromosomal deletion on 5p. What is the diagnosis?</span></p>",
      "unique_key": "Q8740084",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Cri du Chat Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cri du Chat Syndrome is caused by a <strong>5p deletion</strong> and is characterized by a <strong>high-pitched cry</strong>, severe developmental delay, and microcephaly.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_K5sE0jA.png\" width=\"600\" height=\"218\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Smith-Lemli-Opitz Syndrome</strong>: Not associated with 5p deletion or a high-pitched cry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rubinstein-Taybi Syndrome</strong>: Features broad thumbs and a beaked nose, not a high-pitched cry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Edward Syndrome</strong>: Characterized by overlapping fingers and micrognathia, not a high-pitched cry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A high-pitched cry in an infant with developmental delay should prompt consideration of Cri du Chat Syndrome and chromosomal deletion testing.</span></p>",
      "correct_choice_id": 355800,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89350/PEDIATRICS_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89350/PEDIATRICS_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89797,
      "choices": [
        {
          "id": 357580,
          "text": "<p><span style=\"font-size:14.0pt;\">IV ceftriaxone</span></p>"
        },
        {
          "id": 357581,
          "text": "<p><span style=\"font-size:14.0pt;\">IV ciprofloxacin</span></p>"
        },
        {
          "id": 357582,
          "text": "<p><span style=\"font-size:14.0pt;\">IV vancomycin and meropenem</span></p>"
        },
        {
          "id": 357583,
          "text": "<p><span style=\"font-size:14.0pt;\">PO trimethoprim-sulfamethoxazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 57-year-old man with HCV-related cirrhosis and a MELD score of 20 presents to the ED with a 2-day history of abdominal pain, fever to 38.5°C, and nausea. He has a history of ascites managed with diuretics and denies recent alcohol use. Paracentesis reveals 510 nucleated cells (75% neutrophils), with no evidence of bleeding. His BP is 110/70 mmHg, and he appears uncomfortable. Which is the most appropriate treatment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3654281",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) IV ceftriaxone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Paracentesis findings (510 cells, 75% neutrophils) indicate spontaneous bacterial peritonitis (SBP) in this cirrhotic patient, confirmed by &gt;250 neutrophils.</span></li><li><span style=\"font-size:14.0pt;\">IV ceftriaxone is the first-line empiric therapy for SBP, covering common gram-negative pathogens like E. coli and Klebsiella.</span></li><li><span style=\"font-size:14.0pt;\">The patient’s fever and discomfort necessitate prompt antibiotic initiation to prevent sepsis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV Ciprofloxacin:</strong> Is used for SBP prophylaxis, not empiric treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IV Vancomycin and meropenem:</strong> Are overly broad for uncomplicated SBP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PO trimethoprim-sulfamethoxazole:&nbsp;</strong>Oral TMP-SMX lacks adequate coverage for SBP pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SBP in cirrhosis is diagnosed by paracentesis showing &gt;250 neutrophils and treated with IV ceftriaxone.</span></li><li><span style=\"font-size:14.0pt;\">Prompt antibiotics are critical to prevent complications like sepsis.</span></li></ul>",
      "correct_choice_id": 357580,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89797/Medicine_Neet_Pg_Gt_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89797/Medicine_Neet_Pg_Gt_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89353,
      "choices": [
        {
          "id": 355812,
          "text": "<p><span style=\"font-size:14.0pt;\">Supplemental oxygen to maintain SpO₂ &gt;92%</span></p>"
        },
        {
          "id": 355813,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous antibiotics</span></p>"
        },
        {
          "id": 355814,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous monitoring of respiratory rate and effort</span></p>"
        },
        {
          "id": 355815,
          "text": "<p><span style=\"font-size:14.0pt;\">Maintenance of normothermia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonate with TTN (transient tachypnoea of newborn) is being monitored in the NICU. Which of the following management strategies is not indicated?</span></p>",
      "unique_key": "Q4490196",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Intravenous antibiotics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Antibiotics are not routinely required for TTN unless there is suspicion of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Supplemental oxygen</strong> <strong>to maintain SpO₂ &gt;92%:</strong> Indicated for hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Continuous monitoring of respiratory rate and effort:</strong> Crucial in TTN management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Maintenance of normothermia:</strong> Important to minimize metabolic demands.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">TTN is managed with supportive care, and antibiotics are reserved for cases with clinical or laboratory evidence of infection.</span></p>",
      "correct_choice_id": 355813,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89353/PEDIATRICS_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89353/PEDIATRICS_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89798,
      "choices": [
        {
          "id": 357584,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Vancomycin</span></p>"
        },
        {
          "id": 357585,
          "text": "<p><span style=\"font-size:14.0pt;\">MRI brain</span></p>"
        },
        {
          "id": 357586,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent trans-esophageal echo</span></p>"
        },
        {
          "id": 357587,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Dexamethasone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old woman with a history of IV drug use presents to the ER with a 4-day history of fever, chills, back pain, and inability to lift her right arm above shoulder level. What is the next step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1633108",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) IV Vancomycin</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with features concerning for <strong>infective endocarditis with possible spinal epidural abscess or vertebral osteomyelitis</strong>, both of which are common in <strong>IV drug users</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Fever + back pain + limb weakness/restriction → suggests <strong>spinal infection with possible neurologic compromise</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Given her IV drug use and high suspicion for <strong>MRSA</strong>, <strong>empiric antibiotic therapy should be started immediately</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IV Vancomycin</strong> provides coverage for <strong>methicillin-resistant Staphylococcus aureus (MRSA)</strong>, the most likely pathogen in this setting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. MRI brain:&nbsp;</strong>Not indicated initially; her presentation suggests <strong>spinal</strong>, not intracranial, pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Urgent Trans-esophageal echo:&nbsp;</strong>Urgent Transesophageal echocardiography (TEE) is important in diagnosing endocarditis, but <strong>antibiotics must be started immediately</strong> in febrile IV drug users with systemic signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IV Dexamethasone:&nbsp;</strong>Steroids are used for <strong>spinal cord compression due to malignancy</strong>, not first-line for spinal infections. Antibiotics come first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>IV drug users with fever and back pain</strong> should raise concern for <strong>epidural abscess or vertebral osteomyelitis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Empiric IV Vancomycin</strong> is the most appropriate first step to cover <strong>MRSA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Imaging and TEE are important but <strong>should not delay empiric therapy</strong> in suspected serious bacterial infection.</span></li></ul>",
      "correct_choice_id": 357584,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89798/MEDICINE_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89798/MEDICINE_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89305,
      "choices": [
        {
          "id": 355620,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum beta-hCG concentration</span></p>"
        },
        {
          "id": 355621,
          "text": "<p><span style=\"font-size:14.0pt;\">Characteristic snowstorm appearance on ultrasound</span></p>"
        },
        {
          "id": 355622,
          "text": "<p><span style=\"font-size:14.0pt;\">Histopathological examination showing hydropic villi and trophoblastic proliferation</span></p>"
        },
        {
          "id": 355623,
          "text": "<p><span style=\"font-size:14.0pt;\">History of passing grape-like vesicles per vagina</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the definitive method for diagnosing&nbsp;molar pregnancy?</span></p>",
      "unique_key": "Q6735442",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Histopathological examination showing hydropic villi and trophoblastic proliferation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While clinical presentation, elevated <strong>beta-hCG levels</strong>, and characteristic <strong>ultrasound findings (snowstorm appearance)</strong> are highly suggestive of <strong>molar pregnancy</strong>, the <strong>definitive diagnosis</strong> requires <strong>histopathological confirmation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Microscopic examination of evacuated tissue revealing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hydropic swelling of chorionic villi</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Circumferential trophoblastic proliferation</strong> is the gold standard for diagnosis.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Histological analysis not only confirms the diagnosis but also helps differentiate between <strong>complete</strong> and <strong>partial molar pregnancy</strong>, which have different management and malignant potential.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated serum beta-hCG concentration:</strong> Incorrect. Although <strong>markedly increased beta-hCG</strong> levels are a hallmark of molar pregnancy, this finding is not specific enough for a definitive diagnosis because beta-hCG can also be elevated in normal pregnancy, multiple gestations, or choriocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Characteristic snowstorm appearance on ultrasound:</strong> Incorrect. The <strong>snowstorm pattern on ultrasound</strong> is a classic imaging finding suggestive of molar pregnancy but is <strong>not diagnostic</strong>. Ultrasound cannot distinguish molar pregnancy from other gestational trophoblastic diseases with certainty.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. History of passing grape-like vesicles per vagina:</strong> Incorrect. Although <strong>passing clear or grape-like vesicles</strong> is a notable clinical feature of molar pregnancy, it is neither consistent nor definitive. This clinical sign alone does not confirm the diagnosis without histological evidence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The definitive diagnosis of molar pregnancy is established by histopathological examination showing hydropic chorionic villi and trophoblastic proliferation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">obsClinical presentation, elevated beta-hCG, and ultrasound findings are supportive but not diagnostic<strong>.</strong></span></li></ul>",
      "correct_choice_id": 355622,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89305/OBG_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89305/OBG_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89431,
      "choices": [
        {
          "id": 356120,
          "text": "<p><span style=\"font-size:14.0pt;\">Waxy cast</span></p>"
        },
        {
          "id": 356121,
          "text": "<p><span style=\"font-size:14.0pt;\">RBC cast</span></p>"
        },
        {
          "id": 356122,
          "text": "<p><span style=\"font-size:14.0pt;\">WBC cast</span></p>"
        },
        {
          "id": 356123,
          "text": "<p><span style=\"font-size:14.0pt;\">Maltese cross cast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male is diagnosed with Fabry disease presents with progressive renal involvement. A urinalysis is ordered. Which of the following urinary casts or findings is most likely to be seen in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1892501",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Maltese cross cast</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fabry disease</strong> is an <strong>X-linked recessive lysosomal storage disorder</strong> caused by a deficiency of the enzyme <strong>α-galactosidase A</strong>, leading to the accumulation of <strong>globotriaosylceramide (Gb3)</strong> in various tissues, including <strong>renal epithelial cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>urine microscopy</strong>, <strong>lipid-containing oval fat bodies</strong> are seen due to nephrotic-range proteinuria and lipiduria.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These fat bodies exhibit a <strong>\"Maltese cross\"</strong> pattern under polarized light, which is a <strong>hallmark finding</strong> in <strong>Fabry disease</strong> and other causes of lipiduria.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-05%20102054.jpeg\" width=\"464\" height=\"506\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Waxy casts</strong>: Seen in <strong>chronic kidney disease</strong> and <strong>end-stage renal failure</strong>, not specific to Fabry disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. RBC casts</strong>: Typically found in <strong>glomerulonephritis</strong> (e.g., post-streptococcal GN, lupus nephritis), not Fabry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. WBC casts</strong>: Seen in <strong>interstitial nephritis</strong> or <strong>pyelonephritis</strong>, not in Fabry disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>Fabry disease</strong>, the <strong>accumulation of lipid-rich material</strong> in renal tubules leads to the presence of <strong>Maltese cross-shaped oval fat bodies</strong> on <strong>urine microscopy</strong> under polarized light.</span></li><li><span style=\"font-size:14.0pt;\">This is a distinguishing feature and helps in clinical recognition of <strong>lipiduria associated with nephrotic-range proteinuria</strong>.</span></li></ul>",
      "correct_choice_id": 356123,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89431/PATHOLOGY_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89431/PATHOLOGY_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89057,
      "choices": [
        {
          "id": 354648,
          "text": "<p><span style=\"font-size:14.0pt;\">Trypanosoma cruzi – Romana’s sign</span></p>"
        },
        {
          "id": 354649,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasma gondii – Ring-enhancing brain lesions</span></p>"
        },
        {
          "id": 354650,
          "text": "<p><span style=\"font-size:14.0pt;\">Babesia microti – Maltese cross forms on blood smear</span></p>"
        },
        {
          "id": 354651,
          "text": "<p><span style=\"font-size:14.0pt;\">Leishmania donovani – Amastigotes in macrophages</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy returns from a family trip to rural Brazil and presents with unilateral periorbital swelling, conjunctivitis, and a subcutaneous “chagoma” at the site of a recent insect bite. Which pathogen and finding pair is most consistent with his presentation?</span></p>",
      "unique_key": "Q7325510",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Trypanosoma cruzi – Romana’s sign</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Romana’s sign</strong> is the characteristic painless, unilateral periorbital edema and conjunctival inflammation seen in <strong>acute Chagas disease</strong> caused by Trypanosoma cruzi.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The parasite enters through the conjunctiva or a bite wound of the reduviid (“kissing”) bug, forming a local inflammatory “chagoma” and leading to this distinctive ocular finding within days of infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Toxoplasma gondii – Ring-enhancing brain lesions:</strong> Typical of reactivated toxoplasmosis in immunocompromised hosts, not associated with periorbital swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Babesia microti – Maltese cross forms on blood smear:</strong> Causes hemolytic anemia; no periorbital sign or chagoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leishmania donovani – Amastigotes in macrophages:</strong> Visceral leishmaniasis presents with hepatosplenomegaly and pancytopenia, not ocular swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a patient develops painless, one-sided periorbital swelling after exposure to reduviid bugs, think <strong>Romana’s sign or chagoma’s</strong> of <strong>acute Chagas disease</strong>.</span></p>",
      "correct_choice_id": 354648,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89057/MICROBIOLOGY_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89057/MICROBIOLOGY_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89374,
      "choices": [
        {
          "id": 355896,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased afferent firing from baroreceptors → Increased vagal output</span></p>"
        },
        {
          "id": 355897,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased carotid sinus firing → Increased parasympathetic tone</span></p>"
        },
        {
          "id": 355898,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of aortic arch baroreceptors → Sympathetic inhibition</span></p>"
        },
        {
          "id": 355899,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemoreceptor stimulation → Enhanced parasympathetic discharge</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman undergoes carotid massage for paroxysmal supraventricular tachycardia (PSVT). Seconds after massage, she experiences bradycardia, mild hypotension, and lightheadedness. Which of the following physiological changes best explains the observed bradycardia?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9577099",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Increased carotid sinus firing → Increased parasympathetic tone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Carotid massage</strong> mechanically stimulates <strong>baroreceptors in the carotid sinus</strong>, which perceive it as <strong>increased BP</strong>. This leads to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">↑ <strong>baroreceptor firing</strong></span></li><li><span style=\"font-size:14.0pt;\">↑ <strong>afferent signals via glossopharyngeal nerve</strong></span></li><li><span style=\"font-size:14.0pt;\">↑ <strong>vagal stimulation to SA and AV nodes</strong></span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Result: <strong>Bradycardia and transient hypotension</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This is used therapeutically in PSVT to <strong>slow AV nodal conduction</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20114134.jpeg\" width=\"714\" height=\"603\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased afferent firing</strong> <strong>from baroreceptors → Increased vagal</strong> <strong>output:</strong> Occurs in hypotension—not during carotid massage. It would <strong>increase</strong> sympathetic tone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Activation of aortic arch baroreceptors → Sympathetic inhibition:</strong> Less sensitive; mainly respond to <strong>higher BP ranges</strong>. Carotid sinus dominates reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chemoreceptor stimulation → Enhanced parasympathetic discharge:</strong> Respond to hypoxia/CO₂—not involved here. They cause <strong>tachycardia</strong>, not bradycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Carotid sinus baroreceptor activation</strong> triggers a <strong>parasympathetic reflex</strong> that slows heart rate, which can be used therapeutically in <strong>supraventricular tachycardias</strong>.</span></p>",
      "correct_choice_id": 355897,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89374/PHYSIOLOGY_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89374/PHYSIOLOGY_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89803,
      "choices": [
        {
          "id": 357604,
          "text": "<p><span style=\"font-size:14.0pt;\">Provide reassurance</span></p>"
        },
        {
          "id": 357605,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal biopsy</span></p>"
        },
        {
          "id": 357606,
          "text": "<p><span style=\"font-size:14.0pt;\">Start steroids</span></p>"
        },
        {
          "id": 357607,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop hydroxychloroquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman with SLE, lupus nephritis, and antiphospholipid syndrome on warfarin presents with a 3-week history of increasing fatigue, low-grade fevers, rash, and bilateral wrist pain/swelling. She is adherent to hydroxychloroquine. Labs reveal low C3/C4, and elevated ESR/CRP. What is the next best step in her management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3481417",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Start steroids</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is consistent with active SLE flare (fever, rash, arthritis, low C3/C4 and elevated ESR/CRP).</span></li><li><span style=\"font-size:14.0pt;\">Systemic steroids are indicated to control acute SLE flare symptoms, including joint inflammation and systemic inflammation.</span></li><li><span style=\"font-size:14.0pt;\">Hydroxychloroquine should be continued for long-term SLE management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Provide Reassurance:</strong> Is inappropriate with active SLE symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Renal biopsy:</strong> Is not indicated without proteinuria or hematuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stop hydroxychloroquine:&nbsp;</strong>Is unnecessary; it’s essential for SLE control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Active SLE flares require systemic steroids to manage symptoms like arthritis and rash.</span></li><li><span style=\"font-size:14.0pt;\">Continuation of hydroxychloroquine is critical for long-term disease control.</span></li></ul>",
      "correct_choice_id": 357606,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89803/Medicine_Neet_Pg_Gt_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89803/Medicine_Neet_Pg_Gt_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89426,
      "choices": [
        {
          "id": 356100,
          "text": "<p><span style=\"font-size:14.0pt;\">Defective B-cell maturation due to RAG1/2 mutation</span></p>"
        },
        {
          "id": 356101,
          "text": "<p><span style=\"font-size:14.0pt;\">Defective interaction between B-cells and T-cells due to CD40L mutation</span></p>"
        },
        {
          "id": 356102,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired antigen presentation due to MHC class I deficiency</span></p>"
        },
        {
          "id": 356103,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation in BTK gene leading to absence of mature B-cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy is brought to the clinic for evaluation of recurrent ear and respiratory infections. His past history includes episodes of pneumonia and otitis media. He also developed oral thrush and chronic diarrhea. Physical examination reveals no lymphadenopathy or tonsillar tissue. Laboratory testing shows: Hemoglobin 9.8 g/dL, Platelets 105,000/μL, TLC 3,200/Μl and serum Ig levels as IgM (markedly elevated), IgG (decreased) and IgA (decreased). Flow cytometry reveals normal numbers of CD19+ B-cells and CD3+ T-cells. Genetic testing is likely to conform which of the following as the underlying mechanism of this patient’s condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7860963",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Defective interaction between B-cells and T-cells due to CD40L mutation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child has <strong>Hyper-IgM Syndrome</strong>, most often caused by an <strong>X-linked mutation in CD40 ligand (CD40L)</strong> on T cells, which impairs the ability of T cells to stimulate B cells to undergo <strong>class-switch recombination</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As a result:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>IgM is markedly elevated</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>IgG, IgA, and IgE are decreased</strong></span></li><li><span style=\"font-size:14.0pt;\">Despite <strong>normal numbers of B- and T-cells</strong>, there is impaired communication between them</span></li><li><span style=\"font-size:14.0pt;\">Patients present with recurrent <strong>sinopulmonary infections</strong>, <strong>opportunistic infections</strong>, and sometimes <strong>cytopenias</strong> (anemia, thrombocytopenia, leukopenia)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Defective B-cell maturation due to RAG1/2 mutation</strong>: This is seen in <strong>Severe Combined Immunodeficiency (SCID)</strong> due to failure of V(D)J recombination, leading to absence of both B- and T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Impaired antigen presentation due to MHC class I deficiency</strong>: Leads to low CD8+ T-cells and recurrent <strong>viral infections</strong>, but does not cause hyper-IgM or affect B-T interaction via CD40/CD40L.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mutation in BTK gene leading to absence of mature B-cells</strong>: Seen in <strong>X-linked agammaglobulinemia (Bruton’s)</strong>, characterized by absence of mature B-cells and all immunoglobulin classes, not elevated IgM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyper-IgM Syndrome</strong> is caused by a defect in <strong>CD40–CD40L interaction</strong>, leading to failure of class-switch recombination despite normal numbers of B and T cells.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It presents with elevated IgM, low IgG/IgA, recurrent infections, and X-linked inheritance (CD40L mutation).</span></li></ul>",
      "correct_choice_id": 356101,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89426/PATHOLOGY_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89426/PATHOLOGY_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89589,
      "choices": [
        {
          "id": 356748,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Osteochondroma</span></p>"
        },
        {
          "id": 356749,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Ewing sarcoma</span></p>"
        },
        {
          "id": 356750,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Chondrosarcoma</span></p>"
        },
        {
          "id": 356751,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteosarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old male presents with a painless, hard, and immobile mass located near his left knee. The mass has been gradually increasing in size over the past year. On physical examination, there is a bony protuberance on the distal femur. The overlying skin appears normal, and there is no erythema or warmth. Radiographs of the knee are shown below. Based on the X-ray findings and clinical presentation, which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2JHGPUm.png\" width=\"342\" height=\"441\"></strong></span></p>",
      "unique_key": "Q5150627",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. A) Osteochondroma</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most common benign bone tumour. It is an outgrowth of bone covered by a cartilaginous cap.</span></li><li><span style=\"font-size:14.0pt;\">Typically presents in adolescents and young adults (fitting the 15-year-old).</span></li><li><span style=\"font-size:14.0pt;\">Often found near growth plates, especially around the knee (distal femur, proximal tibia) – fitting \"near his left knee\" and \"distal femur.\"</span></li><li><span style=\"font-size:14.0pt;\">Usually painless (unless causing mechanical irritation, nerve compression, or fracture), hard, immobile, gradually growing, and presents as a bony protuberance. Overlying skin is typically normal.</span></li><li><span style=\"font-size:14.0pt;\">Characteristically appears as a sessile or pedunculated bony outgrowth from the external surface of the bone, with the cortex and medullary cavity of the lesion being continuous with the underlying bone. This continuity is the hallmark radiographic sign.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option B. Ewing Sarcoma:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A highly malignant primary bone tumour.</span></li><li><span style=\"font-size:14.0pt;\">Common in children and young adults (fits the age).</span></li><li><span style=\"font-size:14.0pt;\">Often presents with pain, swelling, and sometimes systemic symptoms (fever, weight loss). The pain is usually progressive and can be severe. It is rarely painless for a year.</span></li><li><span style=\"font-size:14.0pt;\">Typically presents as an aggressive, lytic lesion in the diaphysis or meta diaphysis of long bones, often with a characteristic \"onion-skin\" periosteal reaction. Not usually a discrete \"bony protuberance.\"</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Chondrosarcoma:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A malignant tumour of cartilage.</span></li><li><span style=\"font-size:14.0pt;\">Less common in adolescents; usually affects older adults (over 40-50 years old), although secondary chondrosarcomas can arise from osteochondromas in younger individuals, this is usually not the initial presentation and implies malignant transformation.</span></li><li><span style=\"font-size:14.0pt;\">Often slow growing but can be painful.</span></li><li><span style=\"font-size:14.0pt;\">May show calcification within the cartilaginous matrix (rings and arcs pattern), endosteal scalloping, and cortical destruction. Not typically a continuous bony outgrowth.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Osteosarcoma:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A highly malignant primary bone tumour that produces osteoid (immature bone).</span></li><li><span style=\"font-size:14.0pt;\">Most common in adolescents and young adults (fits the age).</span></li><li><span style=\"font-size:14.0pt;\">Often found in the metaphysis of long bones, especially around the knee (distal femur, proximal tibia).</span></li><li><span style=\"font-size:14.0pt;\">Typically presents with significant pain, swelling, and sometimes a palpable mass. The pain is usually severe and progressive. A painless mass for a year makes this less likely for an initial presentation.</span></li><li><span style=\"font-size:14.0pt;\">Aggressive lesion with osteoid matrix formation (sclerotic areas), cortical destruction, soft tissue mass, and classic periosteal reactions like a \"sunburst\" appearance or Codman's triangle. Not a continuous bony outgrowth.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">The combination of the patient's age, the nature of the mass, and the presumed radiographic findings strongly points to Osteochondroma.</span></p>",
      "correct_choice_id": 356748,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89589/Orthopedics_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89589/Orthopedics_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89409,
      "choices": [
        {
          "id": 356032,
          "text": "<p><span style=\"font-size:14.0pt;\">Radioiodine scan</span></p>"
        },
        {
          "id": 356033,
          "text": "<p><span style=\"font-size:14.0pt;\">Post-operative calcitonin and CEA</span></p>"
        },
        {
          "id": 356034,
          "text": "<p><span style=\"font-size:14.0pt;\">Conservative management</span></p>"
        },
        {
          "id": 356035,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female has recently undergone total thyroidectomy for a thyroid mass. The histopathological examination shows papillary thyroid cancer. What would be the further management of this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4827427",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Radioiodine scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">After a total thyroidectomy for papillary thyroid cancer, the usual next step is a radio-iodine scan to look for metastasis.</span></li><li><span style=\"font-size:14.0pt;\">It is performed 3-6 weeks postoperatively&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After total thyroidectomy for papillary thyroid cancer, a radioiodine scan (also known as I-123 or RAI scan) is often used to detect any remaining thyroid tissue or metastatic disease.</span></li><li><span style=\"font-size:14.0pt;\">It can also aid in planning for subsequent radioactive iodine therapy, if necessary, to ablate residual tissue or treat metastatic disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient is usually given a dose of radioactive iodine, which is taken up by any remaining thyroid cells, and then imaging is done to determine the distribution of the radioactivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Post-operative calcitonin and CEA:&nbsp;</strong>Incorrect They are performed in medullary thyroid cancer. In PTC, serum Thyroglobulin is done.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Conservative management:&nbsp;</strong>Incorrect. Simply monitoring without further treatment is not the standard of care for papillary thyroid cancer after surgery, especially when the cancer is of significant size, shows aggressive features, or has spread to lymph nodes or distant sites. Typically, the patient will undergo some form of adjuvant therapy or monitoring, often starting with a radioiodine scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chemotherapy:</strong> Incorrect for early and most intermediate stages. Chemotherapy isn't a standard treatment for most thyroid cancers. However, it might be recommended for people who don't respond to standard treatments and for certain types of aggressive thyroid cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radioiodine scan to detect any remaining thyroid tissue and potential metastasis usually after 3-6 weeks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Based on the findings, further therapeutic radioactive iodine might be administered. Regular follow-up, including blood tests and imaging studies, will be necessary to monitor for any recurrence or metastasis.</span></li></ul>",
      "correct_choice_id": 356032,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89409/SURGERY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89409/SURGERY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89367,
      "choices": [
        {
          "id": 355868,
          "text": "<p><span style=\"font-size:14.0pt;\">Simple diffusion</span></p>"
        },
        {
          "id": 355869,
          "text": "<p><span style=\"font-size:14.0pt;\">Exocytosis</span></p>"
        },
        {
          "id": 355870,
          "text": "<p><span style=\"font-size:14.0pt;\">Receptor-mediated endocytosis</span></p>"
        },
        {
          "id": 355871,
          "text": "<p><span style=\"font-size:14.0pt;\">Facilitated diffusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child presents with signs of developmental delay and recurrent infections. Genetic testing reveals a rare inherited disorder affecting vesicular trafficking. Further studies indicate a defect in a coated protein involved in internalization of molecules such as LDL cholesterol and transferrin. The clinician suspects a dysfunction in a protein that forms triskelion-shaped scaffolds around budding vesicles. Which cellular process is primarily impaired in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8841681",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Receptor-mediated endocytosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical scenario describes a <strong>clathrin-related transport disorder</strong>. <strong>Clathrin</strong> is a protein that forms a <strong>coated pit</strong> on the cytoplasmic side of the plasma membrane, essential for <strong>receptor-mediated endocytosis</strong>—a selective process used to internalize nutrients (like iron via transferrin or cholesterol via LDL receptors) and hormones.</span></li><li><span style=\"font-size:14.0pt;\">Defects in clathrin or its adaptor proteins impair <strong>vesicle formation</strong>, leading to inadequate uptake of critical macromolecules.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Simple diffusion:</strong> Passive movement of small nonpolar molecules (e.g., O₂, CO₂), does <strong>not involve proteins</strong> or vesicles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Exocytosis:</strong> Involves <strong>secretion</strong>, not uptake, and uses different machinery (e.g., SNARE proteins).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Facilitated diffusion:</strong> Uses <strong>carrier or channel proteins</strong>, not vesicle formation or clathrin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clathrin-mediated receptor endocytosis</strong> is a critical cellular process for internalizing specific molecules.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Defects in clathrin</strong> impair this pathway, leading to clinical consequences such as nutrient deficiency or signal transduction errors.</span></li></ul>",
      "correct_choice_id": 355870,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89367/PHYSIOLOGY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89367/PHYSIOLOGY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89044,
      "choices": [
        {
          "id": 354596,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid overgrowth of contaminants within 3–5 days</span></p>"
        },
        {
          "id": 354597,
          "text": "<p><span style=\"font-size:14.0pt;\">Faster growth of Leptospira with enhanced motility</span></p>"
        },
        {
          "id": 354598,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete inhibition of Leptospira growth</span></p>"
        },
        {
          "id": 354599,
          "text": "<p><span style=\"font-size:14.0pt;\">Conversion of Leptospira into nonmotile coccoid forms</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">While establishing cultures for suspected leptospirosis, you accidentally incubate Fletcher’s semisolid medium at 37°C instead of the recommended 30°C. What is the most likely outcome?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8468977",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Complete inhibition of Leptospira growth</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Leptospira are <strong>obligate aerobes</strong> with a narrow optimal growth temperature around <strong>28–30°C</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Their enzymes and membrane structures are adapted to this lower temperature.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Incubation at <strong>37°C</strong> disrupts their metabolic processes and prevents replication altogether.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Unlike some bacteria that tolerate a broad temperature range or form survival variants, Leptospira simply <strong>fail to grow</strong> at body temperature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rapid overgrowth of contaminants within 3–5 days:</strong> Contaminants may grow at 37°C, but the defining effect is absence of Leptospira growth rather than just contaminants flourishing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Faster growth of Leptospira with enhanced motility:</strong> Higher temperatures inhibit Leptospira; they do not speed up growth or motility above their optimum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Option D. Conversion of Leptospira into nonmotile coccoid forms:</strong> Leptospira do not form coccoid or spore‐like survival forms; they simply do not replicate when conditions are unfavorable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Leptospira culture requires incubation at ~30°C; temperatures at or above 37°C inhibit growth completely.</span></p>",
      "correct_choice_id": 354598,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89044/MICROBIOLOGY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89044/MICROBIOLOGY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89399,
      "choices": [
        {
          "id": 355992,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior orbital fissure</span></p>"
        },
        {
          "id": 355993,
          "text": "<p><span style=\"font-size:14.0pt;\">Cavernous sinus</span></p>"
        },
        {
          "id": 355994,
          "text": "<p><span style=\"font-size:14.0pt;\">Optic canal</span></p>"
        },
        {
          "id": 355995,
          "text": "<p><span style=\"font-size:14.0pt;\">Infratemporal fossa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman with facial cellulitis near the nose<strong>&nbsp;</strong>develops<strong>&nbsp;</strong>headache, ophthalmoplegia, ptosis<strong>,&nbsp;</strong>and loss of corneal reflex on the right side. Neurologic exam reveals impaired abduction and sensory loss in V1 territory. Which of the following structures is most likely involved?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7141715",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cavernous sinus</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Cavernous sinus thrombosis</strong> from <strong>facial infection</strong> can affect CN III, IV, V1, V2, VI, and cause <strong>corneal reflex loss, ophthalmoplegia, and ptosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Superior orbital fissure</strong>: Carries similar nerves but not likely infected from facial cellulitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Optic canal</strong>: Only CN II and ophthalmic artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Infratemporal fossa</strong>: Involved in mandibular nerve lesions, not ophthalmoplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Facial infections in the danger triangle</strong> can spread to the <strong>cavernous sinus</strong>, leading to <strong>multiple cranial nerve palsies and ophthalmic signs</strong>.</span></p>",
      "correct_choice_id": 355993,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89399/ANATOMY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89399/ANATOMY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89432,
      "choices": [
        {
          "id": 356124,
          "text": "<p><span style=\"font-size:14.0pt;\">BCR-ABL fusion gene</span></p>"
        },
        {
          "id": 356125,
          "text": "<p><span style=\"font-size:14.0pt;\">CALR mutation</span></p>"
        },
        {
          "id": 356126,
          "text": "<p><span style=\"font-size:14.0pt;\">JAK2 V617F mutation</span></p>"
        },
        {
          "id": 356127,
          "text": "<p><span style=\"font-size:14.0pt;\">MPL mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man presents with headache, facial plethora, pruritus after hot showers. Physical examination shows splenomegaly. Laboratory evaluation shows elevated hemoglobin and hematocrit. Leukocyte and platelet counts are also increased. Bone marrow biopsy reveals hypercellularity with prominent erythroid, granulocytic, and megakaryocytic proliferation. Serum erythropoietin level is decreased. Which of the following mutations is most strongly associated with the pathogenesis of this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4631154",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) JAK2 V617F mutation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with features suggestive of <strong>Polycythemia Vera (PV)</strong>, a <strong>chronic myeloproliferative neoplasm</strong> characterized by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Erythrocytosis</strong> (↑ RBC mass)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Leukocytosis</strong> and <strong>thrombocytosis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low serum erythropoietin levels</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypercellular bone marrow with panmyelosis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Splenomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Aquagenic pruritus</strong> (pruritus triggered by hot water)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>JAK2 V617F mutation</strong> is present in <strong>&gt;95%</strong> of PV cases and leads to constitutive activation of the <strong>JAK-STAT signaling pathway</strong>, promoting uncontrolled proliferation of hematopoietic cells independent of erythropoietin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. BCR-ABL fusion gene:</strong> Seen in <strong>Chronic Myeloid Leukemia (CML)</strong>, not in PV. It results from the <strong>t(9;22)</strong> translocation (Philadelphia chromosome).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CALR mutation:</strong> Found in some cases of <strong>essential thrombocythemia</strong> and <strong>primary myelofibrosis</strong>, but not typically associated with PV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. MPL mutation:</strong> Associated with <strong>myeloproliferative disorders</strong> like <strong>essential thrombocythemia</strong> and <strong>primary myelofibrosis</strong>, but not PV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Polycythemia Vera</strong> is a myeloproliferative neoplasm characterized by <strong>JAK2 V617F mutation</strong>, which drives panmyelosis and elevated red cell mass.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;This mutation leads to erythropoietin-independent proliferation via <strong>JAK-STAT pathway activation</strong>.</span></li></ul>",
      "correct_choice_id": 356126,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89432/PATHOLOGY_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89432/PATHOLOGY_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89094,
      "choices": [
        {
          "id": 354792,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 354793,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 354794,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 354795,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A biochemistry student measures NADPH production in various metabolic enzymes. Which of the following enzymes generate NADPH under physiological conditions?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Cytosolic Isocitrate dehydrogenase</span></li><li><span style=\"font-size:14.0pt;\">Malic enzyme</span></li><li><span style=\"font-size:14.0pt;\">Succinate dehydrogenase</span></li><li><span style=\"font-size:14.0pt;\">α-Ketoglutarate dehydrogenase</span></li><li><span style=\"font-size:14.0pt;\">Pyruvate dehydrogenase</span></li></ol>",
      "unique_key": "Q6408216",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NADPH is a crucial reducing agent used in <strong>biosynthetic reactions</strong>, <strong>antioxidant defense (e.g., glutathione regeneration)</strong>, and <strong>cytochrome P450 metabolism</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is primarily generated by <strong>cytosolic reactions</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Cytosolic Isocitrate Dehydrogenase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a <strong>NADP⁺-dependent enzyme</strong> (not to be confused with mitochondrial IDH3 which uses NAD⁺).</span></li><li><span style=\"font-size:14.0pt;\">Catalyses the conversion of isocitrate → α-ketoglutarate + <strong>NADPH</strong> (in cytosol).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Yes, it generates NADPH.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Statement 2. Malic Enzyme:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also known as <strong>NADP⁺-dependent malate dehydrogenase</strong> (not to be confused with mitochondrial NAD⁺-dependent malate dehydrogenase).</span></li><li><span style=\"font-size:14.0pt;\">Converts malate → pyruvate + CO₂ + <strong>NADPH</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Yes, it generates NADPH.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Succinate Dehydrogenase:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Part of the <strong>TCA cycle</strong> and <strong>electron transport chain</strong> (Complex II).</span></li><li><span style=\"font-size:14.0pt;\">Uses <strong>FAD</strong>, not NAD⁺ or NADP⁺.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Does NOT generate NADPH.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;α-Ketoglutarate Dehydrogenase:&nbsp;</strong>Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mitochondrial TCA enzyme.</span></li><li><span style=\"font-size:14.0pt;\">Uses <strong>NAD⁺</strong> → NADH, not NADP⁺.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Generates NADH, not NADPH.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Pyruvate Dehydrogenase:&nbsp;</strong>Incorrect</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Converts pyruvate → acetyl-CoA + CO₂ + <strong>NADH</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Does NOT generate NADPH.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20125657.jpg\" width=\"1392\" height=\"532\"></strong></span></p>",
      "correct_choice_id": 354792,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89094/BIOCHEM_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89094/BIOCHEM_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89310,
      "choices": [
        {
          "id": 355640,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate laparotomy</span></p>"
        },
        {
          "id": 355641,
          "text": "<p><span style=\"font-size:14.0pt;\">Reposition the uterus and start intravenous oxytocin infusion</span></p>"
        },
        {
          "id": 355642,
          "text": "<p><span style=\"font-size:14.0pt;\">Arrange for blood transfusion and administer 20 units of oxytocin intravenously</span></p>"
        },
        {
          "id": 355643,
          "text": "<p><span style=\"font-size:14.0pt;\">Obtain an urgent ultrasound examination</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman, gravida 4 para 3, delivers at 37 weeks of gestation following rapid progression of labor. Immediately after the baby is born, the placenta is expelled spontaneously. Soon after, the patient complains of sudden abdominal pain and collapses. On physical examination, the uterus is not palpable abdominally, and a mass is detected on vaginal examination. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2586392",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Reposition the uterus and start intravenous oxytocin infusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with a classic clinical scenario of <strong>uterine inversion</strong>, a rare but life-threatening obstetric emergency that typically occurs immediately after the delivery of the placenta.</span></li><li><span style=\"font-size:14.0pt;\">Key <strong>clinical features</strong> include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Sudden onset abdominal pain following placental delivery</span></li><li><span style=\"font-size:14.0pt;\">Hemodynamic collapse (shock)</span></li><li><span style=\"font-size:14.0pt;\">Absence of uterine fundus on abdominal palpation</span></li><li><span style=\"font-size:14.0pt;\">A mass felt protruding into or through the vagina</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>immediate management</strong> of uterine inversion is:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Manual repositioning of the uterus (Johnson maneuver)</strong> — The uterus must be promptly pushed back through the vagina into its normal position to prevent irreversible uterine constriction and worsening hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Initiation of uterotonic agents (e.g., oxytocin)</strong> — After successful repositioning, <strong>oxytocin is started</strong> to promote uterine contraction and prevent re-inversion.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">Delay in repositioning increases morbidity due to hemorrhage and shock.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immediate laparotomy:</strong> Incorrect. <strong>Laparotomy</strong> is reserved for cases where <strong>manual repositioning fails</strong> or if the uterus is irreducible by vaginal approach. The next best step in this acute scenario is <strong>immediate manual repositioning</strong>, not surgical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Arrange for blood transfusion and administer 20 units of oxytocin intravenously:</strong> Incorrect. Although <strong>blood transfusion and oxytocin</strong> are critical supportive measures, <strong>repositioning of the inverted uterus is the priority</strong> before administering uterotonics. Administering oxytocin before repositioning can make the uterus more difficult to reposition due to induced contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Obtain an urgent ultrasound examination:</strong> Incorrect. The diagnosis of <strong>uterine inversion</strong> is a <strong>clinical diagnosis</strong> and does not require confirmation by ultrasound. Any delay for imaging can worsen hemorrhage and shock. Immediate repositioning is critical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uterine inversion is an obstetric emergency presenting with shock, abdominal pain, and a vaginal mass following delivery.</span></li><li><span style=\"font-size:14.0pt;\">The immediate management is manual repositioning of the uterus followed by administration of oxytocin to maintain uterine tone.</span></li></ul>",
      "correct_choice_id": 355641,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89310/OBG_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89310/OBG_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89024,
      "choices": [
        {
          "id": 354516,
          "text": "<p><span style=\"font-size:14.0pt;\">Ollier disease</span></p>"
        },
        {
          "id": 354517,
          "text": "<p><span style=\"font-size:14.0pt;\">Maffucci syndrome</span></p>"
        },
        {
          "id": 354518,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiple osteochondromas</span></p>"
        },
        {
          "id": 354519,
          "text": "<p><span style=\"font-size:14.0pt;\">Metachondromatosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child presents with painless swelling of several fingers. A PA radiograph of both hands is shown in the below image. Which diagnosis is most likely?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-30%20123848.jpeg\" width=\"485\" height=\"405\"></span></p>",
      "unique_key": "Q2883264",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ollier disease</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Ollier disease is characterized by <strong>multiple enchondromas</strong>—benign cartilaginous tumors arising within the metaphyses of long bones and small bones of the hands and feet.</span></li><li><span style=\"font-size:14.0pt;\">On radiographs, these appear as expansile, lucent lesions with internal “rings‐and‐arcs” or punctate calcifications reflecting endochondral mineralization.</span></li><li><span style=\"font-size:14.0pt;\">The lesions are asymmetric and confined to the skeleton without associated vascular malformations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maffucci syndrome:</strong> Similar to Ollier but distinguished by the presence of venous malformations or hemangiomas (soft‐tissue calcifications and phleboliths) alongside enchondromas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Multiple osteochondromas:</strong> Show bony exostoses (cartilage‐capped projections) arising from the bone surface and pointing away from the joint; they are not intramedullary lucencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metachondromatosis</strong>: Features both enchondromas and osteochondromas, but the osteochondromas typically point toward the joint and often regress over time, unlike the purely enchondromatous lesions of Ollier.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ollier disease = multiple, asymmetric enchondromas with “rings-and-arcs” calcification on X-ray, no vascular malformations; Maffucci adds hemangiomas, osteochondromas are surface exostoses.</span></p>",
      "correct_choice_id": 354516,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89024/NEETPG-INICET_GT_Radiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89024/NEETPG-INICET_GT_Radiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89207,
      "choices": [
        {
          "id": 355232,
          "text": "<p><span style=\"font-size:14.0pt;\">A prolonged period of case occurrence extending beyond one incubation period</span></p>"
        },
        {
          "id": 355233,
          "text": "<p><span style=\"font-size:14.0pt;\">Frequent secondary cases from person-to-person spread</span></p>"
        },
        {
          "id": 355234,
          "text": "<p><span style=\"font-size:14.0pt;\">An explosive rise and fall in case numbers within one incubation period</span></p>"
        },
        {
          "id": 355235,
          "text": "<p><span style=\"font-size:14.0pt;\">Severity of illness increasing with age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A summer‐camp counselor brings 25 campers to the infirmary complaining of sudden onset abdominal cramps, vomiting, and diarrhea. All symptoms began within 4–6 hours after eating the same contaminated potato salad at lunch. Over the next 12 hours, almost every camper recovers without further transmission. Which feature best characterizes this type of outbreak?</span></p>",
      "unique_key": "Q3597352",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) An explosive rise and fall in case numbers within one incubation period</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This scenario describes a <strong>single‐exposure common‐vehicle (point‐source) outbreak</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Explosive epidemic curve:</strong> A sharp spike in cases occurs shortly after a single exposure (the potato salad), with most cases clustering within one incubation period.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Limited to one incubation period:</strong> Because everyone was exposed at the same time and the source is removed (meal over), new cases decline rapidly without ongoing transmission.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A prolonged period of case occurrence extending beyond one incubation period:&nbsp;</strong>Indicates a <strong>continuous common‐source</strong> outbreak where the source persists (e.g., contaminated water supply), leading to cases over multiple incubation periods.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Frequent secondary cases from person-to-person spread:</strong></span><br><span style=\"font-size:14.0pt;\">Suggests a <strong>propagated (person‐to‐person)</strong> outbreak, not a single‐exposure event.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Severity of illness increasing with age:</strong> Describes a pattern related to host factors, not the outbreak’s temporal pattern; it does not define the outbreak type.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>point‐source outbreak</strong>, look for a rapid surge and decline of cases—all occurring within one incubation period—reflecting simultaneous exposure rather than ongoing or person-to-person spread.</span></p>",
      "correct_choice_id": 355234,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89207/PSM_NEET_PG_GT_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89207/PSM_NEET_PG_GT_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89344,
      "choices": [
        {
          "id": 355776,
          "text": "<p><span style=\"font-size:14.0pt;\">Medroxyprogesterone acetate</span></p>"
        },
        {
          "id": 355777,
          "text": "<p><span style=\"font-size:14.0pt;\">Micronized progesterone</span></p>"
        },
        {
          "id": 355778,
          "text": "<p><span style=\"font-size:14.0pt;\">Levonorgestrel</span></p>"
        },
        {
          "id": 355779,
          "text": "<p><span style=\"font-size:14.0pt;\">Dydrogesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In menopausal women receiving hormone replacement therapy (HRT), which of the following preparations is commonly prescribed to protect the endometrium from the proliferative effects of estrogen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3288320",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Medroxyprogesterone acetate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>menopausal hormone replacement therapy</strong>, <strong>progesterone</strong> is added to <strong>estrogen therapy</strong> in women with an intact uterus to counteract the risk of <strong>endometrial hyperplasia and carcinoma</strong> caused by unopposed estrogen stimulation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medroxyprogesterone acetate (MPA)</strong> is the <strong>most commonly used progestin</strong> for this purpose in HRT regimens.</span></li><li><span style=\"font-size:14.0pt;\">It is effective in <strong>opposing estrogen’s action on the endometrium</strong>, thereby reducing the risk of hyperplasia and malignancy.</span></li><li><span style=\"font-size:14.0pt;\">It can be administered orally or intramuscularly and has an established safety and efficacy profile in menopausal HRT.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Micronized progesterone:</strong> Incorrect. Although <strong>micronized progesterone</strong> is also used in HRT and is better tolerated by some women, it is less commonly used compared to <strong>medroxyprogesterone acetate</strong> in standard practice. However, it may be preferred for its lower risk of breast cancer and cardiovascular side effects in certain patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Levonorgestrel:</strong> Incorrect. <strong>Levonorgestrel</strong> is primarily used in <strong>contraceptive formulations</strong> and intrauterine devices (IUDs), not as a standard systemic progestin in menopausal HRT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dydrogesterone:</strong> Incorrect. <strong>Dydrogesterone</strong> is a synthetic progestin used in selected hormone therapies but is <strong>less commonly used</strong> in standard menopausal HRT compared to <strong>medroxyprogesterone acetate</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Medroxyprogesterone acetate is the most commonly used progestin in hormone replacement therapy for menopausal women with an intact uterus to prevent estrogen-induced endometrial hyperplasia.</span></p>",
      "correct_choice_id": 355776,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89344/OBG_NEET_PG_GT_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89344/OBG_NEET_PG_GT_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89033,
      "choices": [
        {
          "id": 354552,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 354553,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 354554,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 354555,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about Susac Syndrome are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It commonly presents in young females.</span></li><li><span style=\"font-size:14.0pt;\">Retinal involvement is due to branch retinal artery occlusion.</span></li><li><span style=\"font-size:14.0pt;\">Sensorineural hearing loss is a component of the triad.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with large vessel vasculitis.</span></li></ol>",
      "unique_key": "Q8774457",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Susac Syndrome</strong> is a rare autoimmune endotheliopathy characterized by occlusion of microvessels in the brain, retina, and inner ear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It most often affects <strong>young women (usually in their 20s to 40s)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The classic triad includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Encephalopathy (neurological symptoms)</strong> — From microinfarctions in the brain, particularly the corpus callosum</span></li><li><span style=\"font-size:14.0pt;\"><strong>Branch Retinal Artery Occlusions (BRAO)</strong> — Leading to visual disturbances</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensorineural Hearing Loss</strong> — Due to cochlear microvascular involvement</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Susac syndrome is considered a <strong>small vessel vasculopathy</strong>, not large vessel vasculitis.</span></li><li><span style=\"font-size:14.0pt;\">It is thought to be mediated by autoimmune attack on endothelial cells, causing microvascular occlusions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>It commonly presents in young females:&nbsp;</strong>True<strong>.</strong> Susac syndrome predominantly affects <strong>young females</strong>, making this a correct statement.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Retinal involvement is due to branch retinal artery occlusion:&nbsp;</strong>True. The <strong>retinal involvement</strong> is due to <strong>branch retinal artery occlusion (BRAO)</strong>, causing transient or permanent visual symptoms.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Sensorineural hearing loss is a component of the triad:&nbsp;</strong>True. <strong>Sensorineural hearing loss</strong> is indeed part of the classical triad, resulting from microvascular damage to the cochlea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>It is associated with large vessel vasculitis:</strong> False. The condition involves <strong>small vessel vasculopathy</strong>, not <strong>large vessel vasculitis</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Susac syndrome is a rare autoimmune small vessel vasculopathy presenting with the triad of encephalopathy, branch retinal artery occlusion, and sensorineural hearing loss, predominantly in young females.</span></p>",
      "correct_choice_id": 354552,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89033/OPTHALMOLOGY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89033/OPTHALMOLOGY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89375,
      "choices": [
        {
          "id": 355900,
          "text": "<p><span style=\"font-size:14.0pt;\">Thought insertion</span></p>"
        },
        {
          "id": 355901,
          "text": "<p><span style=\"font-size:14.0pt;\">Flight of ideas</span></p>"
        },
        {
          "id": 355902,
          "text": "<p><span style=\"font-size:14.0pt;\">Derailment</span></p>"
        },
        {
          "id": 355903,
          "text": "<p><span style=\"font-size:14.0pt;\">Tangentiality</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man is brought by his family due to disorganized behavior and irrelevant speech. During the interview, he says, “I like to watch TV. My feet are cold. The universe is expanding. You know, elephants have great memories.”. He appears internally preoccupied and often talks to himself. What is the most likely thought disorder?&nbsp;</span></p>",
      "unique_key": "Q2828438",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Derailment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's <strong>speech jumps from one topic to another with no logical connection</strong>, as in: “I like to watch TV. My feet are cold. The universe is expanding. You know, elephants have great memories.”&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is classic <strong>derailment</strong>, a <strong>formal thought disorder</strong> commonly seen in <strong>schizophrenia</strong>. In derailment, the individual’s ideas <strong>slip off the track</strong> onto <strong>unrelated or loosely related topics</strong>, without returning to the original theme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Thought insertion</strong>: It is a <strong>disorder of possession of thoughts</strong> in which the person believes <strong>thoughts are being inserted into their mind</strong> by an external force. It is not a speech/thought flow issue.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Flight of ideas</strong>: Seen in <strong>mania</strong>, where thoughts <strong>rapidly shift</strong> but are <strong>connected by meaningful associations or wordplay</strong>—not evident here.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tangentiality</strong>: Involves <strong>responses that begin to answer a question but never reach the point</strong>, instead going off on tangents. In derailment, the person <strong>switches topics entirely</strong> with no logical progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Derailment is a formal thought disorder characterized by a loss of connection between successive thoughts.</span></p>",
      "correct_choice_id": 355902,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89375/Psychiatry_NEET_PG_GT_Question_1_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89375/Psychiatry_NEET_PG_GT_Question_1_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89186,
      "choices": [
        {
          "id": 355148,
          "text": "<p><span style=\"font-size:14.0pt;\">64.0%</span></p>"
        },
        {
          "id": 355149,
          "text": "<p><span style=\"font-size:14.0pt;\">68.2%</span></p>"
        },
        {
          "id": 355150,
          "text": "<p><span style=\"font-size:14.0pt;\">72.7%</span></p>"
        },
        {
          "id": 355151,
          "text": "<p><span style=\"font-size:14.0pt;\">80.0%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In Village A, the total population is 5,000, of whom 600 are children aged 0–6 years and thus excluded from literacy calculations. If 3,200 of the remaining residents can read and write with understanding in at least one Indian language. Calculate the literacy rate according to the 2011 Census definition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5641134",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 72.7%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Determine the denominator: </strong>The 2011 Census defines literacy rate as the proportion of literates among the population <strong>aged 7 years and above</strong>. Children aged 0–6 years are excluded.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Population&nbsp;≥&nbsp;7&nbsp;years = 5,000 – 600 = 4,400</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Identify the numerator:</strong></span><br><span style=\"font-size:14.0pt;\">Number of literate persons (aged ≥ 7 years) = <strong>3,200</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Compute the literacy rate:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20162826.jpg\" width=\"1016\" height=\"169\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Always exclude</strong> the 0–6 years age group when calculating the <strong>standard literacy rate</strong> under the 2011 Census; use <strong>population aged ≥ 7 years</strong> as the denominator.</span></p>",
      "correct_choice_id": 355150,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89186/PSM_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89186/PSM_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89801,
      "choices": [
        {
          "id": 357596,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood cultures</span></p>"
        },
        {
          "id": 357597,
          "text": "<p><span style=\"font-size:14.0pt;\">Echocardiogram</span></p>"
        },
        {
          "id": 357598,
          "text": "<p><span style=\"font-size:14.0pt;\">Complement levels</span></p>"
        },
        {
          "id": 357599,
          "text": "<p><span style=\"font-size:14.0pt;\">Kidney biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a history of alcoholic cirrhosis, and IV drug use presents to the ER with a 2-day history of a new rash on both lower extremities, malaise, and arthralgias. Examination shows a 2/6 systolic murmur at the lower sternal border, nodular liver, splenomegaly, and 4/5 strength in lower extremities. All of the following can be done except?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7489554",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Kidney biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation (rash, murmur, neurological deficits) in an IV drug user suggests ongoing infection or vasculitis.</span></li><li><span style=\"font-size:14.0pt;\">Blood cultures, echocardiogram, and complement/cryoglobulin testing are critical to evaluate for endocarditis and cryoglobulinemia.</span></li><li><span style=\"font-size:14.0pt;\">Kidney biopsy is premature without evidence of glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood cultures</strong>: Are essential to assess for persistent bacteremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Echocardiogram</strong>: Confirms endocarditis or valvular involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complement levels</strong>: Help evaluate for cryoglobulinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endocarditis in IV drug users requires blood cultures and echocardiogram.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cryoglobulinemia may be seen in IVDU due to risk of HCV infection.&nbsp;</span></li></ul>",
      "correct_choice_id": 357599,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89801/Medicine_Neet_Pg_Gt_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89801/Medicine_Neet_Pg_Gt_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89419,
      "choices": [
        {
          "id": 356072,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyoid bone</span></p>"
        },
        {
          "id": 356073,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior belly of digastric</span></p>"
        },
        {
          "id": 356074,
          "text": "<p><span style=\"font-size:14.0pt;\">Mylohyoid muscle</span></p>"
        },
        {
          "id": 356075,
          "text": "<p><span style=\"font-size:14.0pt;\">Horizontal line through the angle of the mandible</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents to the clinic with a lump under her jaw. On examination, the lump is found to be associated with the submandibular gland. Which structure separates the superficial and deep lobes of the submandibular gland?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6840767",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mylohyoid muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The mylohyoid muscle separates the superficial and deep lobes of the submandibular gland.</span></li><li><span style=\"font-size:14.0pt;\">The submandibular gland wraps around the posterior edge of the mylohyoid muscle, forming its superficial and deep parts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyoid bone:</strong> The hyoid bone is located in the anterior neck and does not play a role in separating the lobes of the submandibular gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Posterior belly of digastric:</strong> The posterior belly of the digastric muscle is located near the submandibular gland, but it does not separate the superficial and deep lobes of the gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Horizontal line through the angle of mandible:</strong> A horizontal line through the angle of the mandible is an anatomical reference but does not separate the superficial and deep lobes of the gland</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The mylohyoid muscle separates the superficial and deep lobes of the submandibular gland.</span></p>",
      "correct_choice_id": 356074,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89419/SURGERY_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89419/SURGERY_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89428,
      "choices": [
        {
          "id": 356108,
          "text": "<p><span style=\"font-size:14.0pt;\">It is associated with autosomal recessive inheritance due to a mismatch repair gene defect</span></p>"
        },
        {
          "id": 356109,
          "text": "<p><span style=\"font-size:14.0pt;\">Cardiac complications include Libman-Sacks endocarditis</span></p>"
        },
        {
          "id": 356110,
          "text": "<p><span style=\"font-size:14.0pt;\">The condition is due to APC mutation on chromosome 5q and is inherited in an autosomal dominant pattern</span></p>"
        },
        {
          "id": 356111,
          "text": "<p><span style=\"font-size:14.0pt;\">The most commonly mutated gene encodes a zinc finger transcription factor involved in pancreatic development</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old man presents with intermittent rectal bleeding, tenesmus, and occasional episodes of spurious diarrhea. He has a strong family history of colorectal cancer. Colonoscopy and biopsy findings of the patient are shown below. Which of the following statements about this patient’s condition is most accurate?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sUBYtbj.png\" width=\"1011\" height=\"345\"></strong></span></p>",
      "unique_key": "Q2606453",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The condition is due to APC mutation on chromosome 5q and is inherited in an autosomal dominant pattern</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s age, symptoms, and <strong>numerous adenomatous polyps</strong> on colonoscopy, along with <strong>signet ring appearance</strong> on microscopy are classic for <strong>Familial Adenomatous Polyposis (FAP)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FAP is caused by mutations in the APC gene located on chromosome 5q.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>It is inherited in an autosomal dominant pattern.</strong></span></li><li><span style=\"font-size:14.0pt;\">Patients typically develop hundreds to thousands of adenomatous polyps in the colon and rectum during adolescence or early adulthood.</span></li><li><span style=\"font-size:14.0pt;\">Without prophylactic colectomy, there is a near-100% risk of developing colorectal cancer.</span></li><li><span style=\"font-size:14.0pt;\">Associated features include increased risk of <strong>IBD</strong>, <strong>Streptococcus bovis endocarditis</strong>, and extracolonic tumors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It is associated with autosomal recessive inheritance due to a mismatch repair gene defect:</strong> Incorrect. This describes Lynch syndrome, not FAP. Lynch is due to mismatch repair gene mutations and is autosomal dominant, not recessive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Cardiac complications include Libman-Sacks endocarditis:</strong> Incorrect. Libman-Sacks endocarditis is associated with <strong>SLE</strong>, not FAP. FAP may predispose to <strong>S. bovis endocarditis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The most commonly mutated gene encodes a zinc finger transcription factor involved in pancreatic development:</strong> Incorrect. This describes mutations in <strong>PDX1</strong>, a transcription factor important in <strong>pancreatic development</strong>, and is <strong>not relevant</strong> to the pathogenesis of FAP or colon cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Familial Adenomatous Polyposis (FAP)</strong> is an autosomal dominant condition due to an <strong>APC gene mutation on chromosome 5q</strong>, characterized by ≥100 adenomatous colonic polyps, with high colorectal cancer risk if not surgically treated.</span></p>",
      "correct_choice_id": 356110,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89428/PATHOLOGY_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89428/PATHOLOGY_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89252,
      "choices": [
        {
          "id": 355408,
          "text": "<p><span style=\"font-size:14.0pt;\">Glipizide</span></p>"
        },
        {
          "id": 355409,
          "text": "<p><span style=\"font-size:14.0pt;\">Glibenclamide</span></p>"
        },
        {
          "id": 355410,
          "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 355411,
          "text": "<p><span style=\"font-size:14.0pt;\">Canagliflozin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man on treatment of type 2 diabetes reports progressive weight gain and worsening congestive heart failure. Which antihyperglycemic agent would be least likely to exacerbate his heart failure or cause weight gain?</span></p>",
      "unique_key": "Q1162591",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Canagliflozin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Canagliflozin</strong> is an SGLT2 inhibitor that promotes urinary glucose and sodium excretion, leading to <strong>osmotic diuresis, mild weight loss, and reduced preload/afterload on the heart</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Side effects:&nbsp;</strong>UTI and EKA</span></li><li><span style=\"font-size:14.0pt;\">Large clinical trials (e.g., CANVAS, EMPA-REG) have shown it <strong>reduces hospitalization for heart failure</strong> and is beneficial in such patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glipizide</strong>: A sulfonylurea that increases insulin secretion. Increased circulating insulin promotes <strong>lipogenesis</strong>, leading to <strong>weight gain</strong>. Though it does not directly worsen CHF, the associated weight gain can indirectly aggravate fluid overload in CHF patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glibenclamide</strong>: Another sulfonylurea, similar in mechanism to glipizide, causing <strong>weight gain</strong> and posing a risk of <strong>hypoglycemia</strong>, which may trigger sympathetic stimulation and potentially worsen CHF symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pioglitazone</strong>: A thiazolidinedione (TZD) that activates <strong>PPAR-γ receptors</strong>, improving insulin sensitivity but causing <strong>fluid retention, edema, and weight gain</strong>. It is <strong>contraindicated in patients with symptomatic heart failure</strong> because it can worsen CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a patient with type 2 diabetes and worsening congestive heart failure, choose an SGLT2 inhibitor like <strong>canagliflozin</strong> to avoid weight gain and fluid retention—in contrast to sulfonylureas or thiazolidinediones, which exacerbate these issues.</span></p>",
      "correct_choice_id": 355411,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89252/PHARMA_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89252/PHARMA_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89397,
      "choices": [
        {
          "id": 355984,
          "text": "<p><span style=\"font-size:14.0pt;\">Right cerebral peduncle and oculomotor nerve fascicle</span></p>"
        },
        {
          "id": 355985,
          "text": "<p><span style=\"font-size:14.0pt;\">Left internal capsule</span></p>"
        },
        {
          "id": 355986,
          "text": "<p><span style=\"font-size:14.0pt;\">Right abducens nucleus</span></p>"
        },
        {
          "id": 355987,
          "text": "<p><span style=\"font-size:14.0pt;\">Right optic tract</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man presents with right-sided ptosis, eye deviation down and out<strong>,&nbsp;</strong>and<strong>&nbsp;</strong>left-sided hemiparesis<strong>.</strong> He also shows an impaired pupillary light reflex on the right. Which of the following is the most likely site of the lesion?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9975186",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Right cerebral peduncle and oculomotor nerve fascicle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is <strong>Weber syndrome</strong>, a <strong>midbrain stroke</strong> involving the <strong>oculomotor nerve fascicle</strong> (causing third nerve palsy) and <strong>cerebral peduncle</strong> (causing contralateral hemiparesis).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Left internal capsule</strong>: Would cause <strong>contralateral hemiparesis</strong> but no cranial nerve palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Right abducens nucleus</strong>: Would cause lateral gaze palsy, not third nerve involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Right optic tract</strong>: Would cause <strong>left homonymous hemianopia</strong>, not motor deficits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Weber syndrome</strong> is due to a <strong>midbrain infarct</strong> affecting the <strong>oculomotor fascicle</strong> and <strong>corticospinal fibers</strong>, causing <strong>ipsilateral CN III palsy and contralateral hemiparesis</strong>.</span></p>",
      "correct_choice_id": 355984,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89397/ANATOMY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89397/ANATOMY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89788,
      "choices": [
        {
          "id": 357544,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastroenterology consultation for possible EGD</span></p>"
        },
        {
          "id": 357545,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiation of a calcium channel blocker</span></p>"
        },
        {
          "id": 357546,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgery consultation for possible esophagectomy</span></p>"
        },
        {
          "id": 357547,
          "text": "<p><span style=\"font-size:14.0pt;\">Antifungal therapy for empiric coverage of Candida</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with diabetes mellitus, hypertension, COPD, and coronary artery disease presents to the ED with a 5-week history of foul-smelling breath, vomiting after meals, and epigastric pressure. Barium swallow finding is shown below. He reports occasional chest discomfort but denies dysphagia for solids specifically. What is the most appropriate next step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fTBIUdY.png\" width=\"508\" height=\"508\"></strong></span></p>",
      "unique_key": "Q3283597",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Gastroenterology consultation for possible EGD</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The barium swallow shows a bird beak narrowing at the distal end with proximal dilatation, consistent with achalasia, a motility disorder causing dysphagia and regurgitation.</span></li><li><span style=\"font-size:14.0pt;\">Foul-smelling breath, vomiting, and epigastric pressure are common symptoms of achalasia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">EGD (Esophagogastroduodenoscopy) is essential to confirm achalasia and assess for complications like esophagitis or malignancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Initiation of a calcium channel blocker:&nbsp;</strong>Calcium channel blockers may relieve symptoms but require diagnostic confirmation first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Surgery consultation for possible esophagectomy:&nbsp;</strong>Esophagectomy is not first-line; EGD is needed to guide treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antifungal therapy for empiric coverage of Candida:&nbsp;</strong>Antifungal therapy is inappropriate without evidence of fungal infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Achalasia is characterized by esophageal dilation, regurgitation, and risk of aspiration.</span></li><li><span style=\"font-size:14.0pt;\">EGD is the initial diagnostic step to confirm the condition and guide management.</span></li></ul>",
      "correct_choice_id": 357544,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89788/Medicine_Neet_Pg_Gt_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89788/Medicine_Neet_Pg_Gt_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89254,
      "choices": [
        {
          "id": 355416,
          "text": "<p><span style=\"font-size:14.0pt;\">It inhibits ATP-citrate lyase, reducing cholesterol synthesis upstream of HMG-CoA reductase.</span></p>"
        },
        {
          "id": 355417,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a prodrug that is activated primarily in the liver, minimizing the risk of myopathy.</span></p>"
        },
        {
          "id": 355418,
          "text": "<p><span style=\"font-size:14.0pt;\">It significantly lowers triglycerides by activating PPAR-α receptors.</span></p>"
        },
        {
          "id": 355419,
          "text": "<p><span style=\"font-size:14.0pt;\">It may increase serum uric acid levels.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with a history of coronary artery disease and statin-associated myopathy is started on bempedoic acid for hypercholesterolemia. Which of the following statements about bempedoic acid is false?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9332608",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It significantly lowers triglycerides by activating PPAR-α receptors&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bempedoic acid does <strong>not</strong> activate PPAR-α and has only minimal impact on triglyceride levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its primary mechanism is inhibition of <strong>ATP-citrate lyase (ACL)</strong> in hepatocytes, which decreases acetyl-CoA availability for cholesterol synthesis upstream of HMG-CoA reductase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It inhibits ATP-citrate lyase, reducing cholesterol synthesis upstream of HMG-CoA reductase: </strong>True. Bempedoic acid inhibits <strong>ATP-citrate lyase (ACL)</strong>, reducing hepatic cholesterol synthesis and upregulating LDL receptors, lowering LDL-C.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>It is a prodrug that is activated primarily in the liver, minimizing the risk of myopathy: </strong>True. It is a <strong>prodrug</strong> converted to <strong>bempedoyl-CoA</strong> by <strong>ACSVL1</strong> enzyme, which is expressed mainly in the <strong>liver</strong> and not in skeletal muscle, explaining its <strong>low risk of myopathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>It may increase serum uric acid levels: </strong>True. Adverse effects include <strong>hyperuricemia</strong> (risk of gout) and <strong>rare tendon rupture</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bempedoic acid lowers LDL-C by <strong>ACL inhibition</strong> in the liver and carries a <strong>low myopathy risk</strong> but does <strong>not</strong> lower triglycerides via PPAR-α and may <strong>increase uric acid</strong>.</span></p>",
      "correct_choice_id": 355418,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89254/PHARMA_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89254/PHARMA_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89047,
      "choices": [
        {
          "id": 354608,
          "text": "<p><span style=\"font-size:14.0pt;\">Ehrlichia chaffeensis – Amblyomma americanum</span></p>"
        },
        {
          "id": 354609,
          "text": "<p><span style=\"font-size:14.0pt;\">Ehrlichia ewingii – Amblyomma americanum</span></p>"
        },
        {
          "id": 354610,
          "text": "<p><span style=\"font-size:14.0pt;\">Anaplasma phagocytophilum – Ixodes scapularis</span></p>"
        },
        {
          "id": 354611,
          "text": "<p><span style=\"font-size:14.0pt;\">Neorickettsia sennetsu – Ingestion of infected fish</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old rancher from Minnesota presents in spring with fever, headache, and profound neutropenia. A peripheral smear shows morulae within granulocytes. Which organism is most likely responsible, and what is its primary tick vector?</span></p>",
      "unique_key": "Q8498854",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Anaplasma phagocytophilum – Ixodes scapularis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pathogen biology:</strong> Anaplasma phagocytophilum infects neutrophils, forming characteristic intracytoplasmic morulae (microcolonies) within granulocytes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical features:</strong> Human granulocytic anaplasmosis typically presents in spring–summer with fever, severe myalgias, headache, and laboratory findings of <strong>neutropenia</strong>, thrombocytopenia, and mild transaminitis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vector and geography:</strong> In the Upper Midwest and northeastern United States (including Minnesota), Ixodes scapularis (black-legged tick) transmits A. phagocytophilum.</span></li><li><span style=\"font-size:14.0pt;\">These features contrast with other Anaplasmataceae members that infect monocytes, use different vectors, or require alternative exposure routes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ehrlichia chaffeensis – Amblyomma americanum:</strong> Causes human monocytic ehrlichiosis with morulae in <strong>monocytes</strong>, not neutrophils. The Lone Star tick transmits it, and patients often show lymphopenia and elevated liver enzymes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ehrlichia ewingii – Amblyomma americanum:</strong> Also infects granulocytes, but E. ewingii infections are rarer, typically milder, and epidemiologically overlap E. chaffeensis. It does not explain the classic Ixodes–Minnesota ecology nor the degree of neutropenia seen here. It is not tick mediated</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neorickettsia sennetsu – Ingestion of infected fish:</strong> Causes a mononucleosis‐like illness with atypical lymphocytosis, acquired by eating fish with trematode vectors—not by tick bite—and does not produce neutrophil morulae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a patient with early summer fever, headache, and intraneutrophilic morulae from Minnesota, think <strong>granulocytic anaplasmosis</strong> (Anaplasma phagocytophilum via Ixodes scapularis), not monocytic ehrlichiosis or fish‐borne Neorickettsia.</span></p>",
      "correct_choice_id": 354610,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89047/MICROBIOLOGY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89047/MICROBIOLOGY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89070,
      "choices": [
        {
          "id": 354700,
          "text": "<p><span style=\"font-size:14.0pt;\">Cochlear implant</span></p>"
        },
        {
          "id": 354701,
          "text": "<p><span style=\"font-size:14.0pt;\">Tympanoplasty with ossiculoplasty</span></p>"
        },
        {
          "id": 354702,
          "text": "<p><span style=\"font-size:14.0pt;\">Bone Anchored Hearing Aid (BAHA)</span></p>"
        },
        {
          "id": 354703,
          "text": "<p><span style=\"font-size:14.0pt;\">Auditory brainstem implant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy presents with chronic right ear discharge for the past year, unresponsive to multiple courses of antibiotics. He also has congenital canal<strong>&nbsp;</strong>atresia on the same side, making air-conduction hearing aid fitting unsuccessful. His bone conduction threshold is 30 dB, and cochlear function is normal on audiometry. Which of the following is the most appropriate next step for hearing rehabilitation?</span></p>",
      "unique_key": "Q4177014",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bone Anchored Hearing Aid (BAHA)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">BAHA is indicated when:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Air-conduction (AC) hearing aids cannot be used</strong>, e.g.:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>Canal atresia</strong> (congenital/acquired)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic ear discharge</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Feedback/discomfort</strong> from AC aids</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Conductive or mixed hearing loss</strong> where surgery is contraindicated</span></li><li><span style=\"font-size:14.0pt;\"><strong>Single-sided hearing loss</strong> with a normal cochlea</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This patient has <strong>canal atresia</strong>, <strong>chronic discharge</strong>, and a <strong>normal functioning cochlea and cochlear nerve</strong> (bone conduction threshold = 30 dB), fulfilling <strong>all criteria</strong> for BAHA.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20101749.jpeg\" width=\"1100\" height=\"591\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_w5IgMS2.png\" width=\"636\" height=\"664\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cochlear implant</strong>: Reserved for <strong>sensorineural hearing loss</strong> with <strong>non-functional cochlea/nerve</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tympanoplasty with ossiculoplasty</strong>: Not suitable due to <strong>chronic infection</strong> and <strong>canal atresia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Auditory brainstem implant</strong>: Used in <strong>bilateral acoustic neuromas</strong> or <strong>non-functional cochlea/nerve</strong>, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>BAHA</strong> is indicated in <strong>conductive/mixed hearing loss</strong> where <strong>air-conduction aids cannot be used</strong>, provided the <strong>cochlea and auditory nerve are functional</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is a key tool in managing <strong>canal atresia</strong>, <strong>chronic discharge</strong>, or <strong>single-sided deafness</strong> with good cochlear reserve.</span></li></ul>",
      "correct_choice_id": 354702,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89070/ENT_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89070/ENT_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89328,
      "choices": [
        {
          "id": 355712,
          "text": "<p><span style=\"font-size:14.0pt;\">Propylthiouracil (PTU) in the 1st trimester followed by methimazole in the 2nd and 3rd trimesters</span></p>"
        },
        {
          "id": 355713,
          "text": "<p><span style=\"font-size:14.0pt;\">Methimazole throughout pregnancy</span></p>"
        },
        {
          "id": 355714,
          "text": "<p><span style=\"font-size:14.0pt;\">Methimazole during the 1st trimester and Propylthiouracil (PTU) in the 2nd and 3rd trimesters</span></p>"
        },
        {
          "id": 355715,
          "text": "<p><span style=\"font-size:14.0pt;\">Propylthiouracil (PTU) for the entire duration of pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman is diagnosed with Graves' disease at her first prenatal visit. She requires antithyroid medication for hyperthyroidism management. According to the recommendations of the American Thyroid Association (ATA), which of the following is the safest treatment approach for her condition during pregnancy?</span></p>",
      "unique_key": "Q6801234",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Propylthiouracil (PTU) in the 1st trimester followed by methimazole in the 2nd and 3rd trimesters</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>American Thyroid Association (ATA)</strong> recommends a trimester-specific approach for the treatment of <strong>hyperthyroidism in pregnancy</strong> due to the differing risk profiles of <strong>methimazole (MMI)</strong> and <strong>propylthiouracil (PTU)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Propylthiouracil (PTU)</strong> is preferred in the <strong>first trimester</strong> because <strong>methimazole is associated with teratogenic effects</strong> when used during organogenesis (e.g., aplasia cutis, choanal atresia, tracheoesophageal fistula).</span></li><li><span style=\"font-size:14.0pt;\">After the <strong>first trimester</strong>, the risk of methimazole-associated birth defects declines, while the risk of <strong>PTU-induced hepatotoxicity</strong> increases with longer use. Therefore, <strong>methimazole is recommended in the 2nd and 3rd trimesters</strong> to minimize the risk of maternal liver injury.</span></li><li><span style=\"font-size:14.0pt;\">This switch strategy balances fetal and maternal safety throughout the pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methimazole throughout pregnancy</strong>: Incorrect. <strong>Methimazole</strong> use during the <strong>first trimester</strong> is avoided due to its association with congenital anomalies. Continuous use throughout pregnancy disregards the teratogenic risk in early gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methimazole during the 1st trimester and Propylthiouracil (PTU) in the 2nd and 3rd trimesters:</strong> Incorrect. This approach is not recommended. Using <strong>methimazole in the 1st trimester</strong> exposes the fetus to the risk of congenital malformations, which is specifically why <strong>PTU is preferred early in pregnancy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Propylthiouracil (PTU) for the entire duration of pregnancy:</strong> Incorrect. Though <strong>PTU is safer during the 1st trimester</strong>, prolonged use increases the risk of <strong>severe hepatotoxicity</strong> in the mother, making long-term therapy throughout pregnancy inadvisable. The switch to <strong>methimazole</strong> after the <strong>first trimester</strong> is the correct strategy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The American Thyroid Association recommends using propylthiouracil (PTU) in the first trimester of pregnancy due to the teratogenicity risk of methimazole, followed by switching to methimazole in the second and third trimesters to minimize the risk of PTU-induced hepatotoxicity.</span></p>",
      "correct_choice_id": 355712,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89328/OBG_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89328/OBG_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89345,
      "choices": [
        {
          "id": 355780,
          "text": "<p><span style=\"font-size:14.0pt;\">Bandl’s ring</span></p>"
        },
        {
          "id": 355781,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical stenosis</span></p>"
        },
        {
          "id": 355782,
          "text": "<p><span style=\"font-size:14.0pt;\">McDonald’s constriction ring</span></p>"
        },
        {
          "id": 355783,
          "text": "<p><span style=\"font-size:14.0pt;\">Premature cervical closure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old woman in active labor develops a prolonged second stage of labor. On clinical examination, there is a constriction ring forming between the upper and lower uterine segments, causing signs of obstructed labor. What is this pathological uterine finding called?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7758497",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Bandl’s ring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bandl’s ring</strong> is a pathological <strong>retraction ring</strong> seen in cases of <strong>obstructed labor</strong>, where the <strong>upper uterine segment becomes thickened and contracted</strong> while the <strong>lower uterine segment thins out excessively</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This creates a visible or palpable <strong>transverse groove</strong> (the Bandl’s ring) that rises progressively as obstruction worsens.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with <strong>risk of uterine rupture</strong> if not managed promptly.</span></li><li><span style=\"font-size:14.0pt;\">Bandl’s ring is distinct from physiological constriction rings (like McDonald’s ring) and is considered a <strong>sign of obstructed labor</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-24%20123847.jpg\" width=\"619\" height=\"675\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cervical stenosis:</strong> Incorrect. <strong>Cervical stenosis</strong> refers to a narrowed cervical canal, typically a chronic or congenital condition causing infertility or labor dysfunction, not an acute labor obstruction phenomenon like Bandl’s ring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. McDonald’s constriction ring:</strong> Incorrect. <strong>McDonald’s constriction ring</strong> is a <strong>functional or physiological constriction ring</strong>, usually transient, that may occur during labor without causing obstruction. Unlike <strong>Bandl’s ring</strong>, it is not pathological and not typically associated with obstructed labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Premature cervical closure:</strong> Incorrect. This is not a recognized term in obstetric practice for labor obstruction. It refers more to incompetent cervix in pregnancy rather than an obstructed labor phenomenon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bandl’s ring is a pathological retraction ring formed between the upper and lower uterine segments during obstructed labor, characterized by uterine segmental disproportion and risk of rupture if not treated urgently.</span></p>",
      "correct_choice_id": 355780,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89345/OBG_NEET_PG_GT_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89345/OBG_NEET_PG_GT_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89805,
      "choices": [
        {
          "id": 357612,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryoglobulinemic vasculitis</span></p>"
        },
        {
          "id": 357613,
          "text": "<p><span style=\"font-size:14.0pt;\">Cutaneous small vessel vasculitis</span></p>"
        },
        {
          "id": 357614,
          "text": "<p><span style=\"font-size:14.0pt;\">IgA vasculitis</span></p>"
        },
        {
          "id": 357615,
          "text": "<p><span style=\"font-size:14.0pt;\">Granulomatosis with polyangiitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man presents with a 3-day history of rash and joint pain. He has a recent history of sore throat and fever. Examination shows purpura, ankle/knee swelling, and mild abdominal tenderness. Skin biopsy shows leukocytoclastic vasculitis with immune complex deposits. Which of the following is unlikely?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6041564",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Granulomatosis with polyangiitis</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The combination of palpable purpura, migratory arthralgias, and colicky abdominal pain following a streptococcal‑type illness, together with leukocytoclastic vasculitis on skin biopsy, is classic for IgA‑mediated small‑vessel vasculitis.</span></li><li><span style=\"font-size:14.0pt;\">Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomas, prominent upper and lower respiratory tract involvement, and renal disease (often with c‑ANCA positivity), none of which are present here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cryoglobulinemic vasculitis:&nbsp;</strong>Immune‑complex mediated; can present with purpura and arthralgias, though often in the setting of hepatitis C or cold sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cutaneous small vessel vasculitis:&nbsp;</strong>A broad term for isolated leukocytoclastic vasculitis of the skin, matching the biopsy and rash distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IgA vasculitis:&nbsp;</strong>Presents with the exact triad of purpura, joint pain, and abdominal pain post‑infection, with IgA deposition on biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Post‑infectious palpable purpura plus joint and abdominal symptoms with leukocytoclastic vasculitis strongly indicate IgA vasculitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">GPA is excluded by the absence of granulomas, respiratory tract involvement, and renal manifestations.</span></li></ul>",
      "correct_choice_id": 357615,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89805/MEDICINE_NEET_PG_GT_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89805/MEDICINE_NEET_PG_GT_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89405,
      "choices": [
        {
          "id": 356016,
          "text": "<p><span style=\"font-size:14.0pt;\">Serratus anterior and trapezius</span></p>"
        },
        {
          "id": 356017,
          "text": "<p><span style=\"font-size:14.0pt;\">Pectoralis major and latissimus dorsi</span></p>"
        },
        {
          "id": 356018,
          "text": "<p><span style=\"font-size:14.0pt;\">Rhomboids and levator scapulae</span></p>"
        },
        {
          "id": 356019,
          "text": "<p><span style=\"font-size:14.0pt;\">Subscapularis and teres major</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old climber complains of shoulder weakness and inability to extend the shoulder joint effectively. On examination, you notice atrophy in the pectoral and dorsal regions. Which muscle pair is most likely involved in this clinical scenario?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7534395",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Pectoralis major and latissimus dorsi</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pectoralis major and latissimus dorsi are collectively referred to as the \"climber's muscles\" because of their role in shoulder extension, adduction, and medial rotation.</span></li><li><span style=\"font-size:14.0pt;\">The pectoralis major is a primary muscle of the pectoral region, while the latissimus dorsi is located in the dorsal region.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their dysfunction can significantly impair climbing and similar activities.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serratus anterior and trapezius:</strong> Incorrect. These muscles are involved in scapular stabilization and movement but are not directly responsible for shoulder extension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rhomboids and levator scapulae:</strong> Incorrect. These muscles primarily assist in scapular elevation and retraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Subscapularis and teres major:</strong> Incorrect. While these muscles contribute to internal rotation and adduction of the arm, they are not the primary extensors of the shoulder joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The pectoralis major and latissimus dorsi are essential for shoulder extension and adduction and are commonly referred to as \"climber's muscles\" due to their significant role in activities involving overhead pulling.</span></p>",
      "correct_choice_id": 356017,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89405/ANATOMY_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89405/ANATOMY_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89427,
      "choices": [
        {
          "id": 356104,
          "text": "<p><span style=\"font-size:14.0pt;\">NOTCH1</span></p>"
        },
        {
          "id": 356105,
          "text": "<p><span style=\"font-size:14.0pt;\">GATA3</span></p>"
        },
        {
          "id": 356106,
          "text": "<p><span style=\"font-size:14.0pt;\">Rag ½</span></p>"
        },
        {
          "id": 356107,
          "text": "<p><span style=\"font-size:14.0pt;\">AIRE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A mutation in a gene responsible for expressing self-antigens in the thymus leads to impaired central tolerance and early-onset autoimmune disease affecting multiple organs. Which of the following genes is most likely mutated?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4893723",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) AIRE</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>AIRE (Autoimmune Regulator)</strong> gene encodes a transcription factor that is essential for the expression of peripheral self-antigens in the <strong>medullary thymic epithelial cells</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This enables negative selection of autoreactive T cells, a process critical for the establishment of <strong>central immune tolerance</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mutations in the AIRE gene lead to the condition <strong>autoimmune polyendocrine syndrome type 1 (APS-1)</strong>, characterized by autoimmunity affecting multiple organs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. NOTCH1</strong>: This gene is important for T-cell lineage specification during thymic development but does not participate in peripheral antigen expression or central tolerance mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. GATA3</strong>: GATA3 is a transcription factor involved in the differentiation of <strong>T-helper 2 (Th2) cells</strong> but is not implicated in central tolerance or thymic antigen presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rag ½</strong>: These genes are required for V(D)J recombination in B and T lymphocytes to generate diverse antigen receptors but do not regulate expression of tissue-specific antigens in the thymus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>AIRE gene</strong> plays a critical role in <strong>central immune tolerance</strong> by enabling thymic expression of peripheral self-antigens, allowing deletion of autoreactive T cells. Its deficiency can lead to severe autoimmune disease.</span></p>",
      "correct_choice_id": 356107,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89427/PATHOLOGY_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89427/PATHOLOGY_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89214,
      "choices": [
        {
          "id": 355260,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 355261,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 355262,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 355263,
          "text": "<p><span style=\"font-size:14.0pt;\">All except 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy finds his unbroken forearm licked by a stray dog in his village. He’s never been vaccinated against rabies. Which statements are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">This is Category I; only wound washing is needed—no vaccine or RIG.</span></li><li><span style=\"font-size:14.0pt;\">Because dogs are high-risk, you should still administer two ID vaccine doses on Days 0 and 3.</span></li><li><span style=\"font-size:14.0pt;\">RIG is only indicated if the dog’s saliva contacts broken skin or mucosa.</span></li><li><span style=\"font-size:14.0pt;\">If you choose IM over ID vaccine for Category I, you still give only two doses.</span></li></ol>",
      "unique_key": "Q9000275",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>This is Category I; only wound washing is needed—no vaccine or RIG: </strong>True. A lick on intact skin is classified as <strong>Category I</strong> exposure. According to WHO guidelines, Category I requires <strong>only thorough wound washing</strong> (15 minutes with soap or detergent and water); neither rabies vaccine nor rabies immune globulin (RIG) is indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>RIG is only indicated if the dog’s saliva contacts broken skin</strong> <strong>or mucosa:</strong> True. RIG is reserved for <strong>Category III</strong> exposures—those involving broken skin or mucosal contamination by potentially rabid saliva. Since the skin was intact, RIG is not indicated here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Because dogs are high-risk, you should still administer two ID vaccine doses on Days 0 and 3: </strong>False. Even though dogs can carry rabies, <strong>prophylactic vaccination</strong> is <strong>not</strong> given for Category I exposures. Administering two ID doses would constitute unnecessary overtreatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4</strong>. <strong>If you choose IM over ID vaccine for Category I, you still give only two doses:&nbsp;</strong>False<strong>.&nbsp;</strong>No vaccine regimen—ID or IM—is indicated in Category I. The choice of route (IM vs. ID) only applies when vaccine is required (Categories II/III).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PEP recommendations by category of exposure:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20163352.jpg\" width=\"968\" height=\"722\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">*Abbreviated vaccination applies only if a full PEP course was completed within the past 3 months.</span></p>",
      "correct_choice_id": 355260,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89214/PSM_NEET_PG_GT_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89214/PSM_NEET_PG_GT_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89342,
      "choices": [
        {
          "id": 355768,
          "text": "<p><span style=\"font-size:14.0pt;\">Four contractions in 20 minutes or eight contractions in 60 minutes with documented cervical changes</span></p>"
        },
        {
          "id": 355769,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical dilatation greater than 1 cm</span></p>"
        },
        {
          "id": 355770,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical effacement more than 80 percent</span></p>"
        },
        {
          "id": 355771,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior position of the cervix</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not considered a diagnostic criterion for preterm labor?</span></p>",
      "unique_key": "Q3303462",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Posterior position of the cervix</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>position of the cervix</strong> (anterior, mid, or posterior) is <strong>not a diagnostic parameter</strong> for preterm labor.</span></li><li><span style=\"font-size:14.0pt;\">Cervical position may vary in labor, but <strong>it is not used as a criterion for diagnosing preterm labor</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A posterior cervix is often seen in early labor or non-laboring cervix.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preterm labor</strong> is defined as <strong>regular uterine contractions</strong> causing <strong>progressive cervical changes (dilatation and/or effacement) before 37 weeks of gestation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis requires both uterine activity and cervical changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Four contractions in 20 minutes or eight contractions in 60 minutes with documented cervical changes</strong>: Correct diagnostic criterion. Frequent uterine contractions associated with cervical change defines labor, including preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cervical dilatation greater than 1 cm</strong>: Correct diagnostic criterion. Cervical dilatation greater than <strong>1 cm</strong> is significant and diagnostic when accompanied by contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cervical effacement</strong> <strong>more than 80 percent</strong>: Correct diagnostic criterion. Cervical effacement of <strong>80% or more</strong> suggests cervical ripening due to labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The diagnosis of preterm labor requires evidence of regular uterine contractions with progressive cervical changes (dilatation and/or effacement).</span></li><li><span style=\"font-size:14.0pt;\">Cervical position is not part of the diagnostic criteria for preterm labor.</span></li></ul>",
      "correct_choice_id": 355771,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89342/OBG_NEET_PG_GT_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89342/OBG_NEET_PG_GT_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89037,
      "choices": [
        {
          "id": 354568,
          "text": "<p><span style=\"font-size:14.0pt;\">It is neutralized by specific antibodies</span></p>"
        },
        {
          "id": 354569,
          "text": "<p><span style=\"font-size:14.0pt;\">It is heat stable</span></p>"
        },
        {
          "id": 354570,
          "text": "<p><span style=\"font-size:14.0pt;\">It is part of the somatic antigen</span></p>"
        },
        {
          "id": 354571,
          "text": "<p><span style=\"font-size:14.0pt;\">It is poorly antigenic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man is admitted to the intensive care unit with high-grade fever, hypotension, and altered mental status. Blood cultures grow Escherichia coli. Despite fluid resuscitation, he remains hypotensive and requires vasopressors. The patient is diagnosed with septic shock due to Gram-negative bacteremia. Which of the following statements about the endotoxin responsible for his condition is incorrect?&nbsp;</span></p>",
      "unique_key": "Q3776393",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It is neutralized by specific antibodies</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endotoxins are lipopolysaccharides (LPS) found in the outer membrane of Gram-negative bacteria.</span></li><li><span style=\"font-size:14.0pt;\">The toxic component, <strong>lipid A</strong>, is responsible for triggering a strong innate immune response, often resulting in fever, hypotension, disseminated intravascular coagulation (DIC), and septic shock.</span></li><li><span style=\"font-size:14.0pt;\">Importantly, <strong>endotoxins are not effectively neutralized by specific antibodies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is due to their <strong>poor antigenicity</strong> and the fact that the lipid A portion, which mediates toxicity, is relatively hidden from the immune system and structurally conserved across species, making antibody targeting ineffective.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, exotoxins (typically secreted proteins of Gram-positive bacteria) are highly immunogenic and can be neutralized by specific antitoxins or antibodies.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JFuQkKO.png\" width=\"972\" height=\"612\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It is heat stable:</strong> Correct. Endotoxins are heat stable and resist boiling temperatures, which is a key difference from protein-based exotoxins that are heat labile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It is part of the somatic antigen</strong>: Correct. The \"O antigen\" is the outer polysaccharide chain of LPS and contributes to the somatic (O) antigen in serotyping of Gram-negative organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is poorly antigenic</strong>: Correct. Endotoxins stimulate immune responses via Toll-like receptors (especially TLR4), but they are <strong>not strongly immunogenic</strong> in the classical sense. They do not elicit long-lasting immunity or high-affinity antibody production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Endotoxins (lipopolysaccharides of Gram-negative bacteria) are heat-stable, poorly antigenic, and are not effectively neutralized by specific antibodies.</span></p>",
      "correct_choice_id": 354568,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89037/MICROBIOLOGY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89037/MICROBIOLOGY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89369,
      "choices": [
        {
          "id": 355876,
          "text": "<p><span style=\"font-size:14.0pt;\">10 millivolts hyperpolarization</span></p>"
        },
        {
          "id": 355877,
          "text": "<p><span style=\"font-size:14.0pt;\">122 millivolts depolarization</span></p>"
        },
        {
          "id": 355878,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts depolarization</span></p>"
        },
        {
          "id": 355879,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts hyperpolarization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The ICF concentration of K⁺ is 140 mEq/L and ECF concentration is 14 mEq/L, and the cell is permeable only to K⁺. What would be the expected change if the extracellular K⁺ concentration is reduced from 14 to 1.4 millimolar?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5301281",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 61 millivolts hyperpolarization</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This question involves the calculation of the Equilibrium potential (EP) using the <strong>Nernst equation</strong>, which describes the equilibrium potential for an ion.</span></li><li><span style=\"font-size:14.0pt;\">For potassium (K⁺), the Nernst equation can be simplified as:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eNuARXH.png\" alt=\"A black text with black letters\r\n\r\nAI-generated content may be incorrect.\" width=\"365\" height=\"86\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Given:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Initial extracellular concentration [K⁺ outside] = 14 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">Intracellular concentration [K⁺ inside] = 140 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">After the change, [K⁺ outside] = 1.4 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: Calculate initial EP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Before the change:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_d9l6TDK.png\" alt=\"A number of equations with numbers\r\n\r\nAI-generated content may be incorrect.\" width=\"474\" height=\"179\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is the initial resting membrane potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2: Calculate the new EP after reducing [K⁺ outside]</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After reducing extracellular potassium to 1.4 mEq/L:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5d1h5JX.png\" alt=\"A number and equation with numbers\r\n\r\nAI-generated content may be incorrect.\" width=\"464\" height=\"174\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is the new resting membrane potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 3: Determine the change in EP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The initial RMP was <strong>−61 mV</strong>, and the new RMP is <strong>−122 mV</strong>. The change is:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">−122&nbsp;mV−(−61&nbsp;mV) =−61&nbsp;mV</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the membrane potential has <strong>hyperpolarized</strong> by 61 millivolts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When extracellular K⁺ concentration is reduced, the cell undergoes <strong>61 millivolts hyperpolarization</strong>, as the loss of K⁺ leads to the inside of the cell becoming more negative.</span></p>",
      "correct_choice_id": 355879,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89369/PHYSIOLOGY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89369/PHYSIOLOGY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89196,
      "choices": [
        {
          "id": 355188,
          "text": "<p><span style=\"font-size:14.0pt;\">Mass immunization of school children with Vi polysaccharide vaccine</span></p>"
        },
        {
          "id": 355189,
          "text": "<p><span style=\"font-size:14.0pt;\">Construction of community water-treatment plants and promotion of household water boiling</span></p>"
        },
        {
          "id": 355190,
          "text": "<p><span style=\"font-size:14.0pt;\">Weekly administration of prophylactic chloramphenicol to high-risk adults</span></p>"
        },
        {
          "id": 355191,
          "text": "<p><span style=\"font-size:14.0pt;\">Distribution of personal insecticide-treated bed nets to all households</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a region with high endemic typhoid fever, public health officials are designing a prevention program. Which of the following interventions will have the greatest impact on reducing typhoid incidence?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8398949",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Construction of community water-treatment plants and promotion of household water boiling</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Typhoid fever is transmitted primarily via the fecal–oral route through <strong>contaminated water and food</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Improving sanitation—such as safe disposal of feces, filtering or treating community water supplies, and encouraging families to boil or chlorinate drinking water—interrupts the main transmission pathway.</span></li><li><span style=\"font-size:14.0pt;\">These environmental and behavioral measures yield the <strong>largest and most sustained</strong> reduction in typhoid incidence, far surpassing the impact of any single biomedical intervention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mass immunization of school children with Vi polysaccharide vaccine:</strong> While vaccination provides individual protection, its coverage and duration are limited (the Vi vaccine requires boosters and does not induce strong community herd immunity). Alone, it cannot match the broad reach of improved water and sanitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Weekly administration of prophylactic chloramphenicol to high-risk adults:&nbsp;</strong>Antibiotic prophylaxis risks resistance, adverse effects, and is not a sustainable public-health strategy. It treats individuals rather than addressing environmental sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Distribution of personal insecticide-treated bed nets to all households:</strong> Bed nets control vector-borne diseases like malaria, not typhoid, which is not spread by mosquitoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For typhoid control, prioritize <strong>safe water and proper fecal disposal</strong> over mass vaccination or chemoprophylaxis—addressing the root source of infection delivers the greatest epidemiologic benefit.</span></p>",
      "correct_choice_id": 355189,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89196/PSM_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89196/PSM_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89286,
      "choices": [
        {
          "id": 355544,
          "text": "<p><span style=\"font-size:14.0pt;\">Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug.&nbsp;</span></p>"
        },
        {
          "id": 355545,
          "text": "<p><span style=\"font-size:14.0pt;\">Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug.&nbsp;</span></p>"
        },
        {
          "id": 355546,
          "text": "<p><span style=\"font-size:14.0pt;\">Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.</span></p>"
        },
        {
          "id": 355547,
          "text": "<p><span style=\"font-size:14.0pt;\">Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old researcher is studying a novel antiviral drug that has shown promise in in-vitro studies. The researcher is in the process of planning the clinical development of the drug. She explains to her team that the next step involves a phase zero clinical trial, which will be crucial in determining whether to move on to phase I trials. The team is confused, as they are not familiar with phase zero clinical trials. Which of the following statements is true regarding phase zero clinical trials, that would help the team understand its significance?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3250772",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement and metabolism of the drug in the human body.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The main aim of phase zero trials is to gather preliminary data on pharmacokinetics and assess whether the drug behaves in humans as it does in preclinical models.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the statement that would best help the team understand the significance of phase zero trials is that they primarily focus on pharmacokinetics and provide initial human data on the movement and metabolism of the drug.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug:</strong> This statement is incorrect. Phase zero clinical trials are human trials that precede phase I trials. They are not animal studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug:</strong> This is incorrect. Phase zero trials are not designed to provide comprehensive data on safety and efficacy but are focused on pharmacokinetics and perhaps some initial pharmacodynamic data.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question:</strong> This is incorrect. Phase zero trials are exploratory trials that precede phase I trials; they are not focused on therapeutic outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Phase 0 trials</strong> are <strong>exploratory human PK studies</strong>—they use microdoses to rapidly assess whether a drug’s absorption and metabolism in humans justify advancing to full safety and efficacy testing.</span></p>",
      "correct_choice_id": 355546,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89286/PHARMA_NEET_PG_GT_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89286/PHARMA_NEET_PG_GT_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89334,
      "choices": [
        {
          "id": 355736,
          "text": "<p><span style=\"font-size:14.0pt;\">5 grams of 50% magnesium sulfate intramuscularly in alternate buttocks every 4 hours until 24 hours after delivery or the last seizure</span></p>"
        },
        {
          "id": 355737,
          "text": "<p><span style=\"font-size:14.0pt;\">5 grams of 50% magnesium sulfate intramuscularly in the same buttock every 6 hours until 24 hours after delivery</span></p>"
        },
        {
          "id": 355738,
          "text": "<p><span style=\"font-size:14.0pt;\">4 grams of 50% magnesium sulfate intramuscularly every 4 hours until onset of labor</span></p>"
        },
        {
          "id": 355739,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous intravenous infusion of magnesium sulfate at 1 gram per hour until 24 hours postpartum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following correctly describes the maintenance dosing protocol according to the Pritchard regimen for magnesium sulfate administration?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2885275",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 5 grams of 50% magnesium sulfate intramuscularly in alternate buttocks every 4 hours until 24 hours after delivery or the last seizure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Pritchard regimen</strong> is a well-established protocol for the prevention and treatment of seizures in women with <strong>eclampsia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Loading dose</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>4 grams of 20% magnesium sulfate intravenously over 5–10 minutes</strong></span></li><li><span style=\"font-size:14.0pt;\">Followed by <strong>5 grams of 50% magnesium sulfate intramuscularly into each buttock</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Maintenance dose</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>5 grams of 50% magnesium sulfate intramuscularly every 4 hours</strong></span></li><li><span style=\"font-size:14.0pt;\">Administered in <strong>alternate buttocks</strong> to avoid local irritation</span></li><li><span style=\"font-size:14.0pt;\">Continued for <strong>24 hours after delivery or the last seizure</strong>, whichever is later</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This regimen ensures therapeutic levels of magnesium sulfate are maintained to prevent recurrence of seizures in eclamptic patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Pritchard regimen for eclampsia involves a maintenance dose of 5 grams of 50% magnesium sulfate given intramuscularly into alternate buttocks every 4 hours until 24 hours after delivery or the last seizure, whichever is later.</span></p>",
      "correct_choice_id": 355736,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89334/OBG_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89334/OBG_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89368,
      "choices": [
        {
          "id": 355872,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurons: −60 to −70 mV</span></p>"
        },
        {
          "id": 355873,
          "text": "<p><span style=\"font-size:14.0pt;\">Skeletal muscle: −85 to −95 mV</span></p>"
        },
        {
          "id": 355874,
          "text": "<p><span style=\"font-size:14.0pt;\">Hair (cochlea): −15 to −40 mV</span></p>"
        },
        {
          "id": 355875,
          "text": "<p><span style=\"font-size:14.0pt;\">Smooth muscle: −8 to −12 Mv</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect option with regards to Resting membrane potential in different cells:&nbsp;</span></p>",
      "unique_key": "Q3417755",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Smooth muscle: −8 to −12 mV</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Smooth muscle cells have a resting membrane potential closer to <strong>−50 to −60 mV</strong>, not −8 to −12 mV.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>−8 to −12 mV</strong> range is typically seen in <strong>red blood cells (RBCs)</strong>, not smooth muscle cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Neurons: −60 to −70 mV: </strong>This is correct. Neurons typically have a resting membrane potential of <strong>−60 to −70 mV</strong>. This value is maintained by the selective permeability of the membrane to potassium and the action of the sodium-potassium pump.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Skeletal muscle: −85 to −95 mV: </strong>This is correct. Skeletal muscle cells generally have a more negative resting membrane potential, around <strong>−85 to −95 mV</strong>. This is due to the differences in ion channels and permeability compared to neurons.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hair cells (cochlea): −15 to −40 mV: </strong>This is correct. The inner hair cells of the cochlea have a resting membrane potential of <strong>−15 to −40 mV</strong>, which is much less negative than other cells due to their specialized function in hearing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Smooth muscle cells typically have a resting membrane potential of <strong>−50 to −60 mV</strong>, while <strong>−8 to −12 mV</strong> is characteristic of red blood cells.</span></p>",
      "correct_choice_id": 355875,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89368/PHYSIOLOGY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89368/PHYSIOLOGY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89062,
      "choices": [
        {
          "id": 354668,
          "text": "<p><span style=\"font-size:14.0pt;\">Culture of sputum on Sabouraud dextrose agar</span></p>"
        },
        {
          "id": 354669,
          "text": "<p><span style=\"font-size:14.0pt;\">Serologic immunodiffusion for gp43 antibodies</span></p>"
        },
        {
          "id": 354670,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct immunofluorescence on biopsy tissue</span></p>"
        },
        {
          "id": 354671,
          "text": "<p><span style=\"font-size:14.0pt;\">Skin test with paracoccidioidin antigen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male coffee farmer in Brazil develops a productive cough, weight loss, and mucocutaneous ulcers on the oropharynx. Sputum cytology shows multiple narrow-based budding yeasts arranged radially around a central mother cell (“pilot wheel”). Which laboratory test provides the fastest, least-invasive confirmation of active infection?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8493323",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Serologic immunodiffusion for gp43 antibodies</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Serologic immunodiffusion for gp43 antibodies</strong> detects precipitins against the 43-kDa glycoprotein antigen of Paracoccidioides brasiliensis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Results are available within 1–2 days, correlate with disease activity, and require only a blood sample—making it the fastest, least invasive way to confirm active infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Culture of sputum on Sabouraud dextrose agar:</strong> Highly specific but requires 4-6 weeks for mold growth at 25°C and subsequent yeast conversion at 37°C.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Direct immunofluorescence on mucosal biopsy:</strong> Sensitive but invasive (requires tissue), specialized, and not widely available.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Skin test with paracoccidioidin:</strong> Indicates prior sensitization (cell-mediated immunity) rather than active disease; may be negative in severe cases. It is type IV hypersensitivity reaction (delayed)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For suspected paracoccidioidomycosis with characteristic “pilot-wheel” yeast on microscopy, <strong>gp43 immunodiffusion</strong> is the quickest way to confirm active disease.</span></p>",
      "correct_choice_id": 354669,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89062/MICROBIOLOGY_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89062/MICROBIOLOGY_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89790,
      "choices": [
        {
          "id": 357552,
          "text": "<p><span style=\"font-size:14.0pt;\">Achalasia</span></p>"
        },
        {
          "id": 357553,
          "text": "<p><span style=\"font-size:14.0pt;\">Esophageal web</span></p>"
        },
        {
          "id": 357554,
          "text": "<p><span style=\"font-size:14.0pt;\">Stroke</span></p>"
        },
        {
          "id": 357555,
          "text": "<p><span style=\"font-size:14.0pt;\">Zenker diverticulum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 75-year-old woman with diabetes, hypertension, hyperlipidemia, and peripheral artery disease presents with a 2-month history of cough while eating, difficulty initiating swallowing, and recent dysarthria affecting her speech clarity. She denies weight loss, chest pain, or choking on solids, and her symptoms began abruptly after a family gathering. Her examination shows no other focal neurological deficits, but her BP is 160/95 mmHg. Which of the following is the most likely cause of her symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4720626",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Stroke</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sudden-onset dysphagia, dysarthria, and cough while eating in an elderly patient with vascular risk factors (diabetes, hypertension, hyperlipidemia) suggest a neurologic etiology, likely a stroke affecting the brainstem or cortex.</span></li><li><span style=\"font-size:14.0pt;\">Stroke can impair swallowing and speech muscles, leading to these symptoms.</span></li><li><span style=\"font-size:14.0pt;\">The abrupt onset and absence of chronic esophageal symptoms support a neurological cause.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Achalasia:&nbsp;</strong>Causes chronic dysphagia for solids and liquids, not dysarthria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Esophageal webs:&nbsp;</strong>Cause dysphagia for solids, not dysarthria or cough.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Zenker diverticulum</strong>: Causes regurgitation and dysphagia but not dysarthria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Stroke is a common cause of sudden dysphagia and dysarthria in patients with vascular risk factors.</span></li><li><span style=\"font-size:14.0pt;\">Neurologic evaluation, including imaging, is critical for diagnosis.</span></li></ul>",
      "correct_choice_id": 357554,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89790/Medicine_Neet_Pg_Gt_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89790/Medicine_Neet_Pg_Gt_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89253,
      "choices": [
        {
          "id": 355412,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesna</span></p>"
        },
        {
          "id": 355413,
          "text": "<p><span style=\"font-size:14.0pt;\">Amifostine</span></p>"
        },
        {
          "id": 355414,
          "text": "<p><span style=\"font-size:14.0pt;\">N-acetylcysteine</span></p>"
        },
        {
          "id": 355415,
          "text": "<p><span style=\"font-size:14.0pt;\">Leucovorin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man with metastatic ovarian-carcinoma–associated melanoma receives high-dose ifosfamide prior to autologous stem-cell transplant. Within days he develops gross hematuria and bladder pain. Which co-therapy would best prevent this complication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6938224",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mesna</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is haemorrhagic cystitis&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Ifosfamide is an alkylating agent whose urinary excretion yields the urotoxic metabolite acrolein.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mesna (2-mercaptoethane sulfonate) provides a free thiol that conjugates acrolein in the bladder lumen, preventing mucosal injury and hemorrhagic cystitis without interfering with antitumor activity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amifostine:</strong> A cytoprotective thiol used to reduce cisplatin-induced nephrotoxicity and xerostomia with radiation; does not reliably detoxify acrolein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. N-acetylcysteine:</strong> Replenishes glutathione in hepatocytes but lacks sufficient bladder concentration to neutralize acrolein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leucovorin:</strong> Folinic acid “rescue” for high-dose methotrexate therapy; has no role in preventing alkylator-induced cystitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When administering <strong>high-dose nitrogen mustards</strong> (e.g., melphalan, cyclophosphamide), co-administer <strong>mesna</strong> to <strong>neutralize acrolein</strong> and protect the bladder mucosa from hemorrhagic cystitis.</span></p>",
      "correct_choice_id": 355412,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89253/PHARMA_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89253/PHARMA_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89329,
      "choices": [
        {
          "id": 355716,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are incorrect</span></p>"
        },
        {
          "id": 355717,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4 are incorrect</span></p>"
        },
        {
          "id": 355718,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 5 only incorrect</span></p>"
        },
        {
          "id": 355719,
          "text": "<p><span style=\"font-size:14.0pt;\">5 is the only incorrect one</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following sonographic findings is/are incorrect about<strong>&nbsp;</strong>Placenta Accreta Spectrum (PAS)?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Placental lacunae</span></li><li><span style=\"font-size:14.0pt;\">Thinning of the retroplacental myometrium</span></li><li><span style=\"font-size:14.0pt;\">Disruption of the bladder-uterine serosal interface</span></li><li><span style=\"font-size:14.0pt;\">Bridging vessels from the placenta to the bladder-serosal interface</span></li><li><span style=\"font-size:14.0pt;\">Thickened retroplacental myometrium (&gt;5 mm) and smooth, undistorted uterine contour</span></li></ol>",
      "unique_key": "Q3687142",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 5 is the only incorrect one</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Thickened retroplacental myometrium (&gt;5 mm) and smooth, undistorted uterine contour</strong>: Incorrect.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This is <strong>NOT</strong> characteristic of PAS.</span></li><li><span style=\"font-size:14.0pt;\">PAS is associated with <strong>thinning</strong>, not <strong>thickening</strong>, of the retroplacental myometrium.</span></li><li><span style=\"font-size:14.0pt;\">Furthermore, the uterus often shows a <strong>bulge or distortion of its normal contour</strong> due to abnormal placental invasion.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>a thickened myometrium with a smooth, undistorted contour</strong> suggests a normal placental attachment, not PAS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Placental lacunae</strong>: Correct. These are multiple irregular vascular spaces seen within the placenta, giving a “Swiss cheese” or “moth-eaten” appearance on ultrasound. This is a typical finding of PAS and is considered a characteristic feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Thinning of the retroplacental myometrium</strong>: Correct. Thinning (often &lt;1 mm) of the myometrium underlying the placenta is a well-recognized sonographic sign of PAS. It occurs due to abnormal trophoblastic invasion into the myometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Disruption of the bladder-uterine serosal interface</strong>: Correct.&nbsp;The loss of the normal hypoechoic boundary between the uterus and bladder on ultrasound is a key feature in severe forms of PAS, especially <strong>placenta percreta</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Bridging vessels from the placenta to the bladder-serosal interface</strong>: Correct. Bridging vessels crossing from the placenta into adjacent structures, especially the bladder, seen on Doppler imaging, are a hallmark of invasive placental disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Placenta Accreta Spectrum is diagnosed by ultrasound features such as placental lacunae, thinning of the retroplacental myometrium, disruption of the bladder-uterine interface, and bridging vessels; a thickened retroplacental myometrium with a smooth uterine contour is not characteristic of PAS and is considered incorrect.</span></p>",
      "correct_choice_id": 355719,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89329/OBG_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89329/OBG_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89417,
      "choices": [
        {
          "id": 356064,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravesical BCG</span></p>"
        },
        {
          "id": 356065,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic chemotherapy</span></p>"
        },
        {
          "id": 356066,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical cystectomy</span></p>"
        },
        {
          "id": 356067,
          "text": "<p><span style=\"font-size:14.0pt;\">Radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male smoker presents with painless hematuria. Further investigation reveals bladder cancer extending up to the muscle layer. What should be the treatment of choice for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4981054",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Radical cystectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radical cystectomy is the standard treatment for muscle-invasive bladder cancer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves the removal of the bladder and surrounding tissues/organs (such as prostate in men and uterus in women), and it provides the best chance for long-term survival and disease control.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Intravesical BCG:</strong> Intravesical BCG is typically used for non-muscle invasive bladder cancer (NMIBC). It is effective in reducing recurrence and progression of superficial bladder cancer but is not adequate for muscle-invasive disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Systemic chemotherapy:</strong> While systemic chemotherapy can be used as part of the treatment plan, especially in a neoadjuvant setting (before surgery) or for metastatic disease, it is not the primary treatment of choice for muscle-invasive bladder cancer without metastatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Radiotherapy:</strong> Radiotherapy can be an option for patients who are not candidates for surgery, but it is typically not the first-line treatment for muscle-invasive bladder cancer when the patient is otherwise healthy and a surgical candidate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For muscle-invasive bladder cancer, the treatment of choice is radical cystectomy, which involves the removal of the bladder and surrounding tissues to achieve the best long-term outcomes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Painless hematuria in a smoker is highly suggestive of bladder carcinoma and should prompt thorough evaluation.</span></li></ul>",
      "correct_choice_id": 356066,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89417/SURGERY_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89417/SURGERY_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89412,
      "choices": [
        {
          "id": 356044,
          "text": "<p><span style=\"font-size:14.0pt;\">T4a</span></p>"
        },
        {
          "id": 356045,
          "text": "<p><span style=\"font-size:14.0pt;\">T3</span></p>"
        },
        {
          "id": 356046,
          "text": "<p><span style=\"font-size:14.0pt;\">T4b</span></p>"
        },
        {
          "id": 356047,
          "text": "<p><span style=\"font-size:14.0pt;\">&nbsp;M1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to 8th AJCC classification of colorectal cancers, tumor deposits in the visceral peritoneum and serosal breach is staged as?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9759908",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) T4a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mgV96hg.png\" width=\"553\" height=\"663\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to 8th AJCC classification of colorectal cancers, tumor deposits in the visceral peritoneum and serosal breach is&nbsp;staged&nbsp;as&nbsp;T4a.</span></p>",
      "correct_choice_id": 356044,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89412/SURGERY_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89412/SURGERY_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89795,
      "choices": [
        {
          "id": 357572,
          "text": "<p><span style=\"font-size:14.0pt;\">Bronchiolitis obliterans</span></p>"
        },
        {
          "id": 357573,
          "text": "<p><span style=\"font-size:14.0pt;\">Invasive pulmonary aspergillosis</span></p>"
        },
        {
          "id": 357574,
          "text": "<p><span style=\"font-size:14.0pt;\">MRSA pneumonia</span></p>"
        },
        {
          "id": 357575,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory syncytial virus infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old woman, 8 months post-allogeneic stem cell transplant for leukemia, presents with a 5-day history of increased cough, shortness of breath, and low-grade fever. She is on steroids for graft-versus-host disease and TMP-SMX for Pneumocystis prophylaxis. A CT chest is done and shown below. She denies recent travel or sick contacts. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xM8yAIu.png\" width=\"713\" height=\"584\"></strong></span></p>",
      "unique_key": "Q3012274",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Invasive pulmonary aspergillosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The CT chest shows multiple pulmonary nodules with ground-glass opacities (“halo sign”), suggests invasive pulmonary aspergillosis (IPA), common in immunocompromised patients post-transplant.</span></li><li><span style=\"font-size:14.0pt;\">Steroid use and immunosuppression increase IPA risk, and the halo sign is a classic radiologic finding.</span></li><li><span style=\"font-size:14.0pt;\">Prompt antifungal therapy is critical to prevent progression in this high-risk patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bronchiolitis obliterans:</strong> Causes chronic cough and airflow obstruction, not nodules or halo sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MRSA pneumonia:&nbsp;</strong>Lacks the halo sign and it is more common in HAP and post-influenza.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Respiratory syncytial virus infection:&nbsp;</strong>RSV causes bronchiolitis, not nodules or halo sign.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IPA is suspected in immunocompromised patients with pulmonary nodules and halo sign on CT.</span></li><li><span style=\"font-size:14.0pt;\">Elevated galactomannan supports the diagnosis, requiring urgent antifungal therapy.</span></li></ul>",
      "correct_choice_id": 357573,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89795/Medicine_Neet_Pg_Gt_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89795/Medicine_Neet_Pg_Gt_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89180,
      "choices": [
        {
          "id": 355124,
          "text": "<p><span style=\"font-size:14.0pt;\">Fish contains enough carbs to prevent ketosis, so avoid it.</span></p>"
        },
        {
          "id": 355125,
          "text": "<p><span style=\"font-size:14.0pt;\">Fish is essentially carbohydrate-free—an excellent choice on a ketogenic diet.</span></p>"
        },
        {
          "id": 355126,
          "text": "<p><span style=\"font-size:14.0pt;\">Fish provides moderate carbohydrates in the form of glycogen—limit to small portions.</span></p>"
        },
        {
          "id": 355127,
          "text": "<p><span style=\"font-size:14.0pt;\">Fish contains hidden sugars that can spike blood glucose despite low visible carbs.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient on a carbohydrate-restricted diet wonders if eating fish will break ketosis. Which statement is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5456426",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fish is essentially carbohydrate-free—an excellent choice on a ketogenic diet.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ketosis</strong> is maintained when dietary carbohydrate intake is kept very low (typically &lt;20–50 g per day), forcing the body to burn fats for fuel and produce ketone bodies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fish</strong>, including fatty species (salmon, mackerel) and lean varieties (cod, tilapia), contain <strong>virtually 0 g</strong> of carbohydrates per standard serving.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their macronutrient profile is almost entirely <strong>protein and fat</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Because fish lacks appreciable carbs, consuming it does <strong>not</strong> raise blood glucose or insulin levels enough to interrupt ketosis—making it an ideal protein source on a ketogenic regimen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Fish contains enough carbs to prevent ketosis, so avoid it:</strong> Fish has negligible carbohydrate content (&lt;1 g per 100 g), so it <strong>cannot</strong> provide enough carbs to halt ketosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Fish provides moderate carbohydrates in the form of glycogen—limit to small portions:</strong> Although fish muscle contains some glycogen in living tissue, post-harvest glycogen levels drop rapidly, and laboratory analyses show virtually no residual carb content in edible portions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Fish contains hidden sugars that can spike blood glucose despite low visible carbs:</strong> Fish does not contain sugars or hidden carbohydrates; concerns about “hidden carbs” apply to processed foods with added sugars or starches, not to fresh fish.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On a ketogenic or carbohydrate-restricted diet, <strong>fish is one of the safest protein sources</strong>—it offers essential nutrients and fats without carbohydrate content that could interrupt ketosis.</span></p>",
      "correct_choice_id": 355125,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89180/PSM_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89180/PSM_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89371,
      "choices": [
        {
          "id": 355884,
          "text": "<p><span style=\"font-size:14.0pt;\">50 mL</span></p>"
        },
        {
          "id": 355885,
          "text": "<p><span style=\"font-size:14.0pt;\">55 mL</span></p>"
        },
        {
          "id": 355886,
          "text": "<p><span style=\"font-size:14.0pt;\">60 mL</span></p>"
        },
        {
          "id": 355887,
          "text": "<p><span style=\"font-size:14.0pt;\">70 mL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a 32-year-old male, during the clinical examination, his blood pressure was found to be 130/80 mm Hg, heart rate was 60/min, and respiratory rate was 16/min. What would be the stroke volume in this patient, if his cardiac output was 4.2 L?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7954657",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 70 mL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The formula for <strong>Cardiac Output (CO)</strong> is:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_S5slKw3.png\" width=\"830\" height=\"57\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Given:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cardiac output (CO) = 4.2 L/min = 4200 mL/min</span></li><li><span style=\"font-size:14.0pt;\">Heart rate (HR) = 60 beats/min</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To find <strong>Stroke Volume (SV)</strong>, rearrange the formula:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_svuyUIN.png\" width=\"232\" height=\"124\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Substitute the given values:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The stroke volume is 70 mL per beat&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>stroke volume</strong> is the amount of blood pumped by the heart per beat. In this case, with a cardiac output of 4.2 L/min and a heart rate of 60 beats/min, the stroke volume is <strong>70 mL</strong> per beat.</span></p>",
      "correct_choice_id": 355887,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89371/PHYSIOLOGY_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89371/PHYSIOLOGY_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89429,
      "choices": [
        {
          "id": 356112,
          "text": "<p><span style=\"font-size:14.0pt;\">Transfusion-related acute lung injury (TRALI) – Type II hypersensitivity reaction</span></p>"
        },
        {
          "id": 356113,
          "text": "<p><span style=\"font-size:14.0pt;\">Febrile non-hemolytic transfusion reaction – Type I cytokine-mediated reaction</span></p>"
        },
        {
          "id": 356114,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute hemolytic transfusion reaction – Type II hypersensitivity reaction</span></p>"
        },
        {
          "id": 356115,
          "text": "<p><span style=\"font-size:14.0pt;\">Anaphylaxis due to IgA deficiency – Type I hypersensitivity reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man is brought to the emergency department 6 hours after a road traffic accident. On arrival, his blood pressure is 90/60 mm Hg, heart rate is 110/min, and SpO₂ is 92%. He receives a unit of blood for stabilization. A few hours later, he develops fever, tachypnea, hypoxia, and starts bleeding from intravenous and nasogastric tube sites. What is the most likely cause?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3362021",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Acute hemolytic transfusion reaction – Type II hypersensitivity reaction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient developed signs of <strong>acute hemolytic transfusion reaction (AHTR)</strong> following a mismatched&nbsp;blood transfusion, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Fever and chills</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hemoglobinuria</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Bleeding</strong> (may occur secondary to DIC)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypotension and hypoxia</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>AHTR is a classic Type II hypersensitivity reaction</strong>, in which <strong>preformed anti-ABO antibodies</strong> bind to donor red cells and cause <strong>complement-mediated intravascular hemolysis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This may progress to <strong>disseminated intravascular coagulation (DIC)</strong> in severe cases, explaining the bleeding and hypoxia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Transfusion-related acute lung injury(TRALI) – Type II hypersensitivity reaction</strong>: Caused by anti-leukocyte antibodies in donor plasma, leading to <strong>non-cardiogenic pulmonary edema</strong> and <strong>hypoxia</strong>. It does <strong>not cause hemolysis or bleeding</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Febrile non-hemolytic transfusion reaction – Type I cytokine-mediated reaction</strong>: Typically presents with <strong>mild fever and chills</strong> without hemolysis or bleeding. It is caused by <strong>cytokines in stored blood</strong>, not antibodies or hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anaphylaxis due to IgA deficiency – Type I hypersensitivity reaction</strong>: Characterized by <strong>hypotension, urticaria, bronchospasm</strong>, and shock in patients with <strong>IgA deficiency</strong>. It does <strong>not present with hemolysis or DIC-like features</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Acute hemolytic transfusion reaction</strong> is a <strong>Type II hypersensitivity reaction</strong> caused by <strong>preformed antibodies (e.g., anti-ABO)</strong> leading to <strong>intravascular hemolysis</strong>, often presenting with <strong>fever, hypotension, hemoglobinuria</strong>, and in severe cases, <strong>DIC and bleeding</strong>.&nbsp;</span></p>",
      "correct_choice_id": 356114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89429/PATHOLOGY_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89429/PATHOLOGY_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89425,
      "choices": [
        {
          "id": 356096,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of mutated transthyretin in multiple organs</span></p>"
        },
        {
          "id": 356097,
          "text": "<p><span style=\"font-size:14.0pt;\">Wild-type transthyretin deposition with predominant cardiac involvement</span></p>"
        },
        {
          "id": 356098,
          "text": "<p><span style=\"font-size:14.0pt;\">Deposition of amyloid light chains due to plasma cell dyscrasia</span></p>"
        },
        {
          "id": 356099,
          "text": "<p><span style=\"font-size:14.0pt;\">β2-microglobulin accumulation associated with dialysis-related amyloidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 75-year-old man presents with progressive fatigue and exertional dyspnea. He has no significant history of hypertension or ischemic heart disease. Echocardiography reveals concentric left ventricular hypertrophy with diastolic dysfunction. Endomyocardial biopsy shows amyloid deposits, and mass spectrometry confirms transthyretin (TTR) protein. Which of the following best describes the pathogenesis of this patient’s condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1547480",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Wild-type transthyretin deposition with predominant cardiac involvement</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s clinical picture is consistent with <strong>Systemic Senile Amyloidosis</strong>, also referred to as <strong>wild-type ATTR amyloidosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It commonly presents in elderly patients with <strong>cardiac involvement</strong>, particularly <strong>diastolic heart failure</strong> due to restrictive cardiomyopathy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The amyloid is derived from <strong>wild-type transthyretin (TTR)</strong> and is not associated with a genetic mutation (as seen in hereditary ATTR amyloidosis).</span></li><li><span style=\"font-size:14.0pt;\">Key features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Age &gt;65 years</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Wild-type transthyretin</strong> is deposited (not mutated)</span></li><li><span style=\"font-size:14.0pt;\">Cardiac involvement is common and may mimic hypertensive or hypertrophic cardiomyopathy</span></li><li><span style=\"font-size:14.0pt;\">Confirmed by biopsy and mass spectrometry</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Deposition of mutated transthyretin in multiple organs</strong>: This describes <strong>hereditary ATTR amyloidosis</strong>, not senile systemic amyloidosis, which involves <strong>wild-type TTR</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Deposition of amyloid light chains due to plasma cell dyscrasia</strong>: This refers to <strong>AL amyloidosis</strong>, which is associated with multiple myeloma and presents with systemic involvement, not limited to the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. β2-microglobulin accumulation associated with dialysis-related amyloidosis</strong>: This is seen in patients on long-term dialysis and affects <strong>joints and bones</strong>, not typically the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Systemic Senile Amyloidosis (ATTR wild-type)</strong> is caused by deposition of <strong>wild-type transthyretin</strong>, predominantly in the <strong>heart</strong>, leading to <strong>restrictive cardiomyopathy</strong> in the elderly.</span></p>",
      "correct_choice_id": 356097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89425/PATHOLOGY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89425/PATHOLOGY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89093,
      "choices": [
        {
          "id": 354788,
          "text": "<p><span style=\"font-size:14.0pt;\">Allosteric inhibition</span></p>"
        },
        {
          "id": 354789,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition</span></p>"
        },
        {
          "id": 354790,
          "text": "<p><span style=\"font-size:14.0pt;\">Noncompetitive inhibition</span></p>"
        },
        {
          "id": 354791,
          "text": "<p><span style=\"font-size:14.0pt;\">Uncompetitive inhibition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the Lineweaver–Burk plot below, the inhibitor increases the slope without changing the y-intercept (1/Vₘₐₓ). Which type of inhibition does this represent?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fAQKedt.png\" width=\"644\" height=\"525\"></p>",
      "unique_key": "Q7393079",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Competitive inhibition</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">On a Lineweaver–Burk (double-reciprocal) plot:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Y-intercept (1/Vₘₐₓ)</strong> remains the <strong>same</strong> for both curves, indicating that <strong>Vₘₐₓ is unchanged</strong> by the inhibitor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>X-intercept (–1/Kₘ)</strong> shifts <strong>closer to zero</strong> (less negative) when the inhibitor is present, indicating an <strong>increased apparent Kₘ</strong> (lower affinity for substrate).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>slope</strong> of the red line (with inhibitor) is steeper than the blue (no inhibitor), reflecting a larger Kₘ/Vₘₐₓ ratio.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These features—<strong>unchanged Vₘₐₓ</strong> with <strong>increased Kₘ</strong>—are classic for <strong>competitive inhibition</strong>, where the inhibitor competes with substrate for the active site but can be overcome by high substrate concentration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Allosteric inhibition:</strong> Allosteric inhibitors bind at regulatory sites and often <strong>decrease Vₘₐₓ</strong> (shifting the y-intercept upward) and can alter cooperativity. They do <strong>not</strong> leave Vₘₐₓ unchanged with only Kₘ changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Noncompetitive inhibition:</strong> Noncompetitive inhibitors bind equally to the free enzyme and enzyme–substrate complex, <strong>decreasing Vₘₐₓ</strong> (higher 1/Vₘₐₓ) while <strong>Kₘ remains unchanged</strong> (x-intercept constant). The depicted plot shows a change in x-intercept, so it is <strong>not</strong> noncompetitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Uncompetitive inhibition:</strong> Uncompetitive inhibitors bind only to the enzyme–substrate complex, lowering both Vₘₐₓ and apparent Kₘ. On the plot, both y- and x-intercepts would shift in parallel lines. That pattern is <strong>not</strong> seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Competitive inhibition increases apparent Kₘ without changing Vₘₐₓ; on a Lineweaver–Burk plot, this appears as two lines intersecting at the same y-intercept but with different slopes and x-intercepts.</span></p>",
      "correct_choice_id": 354789,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89093/BIOCHEM_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89093/BIOCHEM_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89407,
      "choices": [
        {
          "id": 356024,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypokalemia&nbsp;</span></p>"
        },
        {
          "id": 356025,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 356026,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypocalcemia</span></p>"
        },
        {
          "id": 356027,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypophosphatemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a patient at risk of re-feeding syndrome, which of the following electrolyte imbalances is typically not associated with this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8712793",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hyperkalemia&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Unlike hypokalemia, hyperkalemia is not typically associated with re-feeding syndrome.</span></li><li><span style=\"font-size:14.0pt;\">Instead, rapid re-feeding may lead to increased insulin secretion, which drives potassium into cells, potentially causing hypokalemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Hypokalemia:</strong> Re-feeding syndrome can lead to hypokalemia due to increased cellular uptake of potassium during the anabolic phase, especially if there is concomitant insulin administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Hypocalcemia:</strong> Re-feeding syndrome can cause hypocalcemia due to decreased parathyroid hormone secretion and subsequent impaired bone resorption, leading to low serum calcium levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Hypophosphatemia:</strong> Re-feeding syndrome is characterized by rapid shifts of phosphate into cells during the anabolic phase, leading to hypophosphatemia, which can manifest clinically as weakness, respiratory failure, and arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients at risk of re-feeding syndrome, electrolyte imbalances such as hypokalemia, hypocalcemia, and hypophosphatemia are commonly observed, while hyperkalemia is typically not associated with this condition.</span></p>",
      "correct_choice_id": 356025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89407/SURGERY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89407/SURGERY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89370,
      "choices": [
        {
          "id": 355880,
          "text": "<p><span style=\"font-size:14.0pt;\">1-2-3-4</span></p>"
        },
        {
          "id": 355881,
          "text": "<p><span style=\"font-size:14.0pt;\">1-2-4-3</span></p>"
        },
        {
          "id": 355882,
          "text": "<p><span style=\"font-size:14.0pt;\">3-1-2-4</span></p>"
        },
        {
          "id": 355883,
          "text": "<p><span style=\"font-size:14.0pt;\">1-3-2-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Arrange the sequence of events occurring after the P wave in an ECG:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">a wave in JVP</span></li><li><span style=\"font-size:14.0pt;\">First heart sound</span></li><li><span style=\"font-size:14.0pt;\">Rapid filling of ventricles</span></li><li><span style=\"font-size:14.0pt;\">T wave in ECG</span></li></ol>",
      "unique_key": "Q2269548",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-2-4-3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>P wave</strong> on an ECG represents <strong>atrial depolarization</strong>, which leads to <strong>atrial contraction</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After the P wave, the following sequence of events occurs in a specific order:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. a wave in JVP</strong>: The “<strong>a” wave</strong> in the jugular venous pressure (JVP) is caused by <strong>atrial contraction</strong>, which immediately follows the P wave on the ECG. This event represents the mechanical contraction of the atria after depolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. First heart sound (S1)</strong>: The <strong>first heart sound (S1)</strong> is heard when the <strong>atrioventricular valves (tricuspid and mitral valves)</strong> close at the beginning of <strong>ventricular contraction</strong> (systole). This follows the a wave and is a key indicator of the start of the <strong>isovolumetric contraction</strong> phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. T wave in ECG</strong>: The <strong>T wave</strong> represents <strong>ventricular repolarization</strong>, which leads to <strong>ventricular relaxation</strong>. This is an electrical event that occurs before the mechanical relaxation of the ventricles. Repolarization precedes the mechanical relaxation process, allowing the ventricles to begin filling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Rapid filling of ventricles</strong>: After repolarization (T wave), the ventricles undergo <strong>rapid filling</strong> during the early phase of diastole as the atrioventricular valves reopen. This mechanical event occurs after the electrical repolarization (T wave).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7wh179B.png\" width=\"642\" height=\"548\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sequence breakdown:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>P wave</strong> triggers atrial contraction, which is reflected as the <strong>a wave</strong> in the JVP.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>first heart sound (S1)</strong> occurs as the AV valves close due to increased ventricular pressure.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>T wave</strong> marks ventricular repolarization, signaling the beginning of relaxation.</span></li><li><span style=\"font-size:14.0pt;\">Finally, the <strong>rapid filling of ventricles</strong> happens after relaxation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct sequence following the <strong>P wave</strong> involves:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Atrial contraction (a wave in JVP),</span></li><li><span style=\"font-size:14.0pt;\">First heart sound (AV valve closure),</span></li><li><span style=\"font-size:14.0pt;\">T wave (ventricular repolarization),</span></li><li><span style=\"font-size:14.0pt;\">Rapid ventricular filling.</span></li></ol>",
      "correct_choice_id": 355881,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89370/PHYSIOLOGY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89370/PHYSIOLOGY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89340,
      "choices": [
        {
          "id": 355760,
          "text": "<p><span style=\"font-size:14.0pt;\">Lash and Lash procedure</span></p>"
        },
        {
          "id": 355761,
          "text": "<p><span style=\"font-size:14.0pt;\">Benson and Durfee cerclage</span></p>"
        },
        {
          "id": 355762,
          "text": "<p><span style=\"font-size:14.0pt;\">Wurm’s cerclage</span></p>"
        },
        {
          "id": 355763,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic cerclage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24y G4 presents to you for pre conceptional counselling. She gives a history of recurrent 2<sup>nd</sup> trimester losses and in the last pregnancy, a procedure was done at 14 weeks, despite which she still had an abortion at 18 weeks. Which of the following cervical cerclage procedures would be advised in this woman pre conceptionally as a prophylactic measure for cervical incompetence?</span></p>",
      "unique_key": "Q9203624",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Laparoscopic cerclage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cervical cerclage</strong> is a surgical procedure used to prevent preterm birth by reinforcing a weak or incompetent cervix.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laparoscopic cerclage</strong> is a <strong>transabdominal cerclage</strong> technique performed <strong>before pregnancy or in the first trimester</strong>, especially in women with a history of cervical insufficiency where transvaginal cerclage has failed or is not feasible.</span></li><li><span style=\"font-size:14.0pt;\">It is usually placed <strong>pre-pregnancy</strong> in high-risk women and remains in situ during subsequent pregnancies, avoiding repeated procedures.</span></li><li><span style=\"font-size:14.0pt;\">This approach allows precise placement at the cervico-isthmic junction and is typically done <strong>before conception</strong> in women with recurrent pregnancy loss due to cervical incompetence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lash and Lash cerclage:</strong> Incorrect. The <strong>Lash and Lash stitch</strong> is a <strong>transvaginal stitch</strong> placed before pregnancy for cervical insufficiency. However, it is not routinely performed.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Benson and Durfee cerclage:</strong> Incorrect. <strong>Benson and Durfee cerclage</strong> refer to a <strong>transvaginal cerclage</strong> placed during pregnancy. It is not indicated in nonpregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wurm’s cerclage:</strong> Incorrect. <strong>Wurm’s cerclage</strong> is another type of <strong>transvaginal cerclage</strong> performed in pregnancy, not as a prophylactic measure in the nonpregnant state.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Laparoscopic cerclage is a transabdominal cerclage procedure typically performed in nonpregnant women with cervical insufficiency, particularly when transvaginal cerclage has failed or is contraindicated<strong>.</strong></span></p>",
      "correct_choice_id": 355763,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89340/OBG_NEET_PG_GT_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89340/OBG_NEET_PG_GT_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89095,
      "choices": [
        {
          "id": 354796,
          "text": "<p><span style=\"font-size:14.0pt;\">Hormone-sensitive lipase</span></p>"
        },
        {
          "id": 354797,
          "text": "<p><span style=\"font-size:14.0pt;\">Glycogen phosphorylase</span></p>"
        },
        {
          "id": 354798,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetyl-CoA carboxylase</span></p>"
        },
        {
          "id": 354799,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbamoyl phosphate synthetase I</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old man presents after a 24-hour fast. Which of the following enzyme activities would you expect to be reduced in hepatocytes during fasting?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2657408",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Acetyl-CoA carboxylase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the fasting state, the body shifts from storing nutrients toward mobilizing and utilizing energy reserves.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Acetyl-CoA carboxylase (ACC)</strong> catalyzes the first committed step in <strong>fatty acid synthesis</strong>, converting acetyl-CoA to malonyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fasting decreases insulin</strong> and <strong>increases glucagon</strong>, leading to <strong>phosphorylation and inhibition of ACC</strong> by AMP-activated protein kinase (AMPK) and protein kinase A (PKA).</span></li><li><span style=\"font-size:14.0pt;\">As a result, <strong>fatty acid synthesis is shut off</strong> when energy is needed elsewhere.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hormone-sensitive lipase:</strong> Fasting <strong>activates</strong> HSL in adipose tissue via PKA-mediated phosphorylation, promoting lipolysis to release free fatty acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glycogen phosphorylase:</strong> Fasting <strong>activates</strong> this enzyme in liver (via glucagon and AMP), driving glycogen breakdown to maintain blood glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carbamoyl phosphate synthetase I (CPS I):</strong> Fasting <strong>increases</strong> CPS I activity (via N-acetylglutamate) to enhance the urea cycle for disposal of amino-nitrogen from gluconeogenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fasting inhibits acetyl-CoA carboxylase to block fatty acid synthesis, while it activates catabolic enzymes such as hormone-sensitive lipase, glycogen phosphorylase, and CPS I.</span></p>",
      "correct_choice_id": 354798,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89095/BIOCHEM_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89095/BIOCHEM_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89401,
      "choices": [
        {
          "id": 356000,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 356001,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 356002,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false</span></p>"
        },
        {
          "id": 356003,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Damage to the common peroneal nerve at the neck of fibula causes foot drop.</span></p><p><br><span style=\"font-size:14.0pt;\">Reason (R): The common peroneal nerve supplies the plantar flexors of the foot.</span></p>",
      "unique_key": "Q2775049",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A is true, but R is false</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>common peroneal nerve</strong> wraps around the <strong>neck of the fibula</strong>, making it vulnerable to injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It innervates the <strong>anterior and lateral compartments</strong> of the leg, which are responsible for <strong>dorsiflexion and eversion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Injury leads to <strong>foot drop</strong>.</span><br><span style=\"font-size:14.0pt;\"><strong>Plantarflexion</strong> is done by the <strong>posterior compartment (tibial nerve)</strong>—so the reason is false.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>common peroneal nerve</strong> wraps around the <strong>neck of the fibula</strong>, making it vulnerable to injury. It innervates the <strong>anterior and lateral compartments</strong> of the leg, which are responsible for <strong>dorsiflexion and eversion</strong>. Injury leads to <strong>foot drop</strong>.</span></p>",
      "correct_choice_id": 356002,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89401/ANATOMY_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89401/ANATOMY_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89424,
      "choices": [
        {
          "id": 356092,
          "text": "<p><span style=\"font-size:14.0pt;\">IgM</span></p>"
        },
        {
          "id": 356093,
          "text": "<p><span style=\"font-size:14.0pt;\">IgD</span></p>"
        },
        {
          "id": 356094,
          "text": "<p><span style=\"font-size:14.0pt;\">IgG</span></p>"
        },
        {
          "id": 356095,
          "text": "<p><span style=\"font-size:14.0pt;\">IgA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old boy presents to the emergency department with abdominal pain, arthralgia, and a purpuric rash over his lower extremities. Urinalysis reveals microscopic hematuria and mild proteinuria. A skin biopsy is performed. Which of the following immunoglobulins is most likely to be deposited in the affected tissues?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4587368",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) IgA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation is characteristic of <strong>Henoch-Schönlein purpura (HSP)</strong>, now called <strong>IgA vasculitis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is the most common systemic vasculitis in children.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Palpable purpura</strong> (usually on the lower limbs and buttocks)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Arthralgia or arthritis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Abdominal pain</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Renal involvement</strong> (hematuria, proteinuria)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Biopsy (typically of skin or kidney) reveals <strong>leukocytoclastic vasculitis</strong> with <strong>IgA-dominant immune deposits</strong>, especially in the mesangium of the glomeruli in renal involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IgM</strong>: IgM is not the characteristic immunoglobulin in HSP. Though it may be elevated in certain infections, it is not the deposited immunoglobulin in this vasculitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IgD</strong>: IgD is primarily involved in naive B-cell receptor signaling. It does not play a role in tissue deposition in vasculitic syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IgG</strong>: IgG is involved in many other immune-mediated diseases (e.g., Goodpasture syndrome, lupus nephritis), but not in HSP where IgA predominates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Henoch-Schönlein purpura (IgA vasculitis)</strong> is characterized by <strong>deposition of IgA immune complexes</strong> in small vessels, particularly affecting the skin, gastrointestinal tract, and kidneys.</span></p>",
      "correct_choice_id": 356095,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89424/PATHOLOGY_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89424/PATHOLOGY_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89351,
      "choices": [
        {
          "id": 355804,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal agenesis</span></p>"
        },
        {
          "id": 355805,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary hypoplasia</span></p>"
        },
        {
          "id": 355806,
          "text": "<p><span style=\"font-size:14.0pt;\">Genital anomalies</span></p>"
        },
        {
          "id": 355807,
          "text": "<p><span style=\"font-size:14.0pt;\">Holoprosencephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonate born with failure to pass a Ryles tube, external ear deformities, and eye coloboma is suspected to have a genetic syndrome. What other feature would most likely be present?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9056800",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Genital anomalies</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CHARGE Syndrome</strong> is characterized by <strong>coloboma</strong>, <strong>heart defects</strong>, <strong>atresia choanae</strong>, <strong>growth retardation</strong>, <strong>genital anomalies</strong>, and <strong>ear abnormalities</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CHARGE syndrome:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Coloboma</span></li><li><span style=\"font-size:14.0pt;\">Heart defects</span></li><li><span style=\"font-size:14.0pt;\">Atresia of the choanae</span></li><li><span style=\"font-size:14.0pt;\">Retardation of growth and development</span></li><li><span style=\"font-size:14.0pt;\">Genital and urinary abnormalities</span></li><li><span style=\"font-size:14.0pt;\">Ear abnormalities</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Renal agenesis</strong>: Characteristic of Potter Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pulmonary hypoplasia</strong>: Seen in Potter Syndrome, not CHARGE Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Holoprosencephaly</strong>: Associated with Trisomy 13 or other midline defects, not CHARGE Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Genital anomalies are a hallmark feature of Charge Syndrome, along with choanal atresia, coloboma, and ear abnormalities.</span></p>",
      "correct_choice_id": 355806,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89351/PEDIATRICS_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89351/PEDIATRICS_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89411,
      "choices": [
        {
          "id": 356040,
          "text": "<p><span style=\"font-size:14.0pt;\">Barrett’s esophagus</span></p>"
        },
        {
          "id": 356041,
          "text": "<p><span style=\"font-size:14.0pt;\">Schatzki ring</span></p>"
        },
        {
          "id": 356042,
          "text": "<p><span style=\"font-size:14.0pt;\">Eosinophilic esophagitis</span></p>"
        },
        {
          "id": 356043,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudo-achalasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old female patient came to the physician with complaints of heartburn and regurgitation of food. The symptoms have been present for 3 years but have worsened for the past 3 months. She took over-the-counter medications but the symptoms did not subside. Upper GI endoscopy shows the following presentation. What is your probable diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20114820.jpeg\" width=\"549\" height=\"511\"></p>",
      "unique_key": "Q4007656",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Barrett’s esophagus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image is an upper GI endoscopic image of Barrett's esophagus.</span></li><li><span style=\"font-size:14.0pt;\">It shows tongue shaped projections in the surrounding mucosa.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Schatzki ring</strong>: A Schatzki ring is a narrowing of the lower esophagus that can cause difficulty swallowing (dysphagia). It typically appears as a thin ring on endoscopy and wouldn't show the patchy red mucosa that is indicative of Barrett’s esophagus. The symptoms of heartburn and regurgitation are less specific to a Schatzki ring unless there is accompanying esophagitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Eosinophilic esophagitis</strong>: This is an allergic/immune condition that results in a buildup of eosinophils in the esophagus, leading to esophageal dysfunction. On endoscopy, it can show multiple rings, white specks of eosinophilic infiltrates, and longitudinal furrows, none of which are visible in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudo-achalasia</strong>: This refers to symptoms of achalasia due to carcinoma of esophagus. It would not cause the visible changes seen in Barrett’s esophagus on endoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Barrett’s esophagus is the columnar metaplasia of lower esophagus.</span></p>",
      "correct_choice_id": 356040,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89411/SURGERY_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89411/SURGERY_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89364,
      "choices": [
        {
          "id": 355856,
          "text": "<p><span style=\"font-size:14.0pt;\">It is calculated as (Weight/Height<sup>3</sup>) × 100.</span></p>"
        },
        {
          "id": 355857,
          "text": "<p><span style=\"font-size:14.0pt;\">Anemia is a cause of symmetrical IUGR</span></p>"
        },
        {
          "id": 355858,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a marker of chronic hypoxia in neonates.</span></p>"
        },
        {
          "id": 355859,
          "text": "<p><span style=\"font-size:14.0pt;\">It is elevated in neonates with asymmetrical IUGR.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding ponderal index is true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7733943",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It is calculated as (Weight/Height<sup>3</sup>) × 100.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ponderal index is used to calculate intrauterine growth restriction</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ponderal index is a measure of neonatal nutritional status and is calculated as (Weight/Height<sup>3</sup>) × 100.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Weight in gram and height in cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anemia is a cause of symmetrical IUGR</strong>: Anemia is a cause of asymmetrical IUGR. The causes of symmetrical IUGR is TORCH infections or genetic defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It is a marker of chronic hypoxia in neonates:</strong> Ponderal index reflects nutritional status, not hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is elevated in neonates with asymmetrical IUGR:</strong> It is reduced in asymmetrical IUGR due to disproportionate weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ponderal index is a nutritional assessment tool calculated as (Weight/Height<sup>3</sup>) × 100, with reduced values indicating asymmetrical IUGR.</span></p>",
      "correct_choice_id": 355856,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89364/PEDIATRICS_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89364/PEDIATRICS_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89242,
      "choices": [
        {
          "id": 355372,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 2 and 4 are true</span></p>"
        },
        {
          "id": 355373,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1 and 3 are true</span></p>"
        },
        {
          "id": 355374,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are true</span></p>"
        },
        {
          "id": 355375,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2 and 4 are true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements are true regarding common tinea infections?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Corticosteroids may lead to atypical presentation in tinea infections, termed Tinea incognito.</span></li><li><span style=\"font-size:14.0pt;\">Tinea pedis, or athlete’s foot, is most commonly caused by Trichophyton rubrum.</span></li><li><span style=\"font-size:14.0pt;\">Tinea cruris, commonly known as Dhobi's itch, typically affects the nail folds.</span></li><li><span style=\"font-size:14.0pt;\">Tinea unguium refers to fungal infection of the nail plate but not the nail folds.</span></li></ol>",
      "unique_key": "Q7273865",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only statements 1, 2 and 4 are true</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Corticosteroids may lead to atypical presentation in tinea infections, termed Tinea incognito: </strong>Is true. Corticosteroids can suppress local immunity and alter the appearance of tinea infections, leading to the atypical form known as <strong>Tinea incognito</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Tinea pedis, or athlete’s foot, is most commonly caused by Trichophyton rubrum:&nbsp;</strong>Is true<strong>. Tinea pedis</strong>, or athlete’s foot, is most frequently caused by the dermatophyte <strong>Trichophyton rubrum</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Tinea unguium refers to fungal infection of the nail plate but not the nail folds:&nbsp;</strong>Is true. <strong>Tinea unguium (onychomycosis)</strong> is a <strong>fungal infection of the nail plate</strong> itself and <strong>does not involve the surrounding nail folds</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Tinea cruris, commonly known as Dhobi's itch, typically affects the nail folds:&nbsp;</strong>Is false. <strong>Tinea cruris</strong>, or <strong>Dhobi’s itch</strong>, affects the <strong>groin</strong> region—not the <strong>nail folds</strong>. The term “Dhobi's itch” is commonly used in South Asian countries to describe this condition.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_A1vuSY3.png\" width=\"313\" height=\"333\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tinea unguium affects the <strong>nail plate</strong>, not the surrounding structures like nail folds.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Correct identification of dermatophyte infections based on anatomical distribution and common pathogens is essential for accurate diagnosis and treatment.</span></li></ul>",
      "correct_choice_id": 355372,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89242/DERMA_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89242/DERMA_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89309,
      "choices": [
        {
          "id": 355636,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate cesarean section</span></p>"
        },
        {
          "id": 355637,
          "text": "<p><span style=\"font-size:14.0pt;\">Forceps-assisted vaginal delivery</span></p>"
        },
        {
          "id": 355638,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat fetal scalp blood pH measurement within 30 minutes</span></p>"
        },
        {
          "id": 355639,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer maternal left lateral positioning and intravenous fluids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old primigravida&nbsp;in active labor reaches 5 cm cervical dilation. Cardiotocography (CTG) monitoring shows recurrent late decelerations. A fetal scalp blood sample is obtained, showing a pH of 7.19. What is the next best step in management?</span></p>",
      "unique_key": "Q7542811",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Immediate cesarean section</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The detection of <strong>late decelerations</strong> on CTG is an alarming sign of <strong>uteroplacental insufficiency</strong>, leading to fetal hypoxia and acidosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal scalp blood pH analysis</strong> is used to assess fetal acid-base status during labor:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Normal pH (&gt; 7.25)</strong>: Indicates no immediate concern — continue monitoring.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Borderline pH (7.21–7.24)</strong>: Repeat fetal scalp pH within <strong>30 minutes</strong> to assess trends.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Abnormal pH (≤ 7.20)</strong>: Indicates <strong>fetal acidosis</strong>, requiring <strong>immediate delivery</strong> to prevent hypoxic injury.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case, the fetal scalp blood pH is <strong>7.19</strong>, which is <strong>below the critical threshold of 7.20</strong>, signifying <strong>fetal acidosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of <strong>recurrent late decelerations</strong> combined with <strong>pH ≤ 7.20</strong> mandates <strong>immediate cesarean section</strong> to avoid perinatal complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Forceps-assisted vaginal delivery:</strong> Incorrect. <strong>Forceps delivery</strong> is only indicated when the cervix is <strong>fully dilated</strong> and fetal head is low enough in the birth canal. In this scenario, the cervix is <strong>5 cm dilated</strong>, making operative vaginal delivery inappropriate and unsafe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Repeat fetal scalp blood pH measurement within 30 minutes:</strong> Incorrect. This option is correct only when the pH is <strong>borderline (7.21–7.24)</strong>. However, since the <strong>pH is 7.19</strong>, this indicates established <strong>fetal acidosis</strong>, which requires <strong>immediate delivery</strong>, not a repeat test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer maternal left lateral positioning and intravenous fluids:</strong> Incorrect. While <strong>maternal repositioning and hydration</strong> may help improve uteroplacental perfusion in cases of mild decelerations, they are <strong>not sufficient nor definitive</strong> when fetal scalp pH indicates <strong>acidosis (≤ 7.20)</strong>. Immediate delivery is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A fetal scalp pH of ≤ 7.20 in the presence of late decelerations during labor is indicative of fetal acidosis and mandates immediate cesarean section to prevent hypoxic injury.</span></p>",
      "correct_choice_id": 355636,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89309/OBG_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89309/OBG_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89244,
      "choices": [
        {
          "id": 355380,
          "text": "<p><span style=\"font-size:14.0pt;\">Leprosy</span></p>"
        },
        {
          "id": 355381,
          "text": "<p><span style=\"font-size:14.0pt;\">Leishmaniasis</span></p>"
        },
        {
          "id": 355382,
          "text": "<p><span style=\"font-size:14.0pt;\">Lupus vulgaris</span></p>"
        },
        {
          "id": 355383,
          "text": "<p><span style=\"font-size:14.0pt;\">DLE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male agricultural worker presents with a single, nontender lesion on his forearm. The lesion began as a small papule a few weeks ago and has gradually enlarged, now showing a central ulceration with a crusted surface surrounded by an erythematous rim. The patient recalls traveling to a rural area endemic for sandfly bites. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-04%20112146.jpeg\" width=\"527\" height=\"457\"></p>",
      "unique_key": "Q4752118",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Leishmaniasis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The description of a central ulcer with a crusted appearance and an erythematous border corresponds to the <strong>\"Volcano sign\"</strong>, a classic feature of <strong>Old World cutaneous leishmaniasis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This condition occurs after a bite from an infected sandfly and is endemic in certain rural areas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leprosy:&nbsp;</strong>Leprosy lesions are typically hypopigmented or erythematous macules/plaques with loss of sensation. Central ulceration is uncommon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lupus vulgaris:&nbsp;</strong>Lupus vulgaris, a form of cutaneous tuberculosis, presents as a chronic plaque with reddish-brown “apple-jelly nodules” on diascopy, not as an ulcerated lesion with an erythematous rim.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. DLE:&nbsp;</strong>DLE <strong>(Discoid Lupus Erythematosus)</strong> lesions are erythematous plaques with adherent scales, atrophy, and scarring, but they lack the “Volcano sign.”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>\"Volcano sign\"</strong> is a classic descriptor for cutaneous leishmaniasis. It appears as a central ulcer with a crusted surface surrounded by an erythematous rim, resembling a volcanic crater.</span></li><li><span style=\"font-size:14.0pt;\">This feature helps differentiate leishmaniasis from other dermatological conditions.</span></li></ul>",
      "correct_choice_id": 355381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89244/DERMA_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89244/DERMA_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89281,
      "choices": [
        {
          "id": 355524,
          "text": "<p><span style=\"font-size:14.0pt;\">Metformin</span></p>"
        },
        {
          "id": 355525,
          "text": "<p><span style=\"font-size:14.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 355526,
          "text": "<p><span style=\"font-size:14.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 355527,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He was recently started on a new medication for hypertension. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. Which of the following drugs is most likely responsible for these symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1612562",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hydrochlorothiazide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and visual disturbances.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other symptoms can include dizziness, confusion, and changes in heart rate or rhythm.</span></li><li><span style=\"font-size:14.0pt;\">Hydrochlorothiazide can cause electrolyte abnormalities such as hypokalemia, which can increase the risk of digoxin toxicity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Metformin:</strong> An antihyperglycemic that reduces hepatic gluconeogenesis and improves insulin sensitivity. It has <strong>no effect</strong> on potassium homeostasis or digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lisinopril:&nbsp;</strong>An ACE inhibitor that can cause mild <strong>hyperkalemia</strong> by reducing aldosterone—this would <strong>protect</strong> against, not precipitate, digoxin toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amlodipine:&nbsp;</strong>A dihydropyridine calcium-channel blocker; it does not alter potassium levels or digoxin clearance and is <strong>not</strong> linked to digoxin toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When a patient on digoxin develops toxicity signs after starting a new medication, <strong>check for hypokalemia-inducing agents</strong>—thiazide diuretics like <strong>hydrochlorothiazide</strong> are common culprits.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Always monitor electrolytes closely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note – Digoxin overdose caused by – Quinidine, Verapamil, Amiodarone, Thiazides and Thromycin</span></p>",
      "correct_choice_id": 355527,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89281/PHARMA_NEET_PG_GT_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89281/PHARMA_NEET_PG_GT_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89201,
      "choices": [
        {
          "id": 355208,
          "text": "<p><span style=\"font-size:14.0pt;\">Shift IMI to biweekly “pulse” rounds instead of monthly</span></p>"
        },
        {
          "id": 355209,
          "text": "<p><span style=\"font-size:14.0pt;\">Expand the target age up to 5 years for all antigens, not only measles</span></p>"
        },
        {
          "id": 355210,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase social mobilization to reduce vaccine hesitancy</span></p>"
        },
        {
          "id": 355211,
          "text": "<p><span style=\"font-size:14.0pt;\">Replace vaccination-on-demand with fixed-site delivery only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A surveillance report finds that in areas where more than three consecutive routine immunization sessions were missed, measles outbreaks continue to occur despite ongoing Intensified Mission Indradhanush (IMI) rounds. Which strategic adjustment would most strengthen IMI’s impact in these pockets?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9232930",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increase social mobilization to reduce vaccine hesitancy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Areas that miss multiple sessions often suffer not only from access gaps but also from <strong>community resistance or distrust</strong>—vaccine hesitancy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Merely increasing the frequency of campaigns (Option A) or broadening age groups (Option B) without addressing the underlying reluctance will leave many children unvaccinated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Vaccination-on-demand (Option D) ensures availability but does nothing to overcome fears or misinformation.</span></li><li><span style=\"font-size:14.0pt;\">By <strong>intensifying social mobilization</strong>—engaging local leaders, conducting targeted awareness campaigns, and deploying community health volunteers to address concerns—IMI can convert hesitant families into willing participants, thereby closing the remaining coverage gaps and preventing outbreaks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Shift IMI to biweekly “pulse” rounds instead of monthly:</strong> More frequent campaigns may marginally increase contacts but also strain resources and may still falter if families refuse vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Expanding target age to 5 years for all antigens, not only measles: </strong>While capturing older missed children is beneficial, it doesn’t resolve the root cause of persistent non-uptake in under-2s.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Replace vaccination-on-demand with fixed-site delivery only: </strong>Removing on-demand flexibility would likely reduce access further, particularly for migratory or hard-to-reach populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Effective immunization drives must combine supply-side measures (availability, frequency) with demand-generation strategies (social mobilization) to overcome vaccine hesitancy in low-coverage pockets.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Closing immunization gaps</strong> in high-risk areas requires not just more vaccines, but <strong>strong community engagement</strong> to build trust, dispel myths, and motivate families to participate.</span></li></ul>",
      "correct_choice_id": 355210,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89201/PSM_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89201/PSM_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89203,
      "choices": [
        {
          "id": 355216,
          "text": "<p><span style=\"font-size:14.0pt;\">Ecological fallacy</span></p>"
        },
        {
          "id": 355217,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead‐time bias</span></p>"
        },
        {
          "id": 355218,
          "text": "<p><span style=\"font-size:14.0pt;\">Information bias</span></p>"
        },
        {
          "id": 355219,
          "text": "<p><span style=\"font-size:14.0pt;\">Berkson’s bias</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Researchers note that countries with more physicians per capita tend to have higher cancer survival rates. They warn that simply training more doctors will improve an individual patient’s prognosis. This inference is most likely flawed because of:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8272115",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ecological fallacy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>ecological fallacy</strong> occurs when associations observed at the <strong>group</strong> level are incorrectly assumed to hold at the <strong>individual</strong> level.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;In this scenario, the observation—that countries with more doctors have better cancer survival—may reflect factors such as overall health infrastructure, screening programs, or socioeconomic status, rather than a direct effect of physician density on any one patient’s outcome.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Extrapolating from the country‐level data to predict individual benefit commits the ecological fallacy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lead‐time bias:</strong> Occurs when earlier detection (e.g., through screening) appears to increase survival time without truly delaying death. It does not explain a country‐level association between physician density and outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Information bias:</strong> Arises from systematic errors in measurement or classification of exposure or outcome. Here, data on physicians per capita and survival are unlikely to be misclassified in a way that explains the misleading inference.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Berkson’s bias:</strong> A selection bias seen in hospital‐based studies when patients with multiple conditions are more likely to be hospitalized. This does not apply to aggregated national statistics on doctors and survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Beware the <strong>ecological fallacy</strong>, strong relationships seen when data are averaged across populations can be misleading if used to make predictions about individuals.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Always seek individual-level data before drawing causal conclusions.</span></li></ul>",
      "correct_choice_id": 355216,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89203/PSM_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89203/PSM_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89377,
      "choices": [
        {
          "id": 355908,
          "text": "<p><span style=\"font-size:14.0pt;\">Leukemoid reaction</span></p>"
        },
        {
          "id": 355909,
          "text": "<p><span style=\"font-size:14.0pt;\">Myelosuppression</span></p>"
        },
        {
          "id": 355910,
          "text": "<p><span style=\"font-size:14.0pt;\">Agranulocytosis</span></p>"
        },
        {
          "id": 355911,
          "text": "<p><span style=\"font-size:14.0pt;\">Aplastic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male with treatment-resistant schizophrenia is started on clozapine. After 4 weeks, his CBC reveals an absolute neutrophil count of 700/mm³. Which adverse effect is most likely responsible?</span></p>",
      "unique_key": "Q9831496",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Agranulocytosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clozapine</strong> is reserved for <strong>treatment-resistant schizophrenia</strong> but is associated with a <strong>risk of agranulocytosis</strong>, a potentially life-threatening drop in <strong>neutrophil count</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">An <strong>absolute neutrophil count (ANC) &lt;1000/mm³</strong> is considered <strong>agranulocytosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, an ANC of <strong>700/mm³</strong> after 4 weeks of treatment strongly suggests <strong>clozapine-induced agranulocytosis</strong>, which requires <strong>immediate discontinuation</strong> of the drug and close hematologic monitoring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leukemoid reaction</strong>: Involves <strong>marked elevation</strong> in white blood cell count, mimicking leukemia — not relevant here where <strong>WBC count is low</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Myelosuppression</strong>: A general term for bone marrow suppression affecting multiple cell lines. Although clozapine can cause this, the <strong>specific and critical drop in neutrophils</strong> points more precisely to <strong>agranulocytosis</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Aplastic anemia</strong>: Involves <strong>pancytopenia</strong> (low RBCs, WBCs, and platelets) and hypocellular bone marrow, not <strong>isolated neutropenia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FeRhkDX.png\" width=\"767\" height=\"312\"></strong></span></p>",
      "correct_choice_id": 355910,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89377/Psychiatry_NEET_PG_GT_Question_2_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89377/Psychiatry_NEET_PG_GT_Question_2_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89434,
      "choices": [
        {
          "id": 356132,
          "text": "<p><span style=\"font-size:14.0pt;\">Nephrotic syndrome</span></p>"
        },
        {
          "id": 356133,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatic cirrhosis</span></p>"
        },
        {
          "id": 356134,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 356135,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute inflammation&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most likely diagnosis based on the serum protein electrophoresis given below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_g2Jjbuf.png\" width=\"453\" height=\"469\"></strong></span></p>",
      "unique_key": "Q4287763",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hepatic cirrhosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The serum protein electrophoresis (SPEP) pattern in the image shows:</span></li><li><span style=\"font-size:14.0pt;\">A <strong>reduced albumin peak</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Beta-gamma bridging</strong>: This is a key characteristic finding where the beta and gamma globulin fractions merge without a clear separation.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>broad-based gamma region</strong> elevation due to polyclonal gammopathy (chronic antigenic stimulation)</span></li><li><span style=\"font-size:14.0pt;\">These findings are <strong>classic for hepatic cirrhosis</strong>, especially due to chronic liver disease from alcohol or viral hepatitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The liver’s inability to synthesize albumin leads to hypoalbuminemia, while chronic inflammation increases polyclonal immunoglobulin production.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5dfxM6p.png\" width=\"1197\" height=\"933\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nephrotic syndrome:</strong> Typically shows a <strong>markedly reduced albumin</strong> band but <strong>increased alpha-2 globulin</strong> due to compensatory synthesis of proteins like α2-macroglobulin and ceruloplasmin. <strong>Gamma globulins are often low</strong>, not broad-based.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Multiple myeloma:</strong> Shows a <strong>sharp monoclonal spike (M spike)</strong> in the gamma or beta region, not a <strong>broad-based elevation</strong> as seen here. Also, albumin may be relatively preserved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute inflammation:</strong> Typically causes <strong>elevations in alpha-1 and alpha-2 regions</strong>, due to increased acute-phase reactants. Gamma globulin elevation is <strong>not prominent</strong> or diffuse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Beta-gamma bridging on serum protein electrophoresis is a hallmark of hepatic cirrhosis</strong>, reflecting polyclonal gammopathy from chronic antigenic stimulation along with decreased albumin production.</span></p>",
      "correct_choice_id": 356133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89434/PATHOLOGY_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89434/PATHOLOGY_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89031,
      "choices": [
        {
          "id": 354544,
          "text": "<p><span style=\"font-size:14.0pt;\">Haab’s striae</span></p>"
        },
        {
          "id": 354545,
          "text": "<p><span style=\"font-size:14.0pt;\">Axenfeld’s line</span></p>"
        },
        {
          "id": 354546,
          "text": "<p><span style=\"font-size:14.0pt;\">Sampaolesi’s line</span></p>"
        },
        {
          "id": 354547,
          "text": "<p><span style=\"font-size:14.0pt;\">Vogt’s line</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man with a history of progressive visual loss is diagnosed with pseudoexfoliation glaucoma. On gonioscopic examination, dense pigmentation is observed anterior to Schwalbe’s line in the inferior quadrant of the angle. What is this finding known as?</span></p>",
      "unique_key": "Q2109108",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Sampaolesi’s line</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Sampaolesi’s line</strong> refers to a <strong>pigmented line anterior to Schwalbe’s line</strong> seen on gonioscopy, commonly in the <strong>inferior angle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is associated with <strong>excessive trabecular meshwork pigmentation</strong>, often due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Pseudoexfoliation glaucoma</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pigment dispersion glaucoma</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Other secondary open-angle glaucomas</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In <strong>pseudoexfoliation glaucoma</strong>, abnormal fibrillary material accumulates in the anterior segment, leading to trabecular blockage and elevated intraocular pressure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The increased pigment dispersion in this condition is what creates the <strong>Sampaolesi’s line</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DszxXET.png\" width=\"521\" height=\"586\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Haab’s striae:</strong> Incorrect. These are <strong>horizontal breaks in Descemet’s membrane</strong>, seen in <strong>congenital glaucoma</strong>, not angle pigmentation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aeYmH6m.png\" width=\"450\" height=\"310\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Axenfeld’s line:</strong> Incorrect. Refers to <strong>anteriorly displaced Schwalbe’s line</strong> associated with <strong>Axenfeld-Rieger anomaly</strong>, not pigment deposition.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4zgB1kk.png\" width=\"479\" height=\"374\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vogt’s line:</strong> Incorrect. Vogt’s striae are <strong>vertical lines in the deep corneal stroma</strong> seen in <strong>keratoconus</strong>, unrelated to angle structures.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qQiNoja.png\" width=\"379\" height=\"312\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sampaolesi’s line</strong> is a pigmented line seen anterior to Schwalbe’s line on gonioscopy, classically associated with <strong>pseudoexfoliation and pigment dispersion syndromes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is an important clue for diagnosing <strong>secondary open-angle glaucomas</strong>.</span></li></ul>",
      "correct_choice_id": 354546,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89031/OPTHALMOLOGY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89031/OPTHALMOLOGY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89035,
      "choices": [
        {
          "id": 354560,
          "text": "<p><span style=\"font-size:14.0pt;\">Inform the patient that effect of LASIK will last for only 7.5 years</span></p>"
        },
        {
          "id": 354561,
          "text": "<p><span style=\"font-size:14.0pt;\">The patient should have keratometry values between 30–40 D</span></p>"
        },
        {
          "id": 354562,
          "text": "<p><span style=\"font-size:14.0pt;\">The laser should ablate 25 µm per diopter of correction</span></p>"
        },
        {
          "id": 354563,
          "text": "<p><span style=\"font-size:14.0pt;\">At least 300 µm of stromal bed must remain post-procedure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man with a stable refraction of –7.50 D in both eyes presents for LASIK evaluation. His central corneal thickness measures 520 µm, and you plan a 110 µm flap. Which of the following must be ensured before proceeding with LASIK to minimize the risk of postoperative ectasia?</span></p>",
      "unique_key": "Q9086684",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) At least 300 µm of stromal bed must remain post-procedure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most critical safety parameter in LASIK is preserving an adequate <strong>residual stromal bed (RSB)</strong> after flap creation and laser ablation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Insufficient RSB predisposes the cornea to biomechanical weakening and postoperative ectasia.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flap thickness:</strong> 110 µm</span></li><li><span style=\"font-size:14.0pt;\"><strong>Estimated ablation depth:</strong> ~12–15 µm per diopter</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">For –7.50 D: 7.5 D × 14 µm/D ≈ 105 µm</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Total tissue removal:</strong> 110 µm + 105 µm = 215 µm</span></li><li><span style=\"font-size:14.0pt;\"><strong>RSB calculation:</strong> 520 µm – 215 µm = 305 µm</span></li><li><span style=\"font-size:14.0pt;\">Most guidelines now recommend <strong>300 µm</strong> of RSB.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7tUTkUn.png\" width=\"1201\" height=\"835\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inform the patient that effect of LASIK will last for only 7.5 years:&nbsp;</strong>LASIK can provide long-lasting results, especially if refraction is stable and myopia is not progressive. This is a counselling point, not a surgical safety criterion to prevent ectasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The patient should have keratometry values between 30–40 D:</strong> Normal adult keratometry ranges roughly 40–47 D. Values below 40 D indicate an abnormally flat cornea, which may affect flap adhesion but are not the primary safety criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The laser should ablate 25 µm per diopter of correction:&nbsp;</strong>Contemporary excimer lasers remove approximately <strong>10–15 µm per diopter</strong>, not 25 µm. Overestimating the ablation depth would lead to unnecessary cancellation of surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ensure a residual stromal bed of 300 µm after LASIK to minimize the risk of corneal ectasia, particularly in high myopes.</span></p>",
      "correct_choice_id": 354563,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89035/OPTHALMOLOGY_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89035/OPTHALMOLOGY_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89069,
      "choices": [
        {
          "id": 354696,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal auditory canal</span></p>"
        },
        {
          "id": 354697,
          "text": "<p><span style=\"font-size:14.0pt;\">Round window of the cochlea</span></p>"
        },
        {
          "id": 354698,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral recess of the fourth ventricle</span></p>"
        },
        {
          "id": 354699,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior colliculus of the midbrain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old patient with Neurofibromatosis type 2 undergoes surgical resection for bilateral acoustic neuromas. Postoperatively, the patient is found to have bilateral auditory nerve destruction, making cochlear implantation ineffective. An auditory brainstem implant (ABI) is planned to restore auditory perception. Where is the auditory brainstem implant placed?</span></p>",
      "unique_key": "Q4153021",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lateral recess of the fourth ventricle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>auditory brainstem implant (ABI)</strong> is designed for patients in whom the <strong>auditory nerve is non-functional or absent</strong>, as in <strong>bilateral vestibular schwannomas (acoustic neuromas)</strong>—especially in <strong>Neurofibromatosis type 2</strong>. Unlike cochlear implants, ABIs <strong>bypass the auditory nerve</strong> and <strong>directly stimulate the cochlear nucleus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The cochlear nucleus is located in the <strong>lateral recess of the fourth ventricle</strong>, making this the <strong>precise site</strong> for ABI placement.</span></li><li><span style=\"font-size:14.0pt;\">The device allows sound perception by stimulating the brainstem auditory pathway directly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Internal auditory canal</strong>: This is where the vestibulocochlear nerve passes, but <strong>not a site for ABI placement</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Round window of the cochlea</strong>: This is the site for <strong>cochlear implants</strong>, not ABI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inferior colliculus of the midbrain</strong>: Higher auditory center; <strong>not targeted</strong> by ABI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>auditory brainstem implant (ABI)</strong> is used when the <strong>auditory nerve is destroyed</strong>, commonly in <strong>bilateral acoustic neuroma</strong>, and is surgically <strong>placed in the lateral recess of the fourth ventricle</strong> to stimulate the <strong>cochlear nucleus</strong> directly.</span></p>",
      "correct_choice_id": 354698,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89069/ENT_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89069/ENT_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89255,
      "choices": [
        {
          "id": 355420,
          "text": "<p><span style=\"font-size:14.0pt;\">Obese diabetics</span></p>"
        },
        {
          "id": 355421,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-diabetics</span></p>"
        },
        {
          "id": 355422,
          "text": "<p><span style=\"font-size:14.0pt;\">Type 2 diabetics</span></p>"
        },
        {
          "id": 355423,
          "text": "<p><span style=\"font-size:14.0pt;\">Diabetics not responding to sulfonylureas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Metformin is least likely to reduce blood sugar in which of the following patients?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5981308",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Non-diabetics</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Metformin is an oral medication commonly used to treat type 2 diabetes. It works by reducing glucose production in the liver, improving insulin sensitivity in peripheral tissues, and reducing glucose absorption in the intestines.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">As a result, metformin helps to lower blood sugar levels in individuals with diabetes.</span></li><li><span style=\"font-size:14.0pt;\">In non-diabetic individuals, who already have normal blood sugar regulation, the use of metformin is not indicated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Metformin does not cause hypoglycemia and since the blood sugar levels of non-diabetics are within the normal range, metformin cannot further reduce blood sugar.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Obese diabetics:</strong> Metformin is commonly prescribed to obese individuals with type 2 diabetes as it helps improve insulin sensitivity and control blood sugar levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Type 2 diabetics:</strong> Metformin is considered a first-line treatment for type 2 diabetes and is widely used to reduce blood sugar levels in these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Diabetics not responding to sulfonylureas:</strong> When individuals with diabetes do not respond adequately to sulfonylureas (another class of antidiabetic medication), metformin is often added as an adjunct therapy to help improve blood sugar control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Metformin is <strong>ineffective</strong> at lowering blood sugar in <strong>non-diabetics</strong>; its therapeutic benefit depends on correcting the pathological <strong>insulin resistance</strong> and <strong>excessive hepatic glucose production</strong> of type 2 diabetes.</span></p>",
      "correct_choice_id": 355421,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89255/PHARMA_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89255/PHARMA_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89200,
      "choices": [
        {
          "id": 355204,
          "text": "<p><span style=\"font-size:14.0pt;\">Efficacy</span></p>"
        },
        {
          "id": 355205,
          "text": "<p><span style=\"font-size:14.0pt;\">Effectiveness</span></p>"
        },
        {
          "id": 355206,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal validity</span></p>"
        },
        {
          "id": 355207,
          "text": "<p><span style=\"font-size:14.0pt;\">Cost‐effectiveness</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A city launches a fall‐prevention exercise program for community‐dwelling seniors. In a controlled trial, supervised sessions reduced fall rates by 40%. When rolled out citywide under usual conditions—with variable attendance and instructor skill—the program reduced falls by 25%. The reduction observed under routine community implementation reflects the programs:</span></p>",
      "unique_key": "Q7577388",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Effectiveness</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Effectiveness</strong> measures how well an intervention performs <strong>in real‐world settings</strong>, incorporating factors such as participant adherence, variability in delivery, and system constraints.</span></li><li><span style=\"font-size:14.0pt;\">The 25% reduction seen in routine practice indicates the program’s effectiveness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Efficacy</strong>: Refers to performance under the <strong>ideal conditions</strong> of a controlled trial (40% reduction), not routine implementation. Lab conditions are fully controlled</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Internal validity</strong>: Relates to the rigor and freedom from bias within a study design, not the real‐world impact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cost‐effectiveness</strong>: Evaluates the economic value (cost per fall prevented), which is a separate consideration from the program’s performance. It is output in terms of results achieved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">An intervention’s <strong>effectiveness</strong> reflects its impact in usual practice, which is often lower than its <strong>efficacy</strong> measured under controlled conditions.</span></p>",
      "correct_choice_id": 355205,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89200/PSM_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89200/PSM_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89189,
      "choices": [
        {
          "id": 355160,
          "text": "<p><span style=\"font-size:14.0pt;\">Permethrin, 25 mg/m²</span></p>"
        },
        {
          "id": 355161,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyfluthrin, 50 mg/m²</span></p>"
        },
        {
          "id": 355162,
          "text": "<p><span style=\"font-size:14.0pt;\">Etofenprox, 10 mg/m²</span></p>"
        },
        {
          "id": 355163,
          "text": "<p><span style=\"font-size:14.0pt;\">Lambdacyhalothrin, 5 mg/m²</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">To treat nets in a high‐resistance area where mosquitoes have partial tolerance to deltamethrin, which alternative pyrethroid and dosage would best match deltamethrin’s initial efficacy?</span></p>",
      "unique_key": "Q3571092",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cyfluthrin, 50 mg/m²</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cyfluthrin at 50 mg/m²</strong> delivers a nominal twice-the–surface concentration (5% formulation) compared to deltamethrin’s 2.5% at 25 mg/m².&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This dosage produces a comparable knockdown and mortality rate against pyrethroid-tolerant mosquitoes, compensating for their reduced sensitivity.</span></li><li><span style=\"font-size:14.0pt;\">Simply increasing deltamethrin concentration risks accelerated wash-off and resistance selection, whereas cyfluthrin’s intrinsic potency and higher dosing maintain efficacy without frequent retreatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Permethrin, 25 mg/m²:</strong> Permethrin at this dosage (2% formulation) has inherently lower potency against Anopheles than deltamethrin; it would underperform in tolerant populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Etofenprox, 10 mg/m²:</strong> Although etofenprox is a pyrethroid-like compound, a 10 mg/m² dosage falls well below the effective surface load needed to match deltamethrin’s knockdown rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lambdacyhalothrin, 5 mg/m²:</strong> Lambdacyhalothrin is highly potent, but at only 5 mg/m² (0.5% formulation), its total active load is too low to overcome partial resistance and would give suboptimal control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When migrating from deltamethrin in a <strong>high-resistance setting</strong>, choose <strong>cyfluthrin at 50 mg/m²</strong> (5% formulation) to replicate the original net efficacy, rather than simply raising deltamethrin doses or using lower-load alternatives.</span></p>",
      "correct_choice_id": 355161,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89189/PSM_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89189/PSM_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89028,
      "choices": [
        {
          "id": 354532,
          "text": "<p><span style=\"font-size:14.0pt;\">Persistence of hyperintensity on fat-suppressed T1 images</span></p>"
        },
        {
          "id": 354533,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of signal on T2-weighted images (T2 shading)</span></p>"
        },
        {
          "id": 354534,
          "text": "<p><span style=\"font-size:14.0pt;\">Homogeneous enhancement after gadolinium administration</span></p>"
        },
        {
          "id": 354535,
          "text": "<p><span style=\"font-size:14.0pt;\">Signal dropout on opposed-phase chemical-shift imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman with chronic pelvic pain undergoes pelvic MRI. A left ovarian cyst appears hyperintense on both standard T1‐weighted and fat‐suppressed T1 images. Which finding confirms that the high T1 signal arises from blood rather than fat?</span></p>",
      "unique_key": "Q5510639",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Persistence of hyperintensity on fat-suppressed T1 images</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">T1 hyperintense&nbsp;→ Fat and blood&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fat‐suppression techniques selectively null the signal from lipids.</span></li><li><span style=\"font-size:14.0pt;\">A true fatty lesion (e.g., a dermoid cyst) will lose its high T1 signal when fat‐sat pulses are applied.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, blood breakdown products (methemoglobin) remain bright on T1 even after fat suppression because their T1 shortening effect is independent of lipid content.</span></li><li><span style=\"font-size:14.0pt;\">Thus, if a cyst remains hyperintense after fat saturation, the high signal must be due to proteinaceous or hemorrhagic content, diagnostically pointing to an endometrioma (chocolate cyst).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Loss of signal on T2-weighted images (T2 shading):</strong> While endometriomas often show “T2 shading” (progressive loss of T2 signal due to chronic blood products), this finding is supportive rather than confirmatory of blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Homogeneous enhancement after gadolinium administration</strong>: Enhancement indicates vascularized tissue or septations, not the simple presence of blood. A hemorrhagic cyst typically does not enhance centrally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Signal dropout on opposed-phase chemical-shift imaging:</strong> Opposed-phase (in-out) imaging detects microscopic fat by comparing in-phase and out-phase signals. A blood‐filled cyst usually shows no significant chemical-shift artifact, but this technique is less specific than fat suppression for distinguishing blood from fat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On MRI, persistence of T1 hyperintensity after fat‐suppression is the most specific indicator of hemorrhagic (blood) content, distinguishing endometriomas from lipid‐containing lesions.</span></p>",
      "correct_choice_id": 354532,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89028/NEETPG-INICET_GT_Radiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89028/NEETPG-INICET_GT_Radiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89588,
      "choices": [
        {
          "id": 356744,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 356745,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Renal osteodystrophy</span></p>"
        },
        {
          "id": 356746,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Osteomalacia</span></p>"
        },
        {
          "id": 356747,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with a history of chronic kidney disease (CKD) presents with complaints of bone pain, muscle weakness, and increased fracture risk. His kidney function has been declining over the past few years, and he is currently on haemodialysis. His laboratory results reveal elevated serum phosphate and low serum calcium. His parathyroid hormone (PTH) levels are markedly elevated, and a radiograph shows subperiosteal resorption of bone, especially in the phalanges. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3431806",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. B) Renal osteodystrophy</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Renal Osteodystrophy is a broad term for bone complications of chronic kidney disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It encompasses several types, but the patient's presentation specifically points to secondary hyperparathyroidism, a common and severe form of renal osteodystrophy.</span></li><li><span style=\"font-size:14.0pt;\">In CKD, the kidneys lose their ability to excrete phosphate, leading to hyperphosphatemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They also cannot adequately activate Vitamin D, leading to decreased calcium absorption and hypocalcaemia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both hyperphosphatemia and hypocalcaemia stimulate the parathyroid glands to produce excessive PTH (secondary hyperparathyroidism).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">High PTH then causes excessive bone resorption, particularly the classic subperiosteal resorption seen on radiographs.</span></li><li><span style=\"font-size:14.0pt;\">The patient's age, CKD, dialysis status, lab abnormalities (high phosphate, low calcium, high PTH), and radiographic findings (subperiosteal resorption) perfectly align with this diagnosis.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option A. Osteoporosis:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While CKD patients can have osteoporosis, the markedly elevated PTH, subperiosteal resorption, elevated phosphate, and low calcium are not typical features of primary osteoporosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Osteoporosis is characterized by reduced bone mass and microarchitectural deterioration leading to fragility fractures, but not necessarily these specific lab and radiographic findings.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Osteomalacia:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is defective mineralization of bone in adults, usually due to severe vitamin D deficiency.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it can cause bone pain and muscle weakness and is related to vitamin D metabolism, it typically presents with low phosphate levels (due to decreased renal reabsorption in response to vitamin D deficiency) and low to normal PTH (unless it's secondary hyperparathyroidism due to severe vitamin D deficiency, but the primary cause here is kidney failure affecting multiple aspects of mineral metabolism).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The subperiosteal resorption is also not characteristic of pure osteomalacia.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Rickets:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the equivalent of osteomalacia in children, where defective mineralization affects growing bone and growth plates.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient is 55 years old, making rickets an impossible diagnosis.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">The constellation of findings—CKD (especially on dialysis), elevated phosphate, low calcium, markedly elevated PTH, and subperiosteal bone resorption—is highly characteristic of renal osteodystrophy.</span></p>",
      "correct_choice_id": 356745,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89588/Orthopedics_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89588/Orthopedics_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89786,
      "choices": [
        {
          "id": 357536,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer intravenous (IV) hydrocortisone 100 mg</span></p>"
        },
        {
          "id": 357537,
          "text": "<p><span style=\"font-size:14.0pt;\">Assess thyroid function and Antidiuretic hormones (ADH)</span></p>"
        },
        {
          "id": 357538,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for MRI pituitary protocol</span></p>"
        },
        {
          "id": 357539,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for neurosurgical consultation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents to the emergency department with severe headache and visual field disturbances. On examination her vitals are - T 37.5°C, HR 100 beats/min, BP 90/60 mmHg, RR 22 breaths/min. She is alert, oriented, with intact extraocular movements. Labs: Sodium 132 mEq/L, Potassium 4.2 mEq/L, Creatinine 0.8 mg/dL. CT head is shown below, what is the next best step in her management?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_z7cRTc4.png\" width=\"332\" height=\"307\"></span></p>",
      "unique_key": "Q3370796",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Administer</strong> <strong>intravenous (IV) hydrocortisone 100 mg</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation of severe headache, visual field disturbances, and a sellar mass with hemorrhage on CT suggests pituitary apoplexy, a medical emergency due to hemorrhage or infarction of a pituitary tumor.</span></li><li><span style=\"font-size:14.0pt;\">Hypotension (BP 90/60 mmHg) and hyponatremia (Na 132 mEq/L) indicate possible adrenal insufficiency from loss of ACTH production due to pituitary damage.</span></li><li><span style=\"font-size:14.0pt;\">Immediate administration of IV hydrocortisone is critical to stabilize the patient by addressing potential adrenal crisis, which can be life-threatening.</span></li><li><span style=\"font-size:14.0pt;\">Hydrocortisone provides glucocorticoid replacement, supporting hemodynamic stability while further diagnostic and therapeutic steps are planned.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Assess thyroid function and Antidiuretic hormones (ADH):</strong> While evaluating thyroid function and ADH levels is part of the workup for pituitary dysfunction, it is not the immediate priority. Addressing adrenal insufficiency takes precedence due to the risk of hemodynamic collapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Refer for MRI pituitary protocol:</strong> An MRI is useful for detailed imaging of the pituitary, but it is not the urgent first step when the patient is hemodynamically unstable and at risk of adrenal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Refer for neurosurgical consultation:</strong> Neurosurgical consultation is appropriate for definitive management, but stabilizing the patient with hydrocortisone is the priority to prevent further deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pituitary apoplexy is a medical emergency requiring immediate IV hydrocortisone to address potential adrenal insufficiency caused by ACTH deficiency.</span></li><li><span style=\"font-size:14.0pt;\">Prompt recognition of symptoms like headache, visual disturbances, and hypotension in the context of a sellar mass is critical for timely intervention.</span></li><li><span style=\"font-size:14.0pt;\">Stabilization with glucocorticoids precedes further diagnostic imaging or surgical consultation to ensure patient safety.</span></li></ul>",
      "correct_choice_id": 357536,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89786/Medicine_Neet_Pg_Gt_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89786/Medicine_Neet_Pg_Gt_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89418,
      "choices": [
        {
          "id": 356068,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer a hemostatic agent through the chest tube</span></p>"
        },
        {
          "id": 356069,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue resuscitation for the next 6 hours</span></p>"
        },
        {
          "id": 356070,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent thoracentesis</span></p>"
        },
        {
          "id": 356071,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency thoracotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old male patient was brought to the ER after a road traffic accident. On examination, left-sided hydrothorax was noted. Tube thoracostomy was done and around 1850 ml blood was drained in 1 hour. What is the most appropriate management for this patient?</span></p>",
      "unique_key": "Q3513500",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>D) Emergency thoracotomy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In massive hemothorax, presence of &gt;1500 ml blood in ICD immediately is an indication for thoracotomy.</span></li><li><span style=\"font-size:14.0pt;\">Given the significant blood loss (1850 ml) and the critical condition of the patient, emergency thoracotomy is the most appropriate management.</span></li><li><span style=\"font-size:14.0pt;\">It allows for direct access to the bleeding source for immediate control of bleeding and repair of injuries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer a hemostatic agent through the chest tube:</strong> This is not appropriate when there is a massive blood loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Continue resuscitation for the next 6 hours:</strong> While resuscitation is necessary, immediate control of bleeding is critical in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Urgent thoracentesis:</strong> This is not the suitable intervention for a severe condition like this.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cases of significant blood loss and critical condition, emergency thoracotomy is essential to control bleeding and repair injuries immediately.</span></p>",
      "correct_choice_id": 356071,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89418/SURGERY_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89418/SURGERY_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89308,
      "choices": [
        {
          "id": 355632,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic bipolar coagulation forceps</span></p>"
        },
        {
          "id": 355633,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic monopolar hook cautery</span></p>"
        },
        {
          "id": 355634,
          "text": "<p><span style=\"font-size:14.0pt;\">Ultrasonic harmonic scalpel</span></p>"
        },
        {
          "id": 355635,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine manipulator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most appropriate identification of this surgical instrument?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V1GHFT3.png\" width=\"559\" height=\"494\"></p>",
      "unique_key": "Q3448475",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ultrasonic harmonic scalpel</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The instrument shown and described is the <strong>Ultrasonic harmonic scalpel</strong>, a commonly used tool in laparoscopic surgery. It works by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Generating <strong>ultrasonic vibrations (55,000 Hz)</strong> at the tip, causing protein denaturation and coagulation of tissues.</span></li><li><span style=\"font-size:14.0pt;\">Allowing <strong>simultaneous cutting and coagulation</strong> with minimal thermal damage to adjacent structures.</span></li><li><span style=\"font-size:14.0pt;\">Being controlled via a <strong>handpiece and foot pedal</strong>, connected to a power generator.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The harmonic scalpel is preferred in laparoscopic and open surgeries for its ability to reduce operative time and improve hemostasis with less lateral heat spread compared to electrocautery devices.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Laparoscopic bipolar coagulation forceps:</strong> Incorrect. Bipolar forceps pass current between two tips of the forceps, used for coagulation only, and do not cut. They lack ultrasonic vibration and do not require the specific generator system shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laparoscopic monopolar hook cautery:</strong> Incorrect. The monopolar hook uses a single electrode with current passing through the body to a grounding pad, primarily for cutting or coagulation. It differs in appearance (typically a hook) and working principle (electrocautery, not ultrasonic).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Uterine manipulator:</strong> Incorrect. The uterine manipulator is an instrument used to move or stabilize the uterus during gynecologic surgery. It has no cutting or coagulation function and does not connect to a generator.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ultrasonic harmonic scalpel is a laparoscopic surgical device that uses ultrasonic vibrations to achieve simultaneous cutting and coagulation with minimal lateral thermal damage, making it ideal for precise dissection in minimally invasive surgery.</span></p>",
      "correct_choice_id": 355634,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89308/OBG_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89308/OBG_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89415,
      "choices": [
        {
          "id": 356056,
          "text": "<p><span style=\"font-size:14.0pt;\">8</span></p>"
        },
        {
          "id": 356057,
          "text": "<p><span style=\"font-size:14.0pt;\">9</span></p>"
        },
        {
          "id": 356058,
          "text": "<p><span style=\"font-size:14.0pt;\">10</span></p>"
        },
        {
          "id": 356059,
          "text": "<p><span style=\"font-size:14.0pt;\">11</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Following head trauma, a patient opens eyes to pain, localizes pain on the right shoulder but withdraws on the left side, and speaks incoherent words. His GCS is?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8585735",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 10</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Glasgow Coma Scale (GCS) is used to assess the consciousness level of a patient following a head injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It evaluates three responses: eye opening, verbal response, and motor response.</span></li></ul><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Eye Opening Response:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Spontaneous (4 points)</span></li><li><span style=\"font-size:14.0pt;\">To verbal command (3 points)</span></li><li><span style=\"font-size:14.0pt;\">To pain (2 points) - This patient</span></li><li><span style=\"font-size:14.0pt;\">No response (1 point)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Verbal Response:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Oriented (5 points)</span></li><li><span style=\"font-size:14.0pt;\">Confused conversation (4 points)</span></li><li><span style=\"font-size:14.0pt;\">Inappropriate words (3 points) - This patient</span></li><li><span style=\"font-size:14.0pt;\">Incomprehensible sounds (2 points)</span></li><li><span style=\"font-size:14.0pt;\">No response (1 point)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Motor Response:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Obeys commands (6 points)</span></li><li><span style=\"font-size:14.0pt;\">Localizes pain (5 points) - This patient</span></li><li><span style=\"font-size:14.0pt;\">Withdraws from pain (4 points)</span></li><li><span style=\"font-size:14.0pt;\">Flexion to pain (3 points)</span></li><li><span style=\"font-size:14.0pt;\">Extension to pain (2 points)</span></li><li><span style=\"font-size:14.0pt;\">No response (1 point)</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Calculation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Eye Opening: 2 points</span></li><li><span style=\"font-size:14.0pt;\">Verbal Response: 3 points</span></li><li><span style=\"font-size:14.0pt;\">Motor Response: 5 points (take the better response)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Total GCS</strong>: 2 + 3 + 5 = 10</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Glasgow Coma Scale is a critical tool for assessing the level of consciousness in patients with head injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A GCS score of 10 indicates moderate head injury, necessitating close monitoring and potentially more intensive medical intervention.</span></li></ul>",
      "correct_choice_id": 356058,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89415/SURGERY_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89415/SURGERY_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89191,
      "choices": [
        {
          "id": 355168,
          "text": "<p><span style=\"font-size:14.0pt;\">Number of ANC cases with complication referred to PHC/FRU</span></p>"
        },
        {
          "id": 355169,
          "text": "<p><span style=\"font-size:14.0pt;\">Number of pregnant women under anemia prophylaxis</span></p>"
        },
        {
          "id": 355170,
          "text": "<p><span style=\"font-size:14.0pt;\">Number of deliveries by untrained birth attendant</span></p>"
        },
        {
          "id": 355171,
          "text": "<p><span style=\"font-size:14.0pt;\">Number of postnatal checkups provided</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A state implements the Global Strategy’s “Survive” goal by reducing neonatal mortality (NNMR). Despite high TT and ANC coverage, NNMR stalls at 15/1,000. Which RCH process indicator should be strengthened to avert neonatal deaths from complications at birth?</span></p>",
      "unique_key": "Q3420405",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Number of ANC cases with complication referred to PHC/FRU</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Global strategy for women, child and adolescent health 2016 – 2030&nbsp;</span><ul><li><span style=\"font-size:14.0pt;\">Survive</span></li><li><span style=\"font-size:14.0pt;\">Thrive</span></li><li><span style=\"font-size:14.0pt;\">Transform</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Despite good TT and early ANC coverage, neonatal deaths often stem from <strong>birth-related complications</strong>—e.g., obstructed labor, pre-eclampsia, hemorrhage—which require <strong>timely referral</strong> to higher-level care (PHC or First Referral Unit).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Strengthening the indicator “ANC cases with complications referred” ensures high-risk pregnancies receive appropriate obstetric intervention before or during labor, directly preventing neonatal asphyxia, sepsis, or prematurity-related deaths.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Number of pregnant women under Anemia prophylaxis:</strong> Important for maternal health, but anemia interventions have a <strong>more indirect</strong> effect on neonatal mortality compared to emergency obstetric referrals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Number of deliveries by untrained birth attendant:</strong> While reducing untrained deliveries is critical, the more actionable indicator is timely <strong>referral of complications</strong>, regardless of attendant type.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Number of Postnatal checkups</strong> <strong>provided:</strong> Postnatal visits can catch neonatal illnesses but do not avert up-front birth complications that cause immediate neonatal deaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To drive NNMR down further, RCH programs must ensure that <strong>high-risk ANC cases are identified and referred promptly</strong> for skilled obstetric care, thereby averting the majority of birth-related neonatal deaths.</span></p>",
      "correct_choice_id": 355168,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89191/PSM_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89191/PSM_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89295,
      "choices": [
        {
          "id": 355580,
          "text": "<p><span style=\"font-size:14.0pt;\">Combined oral contraceptives</span></p>"
        },
        {
          "id": 355581,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 355582,
          "text": "<p><span style=\"font-size:14.0pt;\">Insertion of levonorgestrel-releasing intrauterine system (LNG-IUS)</span></p>"
        },
        {
          "id": 355583,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial ablation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman undergoes an ultrasound which reports a thickened endometrial lining. Subsequent office-based sampling of the endometrium reveals a diagnosis of endometrial hyperplasia without atypia. What is the most appropriate management for this patient?&nbsp;</span></p>",
      "unique_key": "Q3951373",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Insertion of levonorgestrel-releasing intrauterine system (LNG-IUS)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Endometrial hyperplasia without atypia</strong> is a proliferative disorder of the endometrial lining caused by unopposed estrogen stimulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition carries a low risk of progression to endometrial carcinoma (approximately 1-3%) but still requires management to prevent malignant transformation.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>levonorgestrel-releasing intrauterine system (LNG-IUS)</strong> is the recommended first-line treatment for endometrial hyperplasia <strong>without atypia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It delivers progestin directly to the endometrium, promoting glandular atrophy, stromal decidualization, and subsequent thinning of the endometrial lining.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The local progestin effect is superior in reversing hyperplasia compared to systemic therapy. LNG-IUS is also fertility-preserving, making it especially suitable for women who wish to retain their uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Combined oral contraceptives:</strong> Although combined oral contraceptives (COCs) provide systemic progestin, they are not the preferred treatment for endometrial hyperplasia without atypia. COCs offer a lower local progestin concentration in the endometrium compared to LNG-IUS and are typically used for regulating menstrual cycles rather than reversing hyperplasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hysterectomy:</strong> Hysterectomy is a definitive treatment for endometrial disease but is generally reserved for cases of <strong>endometrial hyperplasia with atypia</strong> or when conservative therapy fails. It is an overly aggressive option for <strong>hyperplasia without atypia</strong>, which carries a low risk of malignancy and responds well to medical therapy like LNG-IUS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endometrial ablation:</strong> Endometrial ablation destroys the endometrial lining but is not a first-line treatment for hyperplasia. It does not reliably eliminate hyperplasia or prevent its progression to carcinoma. Additionally, it can obscure future evaluation of the endometrium and is contraindicated in patients desiring future fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The levonorgestrel-releasing intrauterine system (LNG-IUS) is the first-line treatment for endometrial hyperplasia without atypia, providing effective local progestin therapy to reverse hyperplasia and reduce the risk of progression to endometrial carcinoma.</span></p>",
      "correct_choice_id": 355582,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89295/OBG_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89295/OBG_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89402,
      "choices": [
        {
          "id": 356004,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-1, C-3, D-4</span></p>"
        },
        {
          "id": 356005,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-2, C-4, D-3</span></p>"
        },
        {
          "id": 356006,
          "text": "<p><span style=\"font-size:14.0pt;\">A-4, B-1, C-3, D-2</span></p>"
        },
        {
          "id": 356007,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the foramina (Column A) with the structures that pass through them (Column B):<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1EBsh92.png\" width=\"680\" height=\"263\"></strong></span></p>",
      "unique_key": "Q4142764",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A-2, B-1, C-3, D-4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>A-2.&nbsp;Foramen ovale → Mandibular nerve (V₃):</strong> The mandibular division of the trigeminal nerve (V₃) exits the middle cranial fossa via the foramen ovale. V₃ carries motor fibers for mastication plus sensory fibers from the lower face.</span></li><li><span style=\"font-size:14.0pt;\"><strong>B-1.&nbsp;Foramen spinosum → Middle meningeal artery</strong>: The middle meningeal artery (branch of the maxillary artery) enters the cranial vault through the foramen spinosum to supply the dura.</span></li><li><span style=\"font-size:14.0pt;\"><strong>C-3.&nbsp;Jugular foramen → Glossopharyngeal nerve (IX)</strong>: Cranial nerves IX, X, and XI, plus the sigmoid sinus (becoming the internal jugular vein), pass through the jugular foramen. The glossopharyngeal nerve emerges here to innervate the pharynx and carotid sinus.</span></li><li><span style=\"font-size:14.0pt;\"><strong>D-4.&nbsp;Foramen rotundum → Maxillary nerve (V₂):&nbsp;</strong>The maxillary division of the trigeminal nerve (V₂) exits the middle cranial fossa through the foramen rotundum to enter the pterygopalatine fossa, carrying sensation from the midface.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Foramina and the structures passing through them:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Foramen ovale: Mandibular nerve (V3)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Foramen spinosum: Middle meningeal artery</span></li><li><span style=\"font-size:14.0pt;\">Jugular foramen: Glossopharyngeal (IX), Vagus (X), Accessory (XI)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Foramen rotundum: Maxillary nerve (V2)</span></li></ul>",
      "correct_choice_id": 356004,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89402/ANATOMY_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89402/ANATOMY_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89279,
      "choices": [
        {
          "id": 355516,
          "text": "<p><span style=\"font-size:14.0pt;\">B is competitive and C is non-competitive antagonist</span></p>"
        },
        {
          "id": 355517,
          "text": "<p><span style=\"font-size:14.0pt;\">B is non-competitive an C is competitive antagonist</span></p>"
        },
        {
          "id": 355518,
          "text": "<p><span style=\"font-size:14.0pt;\">Both are competitive antagonists</span></p>"
        },
        {
          "id": 355519,
          "text": "<p><span style=\"font-size:14.0pt;\">Both are non-competitive antagonists</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-07-22%20at%2011.19.03.jpeg\" width=\"940\" height=\"627\"></strong></span></p>",
      "unique_key": "Q7807729",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) B is competitive and C is non-competitive antagonist</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows that curve B has a parallel shift to the right compared to curve A, indicative of a competitive antagonist.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Curve C is lower than curve A, suggesting a non-competitive antagonist.</span></li><li><span style=\"font-size:14.0pt;\">B is competitive and C is non-competitive antagonist.</span></li><li><span style=\"font-size:14.0pt;\">B shows a parallel shift to the right, which is characteristic of competitive antagonism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Increasing the concentration of the agonist can overcome the antagonist.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">C shows a reduction in the maximal response that the agonist can produce, characteristic of a non-competitive antagonist.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. B is non-competitive and C is competitive antagonist:</strong> This is incorrect. B shows a parallel shift to the right, which is indicative of competitive antagonism. C shows a reduction in the maximal response, which is indicative of non-competitive antagonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Both are competitive antagonists:</strong> This is incorrect. Curve B shows characteristics of competitive antagonism, but curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Both are non-competitive antagonists:</strong> This is incorrect. Curve B shows characteristics of competitive antagonism as it shifts parallel to the right, while curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Interpret dose–response curves:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Competitive antagonists</strong> cause a <strong>rightward parallel shift</strong> (↑ EC₅₀, unchanged Eₘₐₓ).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Non-competitive antagonists</strong> cause a <strong>↓ in Eₘₐₓ</strong> (may shift EC₅₀ too) and cannot be overcome by increasing agonist.</span></li></ul>",
      "correct_choice_id": 355516,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89279/PHARMA_NEET_PG_GT_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89279/PHARMA_NEET_PG_GT_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89204,
      "choices": [
        {
          "id": 355220,
          "text": "<p><span style=\"font-size:14.0pt;\">Endemic malaria</span></p>"
        },
        {
          "id": 355221,
          "text": "<p><span style=\"font-size:14.0pt;\">Measles outbreaks</span></p>"
        },
        {
          "id": 355222,
          "text": "<p><span style=\"font-size:14.0pt;\">Protein-energy malnutrition</span></p>"
        },
        {
          "id": 355223,
          "text": "<p><span style=\"font-size:14.0pt;\">Rabies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions best illustrates the “tip-of-the-iceberg” phenomenon?</span></p>",
      "unique_key": "Q5027123",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Protein-energy malnutrition</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The “tip of the iceberg” phenomenon describes situations in which the <strong>recognized</strong> or <strong>severe</strong> cases (the visible tip) represent only a small portion of the <strong>total</strong> burden of disease (the submerged mass).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Protein-energy malnutrition (PEM):</strong> Severe forms such as marasmus and kwashiorkor are easily identified, but <strong>milder</strong> undernutrition (wasting, stunting, micronutrient deficiencies) is far more prevalent and often goes unnoticed without active case-finding and growth monitoring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endemic malaria:</strong> While asymptomatic parasitemia occurs in high-transmission areas, symptomatic malaria episodes are commonly reported; the hidden reservoir is smaller relative to PEM’s silent undernutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Measles outbreaks:</strong> Measles infection almost always produces an overt febrile rash illness; subclinical infections are rare, so most cases are visible and reported.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rabies:</strong> Human rabies is nearly universally fatal once symptoms develop, and there is virtually no subclinical or mild form—clinical cases are not just the “tip” but the entire burden.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In conditions like <strong>protein-energy malnutrition</strong>, active surveillance and growth monitoring are essential because the children you see with severe malnutrition represent only the “tip” of a much larger undernourished population.&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">No carriers = No iceberg</span><ul><li><span style=\"font-size:14.0pt;\">Rabies</span></li><li><span style=\"font-size:14.0pt;\">Tetanus</span></li><li><span style=\"font-size:14.0pt;\">Measles</span></li><li><span style=\"font-size:14.0pt;\">Rubella</span></li><li><span style=\"font-size:14.0pt;\">Pertussis</span></li></ul></li></ul>",
      "correct_choice_id": 355222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89204/PSM_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89204/PSM_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89349,
      "choices": [
        {
          "id": 355796,
          "text": "<p><span style=\"font-size:14.0pt;\">Smith-Lemli-Opitz Syndrome</span></p>"
        },
        {
          "id": 355797,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubinstein-Taybi Syndrome</span></p>"
        },
        {
          "id": 355798,
          "text": "<p><span style=\"font-size:14.0pt;\">Cri du Chat Syndrome</span></p>"
        },
        {
          "id": 355799,
          "text": "<p><span style=\"font-size:14.0pt;\">Edward Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy with dysmorphic facial features, syndactyly of the second and third toes, and microcephaly is diagnosed with a cholesterol metabolism defect. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-24%20164013.jpg\" width=\"411\" height=\"609\"></span></p>",
      "unique_key": "Q8068507",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Smith-Lemli-Opitz Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Smith-Lemli-Opitz Syndrome is caused by a defect in <strong>cholesterol metabolism</strong> and presents with <strong>syndactyly</strong>, polydactyly, microcephaly, and intellectual disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rubinstein-Taybi Syndrome</strong>: Broad thumbs and great toe deformity are characteristic, not syndactyly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cri du Chat Syndrome</strong>: Presents with a cat-like cry, not syndactyly or cholesterol metabolism defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Edward Syndrome</strong>: Associated with overlapping fingers and micrognathia but no cholesterol metabolism defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Smith-Lemli-Opitz Syndrome is a metabolic disorder with dysmorphic features and syndactyly.</span></p>",
      "correct_choice_id": 355796,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89349/PEDIATRICS_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89349/PEDIATRICS_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89372,
      "choices": [
        {
          "id": 355888,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-2, C-3, D-4, E-5</span></p>"
        },
        {
          "id": 355889,
          "text": "<p><span style=\"font-size:14.0pt;\">A-4, B-1, C-2, D-5, E-3</span></p>"
        },
        {
          "id": 355890,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-4, D-1, E-5</span></p>"
        },
        {
          "id": 355891,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-4, D-5, E-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following steps of ventricular action potential in the correct order:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5NMw1Nz.png\" width=\"589\" height=\"215\"></strong></span></p>",
      "unique_key": "Q3030473",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A-2, B-3, C-4, D-1, E-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Let's go step by step through the ventricular action potential and match the events:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Phase 0 (Depolarization)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This phase represents <strong>rapid depolarization</strong> due to the <strong>opening of voltage-gated sodium channels</strong>. Sodium ions (Na⁺) rapidly enter the cell, causing a spike in membrane potential.</span></li><li><span style=\"font-size:14.0pt;\">Match: <strong>C-4</strong> <strong>(Opening of voltage-gated sodium channels occurs in Phase 0).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Phase 1 (Initial Repolarization)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During this phase, there is a <strong>transient outward flow of potassium (K⁺)</strong> through transient K⁺ channels, causing a brief dip in the membrane potential.</span></li><li><span style=\"font-size:14.0pt;\">Match: <strong>D-1</strong> <strong>(Transient outward flow of potassium occurs in Phase 1).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Phase 2 (Plateau Phase)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The plateau is due to the <strong>opening of voltage-gated calcium channels</strong>. Calcium ions (Ca²⁺) enter the cell, balancing the outward flow of K⁺, which keeps the membrane potential relatively stable for a short time.</span></li><li><span style=\"font-size:14.0pt;\">Match: <strong>A-2</strong> (<strong>Opening of voltage-gated calcium channels occurs in Phase 2).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Phase 3 (Repolarization)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In this phase, <strong>repolarizing K⁺ currents</strong> dominate, and the membrane potential returns toward the resting level as potassium continues to exit the cell.</span></li><li><span style=\"font-size:14.0pt;\">Match: <strong>B-3</strong> <strong>(Repolarizing K⁺ currents dominate Phase 3)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. No Role</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Leaky sodium channels</strong> have no significant role in the phases of the ventricular action potential.</span></li><li><span style=\"font-size:14.0pt;\">Match: <strong>E-5</strong> <strong>(Leaky sodium channel has no role)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct matching is:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>A-2</strong>: Opening of voltage-gated calcium channels → Phase 2</span></li><li><span style=\"font-size:14.0pt;\"><strong>B-3</strong>: Repolarizing K⁺ currents → Phase 3</span></li><li><span style=\"font-size:14.0pt;\"><strong>C-4</strong>: Opening of voltage-gated sodium channels → Phase 0</span></li><li><span style=\"font-size:14.0pt;\"><strong>D-1</strong>: Transient outward flow of potassium → Phase 1</span></li><li><span style=\"font-size:14.0pt;\"><strong>E-5</strong>: Leaky sodium channel → No role</span></li></ul>",
      "correct_choice_id": 355890,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89372/PHYSIOLOGY_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89372/PHYSIOLOGY_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89586,
      "choices": [
        {
          "id": 356736,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Subscapularis tendon tear</span></p>"
        },
        {
          "id": 356737,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Teres major tendon tear</span></p>"
        },
        {
          "id": 356738,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\">Long head of biceps tendon tear</span></p>"
        },
        {
          "id": 356739,
          "text": "<p><span style=\"font-size:14.0pt;\">Acromioclavicular joint dislocation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A person is able to abduct his arm, internally rotate it, place the back of hand on lumbosacral joint, but is not able to lift it from back. What is etiology?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5572320",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Ans. A) Subscapularis tendon tear</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>subscapularis</strong> is the largest and most powerful muscle of the rotator cuff, located on the anterior (front) part of the scapula.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It is responsible for <strong>internal rotation</strong> of the humerus (upper arm) and plays a role in adduction and extension of the arm.</span></li><li><span style=\"font-size:14.0pt;\">A tear in the <strong>subscapularis tendon</strong> affects the ability to internally rotate the arm and lift it behind the back.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This tendon is crucial for the <strong>internal rotation</strong> of the shoulder and for bringing the hand behind the back, as seen in this patient’s inability to lift the arm after it is placed behind the back.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>test for a subscapularis tear</strong> is called the <strong>\"lift-off\" test</strong>. In this test, the patient is asked to place the back of their hand on their lower back and then try to lift the hand away from the back.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;If the tendon is torn, the patient will be unable to do so.</span></li><li><span style=\"font-size:14.0pt;\">Subscapularis tear leads to weakness in internal rotation, making it difficult to lift the hand from the back.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Despite the intact ability to abduct the arm and place the hand on the lower back, the person cannot lift it due to the lack of effective internal rotation and shoulder stabilization.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option B. Teres Major Tendon Tear:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>teres major</strong> muscle is located on the posterior (back) part of the scapula and plays a role in internal rotation, extension, and adduction of the arm, especially when the arm is in a raised position. The teres major works synergistically with the latissimus dorsi.</span></li><li><span style=\"font-size:14.0pt;\">However, a tear of the <strong>teres major</strong> tendon would not typically result in an inability to lift the arm from the back after placing it there. This is because the <strong>teres major</strong> is less important for the specific movement of lifting the hand from the back compared to the subscapularis, which is responsible for internal rotation and lifting.</span></li><li><span style=\"font-size:14.0pt;\">A tear of the teres major would likely affect movements like adduction and extension, especially when the arm is in a raised position. While it may affect the overall function of the shoulder, it wouldn't specifically impair the ability to lift the hand from behind the back in the way that a subscapularis tear would.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option C. Long Head of Biceps Tendon Tear:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>long head of the biceps tendon</strong> originates from the scapula (specifically the supraglenoid tubercle) and attaches to the biceps muscle. While the biceps is primarily known for its role in elbow flexion, the long head of the biceps also contributes to <strong>shoulder flexion</strong> and <strong>stabilization</strong> of the shoulder joint.</span></li><li><span style=\"font-size:14.0pt;\">A tear in the long head of the biceps tendon would most likely result in <strong>weakness in shoulder flexion</strong> and <strong>pain</strong> during activities involving overhead lifting. However, it would not directly impair the ability to place the hand behind the back or lift it from behind.</span></li><li><p><span style=\"font-size:14.0pt;\">A tear of the long head of the biceps may lead to a <strong>popeye deformity</strong> (bulging of the muscle) and decreased strength in shoulder flexion, but it would not prevent the arm from being placed behind the back or lifting it in the same way as a subscapularis tendon tear.</span></p><p>&nbsp;</p></li></ul><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Option D. Acromioclavicular Joint Dislocation:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>acromioclavicular (AC) joint</strong> is located where the acromion process of the scapula meets the clavicle. Dislocations of the AC joint, also known as <strong>shoulder separations</strong>, typically occur due to trauma (e.g., falling on the shoulder or direct impact). These injuries often lead to pain, swelling, and decreased ability to move the shoulder, especially with overhead or cross-body motions.</span></li><li><span style=\"font-size:14.0pt;\">An <strong>AC joint dislocation</strong> might cause <strong>pain and limited range of motion</strong>, especially during arm elevation or when moving the arm across the body. However, it does not directly affect the specific motion of lifting the hand from behind the back after it has been placed there. The patient's ability to internally rotate and position the arm behind the back might still be intact, even in the presence of an AC joint dislocation.</span></li><li><span style=\"font-size:14.0pt;\">AC joint dislocations primarily cause discomfort, swelling, and weakness in overhead motions. While there may be difficulty lifting the arm, the inability to lift the hand from the lower back as described in the scenario is more likely to be due to a rotator cuff issue, such as a subscapularis tendon tear, rather than an AC joint dislocation.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Subscapularis tendon tear directly impacts the ability to internally rotate the arm and perform movements such as lifting the hand from behind the back.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The subscapularis is a key player in this motion, and a tear in its tendon would result in the specific functional limitation.</span></li></ul>",
      "correct_choice_id": 356736,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89586/Orthopedics_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89586/Orthopedics_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89076,
      "choices": [
        {
          "id": 354720,
          "text": "<p><span style=\"font-size:14.0pt;\">Linburg–Comstock triad</span></p>"
        },
        {
          "id": 354721,
          "text": "<p><span style=\"font-size:14.0pt;\">Waddell’s triad</span></p>"
        },
        {
          "id": 354722,
          "text": "<p><span style=\"font-size:14.0pt;\">Beck’s triad</span></p>"
        },
        {
          "id": 354723,
          "text": "<p><span style=\"font-size:14.0pt;\">Charcot’s triad</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child is struck by the high bumper of a small car. On evaluation, he is found to have a fractured femoral shaft, a splenic laceration, and a contrecoup parietal skull contusion on the opposite side. Which classic injury pattern does this represent?&nbsp;</span></p>",
      "unique_key": "Q9298615",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Waddell’s triad</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Waddell’s triad</strong> describes a characteristic injury pattern seen in pediatric pedestrian–vehicle collisions:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Femoral shaft fracture</strong> from the bumper striking the thigh (“bumper injury”)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intrathoracic or intra-abdominal injury</strong> (here, splenic laceration) from impact with the hood or grille</span></li><li><span style=\"font-size:14.0pt;\"><strong>Contralateral head injury</strong> (parietal contusion) when the child is thrown and strikes the ground on the opposite side</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This sequence reflects initial lower-limb impact at bumper height, secondary torso trauma from the car’s front, and tertiary head impact against the roadway.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_59xde9J.png\" width=\"708\" height=\"386\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Linburg–Comstock triad:</strong> Refers to congenital linkage between flexor pollicis longus and flexor digitorum profundus tendons in the forearm—not related to trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Beck’s triad:&nbsp;</strong>Beck’s triad (hypotension, jugular venous distension, and muffled heart sounds) indicates <strong>cardiac tamponade</strong>, not pedestrian injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Charcot’s triad:&nbsp;</strong>Charcot’s triad (fever, jaundice, right upper-quadrant pain) is seen in <strong>acute cholangitis</strong>, unrelated to trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a child hit by a car, the combination of <strong>femur fracture + intra-abdominal/thoracic injury + contralateral head trauma</strong> strongly suggests <strong>Waddell’s triad</strong>.</span></p>",
      "correct_choice_id": 354721,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89076/FMT_NEETPG-INICET_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89076/FMT_NEETPG-INICET_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89021,
      "choices": [
        {
          "id": 354504,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Elimination</span></p>"
        },
        {
          "id": 354505,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Reabsorption</span></p>"
        },
        {
          "id": 354506,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Metabolism</span></p>"
        },
        {
          "id": 354507,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Redistribution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man was given a single dose of Thiopentone for induction of anesthesia. After 20 minutes he regains consciousness again and is aware of his surroundings. Which property of Thiopentone is responsible for this phenomenon?</span></p>",
      "unique_key": "Q2734701",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Rapid Redistribution</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thiopentone is highly lipid soluble drug and initially it will go to highly vascularized organs of the body like brain, kidney and liver.</span></li><li><span style=\"font-size:14.0pt;\">It acts as GABA agonist and sedates the patient</span></li><li><span style=\"font-size:14.0pt;\">\"<strong>Rapid Redistribution</strong>,\" accurately describes the process by which <strong>thiopentone</strong>, after <strong>inducing anesthesia</strong>, is <strong>redistributed</strong> from the <strong>brain</strong> to other, <strong>less well-perfused tissues</strong> like muscle, fat and bone&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This redistribution results in a <strong>decrease</strong> in the <strong>drug's plasma concentration</strong> and its <strong>effect on the brain</strong>, allowing the patient to <strong>regain consciousness</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>Rapid Elimination:</strong> Refers to the <strong>speed</strong> at which a <strong>drug is removed</strong> from the <strong>body</strong>, which typically <strong>involves processes&nbsp;</strong>such as <strong>renal excretion</strong> or <strong>hepatic metabolism</strong>. <strong>Thiopentone</strong> has a <strong>long elimination half-life</strong>, so this is <strong>not the reason</strong> for the <strong>rapid recovery of consciousness</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Rapid Reabsorption</strong>: Is <strong>not</strong> a term commonly associated with the <strong>pharmacokinetics of anesthesia recovery</strong>. <strong>Reabsorption</strong> typically refers to the <strong>process by which substances</strong> are <strong>transported back</strong> into the <strong>bloodstream from the renal tubules</strong>. This <strong>does not</strong> apply to <strong>thiopentone&nbsp;</strong>and<strong> anesthesia recovery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Rapid Metabolism</strong>: Refers to <strong>how quickly a drug</strong> is <strong>chemically altered</strong> by the <strong>body's metabolic processes</strong>. While thiopentone is <strong>metabolized by the liver</strong>, its <strong>rapid recovery</strong> is <strong>not due to its metabolism</strong>, as the <strong>metabolic breakdown of thiopentone</strong> is <strong>relatively slow</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thiopentone <strong>induces rapid anesthesia</strong> but also <strong>allows for quick recovery</strong> due to <strong>its rapid redistribution</strong> from the <strong>brain</strong> to <strong>less perfused tissues</strong>, which <strong>reduces its concentration</strong> in the <strong>central nervous system</strong> and <strong>restores consciousness</strong>.</span></p>",
      "correct_choice_id": 354507,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89021/ANESTHESIA_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89021/ANESTHESIA_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89245,
      "choices": [
        {
          "id": 355384,
          "text": "<p><span style=\"font-size:14.0pt;\">Nodular type is the commonest clinical presentation in this condition</span></p>"
        },
        {
          "id": 355385,
          "text": "<p><span style=\"font-size:14.0pt;\">PUVA therapy is a risk factor for this condition</span></p>"
        },
        {
          "id": 355386,
          "text": "<p><span style=\"font-size:14.0pt;\">Early diagnosis in Pre-malignant stage is crucial for the prognosis of this condition</span></p>"
        },
        {
          "id": 355387,
          "text": "<p><span style=\"font-size:14.0pt;\">Metastasis is rare</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male presented with a cancerous growth on his face. A diagnosis of Basal Cell Carcinoma is made based on biopsy findings which showed characteristic peripheral palisading of tumour cells. Which of the following statements is incorrect regarding this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5703648",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Early diagnosis in the pre-malignant stage is crucial for the prognosis of this condition</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Basal Cell Carcinoma (BCC) does not have a pre-malignant stage, as it is a primary skin cancer that originates from the basal cells of the epidermis.</span></li><li><span style=\"font-size:14.0pt;\">It typically presents as a local growth and early diagnosis is important to prevent local tissue destruction, but the term \"pre-malignant\" is not appropriate for BCC because it implies a transition from a pre-cancerous lesion to cancer, which is not characteristic of this condition.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Basal Cell Carcinoma Clinical features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Presents as <strong>Pearly translucent nodule with surface telangiectasia</strong>, undergoes central necrosis resulting in <strong>rodent ulcer with a rolled-out margin.&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Nodular type</strong> is the commonest clinical type of basal cell carcinoma. Below image depicts the Nodular Basal Cell Carcinoma.&nbsp;</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20192002.jpg\" width=\"585\" height=\"499\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nodular type is the commonest clinical presentation in this condition:</strong> This statement is true. The nodular form of BCC is the most frequently observed variant and is characterized by a pearly, often ulcerated nodule.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PUVA therapy is a risk factor for this condition:</strong> This is also true. PUVA (psoralen plus UVA) therapy, used for various skin conditions like psoriasis, increases the risk of skin cancer, including BCC.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metastasis is rare:</strong> This statement is correct. BCC is known for local invasiveness, but it rarely metastasizes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Basal Cell Carcinoma is a skin cancer that originates from basal cells of the epidermis, typically presenting as a nodular growth, and while early diagnosis is important to prevent extensive local damage, there is no pre-malignant stage.</span></li><li><span style=\"font-size:14.0pt;\">PUVA therapy is a known risk factor, and metastasis is rare in this condition.</span></li></ul>",
      "correct_choice_id": 355386,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89245/DERMA_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89245/DERMA_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89261,
      "choices": [
        {
          "id": 355444,
          "text": "<p><span style=\"font-size:14.0pt;\">Anticholinergic</span></p>"
        },
        {
          "id": 355445,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholinomimetic</span></p>"
        },
        {
          "id": 355446,
          "text": "<p><span style=\"font-size:14.0pt;\">Opioids</span></p>"
        },
        {
          "id": 355447,
          "text": "<p><span style=\"font-size:14.0pt;\">Salicylates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6619695",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Anticholinergic</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The symptoms of anticholinergic poisoning (Atropine/Dhatura/Belladona) are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D: D</strong>elirium, <strong>D</strong>ry Skin</span></p><p><span style=\"font-size:14.0pt;\"><strong>H: H</strong>yperthermia</span></p><p><span style=\"font-size:14.0pt;\"><strong>A: A</strong>gitation</span></p><p><span style=\"font-size:14.0pt;\"><strong>T: T</strong>achycardia</span></p><p><span style=\"font-size:14.0pt;\"><strong>U: U</strong>rinary</span></p><p><span style=\"font-size:14.0pt;\"><strong>R: R</strong>etention</span></p><p><span style=\"font-size:14.0pt;\"><strong>A: A</strong>ccommodation lost (Blurred vision, mydriasis)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cholinomimetic:</strong> These overstimulate muscarinic receptors, causing salivation, lacrimation, urination, diarrhea, GI cramps, and emesis (SLUDGE), bradycardia, and miosis—<strong>opposite</strong> to the patient’s presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Opioids:</strong> Opioid overdose leads to <strong>miosis</strong> (pinpoint pupils), respiratory depression, hypothermia, and decreased level of consciousness—not agitation or dry, hot skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Salicylates:</strong> Salicylate poisoning produces <strong>tinnitus</strong>, hyperthermia, respiratory alkalosis mixed with metabolic acidosis, and possible dehydration—not the classic anticholinergic signs of dry skin, mydriasis, and decreased bowel sounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a hyperthermic, agitated patient with <strong>dry skin</strong>, <strong>dilated pupils</strong>, and <strong>decreased secretions</strong>, suspect <strong>anticholinergic</strong> toxicity—never opioids or cholinomimetics.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Remember:</strong> Anticholinergic toxicity—often remembered by the mnemonic <strong>“HOT as a hare, DRY as a bone, RED as a beet, BLIND as a bat, MAD as a hatter”</strong>—results from blockade of muscarinic receptors.</span></li></ul>",
      "correct_choice_id": 355444,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89261/PHARMA_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89261/PHARMA_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89406,
      "choices": [
        {
          "id": 356020,
          "text": "<p><span style=\"font-size:14.0pt;\">CECT after 3 days of onset of symptoms</span></p>"
        },
        {
          "id": 356021,
          "text": "<p><span style=\"font-size:14.0pt;\">Administration of 5% dextrose&nbsp;</span></p>"
        },
        {
          "id": 356022,
          "text": "<p><span style=\"font-size:14.0pt;\">Octreotide has a limited role</span></p>"
        },
        {
          "id": 356023,
          "text": "<p><span style=\"font-size:14.0pt;\">Early initiation of oral feedings</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male presents to the emergency department with severe abdominal pain radiating to the back. Laboratory investigations reveal elevated serum amylase and lipase levels. Which of the following is incorrect in the management of the given condition?&nbsp;</span></p>",
      "unique_key": "Q4488693",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Administration of 5% dextrose&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's presentation is suggestive of acute pancreatitis, characterized by severe abdominal pain radiating to the back and elevated serum amylase and lipase levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The management of acute pancreatitis involves supportive care, including pain management, fluid resuscitation, and nutritional support.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Administering solutions with high glucose content can increase triglyceride levels and potentially exacerbate pancreatitis, especially in a patient who is not eating.</span></li><li><span style=\"font-size:14.0pt;\">This could lead to hyperglycemia, which is why it should be avoided.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The fluids preferred are RL or Normal saline.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CECT after 3 days of onset of symptoms:&nbsp;</strong>In patients with severe acute pancreatitis, to distinguish interstitial from necrotising pancreatitis.&nbsp; In the first 72 hours, CT may underestimate the extent of necrosis. Hence, it is done preferably after 3 days of symptom onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Octreotide has a limited role:&nbsp;</strong>Specific treatments such as aprotinin, somatostatin analogues, platelet-activating factor inhibitors and selective gut decontamination have failed to improve out come in numerous clinical trials.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Early initiation of oral feedings:</strong> If the patient is stable and pain is controlled, early initiation of oral feeding is recommended. This approach has been associated with a shorter hospital stay and lower complication rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the management of acute pancreatitis, avoid the administration of high glucose content solutions such as 5% dextrose, as they can exacerbate the condition, and instead focus on pain management, fluid resuscitation, and appropriate nutritional support.</span></p>",
      "correct_choice_id": 356021,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89406/SURGERY_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89406/SURGERY_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89106,
      "choices": [
        {
          "id": 354840,
          "text": "<p><span style=\"font-size:14.0pt;\">Alkaptonuria</span></p>"
        },
        {
          "id": 354841,
          "text": "<p><span style=\"font-size:14.0pt;\">Hawkinsinuria</span></p>"
        },
        {
          "id": 354842,
          "text": "<p><span style=\"font-size:14.0pt;\">Tyrosinemia type I</span></p>"
        },
        {
          "id": 354843,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenylketonuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old boy is brought to the clinic due to recurrent vomiting, growth delay, and a strong unusual odor in his urine. On examination, his developmental milestones are below average. Urine analysis reveals elevated levels of tyrosine and 4-hydroxyphenylpyruvate. Genetic testing reveals a missense mutation in the gene for 4-hydroxyphenylpyruvate<strong>&nbsp;</strong>dioxygenase. Which of the following conditions is most likely?</span></p>",
      "unique_key": "Q7704243",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hawkinsinuria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hawkinsinuria</strong> is a rare metabolic disorder caused by mutations in the <strong>4-hydroxyphenylpyruvate dioxygenase (4-HPPD)</strong> gene, leading to the accumulation of abnormal tyrosine metabolites.</span></li><li><span style=\"font-size:14.0pt;\">It typically presents in infancy or early childhood with:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Vomiting</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Metabolic acidosis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Developmental delay</strong></span></li><li><span style=\"font-size:14.0pt;\">A <strong>strong-smelling urine</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The hallmark is <strong>elevated tyrosine</strong> and <strong>4-hydroxyphenylpyruvate</strong> in urine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alkaptonuria</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by deficiency of <strong>homogentisate oxidase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Leads to accumulation of <strong>homogentisic acid</strong>, with <strong>dark urine</strong> and <strong>ochronosis</strong>, but <strong>not elevated 4-HPP</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tyrosinemia type I</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by <strong>fumarylacetoacetate hydrolase deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>liver failure</strong>, <strong>renal tubular dysfunction</strong>, and <strong>succynlacetoacetate</strong> in urine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phenylketonuria (PKU)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Due to <strong>phenylalanine hydroxylase deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Leads to <strong>high phenylalanine</strong>, not tyrosine or 4-HPP accumulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hawkinsinuria is a rare metabolic disorder resulting from mutations in the 4-hydroxyphenylpyruvate dioxygenase gene, characterized by elevated urinary tyrosine and 4-hydroxyphenylpyruvate, leading to developmental delay, recurrent vomiting, metabolic acidosis, and distinct urinary odor.</span></p>",
      "correct_choice_id": 354841,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89106/BIOCHEM_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89106/BIOCHEM_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89243,
      "choices": [
        {
          "id": 355376,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        },
        {
          "id": 355377,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        },
        {
          "id": 355378,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
        },
        {
          "id": 355379,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the sub-components of structural proteins in Column I with the corresponding disease in Column II:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20191621.jpg\" width=\"1238\" height=\"394\"></span></p>",
      "unique_key": "Q5910152",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-C, 2-D, 3-A, 4-B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-C. Type 1 Collagen</strong> provides <strong>tensile strength</strong>, and its defect leads to <strong>Osteogenesis Imperfecta</strong> (brittle bone disease).</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-D. Type 3 Collagen</strong> is associated with <strong>Ehler Danlos Syndrome</strong> (hyperextensible skin, joint hypermobility).</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-A. Fibrillin</strong> is essential for elasticity and resilience, and its defect causes <strong>Marfan’s Syndrome</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-B. Fibulin</strong> is linked to the disorder <strong>Cutis Laxa</strong>, characterized by loose and inelastic skin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Collagen and elastic fiber sub-components are essential for connective tissue function.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Defects in <strong>Type 1 collagen</strong>, <strong>Type 3 collagen</strong>, <strong>Fibrillin</strong>, and <strong>Fibulin</strong> result in <strong>Osteogenesis Imperfecta</strong>, <strong>Ehler Danlos Syndrome</strong>, <strong>Marfan’s Syndrome</strong>, and <strong>Cutis Laxa</strong>, respectively.</span></li></ul>",
      "correct_choice_id": 355376,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89243/DERMA_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89243/DERMA_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89209,
      "choices": [
        {
          "id": 355240,
          "text": "<p><span style=\"font-size:14.0pt;\">Sentinel surveillance with passive follow‐up</span></p>"
        },
        {
          "id": 355241,
          "text": "<p><span style=\"font-size:14.0pt;\">Passive surveillance augmented by periodic active surveys</span></p>"
        },
        {
          "id": 355242,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous active surveillance with sentinel sites</span></p>"
        },
        {
          "id": 355243,
          "text": "<p><span style=\"font-size:14.0pt;\">Syndromic surveillance with active case finding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A national leprosy program periodically conducts intensive “pulse” surveys in endemic villages—screening everyone door-to-door for new cases over a one-month window—then relies on routine reporting the rest of the year. This combination approach is best described as:</span></p>",
      "unique_key": "Q8025441",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Passive surveillance augmented by periodic active surveys</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Passive Surveillance:</strong> The program relies on routine reporting of diagnosed leprosy cases by health facilities throughout most of the year. This is the “passive” component—cases are reported by clinics as they present.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Periodic Active Surveys:</strong> During designated “pulse” months, health teams go door-to-door to <strong>actively</strong> find new cases, regardless of whether patients sought care.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hybrid Approach:</strong> Combining passive, ongoing reporting with scheduled active case‐finding drives—i.e., “passive surveillance augmented by periodic active surveys”—enhances completeness without the cost of continuous active outreach.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sentinel surveillance with passive follow-up:</strong> Sentinel surveillance involves <strong>selected sites</strong> (e.g., a network of clinics) that continuously report detailed data. Here, the program surveys <strong>all</strong> households in endemic areas, not just sentinels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Continuous active surveillance with sentinel sites:</strong> Continuous active surveillance would require ongoing door-to-door visits year-round, which isn’t the case—the active component is intermittent (“pulse” surveys).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Syndromic surveillance with active case finding:</strong> Syndromic surveillance tracks symptom clusters (e.g., fever, rash) often via electronic or community event reporting; this program specifically examines confirmed leprosy cases through physical examination, not symptom-based syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hybrid surveillance models</strong>—routine passive reporting supplemented by targeted active case-finding campaigns—balance efficiency and completeness, ensuring that elusive cases in hard-to-reach areas are detected without the resource burden of continuous outreach.</span></p>",
      "correct_choice_id": 355241,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89209/PSM_NEET_PG_GT_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89209/PSM_NEET_PG_GT_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89082,
      "choices": [
        {
          "id": 354744,
          "text": "<p><span style=\"font-size:14.0pt;\">RFLP analysis</span></p>"
        },
        {
          "id": 354745,
          "text": "<p><span style=\"font-size:14.0pt;\">PCR amplification</span></p>"
        },
        {
          "id": 354746,
          "text": "<p><span style=\"font-size:14.0pt;\">FISH&nbsp;</span></p>"
        },
        {
          "id": 354747,
          "text": "<p><span style=\"font-size:14.0pt;\">SDS–PAGE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man is being evaluated for a family history of a genetic disorder. To detect specific DNA fragment size variations in his genome, the laboratory digests his DNA with a sequence-specific endonuclease. Which technique is the laboratory most likely performing?&nbsp;</span></p>",
      "unique_key": "Q1593246",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) RFLP analysis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Restriction Fragment Length Polymorphism (RFLP)</strong> analysis uses <strong>restriction endonucleases</strong>—enzymes that cut double-stranded DNA at specific palindromic sequences—to generate a pattern of DNA fragments.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Variations in the DNA sequence (polymorphisms) alter the locations of restriction sites, producing fragments of differing lengths.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These fragments are then separated by agarose gel electrophoresis and visualized, allowing detection of genetic differences or mutations based on fragment size.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PCR amplification:</strong> Polymerase chain reaction uses <strong>DNA polymerase</strong>, primers, and thermal cycling to amplify specific DNA regions. It does <strong>not</strong> require restriction enzymes for amplification, although restriction sites may be used in downstream cloning steps.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. FISH:</strong> Fluorescence in situ hybridization uses fluorescently labeled DNA probes to bind complementary sequences on intact chromosomes in cells. No restriction digestion is involved; visualization is by fluorescence microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. SDS–PAGE:</strong>&nbsp; Sodium dodecyl sulfate–polyacrylamide gel electrophoresis separates <strong>proteins</strong> by size under denaturing conditions. It is unrelated to DNA analysis and does not use restriction enzymes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Restriction endonucleases are the key reagents in RFLP analysis, which detects DNA sequence polymorphisms by generating and resolving fragments of distinct lengths.</span></p>",
      "correct_choice_id": 354744,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89082/BIOCHEM_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89082/BIOCHEM_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89404,
      "choices": [
        {
          "id": 356012,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3</span></p>"
        },
        {
          "id": 356013,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 356014,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 356015,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding muscle structure is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Aponeurosis is a contractile structure aiding in muscle contraction.</span></li><li><span style=\"font-size:14.0pt;\">Raphe refers to the inter-digitation of muscle fibers.</span></li><li><span style=\"font-size:14.0pt;\">Tendons are non-contractile and connect muscles to bones.</span></li><li><span style=\"font-size:14.0pt;\">Muscle belly is the primary contractile portion of a muscle.</span></li></ol>",
      "unique_key": "Q8403795",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) 2, 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement  2.</strong> <strong>Raphe refers to the inter-digitation of muscle fibers:</strong> Correct<strong>.&nbsp; </strong>A raphe is a seam like line where two flat muscle sheets or fibers interlock (interdigitate), providing a shared midline attachment without a tendon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement  3.</strong> <strong>Tendons are non-contractile and connect muscles to bones:</strong> Correct<strong>.&nbsp;</strong>Tendons are dense, fibrous, non-contractile structures composed mainly of collagen that transmit force from the muscle belly to bone, enabling movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement  4.</strong> <strong>Muscle belly is the primary contractile portion of a muscle:</strong> Correct<strong>.&nbsp;</strong>The muscle belly (or body) contains the contractile fibers (sarcomere bearing myocytes) that generate force when stimulated—this is the primary site of contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Aponeurosis is a contractile structure aiding in muscle contraction:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>An aponeurosis is a broad, flat tendon—not a contractile element. It serves as a non-contractile attachment site, distributing muscle force across a wide area (e.g., the abdominal&nbsp;aponeurosis).<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Raphe is the inter-digitation of muscle fibers.</span></li><li><span style=\"font-size:14.0pt;\">Tendons are non-contractile and attach muscles to bones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Muscle belly is the main contractile structure of the muscle.</span></li></ul>",
      "correct_choice_id": 356013,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89404/ANATOMY_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89404/ANATOMY_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89266,
      "choices": [
        {
          "id": 355464,
          "text": "<p><span style=\"font-size:14.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 355465,
          "text": "<p><span style=\"font-size:14.0pt;\">Propanolol</span></p>"
        },
        {
          "id": 355466,
          "text": "<p><span style=\"font-size:14.0pt;\">Encainide</span></p>"
        },
        {
          "id": 355467,
          "text": "<p><span style=\"font-size:14.0pt;\">Procainamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most similar to?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-07-22%20at%2011.08.27.jpeg\" width=\"672\" height=\"337\"></span></p>",
      "unique_key": "Q7353337",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Procainamide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The graph shows Ia drug</span></li><li><span style=\"font-size:14.0pt;\">This drug is decreasing the slope of phase 0 (Na+ channel blocking property) as well as increasing the action potential duration (K+ channel blocking property).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, it exhibits the properties of class Ia anti-arrhythmic agents.</span></li><li><span style=\"font-size:14.0pt;\">Class Ia anti-arrhythmics include quinidine and procainamide.</span></li><li><span style=\"font-size:14.0pt;\">These drugs can result in QT prolongation in ECG.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lignocaine:</strong> A Class Ib agent that <strong>shortens</strong> action potential duration by accelerating Phase 3 repolarization and has only minimal effect on Phase 0 slope at therapeutic doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Propranolol:</strong> A Class II β-blocker that slows spontaneous depolarization in pacemaker cells and reduces sympathetic tone but <strong>does not</strong> significantly alter the Phase 0 upstroke or action potential duration in atrial/ventricular myocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Encainide:</strong> A Class Ic agent that powerfully <strong>slows Phase 0</strong> (markedly reducing conduction velocity) but <strong>has little effect</strong> on action potential duration, leaving repolarization unchanged.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Distinguish Class I antiarrhythmics by their Phase 0 and repolarization effects:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Ia (e.g., procainamide):</strong> ↓ Phase 0 slope + ↑ APD</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ib (e.g., lignocaine):</strong> ↓ APD</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ic (e.g., encainide):</strong> marked ↓ Phase 0 slope, no change in APD</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Procainamide</strong> (Class Ia) uniquely both slows the upstroke (sodium block) and prolongs repolarization (potassium block), fitting the action-potential changes shown.</span></li></ul>",
      "correct_choice_id": 355467,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89266/PHARMA_NEET_PG_GT_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89266/PHARMA_NEET_PG_GT_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89025,
      "choices": [
        {
          "id": 354520,
          "text": "<p><span style=\"font-size:14.0pt;\">¹⁸F-FDG</span></p>"
        },
        {
          "id": 354521,
          "text": "<p><span style=\"font-size:14.0pt;\">⁶⁸Ga-DOTATATE</span></p>"
        },
        {
          "id": 354522,
          "text": "<p><span style=\"font-size:14.0pt;\">¹⁸F-NaF</span></p>"
        },
        {
          "id": 354523,
          "text": "<p><span style=\"font-size:14.0pt;\">¹¹C-Methionine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with suspected metastatic neuroendocrine tumor undergoes PET imaging to localize disease. Which tracer specifically binds somatostatin receptors and is best suited for this purpose?&nbsp;</span></p>",
      "unique_key": "Q2077908",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) ⁶⁸Ga-DOTATATE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">⁶⁸Ga-DOTATATE is a radiolabeled somatostatin analogue that binds with high affinity to somatostatin receptor subtype 2, which is overexpressed on the majority of well-differentiated neuroendocrine tumor cells.</span></li><li><span style=\"font-size:14.0pt;\">After intravenous injection, ⁶⁸Ga-DOTATATE localizes to both primary and metastatic lesions, allowing high-contrast imaging on PET/CT.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its receptor-targeted mechanism provides superior sensitivity and specificity for neuroendocrine tumors compared with metabolic or nonspecific tracers.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ¹⁸F-FDG:</strong> Reflects glucose metabolism and is standard IOC for metastasis in almost every cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ¹⁸F-NaF:</strong> A bone-seeking tracer used for detecting skeletal metastases by localizing to areas of active bone turnover; it does not target tumor receptors or soft-tissue lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ¹¹C-Methionine:</strong> An amino-acid tracer used primarily in brain tumor and some prostate cancer imaging to assess protein synthesis; it does not bind somatostatin receptors and is not indicated for neuroendocrine tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For imaging well-differentiated neuroendocrine tumors, use receptor-targeted ⁶⁸Ga-DOTATATE PET rather than metabolic or bone-specific tracers.</span></p>",
      "correct_choice_id": 354521,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89025/NEETPG-INICET_GT_Radiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89025/NEETPG-INICET_GT_Radiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89250,
      "choices": [
        {
          "id": 355400,
          "text": "<p><span style=\"font-size:14.0pt;\">Leuprolide</span></p>"
        },
        {
          "id": 355401,
          "text": "<p><span style=\"font-size:14.0pt;\">Goserelin</span></p>"
        },
        {
          "id": 355402,
          "text": "<p><span style=\"font-size:14.0pt;\">Degarelix</span></p>"
        },
        {
          "id": 355403,
          "text": "<p><span style=\"font-size:14.0pt;\">Abiraterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man with metastatic prostate cancer is started on a GnRH antagonist to achieve rapid testosterone suppression without a flare. Which drug best fits this profile?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8363959",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Degarelix</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Degarelix is a competitive GnRH (LHRH) receptor antagonist that immediately blocks pituitary GnRH signaling.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This direct antagonism causes an abrupt drop in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to prompt suppression of testosterone production by the testes—without the transient surge (“flare”) seen with GnRH agonists.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leuprolide:</strong> A GnRH agonist that initially stimulates the GnRH receptor, causing a transient rise in LH/FSH and testosterone (the “flare”) before downregulation occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Goserelin:</strong> Another GnRH agonist with the same mechanism and flare phenomenon as leuprolide.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abiraterone:</strong> An inhibitor of CYP17A1 that reduces androgen synthesis in the adrenals and tumor, but does not act at the GnRH receptor and does not prevent the initial hormone flare.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Understand that <strong>GnRH antagonists</strong> (like degarelix) provide <strong>immediate</strong> testosterone suppression <strong>without</strong> the initial hormone surge associated with <strong>GnRH agonists</strong> (leuprolide, goserelin).</span></p>",
      "correct_choice_id": 355402,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89250/PHARMA_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89250/PHARMA_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89216,
      "choices": [
        {
          "id": 355268,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 355269,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 355270,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 355271,
          "text": "<p><span style=\"font-size:14.0pt;\">All except 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old nonpregnant, nonlactating woman attends her community clinic for routine care. She knows she’s prescribed an iron–folic acid tablet weekly instead of daily. Which of the following statements about her regimen are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">She should take 60 mg elemental iron + 500 mcg folic acid once weekly.</span></li><li><span style=\"font-size:14.0pt;\">The prophylactic tablet for her age group is colored red.</span></li><li><span style=\"font-size:14.0pt;\">Weekly dosing is chosen to improve adherence and reduce side effects.</span></li><li><span style=\"font-size:14.0pt;\">If she becomes pregnant, she should switch to the same weekly dose but double the folic acid.</span></li></ol>",
      "unique_key": "Q6058964",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. She should take 60 mg elemental iron + 500 mcg folic acid once weekly:</strong> Nonpregnant, nonlactating women aged 20–49 receive <strong>60 mg elemental iron</strong> plus <strong>500 mcg folic acid</strong> once weekly. This regimen maintains iron stores without daily gastrointestinal side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. The prophylactic tablet for her age group is colored red:</strong> To aid program identification and adherence, the weekly iron–folate tablet for this group is <strong>red</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Rationale for weekly dosing:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Adherence:</strong> Once-weekly dosing fits more easily into a busy adult’s schedule.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tolerability:</strong> Less frequent dosing reduces risk of constipation, nausea, and other iron-related side effects compared to daily supplementation in asymptomatic women.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. If she becomes pregnant, she should switch to the same weekly dose but double the folic acid:&nbsp;</strong>False<strong>. Pregnant women</strong> require <strong>daily</strong> supplementation of <strong>60 mg iron + 500 mcg folic acid</strong> (the same tablet color) starting by the second trimester and continuing for at least 180 days postpartum. They do <strong>not</strong> use a weekly regimen with altered folic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Prophylactic iron-folic acid regimen (<strong>Anemia Mukt Bharat)</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20163500.jpg\" width=\"1034\" height=\"485\"></span></p>",
      "correct_choice_id": 355269,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89216/PSM_NEET_PG_GT_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89216/PSM_NEET_PG_GT_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89357,
      "choices": [
        {
          "id": 355828,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of linear skull fracture</span></p>"
        },
        {
          "id": 355829,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid resolution within 2-3 days</span></p>"
        },
        {
          "id": 355830,
          "text": "<p><span style=\"font-size:14.0pt;\">Involvement of subperiosteal hemorrhage</span></p>"
        },
        {
          "id": 355831,
          "text": "<p><span style=\"font-size:14.0pt;\">Associated with hyperbilirubinemia in &gt;50% of cases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is a key clinical feature that differentiates caput succedaneum from cephalhematoma?</span></p>",
      "unique_key": "Q7178689",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Rapid resolution within 2-3 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Caput succedaneum resolves rapidly, typically within 2-3 days, as it is a benign subcutaneous swelling that develops due to pressure during delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Presence of linear skull fracture:</strong> Associated with cephalhematoma in 5-25% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Involvement of subperiosteal hemorrhage:</strong> This is a feature of cephalhematoma, not caput succedaneum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Associated with hyperbilirubinemia in &gt;50% of cases:</strong> Hyperbilirubinemia is more commonly associated with cephalhematoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Caput succedaneum is a subcutaneous swelling that resolves within 2-3 days, whereas cephalhematoma takes weeks to resolve and may cause hyperbilirubinemia.</span></p>",
      "correct_choice_id": 355829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89357/PEDIATRICS_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89357/PEDIATRICS_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89414,
      "choices": [
        {
          "id": 356052,
          "text": "<p><span style=\"font-size:14.0pt;\">Linear stapler</span></p>"
        },
        {
          "id": 356053,
          "text": "<p><span style=\"font-size:14.0pt;\">Circular stapler&nbsp;</span></p>"
        },
        {
          "id": 356054,
          "text": "<p><span style=\"font-size:14.0pt;\">Endo stapler&nbsp;</span></p>"
        },
        {
          "id": 356055,
          "text": "<p><span style=\"font-size:14.0pt;\">Skin stapler</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the stapler in the image given below:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xeuvMJF.png\" width=\"863\" height=\"487\"></strong></span></p>",
      "unique_key": "Q3617035",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Linear stapler</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The above instrument is a linear stapler.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use: It is used to divide and close the bowel completely or partially.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_g5CnSDb.png\" width=\"336\" height=\"401\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Linear stapler is used to divide and close the bowel completely&nbsp;or&nbsp;partially.</span></p>",
      "correct_choice_id": 356052,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89414/SURGERY_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89414/SURGERY_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89289,
      "choices": [
        {
          "id": 355556,
          "text": "<p><span style=\"font-size:14.0pt;\">MDR Tuberculosis</span></p>"
        },
        {
          "id": 355557,
          "text": "<p><span style=\"font-size:14.0pt;\">Pre-XDR Tuberculosis</span></p>"
        },
        {
          "id": 355558,
          "text": "<p><span style=\"font-size:14.0pt;\">XDR Tuberculosis</span></p>"
        },
        {
          "id": 355559,
          "text": "<p><span style=\"font-size:14.0pt;\">Rifampicin resistant Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old male with a history of tuberculosis presents with cough, fever, and night sweats. He completed anti-tuberculosis treatment but now has recurrent symptoms. Sputum culture shows Mycobacterium tuberculosis resistant to rifampicin and ethambutol, but sensitive to other first-line drugs as well as linezolid and bedaquiline. Which type of tuberculosis can this be classified as?</span></p>",
      "unique_key": "Q5095426",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Rifampicin resistant Tuberculosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rifampicin-resistant TB</strong> is defined as M. tuberculosis strains resistant to <strong>rifampicin</strong> (with or without resistance to other first-line drugs <strong>except</strong> isoniazid).</span></li><li><span style=\"font-size:14.0pt;\">In this case, the isolate is resistant to rifampicin (plus ethambutol, which does not affect the definition) but remains sensitive to isoniazid, so it fits the rifampicin-resistant category.</span></li><li><span style=\"font-size:14.0pt;\">Early identification of rifampicin resistance is crucial because these cases require specialized regimens—often incorporating newer drugs—rather than the standard first-line four-drug therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. MDR tuberculosis:</strong> Defined as resistance to <strong>at least</strong> <strong>rifampicin</strong> and <strong>isoniazid</strong>. Here, isoniazid remains effective, so it is <strong>not</strong> MDR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pre-XDR tuberculosis:</strong> Applies to <strong>MDR-TB</strong> (rifampicin + isoniazid resistance) plus additional resistance to either a <strong>fluoroquinolone</strong> or a <strong>second-line injectable</strong>. Our patient is not MDR, so he cannot be pre-XDR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. XDR tuberculosis:&nbsp;</strong>Defined as MDR-TB with further resistance to <strong>any fluoroquinolone</strong> and <strong>at least one second-line injectable</strong> (e.g., amikacin). Again, because isoniazid is still active, this is not MDR or XDR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Learn the World Health Organization–endorsed TB resistance classifications:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rifampicin Resistant TB:</strong> Resistance to rifampicin alone (or rifampicin plus drugs other than isoniazid) without resistance to isoniazid.</span></li><li><span style=\"font-size:14.0pt;\"><strong>MDR-TB:</strong> Resistant to at least <strong>both rifampicin and isoniazid</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pre-XDR-TB:</strong> MDR-TB with additional resistance to either a fluoroquinolone or a second-line injectable drug.</span></li><li><span style=\"font-size:14.0pt;\"><strong>XDR-TB:</strong> MDR-TB with additional resistance to fluoroquinolones and at least one second-line injectable drug.</span></li></ul>",
      "correct_choice_id": 355559,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89289/PHARMA_NEET_PG_GT_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89289/PHARMA_NEET_PG_GT_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89331,
      "choices": [
        {
          "id": 355724,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal tachycardia</span></p>"
        },
        {
          "id": 355725,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal heart rate abnormalities suggestive of fetal distress</span></p>"
        },
        {
          "id": 355726,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous severe abdominal pain unrelieved by contractions</span></p>"
        },
        {
          "id": 355727,
          "text": "<p><span style=\"font-size:14.0pt;\">Fresh vaginal bleeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A multiparous woman with a history of an uncomplicated lower segment cesarean section (LSCS) in her first pregnancy is now in active labor. She has been allowed a trial of labor after cesarean (TOLAC). During labor monitoring, the care team remains vigilant for signs of uterine scar rupture. Which of the following is the earliest warning sign of uterine scar rupture in this scenario?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8626511",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fetal heart rate abnormalities suggestive of fetal distress</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Uterine scar rupture</strong> is a critical obstetric emergency that can occur in women undergoing <strong>trial of labor after cesarean (TOLAC)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The rupture may lead to catastrophic outcomes for both mother and fetus.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>earliest and most sensitive clinical indicator of scar rupture</strong> is the development of <strong>fetal distress</strong>, typically observed as <strong>abnormal fetal heart rate patterns on cardiotocography (CTG)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These <strong>abnormalities</strong> include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Bradycardia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Recurrent late decelerations</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Variable decelerations with loss of variability</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Fetal distress appears <strong>before maternal signs and symptoms</strong> because the fetus is more sensitive to uteroplacental compromise caused by uterine rupture.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, <strong>fetal heart rate abnormalities are the earliest detectable warning sign</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Maternal tachycardia:</strong> Incorrect. <strong>Maternal tachycardia</strong> may occur as a secondary sign due to hemorrhage or pain following uterine rupture, but it is <strong>not an early or specific sign</strong> of scar rupture. It often develops after fetal distress has already been noted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Continuous severe abdominal pain unrelieved by contractions:</strong> Incorrect. Although <strong>severe, continuous abdominal pain</strong> can indicate uterine rupture, it is usually a <strong>later sign</strong> following fetal compromise. Pain can also be nonspecific during labor and may not always be a reliable early warning.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fresh vaginal bleeding:</strong> Incorrect. <strong>Fresh vaginal bleeding</strong> is a recognized sign of uterine rupture but typically occurs after fetal distress and uterine changes have taken place. It is not considered an early warning sign and may be absent in some cases of rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fetal heart rate abnormalities are the earliest and most sensitive clinical indicator of uterine scar rupture in women undergoing trial of labor after cesarean delivery, often preceding maternal symptoms like pain, tachycardia, or vaginal bleeding.</span></p>",
      "correct_choice_id": 355725,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89331/OBG_NEET_PG_GT_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89331/OBG_NEET_PG_GT_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89053,
      "choices": [
        {
          "id": 354632,
          "text": "<p><span style=\"font-size:14.0pt;\">India ink</span></p>"
        },
        {
          "id": 354633,
          "text": "<p><span style=\"font-size:14.0pt;\">Periodic acid–Schiff (PAS)</span></p>"
        },
        {
          "id": 354634,
          "text": "<p><span style=\"font-size:14.0pt;\">Picrosirius red</span></p>"
        },
        {
          "id": 354635,
          "text": "<p><span style=\"font-size:14.0pt;\">Mucicarmine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During outbreak investigations in South Africa, researchers collect environmental samples of sphagnum moss. Laboratory culture at 25°C yields hyphae with slender conidiophores and terminal conidia arranged in rosettes. Which microscopy stain would best visualize these fungi directly in clinical corneal scrapings?</span></p>",
      "unique_key": "Q7013646",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Periodic acid–Schiff (PAS)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>PAS stain</strong> highlights <strong>fungal cell walls</strong> (polysaccharides) in tissue or smears, turning hyphae and yeast magenta against a light background.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In ocular sporotrichosis, PAS best visualizes both slender hyphae and cigar-shaped yeasts.</span></li><li><span style=\"font-size:14.0pt;\">India ink is for cryptococcal capsule; picrosirius red and mucicarmine stain collagen and cryptococcal mucin, respectively.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. India ink:</strong> Negative stain for encapsulated yeasts (Cryptococcus), not filamentous fungi.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Picrosirius red:</strong> Stains collagen, not fungal cell walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mucicarmine:</strong> Stains polysaccharide capsule of Yeast (Cryptococcus spp.)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use PAS stain to directly visualize Sporothrix hyphae and yeast in clinical specimens by highlighting fungal polysaccharide walls.</span></p>",
      "correct_choice_id": 354633,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89053/MICROBIOLOGY_NEET_PG_GT_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89053/MICROBIOLOGY_NEET_PG_GT_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89083,
      "choices": [
        {
          "id": 354748,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA methylation at CpG islands</span></p>"
        },
        {
          "id": 354749,
          "text": "<p><span style=\"font-size:14.0pt;\">Histone deacetylation</span></p>"
        },
        {
          "id": 354750,
          "text": "<p><span style=\"font-size:14.0pt;\">Histone acetylation</span></p>"
        },
        {
          "id": 354751,
          "text": "<p><span style=\"font-size:14.0pt;\">Histone sumoylation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A research team observes that certain regions of a patient’s genome are more transcriptionally active, with relaxed chromatin structure and increased access to transcription factors. Which modification is most directly associated with this permissive chromatin state?</span></p>",
      "unique_key": "Q5662202",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Histone acetylation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Histone acetylation is the modification <strong>most directly associated with transcriptionally active (euchromatin) regions</strong> of DNA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Here's why:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Histone proteins have positively charged lysine residues that interact tightly with the negatively charged DNA.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Acetylation of lysine residues</strong> on histone tails by <strong>histone acetyltransferases (HATs)</strong> neutralizes these positive charges.</span></li><li><span style=\"font-size:14.0pt;\">This <strong>loosens the DNA-histone interaction</strong>, resulting in a <strong>more relaxed, open chromatin structure</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Open chromatin allows <strong>transcription factors and RNA polymerase</strong> to access DNA more easily, thereby <strong>enhancing gene transcription</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DNA methylation at CpG islands:</strong> Typically associated with <strong>gene silencing</strong>, especially when located in gene promoters. Methylated DNA recruits proteins that <strong>condense chromatin</strong> and block transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Histone deacetylation:</strong> The <strong>removal of acetyl groups</strong> by <strong>histone deacetylases (HDACs)</strong> causes chromatin to <strong>become more compact</strong>, thereby <strong>repressing transcription</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Histone sumoylation:</strong> Sumoylation (attachment of small ubiquitin-like modifier proteins) is often linked to <strong>chromatin compaction</strong> and <strong>transcriptional repression</strong>, though its role is context-dependent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Acetylation of histone lysine residues is a key epigenetic mark of permissive chromatin, enhancing gene transcription by loosening nucleosome–DNA interactions.</span></p>",
      "correct_choice_id": 354750,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89083/BIOCHEM_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89083/BIOCHEM_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89026,
      "choices": [
        {
          "id": 354524,
          "text": "<p><span style=\"font-size:14.0pt;\">Isolated pleural effusion without mediastinal involvement</span></p>"
        },
        {
          "id": 354525,
          "text": "<p><span style=\"font-size:14.0pt;\">Mediastinal air invasion requiring urgent surgical repair</span></p>"
        },
        {
          "id": 354526,
          "text": "<p><span style=\"font-size:14.0pt;\">Localized pericarditis amenable to conservative management</span></p>"
        },
        {
          "id": 354527,
          "text": "<p><span style=\"font-size:14.0pt;\">Subdiaphragmatic abscess formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the setting of suspected Boerhaave syndrome, the presence of Hamman’s sign most strongly indicates:&nbsp;</span></p>",
      "unique_key": "Q3981785",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Mediastinal air invasion requiring urgent surgical repair</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Hamman’s crunch indicates a subcutaneous emphysema&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hamman’s sign—a systolic “crunch” or crunching crepitus heard over the precordium—is produced by air within the mediastinum being compressed by the beating heart.</span></li><li><span style=\"font-size:14.0pt;\">In Boerhaave syndrome, a full‐thickness esophageal tear allows oesophageal and gastric air (and possibly fluid) to escape into the mediastinum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The detection of Hamman’s sign:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Confirms pneumomediastinum rather than an isolated pleural process.</span></li><li><span style=\"font-size:14.0pt;\">Correlates with significant mediastinal contamination by air (and potentially gastric contents), which carries a high risk of mediastinitis and sepsis.</span></li><li><span style=\"font-size:14.0pt;\">Mandates urgent surgical intervention to repair the esophageal perforation and decontaminate the mediastinum—delay increases morbidity and mortality.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Isolated pleural effusion without mediastinal involvement:</strong> A pleural effusion produces dullness to percussion and diminished breath sounds; it does not cause mediastinal crunches.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Localized pericarditis amenable to conservative management</strong>: Pericardial friction rubs produce scratching sounds but are not synchronous with heart sounds in the same manner and are not caused by mediastinal air.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Subdiaphragmatic abscess formation</strong>: Abscess below the diaphragm may cause abdominal signs but does not produce precordial crepitus or Hamman’s sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hamman’s sign = mediastinal air. In a post‐emesis patient with chest pain, it signifies esophageal perforation (Boerhaave) and necessitates urgent surgical repair to prevent life‐threatening mediastinitis.</span></p>",
      "correct_choice_id": 354525,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89026/NEETPG-INICET_GT_Radiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89026/NEETPG-INICET_GT_Radiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89398,
      "choices": [
        {
          "id": 355988,
          "text": "<p><span style=\"font-size:14.0pt;\">Axillary nerve</span></p>"
        },
        {
          "id": 355989,
          "text": "<p><span style=\"font-size:14.0pt;\">Suprascapular nerve</span></p>"
        },
        {
          "id": 355990,
          "text": "<p><span style=\"font-size:14.0pt;\">Upper trunk of the brachial plexus</span></p>"
        },
        {
          "id": 355991,
          "text": "<p><span style=\"font-size:14.0pt;\">Spinal accessory nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old male sustains a deep laceration to the posterior triangle of the neck during a knife fight. He now complains of pain and paresthesia over the shoulder tip and lateral arm<strong>,&nbsp;</strong>along with weakness in shoulder abduction<strong>.&nbsp;</strong>Which nerve is most likely injured?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6887931",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Upper trunk of the brachial plexus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>upper trunk (C5–C6)</strong> gives rise to the <strong>suprascapular</strong>, <strong>axillary</strong>, and <strong>musculocutaneous nerves</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Injury in the posterior triangle affects <strong>sensation in the shoulder region</strong> and <strong>abduction (deltoid, supraspinatus)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Axillary nerve</strong>: Affects abduction and deltoid, but not sensation over supraspinatus or shoulder tip.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Suprascapular nerve</strong>: Affects supraspinatus/infraspinatus, not lateral arm sensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Spinal accessory nerve</strong>: Affects trapezius, not sensation or shoulder abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Upper trunk lesions</strong> of the <strong>brachial plexus</strong> cause <strong>Erb’s palsy</strong>—loss of abduction, lateral rotation, elbow flexion, and shoulder sensation.</span></p>",
      "correct_choice_id": 355990,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89398/ANATOMY_NEET_PG_GT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89398/ANATOMY_NEET_PG_GT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89799,
      "choices": [
        {
          "id": 357588,
          "text": "<p><span style=\"font-size:14.0pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 357589,
          "text": "<p><span style=\"font-size:14.0pt;\">Granulomatosis with polyangiitis</span></p>"
        },
        {
          "id": 357590,
          "text": "<p><span style=\"font-size:14.0pt;\">Eosinophilic granulomatosis with polyangiitis</span></p>"
        },
        {
          "id": 357591,
          "text": "<p><span style=\"font-size:14.0pt;\">Microscopic polyangiitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man presents to the ER with a 1-week history of diffuse abdominal pain, difficulty ambulating, and three episodes of hematochezia. He reports left ankle tingling and weakness for 2 weeks, with two falls due to loss of balance. Examination shows 3/5 strength in foot dorsiflexion and palpable purpura on lower extremities. Renal arteriography is done and is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zBMw5nu.png\" width=\"574\" height=\"452\"></strong></span></p>",
      "unique_key": "Q6326932",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Polyarteritis nodosa</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The renal artery angiography shows multiple aneurysms and occlusions, characteristic of polyarteritis nodosa (PAN), a medium-vessel vasculitis.</span></li><li><span style=\"font-size:14.0pt;\">Abdominal pain, hematochezia, purpura, and neurological symptoms (ankle weakness) in an IV drug user support PAN, often associated with hepatitis or drug-related triggers.</span></li><li><span style=\"font-size:14.0pt;\">The absence of respiratory symptoms or eosinophilia narrows the diagnosis to PAN.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Granulomatosis with polyangiitis:</strong> Involves small vessels and respiratory symptoms, not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Eosinophilic granulomatosis with polyangiitis:</strong> Features asthma and eosinophilia, absent in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Microscopic polyangiitis:</strong> Causes glomerulonephritis, not renal artery aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PAN is a medium-vessel vasculitis presenting with renal artery aneurysms, abdominal pain, and neurological deficits.</span></li><li><span style=\"font-size:14.0pt;\">Angiography is key for diagnosis, especially in high-risk patients like IV drug users.</span></li></ul>",
      "correct_choice_id": 357588,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89799/Medicine_Neet_Pg_Gt_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89799/Medicine_Neet_Pg_Gt_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89079,
      "choices": [
        {
          "id": 354732,
          "text": "<p><span style=\"font-size:14.0pt;\">Regular rigor mortis of skeletal muscle begins approximately 1–2 hours after death</span></p>"
        },
        {
          "id": 354733,
          "text": "<p><span style=\"font-size:14.0pt;\">Cadaveric spasm can involve involuntary (smooth) muscles</span></p>"
        },
        {
          "id": 354734,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigor mortis affects voluntary (skeletal) muscles</span></p>"
        },
        {
          "id": 354735,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigor mortis can also involve involuntary (smooth) muscles</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which statement about postmortem muscle changes is incorrect?</span></p>",
      "unique_key": "Q1849810",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Cadaveric spasm can involve involuntary (smooth) muscles</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cadaveric spasm</strong> (“instantaneous rigor”) is an immediate postmortem stiffening of <strong>voluntary</strong> muscles active at the moment of death—classically seen in a clenched fist or jaw grip. It does <strong>not</strong> affect <strong>involuntary</strong> (smooth) muscle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rigor mortis</strong> sets in when ATP depletion locks actin–myosin bridges in all muscle types. It typically begins <strong>1–2 hours after death</strong> in small muscles and by 4–6 hours in large muscle groups, peaks around 12–24 hours, and resolves by 48–72 hours. Both <strong>skeletal (voluntary)</strong> and <strong>smooth (involuntary)</strong> muscles (e.g., iris, vessel walls) exhibit rigor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Regular rigor mortis of skeletal muscle begins approximately 1–2 hours after death:</strong> True. Early rigor in small muscles can be detectable as soon as 1–2 hours postmortem under cool conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Rigor mortis affects voluntary (skeletal) muscles:</strong> True. Skeletal (voluntary) muscles are prominently stiff in rigor mortis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Rigor mortis can also involve involuntary (smooth) muscles</strong>: True. Smooth muscle in vessels and the iris also undergoes delayed stiffening during rigor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cadaveric spasm</strong> involves only <strong>voluntary</strong> muscle fibers active at death; <strong>smooth muscle</strong> stiffening is a feature of <strong>rigor mortis</strong>, not cadaveric spasm.</span></p>",
      "correct_choice_id": 354733,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89079/FMT_NEETPG-INICET_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89079/FMT_NEETPG-INICET_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89348,
      "choices": [
        {
          "id": 355792,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubinstein-Taybi Syndrome</span></p>"
        },
        {
          "id": 355793,
          "text": "<p><span style=\"font-size:14.0pt;\">Cri du Chat Syndrome</span></p>"
        },
        {
          "id": 355794,
          "text": "<p><span style=\"font-size:14.0pt;\">Smith-Lemli-Opitz Syndrome</span></p>"
        },
        {
          "id": 355795,
          "text": "<p><span style=\"font-size:14.0pt;\">Edward Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old male presents with developmental delay, broad thumbs, microcephaly, and a beaked nose. Echocardiography reveals an atrial septal defect. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JG5Qjza.png\" width=\"457\" height=\"416\"></p>",
      "unique_key": "Q2092789",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Rubinstein-Taybi Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rubinstein-Taybi Syndrome is characterized by <strong>broad thumbs</strong>, microcephaly, mental retardation, a <strong>beaked nose</strong>, and cardiac anomalies like ASD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cri du Chat Syndrome</strong>: Associated with a high-pitched cry and characteristic facial features, but not broad thumbs or a beaked nose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Smith-Lemli-Opitz Syndrome</strong>: Associated with syndactyly and polydactyly, not broad thumbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Edward Syndrome</strong>: Associated with clenched hands and overlapping fingers, not broad thumbs or beaked nose. They will have rocker bottom feet</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recognize Rubinstein-Taybi Syndrome by its hallmark features like broad thumbs and associated cardiac defects such as ASD.</span></p>",
      "correct_choice_id": 355792,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89348/PEDIATRICS_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89348/PEDIATRICS_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89430,
      "choices": [
        {
          "id": 356116,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade I</span></p>"
        },
        {
          "id": 356117,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade II</span></p>"
        },
        {
          "id": 356118,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade III</span></p>"
        },
        {
          "id": 356119,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man presents with frequent episodes of headache and projectile vomiting. Radiological imaging of the brain reveals a space-occupying lesion. A biopsy is performed and histopathologic examination reveals the findings shown in the image. According to the WHO classification of CNS tumors, which of the following is the most appropriate grade for this tumor?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NVsWNPa.png\" width=\"471\" height=\"335\"></strong></span></p>",
      "unique_key": "Q2832580",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Grade IV</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The histological image provided reveals <strong>hypercellularity</strong>, <strong>nuclear atypia</strong>, <strong>areas of necrosis</strong>, and <strong>microvascular proliferation</strong>, all of which are <strong>hallmarks of glioblastoma</strong>, a Grade IV astrocytoma according to the <strong>WHO classification of CNS tumors</strong>. Glioblastoma (formerly known as glioblastoma multiforme) is the most aggressive and common primary malignant brain tumor in adults.</span></li><li><span style=\"font-size:14.0pt;\">The grading is often taught using the <strong>St. Anne–Mayo grading system</strong>, which assigns increasing grades based on the presence of:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\">Atypia → Grade I</span></li><li><span style=\"font-size:14.0pt;\">Mitoses → Grade II</span></li><li><span style=\"font-size:14.0pt;\">Endothelial proliferation → Grade III</span></li><li><span style=\"font-size:14.0pt;\">Necrosis → <strong>Grade IV</strong> (as seen in glioblastoma)</span></li></ol><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Key features supporting WHO <strong>Grade IV</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Necrosis</strong>: Often with pseudopalisading of tumor cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Endothelial proliferation</strong>: Seen as glomeruloid vascular structures.</span></li><li><span style=\"font-size:14.0pt;\"><strong>High mitotic activity and pleomorphism</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical presentation</strong>: Older age group, rapid onset of neurological symptoms (e.g., headache, vomiting) due to increased intracranial pressure.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Grade I</strong>: Typically reserved for <strong>pilocytic astrocytomas</strong>, which occur in younger patients and exhibit <strong>Rosenthal fibers</strong>, <strong>low mitotic activity</strong>, and <strong>no necrosis or vascular proliferation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Grade II</strong>: Represents <strong>diffuse astrocytomas</strong>—less mitotic activity, no necrosis or endothelial proliferation. These are <strong>less aggressive</strong>, occur in <strong>younger individuals</strong>, and do not match this histological severity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Grade III</strong>: Anaplastic astrocytomas exhibit <strong>increased mitotic activity</strong> and <strong>nuclear atypia</strong>, but <strong>lack necrosis and microvascular proliferation</strong>, which are key to upgrading to Grade IV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>WHO Grade IV CNS tumors</strong>, such as <strong>glioblastoma</strong>, are defined histologically by <strong>necrosis</strong> and <strong>microvascular proliferation</strong>, and clinically by <strong>aggressive behavior</strong> and <strong>poor prognosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recognizing these features is critical in tumor grading and treatment planning.</span></li></ul>",
      "correct_choice_id": 356119,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89430/PATHOLOGY_NEET_PG_GT_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89430/PATHOLOGY_NEET_PG_GT_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89422,
      "choices": [
        {
          "id": 356084,
          "text": "<p><span style=\"font-size:14.0pt;\">Paneth cell hyperplasia</span></p>"
        },
        {
          "id": 356085,
          "text": "<p><span style=\"font-size:14.0pt;\">Flattened intestinal crypts</span></p>"
        },
        {
          "id": 356086,
          "text": "<p><span style=\"font-size:14.0pt;\">Blunting of the intestinal villi</span></p>"
        },
        {
          "id": 356087,
          "text": "<p><span style=\"font-size:14.0pt;\">Focal collections of epithelioid macrophages</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old boy with chronic diarrhea and failure to gain height is found to have certain auto antibodies in his blood. The physician decides to modify his diet which dramatically improves the condition of the patient. If this individual’s duodenal biopsy was to be taken, which of the following histopathologic changes is the expected finding in him?&nbsp;&nbsp;</span></p>",
      "unique_key": "Q5556103",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Blunting of the intestinal villi</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>celiac disease</strong>, an autoimmune enteropathy triggered by gluten in genetically susceptible individuals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hallmark histologic finding on <strong>duodenal biopsy</strong> includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Villous atrophy (blunting)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Crypt hyperplasia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased intraepithelial lymphocytes</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These features lead to <strong>malabsorption</strong> and symptoms such as growth retardation and chronic diarrhea in children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_lwgXvTb.jpeg\" alt=\"Pathology Outlines - Celiac sprue\" width=\"295\" height=\"222\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Paneth cell hyperplasia</strong>: This may be seen in chronic inflammatory conditions like Crohn disease but is not a hallmark of celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Flattened intestinal crypts</strong>: Celiac disease typically shows <strong>crypt hyperplasia</strong>, not flattening. Flattened or absent crypts would suggest a different pathology or mucosal atrophy unrelated to celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Focal collections of epithelioid macrophages</strong>: This description is consistent with <strong>granulomas</strong>, often seen in Crohn disease, but <strong>not characteristic of celiac disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Blunting of the intestinal villi</strong> seen on duodenal biopsy, in conjunction with positive anti-tTG antibodies, is a key diagnostic feature of <strong>celiac disease</strong>.</span></p>",
      "correct_choice_id": 356086,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89422/PATHOLOGY_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89422/PATHOLOGY_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89018,
      "choices": [
        {
          "id": 354492,
          "text": "<p><span style=\"font-size:14.0pt;\">Sinus Tachycardia</span></p>"
        },
        {
          "id": 354493,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperkalaemia</span></p>"
        },
        {
          "id": 354494,
          "text": "<p><span style=\"font-size:14.0pt;\">Myalgia</span></p>"
        },
        {
          "id": 354495,
          "text": "<p><span style=\"font-size:14.0pt;\">Masseter Spasm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a side effect of succinylcholine?</span></p>",
      "unique_key": "Q9251801",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sinus Tachycardia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Succinylcholine is a depolarizing neuromuscular blocking agent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Sinus Tachycardia is typically <strong>not a side effect</strong> of succinylcholine.</span></li><li><span style=\"font-size:14.0pt;\">In fact, <strong>succinylcholine</strong> more <strong>commonly causes bradycardia</strong>, particularly with <strong>repeated doses</strong>, due to its <strong>stimulation</strong> of <strong>muscarinic receptors in the heart</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Succinylcholine produces sinus bradycardia not tachycardia.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Hyperkalemia</strong>: Succinylcholine can cause an <strong>increase</strong> in <strong>serum potassium levels</strong>, which is <strong>especially risky</strong> in patients with <strong>pre-existing hyperkalemia</strong> or those with <strong>risk factors</strong> for <strong>increased potassium release</strong>, such as burn or crush injuries, <strong>neuromuscular diseases</strong>, or <strong>prolonged immobilization</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Myalgia</strong>: <strong>Muscle pain</strong>, or myalgia, is a <strong>common side effect</strong> following the administration of <strong>succinylcholine</strong> due to <strong>muscle fasciculations</strong> that occur <strong>before muscle relaxation</strong>. It is <strong>often experienced</strong> as <strong>generalized muscle soreness</strong> after <strong>recovery from anesthesia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Masseter Spasm</strong>: This is a <strong>known side effect</strong> of <strong>succinylcholine</strong> and is considered an <strong>early sign of malignant hyperthermia</strong>, a <strong>rare</strong> but <strong>life-threatening reaction</strong> to certain <strong>drugs used for anesthesia</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cardiovascular side effects of succinylcholine:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sinus Bradycardia</span></li><li><span style=\"font-size:14.0pt;\">Junctional Rhythm</span></li><li><span style=\"font-size:14.0pt;\">Ventricular Dysrhythmias</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20103011.jpg\" width=\"747\" height=\"600\"></span></p>",
      "correct_choice_id": 354492,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89018/ANESTHESIA_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89018/ANESTHESIA_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89071,
      "choices": [
        {
          "id": 354704,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastric lavage</span></p>"
        },
        {
          "id": 354705,
          "text": "<p><span style=\"font-size:14.0pt;\">Bronchodilator therapy</span></p>"
        },
        {
          "id": 354706,
          "text": "<p><span style=\"font-size:14.0pt;\">Supplemental oxygen</span></p>"
        },
        {
          "id": 354707,
          "text": "<p><span style=\"font-size:14.0pt;\">Routine corticosteroid administration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not recommended in the management of acute kerosene (paraffin) ingestion in children?&nbsp;</span></p>",
      "unique_key": "Q3457674",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Gastric lavage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gastric lavage</strong> is generally <strong>contraindicated</strong> after hydrocarbon ingestion such as kerosene because of the high risk of aspiration and chemical pneumonitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In gastric lavage it increases chances of vomiting&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The low viscosity and high volatility of kerosene mean that any attempt to remove it via lavage can provoke coughing, aspiration into the lungs, and worsen lung injury.</span></li><li><span style=\"font-size:14.0pt;\">Instead, management focuses on supportive care and prevention of respiratory complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bronchodilator therapy:</strong> Indicated if bronchospasm develops secondary to chemical irritation of the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Supplemental oxygen:</strong> Essential to treat or prevent hypoxemia from hydrocarbon-induced pneumonitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Routine corticosteroid administration:</strong> Corticosteroids have <strong>not</strong> been shown to improve outcomes in hydrocarbon pneumonitis and are therefore <strong>not</strong> routinely beneficial; this option is true management but the stem asks for “not recommended,” so it is not the correct distractor here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Gastric lavage is contraindicated</strong> in kerosene poisoning due to the risk of aspiration and that management should prioritize supportive respiratory care, including bronchodilators and oxygen, while steroids offer no proven benefit.</span></p>",
      "correct_choice_id": 354704,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89071/FMT_NEETPG-INICET_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89071/FMT_NEETPG-INICET_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89304,
      "choices": [
        {
          "id": 355616,
          "text": "<p><span style=\"font-size:14.0pt;\">To identify intrinsic sphincter deficiency</span></p>"
        },
        {
          "id": 355617,
          "text": "<p><span style=\"font-size:14.0pt;\">To evaluate the effectiveness of urethral support procedures</span></p>"
        },
        {
          "id": 355618,
          "text": "<p><span style=\"font-size:14.0pt;\">To assess the necessity for endoscopic bulking agent injection</span></p>"
        },
        {
          "id": 355619,
          "text": "<p><span style=\"font-size:14.0pt;\">To diagnose detrusor overactivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the purpose of Bonney’s Test?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2197713",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) To evaluate the effectiveness of urethral support procedures</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The maneuver described is <strong>Bonney’s Test</strong>, a clinical examination technique used to assess <strong>urethral hypermobility</strong> in women with <strong>stress urinary incontinence (SUI)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;By elevating the bladder neck through anterior vaginal wall support, the examiner can check if urine leakage stops when intra-abdominal pressure is increased (e.g., by coughing).</span></li><li><span style=\"font-size:14.0pt;\">If leakage is <strong>prevented</strong> when the bladder neck is supported (as in this case), it suggests that <strong>urethral hypermobility</strong> is the cause of incontinence.</span></li><li><span style=\"font-size:14.0pt;\">This indicates that <strong>surgical interventions aimed at restoring urethral support</strong>, such as <strong>retropubic colposuspension (Burch procedure)</strong> or <strong>sling operations</strong>, may be effective.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-24%20122802.jpg\" width=\"675\" height=\"627\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To identify intrinsic sphincter deficiency:</strong> Incorrect. Intrinsic sphincter deficiency (ISD) leads to incontinence even when the urethra is properly supported. Bonney’s Test is not used to diagnose ISD but rather helps differentiate hypermobility from ISD. If leakage continues despite support, ISD is suspected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To assess the necessity for endoscopic bulking agent injection</strong>: Incorrect. Bulking agents are typically used for <strong>ISD</strong> rather than urethral hypermobility. Bonney’s Test is not performed to assess the need for this treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To diagnose detrusor overactivity</strong>: Incorrect. Detrusor overactivity (urge incontinence) is diagnosed using <strong>urodynamic studies</strong>, not Bonney’s Test. Bonney’s Test specifically assesses for <strong>stress incontinence due to urethral hypermobility</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bonney’s Test is used in women with stress urinary incontinence to assess whether urethral hypermobility is contributing to the leakage by elevating the bladder neck and observing if urine leakage is prevented.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A positive test suggests that surgical procedures aimed at supporting the urethra may be effective<strong>.</strong></span></li></ul>",
      "correct_choice_id": 355617,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89304/OBG_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89304/OBG_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89288,
      "choices": [
        {
          "id": 355552,
          "text": "<p><span style=\"font-size:14.0pt;\">Romiplostim</span></p>"
        },
        {
          "id": 355553,
          "text": "<p><span style=\"font-size:14.0pt;\">Oprelvekin</span></p>"
        },
        {
          "id": 355554,
          "text": "<p><span style=\"font-size:14.0pt;\">Filgrastim</span></p>"
        },
        {
          "id": 355555,
          "text": "<p><span style=\"font-size:14.0pt;\">Erythropoietin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient on anticancer therapy developed infection. Blood Analysis revealed a Total Leucocyte Count of 2000/mm<sup>3</sup>. Which of the following drug is likely to be effective in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4545374",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Filgrastim</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Filgrastim</strong> is a recombinant human <strong>granulocyte colony–stimulating factor (G-CSF)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It binds to G-CSF receptors on bone marrow progenitor cells, selectively stimulating the <strong>proliferation, differentiation, and activation of neutrophils</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In patients with chemotherapy-induced neutropenia (total leukocytes &lt;2,000/mm³), filgrastim accelerates neutrophil recovery, reduces the duration of neutropenia, and lowers the risk of febrile neutropenia and infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Romiplostim:</strong> It stimulates the thrombopoietin receptors. It is used in ITP, given by s/c route.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oprelvekin:</strong> It is IL 11, it stimulates the proliferation of megakaryocytes. Useful in Thrombocytopenia</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Erythropoietin</strong>: RBC growth factor used for the treatment of anemia due to CKD or due to Bone Marrow Suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Filgrastim is a G-CSF (Granulocyte Colony Stimulating Factor) that can be used for chemotherapy induced neutropenia.</span></p>",
      "correct_choice_id": 355554,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89288/PHARMA_NEET_PG_GT_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89288/PHARMA_NEET_PG_GT_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89248,
      "choices": [
        {
          "id": 355392,
          "text": "<p><span style=\"font-size:14.0pt;\">2 only</span></p>"
        },
        {
          "id": 355393,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 355394,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 355395,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">When might a drug that normally follows first‐order kinetics exhibit zero‐order elimination?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">At very low plasma concentrations.</span></li><li><span style=\"font-size:14.0pt;\">When metabolic enzymes become saturated.</span></li><li><span style=\"font-size:14.0pt;\">After a single therapeutic dose.</span></li><li><span style=\"font-size:14.0pt;\">At very high‐dose&nbsp;</span></li></ol>",
      "unique_key": "Q2974266",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. When metabolic enzymes become saturated: </strong>Correct. First‐order elimination assumes that the enzymes or transporters responsible for drug clearance have excess capacity, so rate&nbsp;∝ concentration. When these pathways are overwhelmed—for example, the enzyme is working at its maximum velocity (Vₘₐₓ)—the elimination rate can no longer increase in proportion to rising drug levels. At this point it shifts to zero‐order, removing a constant amount per time regardless of how high the concentration climbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>At very high‐dose:</strong> Correct. In overdose, plasma concentrations often far exceed the Km of metabolic enzymes. Once saturating levels are reached, additional increases in drug concentration will not speed elimination. Hence the body clears a fixed mass of drug per hour (zero‐order), rather than a fixed fraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>At very low plasma concentrations:</strong> Incorrect. At very low concentrations, enzymes are well below saturation and operate in the first‐order range—clearance remains proportional to concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>After a single therapeutic dose:</strong> Incorrect. A single therapeutic dose typically yields concentrations within the first‐order region; only exceptionally large or sustained dosing overwhelms metabolic capacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Zero‐order kinetics</strong> occurs when <strong>elimination pathways are saturated</strong>, resulting in a <strong>constant amount</strong> of drug cleared per unit time—most commonly seen in enzyme‐saturation (high‐dose) contexts like overdoses.</span></p>",
      "correct_choice_id": 355393,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89248/PHARMA_NEET_PG_GT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89248/PHARMA_NEET_PG_GT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89332,
      "choices": [
        {
          "id": 355728,
          "text": "<p><span style=\"font-size:14.0pt;\">To examine the condition of the uterine endometrium</span></p>"
        },
        {
          "id": 355729,
          "text": "<p><span style=\"font-size:14.0pt;\">To assess sperm motility and interaction with cervical mucus</span></p>"
        },
        {
          "id": 355730,
          "text": "<p><span style=\"font-size:14.0pt;\">To confirm ovulation has taken place</span></p>"
        },
        {
          "id": 355731,
          "text": "<p><span style=\"font-size:14.0pt;\">To analyze the consistency and viscosity of cervical mucus alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A couple undergoing evaluation for infertility is advised to undergo a postcoital test (PCT) as part of their diagnostic workup. What is the primary purpose of this test?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9591899",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) To assess sperm motility and interaction with cervical mucus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>postcoital test (PCT)</strong>, also known as the <strong>Sims-Huhner test</strong>, is performed during infertility evaluation to assess the <strong>interaction between sperm and cervical mucus</strong> in the peri-ovulatory period.</span></li><li><span style=\"font-size:14.0pt;\">The cervical mucus, under the influence of estrogen, becomes thin and receptive to sperm penetration around ovulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The test is conducted within <strong>8–12 hours after intercourse</strong>, and a sample of cervical mucus is examined microscopically for:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Presence of motile sperm</span></li><li><span style=\"font-size:14.0pt;\">Number of motile sperm per high-power field</span></li><li><span style=\"font-size:14.0pt;\">Sperm motility pattern (progressive vs. sluggish)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>purpose of this test is to assess whether the sperm can survive and migrate through the cervical mucus</strong>, which is critical for natural conception.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To examine the condition of the uterine endometrium:</strong> Incorrect. The <strong>uterine lining</strong> is assessed by <strong>endometrial biopsy</strong>, not the postcoital test. The PCT does not provide information about endometrial health.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To confirm ovulation has taken place:</strong> Incorrect. The occurrence of <strong>ovulation</strong> is typically confirmed through methods such as <strong>mid-luteal serum progesterone measurement</strong>, <strong>ultrasound follicular monitoring</strong>, or <strong>basal body temperature tracking</strong>, not via the postcoital test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To analyze the consistency and viscosity of cervical mucus alone:</strong> Incorrect. Although the postcoital test includes an assessment of <strong>cervical mucus properties</strong>, its <strong>primary aim is to evaluate sperm survival and motility within the mucus</strong> after intercourse, not just the mucus characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The postcoital test is performed during infertility evaluation to assess sperm motility and survival within the cervical mucus, providing information on the sperm-cervical mucus interaction critical for natural conception.</span></p>",
      "correct_choice_id": 355729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89332/OBG_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89332/OBG_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89420,
      "choices": [
        {
          "id": 356076,
          "text": "<p><span style=\"font-size:14.0pt;\">Mask ventilation</span></p>"
        },
        {
          "id": 356077,
          "text": "<p><span style=\"font-size:14.0pt;\">Laryngeal mask airway (LMA)</span></p>"
        },
        {
          "id": 356078,
          "text": "<p><span style=\"font-size:14.0pt;\">Tracheostomy</span></p>"
        },
        {
          "id": 356079,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasotracheal intubation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male patient is brought to the casualty with maxillofacial trauma after a road traffic accident (RTA). He has altered consciousness and desaturation. What is the preferred method of securing the airway for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3902566",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tracheostomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with severe maxillofacial trauma are highly likely to experience severe airway compromise or obstruction.</span></li><li><span style=\"font-size:14.0pt;\">In such cases, intubation is necessary to maintain airway competency.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given the presence of facial trauma, tracheostomy is the preferred method as it bypasses the obstructed upper airway by creating an opening and placing a stoma in the anterior wall of the trachea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mask ventilation:&nbsp;</strong>Mask ventilation is often difficult in patients with facial trauma due to structural damage and may not provide a secure airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laryngeal mask airway (LMA):</strong> LMA can be used temporarily but is not ideal for long-term airway management in patients with facial trauma as it does not protect against aspiration and may be dislodged.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nasotracheal intubation:</strong> Nasotracheal intubation is contraindicated in patients with facial trauma due to the risk of further injury to the nasal and facial structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tracheostomy</strong> is the preferred method for securing the airway in patients with severe maxillofacial trauma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mask ventilation</strong> and <strong>LMA</strong> may be used temporarily but do not provide a secure airway.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nasotracheal intubation</strong> is contraindicated in facial trauma due to the risk of further injury.</span></li></ul>",
      "correct_choice_id": 356078,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89420/SURGERY_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89420/SURGERY_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89807,
      "choices": [
        {
          "id": 357620,
          "text": "<p><span style=\"font-size:14.0pt;\">Rituximab&nbsp;</span></p>"
        },
        {
          "id": 357621,
          "text": "<p><span style=\"font-size:14.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 357622,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 357623,
          "text": "<p><span style=\"font-size:14.0pt;\">Prednisolone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with T2DM, hypertension, and COPD presents with a 4-day history of worsening shoulder and hip stiffness, lasting over an hour each morning, improving with activity. He denies fever, headache, or vision changes, and has a history of osteoarthritis. Labs show elevated ESR/CRP and normal CPK. What is the most appropriate treatment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2770034",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Prednisolone</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s morning stiffness, proximal joint pain, and elevated ESR/CRP with normal CPK suggest polymyalgia rheumatica (PMR).</span></li><li><span style=\"font-size:14.0pt;\">Steroids (prednisolone) are the first-line treatment, leading to rapid symptom improvement.</span></li><li><span style=\"font-size:14.0pt;\">The absence of systemic symptoms rules out giant cell arteritis at this stage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rituximab:&nbsp;</strong>Is for refractory autoimmune diseases, not first-line for PMR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Infliximab:&nbsp;</strong>Are not used for PMR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methotrexate:&nbsp;</strong>Is for maintenance in some cases, not initial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PMR presents with proximal stiffness and elevated inflammatory markers, treated with steroids.</span></li><li><span style=\"font-size:14.0pt;\">Rapid response to steroids confirms the diagnosis and prevents complications.</span></li></ul>",
      "correct_choice_id": 357623,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89807/MEDICINE_NEET_PG_GT_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89807/MEDICINE_NEET_PG_GT_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89796,
      "choices": [
        {
          "id": 357576,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Aztreonam</span></p>"
        },
        {
          "id": 357577,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Imipenem</span></p>"
        },
        {
          "id": 357578,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral Nitrofurantoin</span></p>"
        },
        {
          "id": 357579,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Ertapenem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old man with a history of renal transplant 2 years ago presents to your clinic with a 3-day history of burning with urination, urinary frequency, and foul-smelling urine. He has a history of ESBL E. coli urinary tract infection 6 months ago and is on tacrolimus for immunosuppression. He denies fever or flank pain, but his creatinine is slightly elevated at 1.5 mg/dL from a baseline of 1.2 mg/dL. Which is the most appropriate empiric antibiotic?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9212075",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) IV Ertapenem</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This renal transplant recipient with immunosuppression presents with features of <strong>lower urinary tract infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The history of <strong>ESBL-producing E. coli</strong> and <strong>mild creatinine rise</strong> raises concern for early graft involvement.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ertapenem</strong>, a <strong>once-daily carbapenem</strong>, is effective against <strong>ESBL-producing Enterobacteriaceae</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is preferred when <strong>Pseudomonas is not suspected</strong>, as it avoids unnecessary broad-spectrum exposure.</span></li><li><span style=\"font-size:14.0pt;\">Particularly useful in <strong>transplant patients</strong> and other <strong>immunosuppressed hosts</strong> where early empiric coverage is essential.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IV Aztreonam:&nbsp;</strong>Not reliably effective against ESBL-producing <strong>E. coli</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV Imipenem:&nbsp;</strong>Active against ESBL but broader than necessary; reserved for severe infections or Pseudomonas risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oral Nitrofurantoin:&nbsp;</strong>Contraindicated in renal dysfunction (eGFR &lt;60 mL/min); inadequate urinary levels in this setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ertapenem</strong> is the empiric drug of choice for <strong>ESBL-associated UTIs</strong> in <strong>renal transplant recipients</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>administered once daily</strong>, making it highly suitable for <strong>outpatient parenteral therapy (OPAT)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nitrofurantoin is not suitable</strong> in patients with <strong>impaired renal function</strong> or systemic symptoms.</span></li></ul>",
      "correct_choice_id": 357579,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89796/Medicine_Neet_Pg_Gt_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89796/Medicine_Neet_Pg_Gt_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89056,
      "choices": [
        {
          "id": 354644,
          "text": "<p><span style=\"font-size:14.0pt;\">Naegleria fowleri</span></p>"
        },
        {
          "id": 354645,
          "text": "<p><span style=\"font-size:14.0pt;\">Acanthamoeba spp.</span></p>"
        },
        {
          "id": 354646,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasma gondii</span></p>"
        },
        {
          "id": 354647,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasmodium falciparum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old girl spends the afternoon swimming in a warm freshwater pond near her friend’s village. A week later she develops profuse, purulent nasal discharge, severe headache, and rapidly progressive encephalitis, succumbing within five days. Which pathogen is the most likely cause of her illness?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6107002",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Naegleria fowleri</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Free living amoebas&nbsp;</span><ul><li><span style=\"font-size:14.0pt;\">Naegleria</span></li><li><span style=\"font-size:14.0pt;\">Acanthamoeba&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Naegleria fowleri—the “brain-eating” amoeba—gains entry via the nasal mucosa when a person swims or dives in warm freshwater.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It migrates along the olfactory nerves through the cribriform plate into the meninges and brain, causing <strong>primary amoebic meningoencephalitis (PAM)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PAM has an extremely rapid onset (days), with intense headache, fever, rhinorrhea, and fulminant meningitis leading to death in most cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acanthamoeba spp.:</strong> Cause chronic granulomatous amoebic encephalitis (GAE) over weeks to months, primarily in immunocompromised hosts, and are acquired by inhalation or through skin lesions—not by acute swimming exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Toxoplasma gondii:</strong> Leads to subacute/chronic meningoencephalitis in immunosuppressed patients; transmission is via ingestion of oocysts or undercooked meat, not nasal entry from water.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Plasmodium falciparum:</strong> Causes severe malaria with cerebral involvement, but does not produce purulent nasal discharge or acute meningoencephalitis after freshwater exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a previously healthy swimmer develops a fulminant, rapidly fatal meningoencephalitis with nasal symptoms days after freshwater exposure, Naegleria fowleri is the presumptive agent.</span></p>",
      "correct_choice_id": 354644,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89056/MICROBIOLOGY_NEET_PG_GT_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89056/MICROBIOLOGY_NEET_PG_GT_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89052,
      "choices": [
        {
          "id": 354628,
          "text": "<p><span style=\"font-size:14.0pt;\">Nocardia</span></p>"
        },
        {
          "id": 354629,
          "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus</span></p>"
        },
        {
          "id": 354630,
          "text": "<p><span style=\"font-size:14.0pt;\">Corynebacterium</span></p>"
        },
        {
          "id": 354631,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man with chronic bronchitis produces a sputum specimen that, on Gram stain, reveals delicate, weakly Gram-positive, branching filamentous bacilli with a beaded appearance. Which organism most likely matches these findings?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20103119.jpg\" width=\"627\" height=\"447\"></span></p>",
      "unique_key": "Q2831802",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Nocardia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Branching filamentous bacilli are of 2 types</span><ul><li><span style=\"font-size:14.0pt;\">Actinomyces – Lumpy Jaw</span></li><li><span style=\"font-size:14.0pt;\">Nocardia – Pulmonary disease and cutaneous disease (mycetoma)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Nocardia species are aerobic, branching filamentous bacteria that stain weakly Gram-positive and often appear beaded.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They exhibit partial acid-fastness due to mycolic acids in their cell wall.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On Gram stain, they form delicate, filamentous networks resembling fungal hyphae, distinguishing them from other bacteria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Streptococcus:</strong> Gram-positive cocci in chains or pairs, not filamentous branching rods.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Corynebacterium:</strong> Club-shaped (“palisading”) Gram-positive rods; do not branch extensively or bead.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mycobacterium tuberculosis:</strong> Thin, slightly curved rods that are weakly Gram-positive but do not form branching filaments and require acid-fast staining for reliable visualization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nocardia on Gram stain - Weakly Gram-positive, branching, filamentous morphology with beaded appearance and partial acid-fast property<strong>.</strong></span></p>",
      "correct_choice_id": 354628,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89052/MICROBIOLOGY_NEET_PG_GT_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89052/MICROBIOLOGY_NEET_PG_GT_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89306,
      "choices": [
        {
          "id": 355624,
          "text": "<p><span style=\"font-size:14.0pt;\">Suppression of luteinizing hormone (LH) secretion</span></p>"
        },
        {
          "id": 355625,
          "text": "<p><span style=\"font-size:14.0pt;\">Stimulation of progesterone receptor-mediated activity</span></p>"
        },
        {
          "id": 355626,
          "text": "<p><span style=\"font-size:14.0pt;\">Enhancement of follicle-stimulating hormone (FSH) release</span></p>"
        },
        {
          "id": 355627,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of estrogen synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman with chronic pelvic pain and dysmenorrhea associated with her menstrual cycles is started on danazol as part of her treatment plan for endometriosis. Which of the following best describes the primary mechanism by which danazol alleviates the symptoms of this condition?</span></p>",
      "unique_key": "Q9574198",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Suppression of luteinizing hormone (LH) secretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Danazol</strong> is a synthetic androgen (Gonadotropic Antagonist) used in the management of <strong>endometriosis</strong> due to its unique endocrine effects. Its <strong>primary mechanism of action</strong> involves <strong>suppression of the pituitary-ovarian axis</strong>, particularly by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Inhibiting the release of luteinizing hormone (LH)</strong></span></li><li><span style=\"font-size:14.0pt;\">This suppression leads to decreased ovarian estrogen production.</span></li><li><span style=\"font-size:14.0pt;\">The resultant hypoestrogenic environment causes <strong>atrophy of ectopic endometrial tissue</strong>, leading to symptomatic relief of pelvic pain and dysmenorrhea associated with endometriosis.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Additionally, danazol exhibits <strong>weak androgenic activity</strong>, contributing to side effects such as acne and hirsutism. However, these androgenic properties are not the primary mechanism by which it treats endometriosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stimulation of progesterone receptor-mediated activity:</strong> Incorrect. Stimulation of <strong>progesterone receptors</strong> is the mechanism of action of <strong>progestin therapy</strong>, not danazol. Progestins act by decidualizing endometrial tissue and suppressing its growth. Danazol does not primarily stimulate progesterone receptor activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Enhancement of follicle-stimulating hormone (FSH) release:</strong> Incorrect. Danazol does not enhance FSH release. In fact, it suppresses the <strong>hypothalamic-pituitary-ovarian axis</strong>, leading to reduced FSH and LH secretion. Increased FSH release would be counterproductive in endometriosis management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of estrogen synthesis:</strong> Incorrect. Direct inhibition of <strong>estrogen synthesis</strong> is the mechanism of action of <strong>aromatase inhibitors</strong>, such as letrozole or anastrozole. While danazol indirectly reduces estrogen levels by suppressing gonadotropin release, it does not directly inhibit estrogen production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Danazol alleviates symptoms of endometriosis primarily by suppressing luteinizing hormone (LH) secretion, leading to decreased estrogen production and subsequent atrophy of ectopic endometrial tissue.</span></p>",
      "correct_choice_id": 355624,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89306/OBG_NEET_PG_GT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89306/OBG_NEET_PG_GT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89352,
      "choices": [
        {
          "id": 355808,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitral valve prolapse</span></p>"
        },
        {
          "id": 355809,
          "text": "<p><span style=\"font-size:14.0pt;\">Patent ductus arteriosus</span></p>"
        },
        {
          "id": 355810,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic dissection</span></p>"
        },
        {
          "id": 355811,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventricular septal defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old female with Turner syndrome presents with complaints of fatigue and decreased exercise tolerance. Cardiac evaluation reveals a bicuspid aortic valve. What other cardiac anomaly should be screened for in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2595757",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Aortic dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Turner syndrome is associated with an increased risk of aortic dissection, especially in the presence of bicuspid aortic valve or coarctation of the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mitral valve prolapse:</strong> More common in Marfan syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Patent ductus arteriosus:</strong> Associated with congenital rubella syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ventricular septal defect:</strong> Can occur in Down syndrome but is less common in Turner syndrome. Associated with Patau syndrome</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Patients with Turner syndrome and cardiovascular anomalies should be screened for aortic dissection.</span></p>",
      "correct_choice_id": 355810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89352/PEDIATRICS_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89352/PEDIATRICS_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89307,
      "choices": [
        {
          "id": 355628,
          "text": "<p><span style=\"font-size:14.0pt;\">Etonogestrel subdermal implant</span></p>"
        },
        {
          "id": 355629,
          "text": "<p><span style=\"font-size:14.0pt;\">Depot medroxyprogesterone acetate injection</span></p>"
        },
        {
          "id": 355630,
          "text": "<p><span style=\"font-size:14.0pt;\">Combined oral contraceptive pills</span></p>"
        },
        {
          "id": 355631,
          "text": "<p><span style=\"font-size:14.0pt;\">Centchroman (Selective estrogen receptor modulator)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old woman comes to the gynecology outpatient department seeking contraceptive advice. She is married, has a 3-year-old son, and is currently taking lamotrigine for epilepsy. She is looking for an effective method of contraception. Use of which of the following contraceptive methods would necessitate increasing the dose of lamotrigine?</span></p>",
      "unique_key": "Q4183714",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Combined oral contraceptive pills</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Combined oral contraceptive pills (COCPs)</strong> contain <strong>estrogen</strong>, which enhances the activity of hepatic enzyme <strong>uridine diphosphate glucuronosyltransferase (UGT1A4)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This enzyme increases the metabolism of <strong>lamotrigine</strong>, reducing its plasma concentration.</span></li><li><span style=\"font-size:14.0pt;\">The decreased lamotrigine levels can increase the risk of seizures in epileptic patients.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, when COCPs are prescribed to a woman on lamotrigine, <strong>her lamotrigine dose may need to be increased</strong> to maintain therapeutic efficacy.</span></li><li><span style=\"font-size:14.0pt;\">Close monitoring of seizure frequency and lamotrigine levels is recommended during the initiation or discontinuation of COCPs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Etonogestrel subdermal implant:</strong> Incorrect. The <strong>etonogestrel implant</strong> is a progestin-only contraceptive that releases the hormone steadily over time. It <strong>does not significantly induce hepatic enzymes</strong> and therefore <strong>does not affect lamotrigine metabolism</strong>, making a dose adjustment unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Depot medroxyprogesterone acetate injection:</strong> Incorrect. <strong>Depot medroxyprogesterone acetate (DMPA)</strong> is a progestin-only injectable contraceptive with no significant impact on hepatic enzyme activity. It <strong>does not alter lamotrigine metabolism</strong>, and no dose change is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Centchroman (Selective estrogen receptor modulator):</strong> Incorrect. <strong>Centchroman</strong> acts as a selective estrogen receptor modulator with a non-hormonal contraceptive effect. It <strong>does not induce hepatic enzymes</strong> and therefore <strong>does not necessitate any change in lamotrigine dosage</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Combined oral contraceptive pills can increase hepatic metabolism of lamotrigine through enzyme induction, potentially lowering drug levels and requiring a dosage adjustment to prevent seizure breakthrough in women with epilepsy.</span></p>",
      "correct_choice_id": 355630,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89307/OBG_NEET_PG_GT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89307/OBG_NEET_PG_GT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89050,
      "choices": [
        {
          "id": 354620,
          "text": "<p><span style=\"font-size:14.0pt;\">Absence of peptidoglycan</span></p>"
        },
        {
          "id": 354621,
          "text": "<p><span style=\"font-size:14.0pt;\">Modified peptidoglycan inaccessible to nutrients</span></p>"
        },
        {
          "id": 354622,
          "text": "<p><span style=\"font-size:14.0pt;\">Obligate intracellular organism</span></p>"
        },
        {
          "id": 354623,
          "text": "<p><span style=\"font-size:14.0pt;\">Requirement for sterol-supplemented medium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old park ranger develops fever, headache, and a maculopapular rash affecting extremities and trunk after hiking in a tick-infested area. Doxycycline is started empirically. Which bacterial feature explains why this organism cannot be cultured on standard laboratory agar?</span></p>",
      "unique_key": "Q2392467",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Obligate intracellular organism</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rickettsia</strong> species (e.g., Rickettsia rickettsii, the agent of Rocky Mountain spotted fever) are <strong>obligate intracellular</strong> bacteria.</span></li><li><span style=\"font-size:14.0pt;\">They lack many metabolic pathways and rely on host cell machinery and ATP to replicate, making them incapable of growing on <strong>cell-free artificial media</strong> such as standard blood or chocolate agar.</span></li><li><span style=\"font-size:14.0pt;\">Instead, they must be cultured in <strong>living host cells</strong> (e.g., yolk sacs, cell lines) or detected by molecular or serologic methods.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Absence of peptidoglycan:</strong> Describes Mycoplasma (which grow on sterol-supplemented PPLO agar) but not Rickettsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Modified peptidoglycan inaccessible to nutrients:</strong> Refers to Chlamydia, which has a reduced or altered cell-wall structure but also requires intracellular culture primarily due to ATP parasitism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Requirement for sterol-supplemented medium: </strong>Characteristic of Mycoplasma species, not obligate intracellular Rickettsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a suspected tick-borne pathogen fails to grow on routine agar but presents with compatible clinical features, think <strong>obligate intracellular organisms</strong> like Rickettsia or Chlamydia—these require living cells for culture.</span></p>",
      "correct_choice_id": 354622,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89050/MICROBIOLOGY_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89050/MICROBIOLOGY_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89066,
      "choices": [
        {
          "id": 354684,
          "text": "<p><span style=\"font-size:14.0pt;\">1st pharyngeal arch</span></p>"
        },
        {
          "id": 354685,
          "text": "<p><span style=\"font-size:14.0pt;\">2nd pharyngeal arch</span></p>"
        },
        {
          "id": 354686,
          "text": "<p><span style=\"font-size:14.0pt;\">Otic vesicle</span></p>"
        },
        {
          "id": 354687,
          "text": "<p><span style=\"font-size:14.0pt;\">Otic capsule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A newborn is diagnosed with congenital stapes fixation leading to conductive hearing loss. Histologic analysis shows abnormal development of the stapes footplate. Which of the following embryological structures is primarily responsible for the development of the stapes footplate?&nbsp;</span></p>",
      "unique_key": "Q2944403",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Otic capsule</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>stapes</strong> has two embryological components:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Stapes suprastructure</strong> (head and crura): Derived from the <strong>2nd pharyngeal arch</strong> (Reichert’s cartilage).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stapes footplate</strong> and <strong>annular ligament</strong>: Derived from the <strong>otic capsule</strong>, a mesenchymal condensation surrounding the <strong>developing otic vesicle</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>otic capsule</strong> is <strong>neural crest– and mesoderm-derived mesenchyme</strong> that ossifies and forms parts of the <strong>bony labyrinth</strong> of the inner ear.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It gives rise not only to the stapes footplate but also to structures like the cochlear capsule and the bony walls of the semicircular canals.</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>fixation of the stapes footplate</strong> (as in <strong>otosclerosis</strong>) involves a structure of <strong>otic capsule origin</strong>, not pharyngeal arch mesoderm.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-01%20at%203.01.18%20PM.jpeg\" width=\"957\" height=\"685\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-01%20at%203.01.19%20PM%20(1).jpeg\" width=\"1042\" height=\"859\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 1st pharyngeal arch:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Derivatives: <strong>Malleus, incus</strong>, and <strong>muscles of mastication</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. 2nd pharyngeal arch:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gives rise to the <strong>stapes suprastructure</strong>, <strong>styloid process</strong>, <strong>lesser horn of hyoid</strong>, and <strong>muscles of facial expression</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Otic vesicle:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Forms the <strong>membranous labyrinth</strong> (e.g., semicircular canals, cochlea, utricle, saccule).</span></li><li><span style=\"font-size:14.0pt;\">It is the <strong>epithelial</strong> component of the inner ear, not the <strong>bony capsule</strong> (which is mesenchymal and forms the footplate).</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-08-01%20at%203.01.19%20PM.jpeg\" width=\"913\" height=\"883\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>stapes footplate and annular ligament</strong> arise from the <strong>otic capsule</strong>, not from pharyngeal arches.</span></li><li><span style=\"font-size:14.0pt;\">This distinction is critical in understanding the embryology and pathology of <strong>congenital and acquired conductive hearing loss</strong>, such as <strong>otosclerosis</strong>, where the <strong>otic capsule–derived footplate becomes fixed</strong>.</span></li></ul>",
      "correct_choice_id": 354687,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89066/ENT_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89066/ENT_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89800,
      "choices": [
        {
          "id": 357592,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic infection</span></p>"
        },
        {
          "id": 357593,
          "text": "<p><span style=\"font-size:14.0pt;\">Amyloidosis</span></p>"
        },
        {
          "id": 357594,
          "text": "<p><span style=\"font-size:14.0pt;\">Infertility</span></p>"
        },
        {
          "id": 357595,
          "text": "<p><span style=\"font-size:14.0pt;\">Intestinal adhesions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old woman presents to the clinic with a history of recurrent fever and severe abdominal pain since childhood, prompting multiple exploratory laparotomies with no clear cause. She immigrated to India from Armenia to work in a hotel Spa and now reports calf muscle pain with exercise, limiting her activity. Without additional therapy, what is not at risk of?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8975962",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Systemic Infection</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">His presentation is <strong>typical of Familial Mediterranean Fever (FMF)</strong>, an <strong>autoinflammatory disease</strong> seen in individuals of <strong>Middle Eastern, Armenian, Turkish, or North African descent</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Recurrent episodes of fever</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Serositis</strong>: abdominal pain, pleuritis, pericarditis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Arthralgia or myalgia</strong>, especially after exertion</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The disease is <strong>not due to infection</strong>, but due to <strong>aberrant innate immune activation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If <strong>left untreated</strong>, FMF can lead to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>AA (serum amyloid A) amyloidosis</strong>, leading to <strong>renal failure</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Infertility</strong>, particularly in women due to <strong>tubal damage from peritonitis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Intestinal adhesions</strong>, due to repeated peritonitis or unnecessary surgeries</span></li></ul></li><li><span style=\"font-size:14.0pt;\">However, since FMF is <strong>not an infectious disease</strong>, it <strong>does not increase the risk of systemic infections</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amyloidosis:&nbsp;</strong>A known complication of FMF due to persistent elevation of <strong>serum amyloid A</strong> protein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infertility:&nbsp;</strong>Chronic pelvic inflammation from peritonitis can impair fertility, especially in women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intestinal adhesions:&nbsp;</strong>Can occur due to <strong>repeated inflammatory episodes or multiple laparotomies</strong>, both of which are common in FMF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Familial Mediterranean Fever</strong> is an <strong>autoinflammatory</strong>, <strong>non-infectious</strong> disorder characterized by recurrent fever and serosal inflammation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic infections are not a risk</strong>; complications arise from <strong>inflammation</strong>, not infection.</span></li><li><span style=\"font-size:14.0pt;\">Untreated FMF may lead to <strong>AA amyloidosis</strong>, <strong>infertility</strong>, and <strong>abdominal adhesions</strong>.</span></li></ul>",
      "correct_choice_id": 357592,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89800/Medicine_Neet_Pg_Gt_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89800/Medicine_Neet_Pg_Gt_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89059,
      "choices": [
        {
          "id": 354656,
          "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus agalactiae</span></p>"
        },
        {
          "id": 354657,
          "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus pneumoniae</span></p>"
        },
        {
          "id": 354658,
          "text": "<p><span style=\"font-size:14.0pt;\">Enterococcus faecalis</span></p>"
        },
        {
          "id": 354659,
          "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus viridans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man is admitted with fever and signs of endocarditis. Blood cultures grow a Gram-positive coccus in pairs. The organism hydrolyzes esculin in the presence of bile and grows in 6.5% NaCl. Which organism is most likely responsible?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9107842",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Enterococcus faecalis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bile esculin test</strong>: Organisms that hydrolyze esculin in the presence of bile produce esculetin, which reacts with ferric citrate in the medium to form a black complex.</span></li><li><span style=\"font-size:14.0pt;\"><strong>6.5% NaCl tolerance</strong>: Only certain streptococci (enterococci) can withstand high salt concentrations, allowing them to grow in media containing 6.5% sodium chloride.</span></li><li><span style=\"font-size:14.0pt;\">Enterococcus faecalis is <strong>both</strong> bile esculin–positive and salt-tolerant.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These features distinguish it from most other streptococci and are the basis for separating the <strong>enterococci</strong> (formerly group D streptococci) from non–enterococcal species.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Streptococcus agalactiae:</strong> Group B strep is bile esculin–negative and cannot grow in 6.5% NaCl. It is gram positive cocci in chains</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Streptococcus pneumoniae:</strong> Optochin-sensitive, bile soluble, but bile esculin–negative and salt sensitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Streptococcus viridans:</strong> Alpha-hemolytic commensals; bile esculin–negative and do not grow in high salt. It is gram positive cocci in chains</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Enterococci (formerly group D streptococci) are distinguished from other α- or β-hemolytic streptococci by their ability to hydrolyze esculin in bile and tolerate high salt concentrations.</span></p>",
      "correct_choice_id": 354658,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89059/MICROBIOLOGY_NEET_PG_GT_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89059/MICROBIOLOGY_NEET_PG_GT_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89096,
      "choices": [
        {
          "id": 354800,
          "text": "<p><span style=\"font-size:14.0pt;\">Familial Hyperchylomicronemia</span></p>"
        },
        {
          "id": 354801,
          "text": "<p><span style=\"font-size:14.0pt;\">Familial Hypercholesterolemia</span></p>"
        },
        {
          "id": 354802,
          "text": "<p><span style=\"font-size:14.0pt;\">Familial Dysbetalipoproteinemia</span></p>"
        },
        {
          "id": 354803,
          "text": "<p><span style=\"font-size:14.0pt;\">Abetalipoproteinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy presents with eruptive xanthomas, recurrent abdominal<strong>&nbsp;</strong>pain, and episodes of acute pancreatitis. Lab results show:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fasting triglycerides &gt;1,000 mg/dL</span></li><li><span style=\"font-size:14.0pt;\">Markedly elevated chylomicrons</span></li><li><span style=\"font-size:14.0pt;\">Undetectable lipoprotein lipase (LPL) activity</span></li></ul><p><span style=\"font-size:14.0pt;\">Which dyslipoproteinemia best fits this presentation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3178492",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Familial Hyperchylomicronemia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a classic presentation of <strong>Familial Hyperchylomicronemia</strong> (Fredrickson Type I).</span></li><li><span style=\"font-size:14.0pt;\">Caused by <strong>LPL deficiency</strong> or <strong>Apo C-II deficiency</strong> (cofactor for LPL)</span></li><li><span style=\"font-size:14.0pt;\">Leads to <strong>massive accumulation of chylomicrons</strong> in plasma</span></li><li><span style=\"font-size:14.0pt;\">Results in <strong>severe hypertriglyceridemia</strong> (&gt;1,000 mg/dL)</span></li><li><span style=\"font-size:14.0pt;\">Common symptoms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Eruptive xanthomas</strong> (especially on extensor surfaces)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Recurrent pancreatitis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hepatosplenomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\">No increased risk of atherosclerosis (unlike other types)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Familial Hypercholesterolemia (Type IIa):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated <strong>LDL</strong>, <strong>normal triglycerides</strong></span></li><li><span style=\"font-size:14.0pt;\">Causes <strong>tendon xanthomas</strong> and early-onset <strong>atherosclerosis</strong>, not pancreatitis or eruptive xanthomas</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Familial Dysbetalipoproteinemia (Type III):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated <strong>IDL/remnant particles</strong></span></li><li><span style=\"font-size:14.0pt;\">Mixed elevation of <strong>cholesterol and triglycerides</strong></span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>palmar xanthomas</strong>, not severe TG elevation or chylomicrons</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abetalipoproteinemia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A rare condition with <strong>absence of Apo B-containing lipoproteins</strong> (chylomicrons, VLDL, LDL)</span></li><li><span style=\"font-size:14.0pt;\">Results in <strong>low cholesterol and TG</strong>, fat malabsorption, <strong>acanthocytosis</strong>, and <strong>neurologic issues</strong>, not hypertriglyceridemia or pancreatitis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Frederickson dyslipoproteinemia types and their primary biochemical defects:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-23%20125803.jpg\" width=\"1220\" height=\"515\"></span></p>",
      "correct_choice_id": 354800,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89096/BIOCHEM_NEET_PG_GT_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89096/BIOCHEM_NEET_PG_GT_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89280,
      "choices": [
        {
          "id": 355520,
          "text": "<p><span style=\"font-size:14.0pt;\">Tolterodine</span></p>"
        },
        {
          "id": 355521,
          "text": "<p><span style=\"font-size:14.0pt;\">Memantine</span></p>"
        },
        {
          "id": 355522,
          "text": "<p><span style=\"font-size:14.0pt;\">Vibegron</span></p>"
        },
        {
          "id": 355523,
          "text": "<p><span style=\"font-size:14.0pt;\">Levetiracetam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder and his previous medication (oxybutynin) was not effective in managing his symptoms. Which of the following drugs is a beta-3 adrenergic receptor agonist that may be effective in treating this patient's symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9574429",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vibegron</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a beta-3 adrenergic receptor agonist (similar to mirabegron) that is used in the treatment of overactive bladder.</span></li><li><span style=\"font-size:14.0pt;\">By stimulating beta-3 adrenergic receptors in the detrusor muscle of the bladder, it relaxes the muscle and improves symptoms like urinary urgency and frequency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tolterodine:</strong> This drug is an antimuscarinic agent, not a beta-3 adrenergic receptor agonist. It is commonly used in the treatment of overactive bladder but works through a different mechanism of action than beta-3 adrenergic receptor agonists.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Memantine:</strong> Memantine is an NMDA receptor antagonist used primarily in the treatment of moderate-to-severe Alzheimer's disease. It has no role in the treatment of overactive bladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Levetiracetam:</strong> Levetiracetam is an antiepileptic drug that is used to treat various types of seizures. It has no role in the treatment of overactive bladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For patient’s intolerant of anticholinergics or with refractory overactive bladder, <strong>β₃-adrenergic agonists</strong> like <strong>vibegron</strong> offer an effective alternative by relaxing detrusor muscle via a distinct receptor pathway and minimizing systemic side effects.</span></p>",
      "correct_choice_id": 355522,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89280/PHARMA_NEET_PG_GT_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89280/PHARMA_NEET_PG_GT_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89176,
      "choices": [
        {
          "id": 355108,
          "text": "<p><span style=\"font-size:14.0pt;\">The second CI is more likely to contain the true mean because it’s narrower.</span></p>"
        },
        {
          "id": 355109,
          "text": "<p><span style=\"font-size:14.0pt;\">The first study had a higher chance of missing the true mean than the second.</span></p>"
        },
        {
          "id": 355110,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing sample size reduces CI width but does not change the confidence level.</span></p>"
        },
        {
          "id": 355111,
          "text": "<p><span style=\"font-size:14.0pt;\">A narrower CI always implies higher confidence in the estimate.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher reports a 95% confidence interval (CI) for a new drug’s mean systolic blood pressure reduction as (8 mm Hg, 12 mm Hg) based on n = 100 patients. He then repeats the study with n = 1,000 patients and finds a 95% CI of (9.5 mm Hg, 10.5 mm Hg). Which statement is true?</span></p>",
      "unique_key": "Q5667286",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increasing sample size reduces CI width but does</strong> <strong>not</strong> <strong>change the confidence level.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Confidence level vs. CI width:</strong>&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>confidence level</strong> (95%) is a property of the method—it means that <strong>if</strong> you repeated the study many times, 95% of those intervals would capture the true mean.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Changing the sample size <strong>does not</strong> alter that 95% coverage guarantee.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Effect of sample size:</strong>&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Increasing <strong>n</strong> reduces the standard error of the mean (SEM = SD/√n), which <strong>narrows</strong> the CI around the sample estimate.</span></li><li><span style=\"font-size:14.0pt;\">Thus, moving from n = 100 to n = 1,000 makes the interval tighter (from a width of 4 mm Hg down to 1 mm Hg) without changing the confidence level.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The second CI is more likely to contain the true mean because it’s narrower:</strong> Narrower CIs are more precise but are <strong>not</strong> inherently more likely to include the true mean—both intervals have a 95% chance under repeated sampling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>The first study had a higher chance of missing the true mean than the second:</strong> Both intervals, being 95% CIs, each have the <strong>same</strong> 5% chance of failing to capture the true mean, regardless of width.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>A narrower CI always implies higher confidence in the estimate:</strong> A narrower interval indicates greater <strong>precision</strong>, not greater <strong>confidence</strong>. Confidence is set by the chosen level (e.g., 95%), not by interval width.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Precision (interval width)</strong> and <strong>confidence (coverage probability)</strong> are distinct: larger samples yield <strong>narrower</strong> CIs, but your stated confidence (e.g., 95%) stays the same unless you choose a different confidence level.</span></p>",
      "correct_choice_id": 355110,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89176/PSM_NEET_PG_GT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/89176/PSM_NEET_PG_GT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}